CN113924109A - Aav介导的基因疗法恢复耳畸蛋白基因 - Google Patents
Aav介导的基因疗法恢复耳畸蛋白基因 Download PDFInfo
- Publication number
- CN113924109A CN113924109A CN202080022300.3A CN202080022300A CN113924109A CN 113924109 A CN113924109 A CN 113924109A CN 202080022300 A CN202080022300 A CN 202080022300A CN 113924109 A CN113924109 A CN 113924109A
- Authority
- CN
- China
- Prior art keywords
- leu
- glu
- lys
- asp
- val
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000623 proteins and genes Proteins 0.000 title claims description 60
- 238000001415 gene therapy Methods 0.000 title description 31
- 230000001404 mediated effect Effects 0.000 title description 8
- 239000013598 vector Substances 0.000 claims abstract description 94
- 210000000067 inner hair cell Anatomy 0.000 claims abstract description 56
- 206010011878 Deafness Diseases 0.000 claims abstract description 49
- 208000016354 hearing loss disease Diseases 0.000 claims abstract description 48
- 231100000895 deafness Toxicity 0.000 claims abstract description 39
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 37
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 37
- 229920001184 polypeptide Polymers 0.000 claims abstract description 36
- 101001134169 Homo sapiens Otoferlin Proteins 0.000 claims abstract description 33
- 102100034198 Otoferlin Human genes 0.000 claims abstract description 31
- 230000014509 gene expression Effects 0.000 claims abstract description 29
- 201000006093 autosomal recessive nonsyndromic deafness 9 Diseases 0.000 claims abstract description 27
- 208000032337 autosomal recessive nonsyndromic hearing loss 9 Diseases 0.000 claims abstract description 27
- 239000012634 fragment Substances 0.000 claims abstract description 27
- 230000035772 mutation Effects 0.000 claims abstract description 26
- 108091033319 polynucleotide Proteins 0.000 claims description 52
- 102000040430 polynucleotide Human genes 0.000 claims description 52
- 239000002157 polynucleotide Substances 0.000 claims description 52
- 108020005067 RNA Splice Sites Proteins 0.000 claims description 27
- 239000002245 particle Substances 0.000 claims description 27
- 241000702423 Adeno-associated virus - 2 Species 0.000 claims description 26
- 108091026890 Coding region Proteins 0.000 claims description 24
- 210000004899 c-terminal region Anatomy 0.000 claims description 15
- 239000008194 pharmaceutical composition Substances 0.000 claims description 14
- 210000000234 capsid Anatomy 0.000 claims description 12
- 230000006798 recombination Effects 0.000 claims description 12
- 238000005215 recombination Methods 0.000 claims description 12
- 241000702421 Dependoparvovirus Species 0.000 claims description 9
- 230000036961 partial effect Effects 0.000 claims description 8
- 230000008488 polyadenylation Effects 0.000 claims description 7
- 239000003937 drug carrier Substances 0.000 claims description 5
- 238000006467 substitution reaction Methods 0.000 claims description 5
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 5
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 2
- 241000699670 Mus sp. Species 0.000 abstract description 77
- 239000002299 complementary DNA Substances 0.000 abstract description 25
- 241000699666 Mus <mouse, genus> Species 0.000 abstract description 21
- 238000011282 treatment Methods 0.000 abstract description 18
- 230000009977 dual effect Effects 0.000 abstract description 11
- 239000013607 AAV vector Substances 0.000 abstract description 10
- 238000010172 mouse model Methods 0.000 abstract description 7
- 238000013459 approach Methods 0.000 abstract description 5
- 230000002265 prevention Effects 0.000 abstract description 4
- 238000011813 knockout mouse model Methods 0.000 abstract description 3
- 238000010200 validation analysis Methods 0.000 abstract description 2
- 210000004027 cell Anatomy 0.000 description 61
- 210000003477 cochlea Anatomy 0.000 description 41
- 238000002347 injection Methods 0.000 description 41
- 239000007924 injection Substances 0.000 description 41
- 230000013707 sensory perception of sound Effects 0.000 description 33
- 108010029485 Protein Isoforms Proteins 0.000 description 28
- 102000001708 Protein Isoforms Human genes 0.000 description 28
- 108020004414 DNA Proteins 0.000 description 24
- KOSRFJWDECSPRO-UHFFFAOYSA-N alpha-L-glutamyl-L-glutamic acid Natural products OC(=O)CCC(N)C(=O)NC(CCC(O)=O)C(O)=O KOSRFJWDECSPRO-UHFFFAOYSA-N 0.000 description 23
- 108010050848 glycylleucine Proteins 0.000 description 23
- 230000004044 response Effects 0.000 description 23
- SITLTJHOQZFJGG-UHFFFAOYSA-N N-L-alpha-glutamyl-L-valine Natural products CC(C)C(C(O)=O)NC(=O)C(N)CCC(O)=O SITLTJHOQZFJGG-UHFFFAOYSA-N 0.000 description 22
- 102000004169 proteins and genes Human genes 0.000 description 22
- 101150006256 Otof gene Proteins 0.000 description 21
- 235000018102 proteins Nutrition 0.000 description 21
- 238000000034 method Methods 0.000 description 19
- YBAFDPFAUTYYRW-UHFFFAOYSA-N N-L-alpha-glutamyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CCC(O)=O YBAFDPFAUTYYRW-UHFFFAOYSA-N 0.000 description 18
- 210000002768 hair cell Anatomy 0.000 description 16
- 108010061238 threonyl-glycine Proteins 0.000 description 16
- 108010038633 aspartylglutamate Proteins 0.000 description 15
- 108010054155 lysyllysine Proteins 0.000 description 15
- 230000001225 therapeutic effect Effects 0.000 description 15
- 108010073969 valyllysine Proteins 0.000 description 15
- 241000282412 Homo Species 0.000 description 14
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 14
- 239000002773 nucleotide Substances 0.000 description 14
- 125000003729 nucleotide group Chemical group 0.000 description 14
- 239000002953 phosphate buffered saline Substances 0.000 description 14
- WGNOPSQMIQERPK-UHFFFAOYSA-N Leu-Asn-Pro Natural products CC(C)CC(N)C(=O)NC(CC(=O)N)C(=O)N1CCCC1C(=O)O WGNOPSQMIQERPK-UHFFFAOYSA-N 0.000 description 13
- 125000003275 alpha amino acid group Chemical group 0.000 description 13
- 239000000203 mixture Substances 0.000 description 13
- 210000002569 neuron Anatomy 0.000 description 13
- MDNAVFBZPROEHO-UHFFFAOYSA-N Ala-Lys-Val Natural products CC(C)C(C(O)=O)NC(=O)C(NC(=O)C(C)N)CCCCN MDNAVFBZPROEHO-UHFFFAOYSA-N 0.000 description 12
- 230000000875 corresponding effect Effects 0.000 description 12
- 108010063718 gamma-glutamylaspartic acid Proteins 0.000 description 12
- 108010015792 glycyllysine Proteins 0.000 description 12
- 108010009298 lysylglutamic acid Proteins 0.000 description 12
- BUZMZDDKFCSKOT-CIUDSAMLSA-N Glu-Glu-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O BUZMZDDKFCSKOT-CIUDSAMLSA-N 0.000 description 11
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 11
- 108010093581 aspartyl-proline Proteins 0.000 description 11
- 108010055341 glutamyl-glutamic acid Proteins 0.000 description 11
- 108010089804 glycyl-threonine Proteins 0.000 description 11
- 238000000585 Mann–Whitney U test Methods 0.000 description 10
- LYERIXUFCYVFFX-GVXVVHGQSA-N Val-Leu-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N LYERIXUFCYVFFX-GVXVVHGQSA-N 0.000 description 10
- 108010047495 alanylglycine Proteins 0.000 description 10
- 108010057821 leucylproline Proteins 0.000 description 10
- 108010012581 phenylalanylglutamate Proteins 0.000 description 10
- 108010071207 serylmethionine Proteins 0.000 description 10
- 238000010361 transduction Methods 0.000 description 10
- 230000026683 transduction Effects 0.000 description 10
- 241000701022 Cytomegalovirus Species 0.000 description 9
- HGCNKOLVKRAVHD-UHFFFAOYSA-N L-Met-L-Phe Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 HGCNKOLVKRAVHD-UHFFFAOYSA-N 0.000 description 9
- 241000700605 Viruses Species 0.000 description 9
- 108010060035 arginylproline Proteins 0.000 description 9
- 108010047857 aspartylglycine Proteins 0.000 description 9
- 108010054813 diprotin B Proteins 0.000 description 9
- 231100000888 hearing loss Toxicity 0.000 description 9
- 230000010370 hearing loss Effects 0.000 description 9
- 108010018006 histidylserine Proteins 0.000 description 9
- 239000012528 membrane Substances 0.000 description 9
- 108010070643 prolylglutamic acid Proteins 0.000 description 9
- XNXRTQZTFVMJIJ-DCAQKATOSA-N Ser-Met-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O XNXRTQZTFVMJIJ-DCAQKATOSA-N 0.000 description 8
- 108010092854 aspartyllysine Proteins 0.000 description 8
- 210000000133 brain stem Anatomy 0.000 description 8
- 108010016616 cysteinylglycine Proteins 0.000 description 8
- 238000009826 distribution Methods 0.000 description 8
- 108010078144 glutaminyl-glycine Proteins 0.000 description 8
- VPZXBVLAVMBEQI-UHFFFAOYSA-N glycyl-DL-alpha-alanine Natural products OC(=O)C(C)NC(=O)CN VPZXBVLAVMBEQI-UHFFFAOYSA-N 0.000 description 8
- 108010015796 prolylisoleucine Proteins 0.000 description 8
- 238000011084 recovery Methods 0.000 description 8
- 230000001953 sensory effect Effects 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 230000000638 stimulation Effects 0.000 description 8
- 231100000462 teratogen Toxicity 0.000 description 8
- 239000003439 teratogenic agent Substances 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 7
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 7
- LGYZYFFDELZWRS-DCAQKATOSA-N Glu-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O LGYZYFFDELZWRS-DCAQKATOSA-N 0.000 description 7
- WGNOPSQMIQERPK-GARJFASQSA-N Leu-Asn-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N1CCC[C@@H]1C(=O)O)N WGNOPSQMIQERPK-GARJFASQSA-N 0.000 description 7
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 7
- FQPQPTHMHZKGFM-XQXXSGGOSA-N Thr-Ala-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O FQPQPTHMHZKGFM-XQXXSGGOSA-N 0.000 description 7
- AQAMPXBRJJWPNI-JHEQGTHGSA-N Thr-Gly-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O AQAMPXBRJJWPNI-JHEQGTHGSA-N 0.000 description 7
- 108010062796 arginyllysine Proteins 0.000 description 7
- 238000010790 dilution Methods 0.000 description 7
- 239000012895 dilution Substances 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 210000003027 ear inner Anatomy 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- XBGGUPMXALFZOT-UHFFFAOYSA-N glycyl-L-tyrosine hemihydrate Natural products NCC(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 XBGGUPMXALFZOT-UHFFFAOYSA-N 0.000 description 7
- 108010068488 methionylphenylalanine Proteins 0.000 description 7
- 108010077112 prolyl-proline Proteins 0.000 description 7
- DVWVZSJAYIJZFI-FXQIFTODSA-N Ala-Arg-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O DVWVZSJAYIJZFI-FXQIFTODSA-N 0.000 description 6
- WDIYWDJLXOCGRW-ACZMJKKPSA-N Ala-Asp-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WDIYWDJLXOCGRW-ACZMJKKPSA-N 0.000 description 6
- RTFWCVDISAMGEQ-SRVKXCTJSA-N Asn-Phe-Asn Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N RTFWCVDISAMGEQ-SRVKXCTJSA-N 0.000 description 6
- LTCKTLYKRMCFOC-KKUMJFAQSA-N Asp-Phe-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O LTCKTLYKRMCFOC-KKUMJFAQSA-N 0.000 description 6
- LRPXYSGPOBVBEH-IUCAKERBSA-N Glu-Gly-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O LRPXYSGPOBVBEH-IUCAKERBSA-N 0.000 description 6
- IRXNJYPKBVERCW-DCAQKATOSA-N Glu-Leu-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O IRXNJYPKBVERCW-DCAQKATOSA-N 0.000 description 6
- IOUQWHIEQYQVFD-JYJNAYRXSA-N Glu-Leu-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O IOUQWHIEQYQVFD-JYJNAYRXSA-N 0.000 description 6
- YPHPEHMXOYTEQG-LAEOZQHASA-N Glu-Val-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCC(O)=O YPHPEHMXOYTEQG-LAEOZQHASA-N 0.000 description 6
- ZQIMMEYPEXIYBB-IUCAKERBSA-N Gly-Glu-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)CN ZQIMMEYPEXIYBB-IUCAKERBSA-N 0.000 description 6
- FXGRXIATVXUAHO-WEDXCCLWSA-N Gly-Lys-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCCN FXGRXIATVXUAHO-WEDXCCLWSA-N 0.000 description 6
- VDIARPPNADFEAV-WEDXCCLWSA-N Leu-Thr-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O VDIARPPNADFEAV-WEDXCCLWSA-N 0.000 description 6
- NCTDKZKNBDZDOL-GARJFASQSA-N Lys-Asn-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCCCN)N)C(=O)O NCTDKZKNBDZDOL-GARJFASQSA-N 0.000 description 6
- IMAKMJCBYCSMHM-AVGNSLFASA-N Lys-Glu-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN IMAKMJCBYCSMHM-AVGNSLFASA-N 0.000 description 6
- OGAZPKJHHZPYFK-GARJFASQSA-N Met-Glu-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N OGAZPKJHHZPYFK-GARJFASQSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- XYSXOCIWCPFOCG-IHRRRGAJSA-N Pro-Leu-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O XYSXOCIWCPFOCG-IHRRRGAJSA-N 0.000 description 6
- NHXZRXLFOBFMDM-AVGNSLFASA-N Val-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C NHXZRXLFOBFMDM-AVGNSLFASA-N 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 6
- 108010060199 cysteinylproline Proteins 0.000 description 6
- 108010079547 glutamylmethionine Proteins 0.000 description 6
- 239000005090 green fluorescent protein Substances 0.000 description 6
- 108010078274 isoleucylvaline Proteins 0.000 description 6
- 108010034529 leucyl-lysine Proteins 0.000 description 6
- 108010056582 methionylglutamic acid Proteins 0.000 description 6
- 238000004806 packaging method and process Methods 0.000 description 6
- 108010051242 phenylalanylserine Proteins 0.000 description 6
- 108010020432 prolyl-prolylisoleucine Proteins 0.000 description 6
- 108010031719 prolyl-serine Proteins 0.000 description 6
- 108010080629 tryptophan-leucine Proteins 0.000 description 6
- 102000007469 Actins Human genes 0.000 description 5
- 108010085238 Actins Proteins 0.000 description 5
- OVQJAKFLFTZDNC-GUBZILKMSA-N Arg-Pro-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O OVQJAKFLFTZDNC-GUBZILKMSA-N 0.000 description 5
- WOZDCBHUGJVJPL-AVGNSLFASA-N Arg-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N WOZDCBHUGJVJPL-AVGNSLFASA-N 0.000 description 5
- HUZGPXBILPMCHM-IHRRRGAJSA-N Asn-Arg-Phe Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HUZGPXBILPMCHM-IHRRRGAJSA-N 0.000 description 5
- QCLHLXDWRKOHRR-GUBZILKMSA-N Asp-Glu-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)N QCLHLXDWRKOHRR-GUBZILKMSA-N 0.000 description 5
- KQBVNNAPIURMPD-PEFMBERDSA-N Asp-Ile-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O KQBVNNAPIURMPD-PEFMBERDSA-N 0.000 description 5
- 102000002110 C2 domains Human genes 0.000 description 5
- 108050009459 C2 domains Proteins 0.000 description 5
- 206010011882 Deafness congenital Diseases 0.000 description 5
- JILRMFFFCHUUTJ-ACZMJKKPSA-N Gln-Ser-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O JILRMFFFCHUUTJ-ACZMJKKPSA-N 0.000 description 5
- LKDIBBOKUAASNP-FXQIFTODSA-N Glu-Ala-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(O)=O LKDIBBOKUAASNP-FXQIFTODSA-N 0.000 description 5
- MXOODARRORARSU-ACZMJKKPSA-N Glu-Ala-Ser Chemical compound C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CCC(=O)O)N MXOODARRORARSU-ACZMJKKPSA-N 0.000 description 5
- MUSGDMDGNGXULI-DCAQKATOSA-N Glu-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O MUSGDMDGNGXULI-DCAQKATOSA-N 0.000 description 5
- QJCKNLPMTPXXEM-AUTRQRHGSA-N Glu-Glu-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CCC(O)=O QJCKNLPMTPXXEM-AUTRQRHGSA-N 0.000 description 5
- UHVIQGKBMXEVGN-WDSKDSINSA-N Glu-Gly-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O UHVIQGKBMXEVGN-WDSKDSINSA-N 0.000 description 5
- 102000018899 Glutamate Receptors Human genes 0.000 description 5
- 108010027915 Glutamate Receptors Proteins 0.000 description 5
- QSTLUOIOYLYLLF-WDSKDSINSA-N Gly-Asp-Glu Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QSTLUOIOYLYLLF-WDSKDSINSA-N 0.000 description 5
- XLFHCWHXKSFVIB-BQBZGAKWSA-N Gly-Gln-Gln Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O XLFHCWHXKSFVIB-BQBZGAKWSA-N 0.000 description 5
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 5
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 5
- PMGDADKJMCOXHX-UHFFFAOYSA-N L-Arginyl-L-glutamin-acetat Natural products NC(=N)NCCCC(N)C(=O)NC(CCC(N)=O)C(O)=O PMGDADKJMCOXHX-UHFFFAOYSA-N 0.000 description 5
- KSZCCRIGNVSHFH-UWVGGRQHSA-N Leu-Arg-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O KSZCCRIGNVSHFH-UWVGGRQHSA-N 0.000 description 5
- WRLPVDVHNWSSCL-MELADBBJSA-N Leu-His-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@@H]2C(=O)O)N WRLPVDVHNWSSCL-MELADBBJSA-N 0.000 description 5
- JFSGIJSCJFQGSZ-MXAVVETBSA-N Leu-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC(C)C)N JFSGIJSCJFQGSZ-MXAVVETBSA-N 0.000 description 5
- VULJUQZPSOASBZ-SRVKXCTJSA-N Leu-Pro-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O VULJUQZPSOASBZ-SRVKXCTJSA-N 0.000 description 5
- IZPVWNSAVUQBGP-CIUDSAMLSA-N Leu-Ser-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O IZPVWNSAVUQBGP-CIUDSAMLSA-N 0.000 description 5
- PBIPLDMFHAICIP-DCAQKATOSA-N Lys-Glu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PBIPLDMFHAICIP-DCAQKATOSA-N 0.000 description 5
- IUWMQCZOTYRXPL-ZPFDUUQYSA-N Lys-Ile-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O IUWMQCZOTYRXPL-ZPFDUUQYSA-N 0.000 description 5
- SKRGVGLIRUGANF-AVGNSLFASA-N Lys-Leu-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O SKRGVGLIRUGANF-AVGNSLFASA-N 0.000 description 5
- YUAXTFMFMOIMAM-QWRGUYRKSA-N Lys-Lys-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O YUAXTFMFMOIMAM-QWRGUYRKSA-N 0.000 description 5
- UGCIQUYEJIEHKX-GVXVVHGQSA-N Lys-Val-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O UGCIQUYEJIEHKX-GVXVVHGQSA-N 0.000 description 5
- 108010002311 N-glycylglutamic acid Proteins 0.000 description 5
- FKFCKDROTNIVSO-JYJNAYRXSA-N Phe-Pro-Met Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(O)=O FKFCKDROTNIVSO-JYJNAYRXSA-N 0.000 description 5
- QCMYJBKTMIWZAP-AVGNSLFASA-N Pro-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]1CCCN1 QCMYJBKTMIWZAP-AVGNSLFASA-N 0.000 description 5
- VGNYHOBZJKWRGI-CIUDSAMLSA-N Ser-Asn-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](N)CO VGNYHOBZJKWRGI-CIUDSAMLSA-N 0.000 description 5
- YBXMGKCLOPDEKA-NUMRIWBASA-N Thr-Asp-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O YBXMGKCLOPDEKA-NUMRIWBASA-N 0.000 description 5
- KZSYAEWQMJEGRZ-RHYQMDGZSA-N Thr-Leu-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O KZSYAEWQMJEGRZ-RHYQMDGZSA-N 0.000 description 5
- 108700019146 Transgenes Proteins 0.000 description 5
- ZSZFTYVFQLUWBF-QXEWZRGKSA-N Val-Asp-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCSC)C(=O)O)N ZSZFTYVFQLUWBF-QXEWZRGKSA-N 0.000 description 5
- SCBITHMBEJNRHC-LSJOCFKGSA-N Val-Asp-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)O)N SCBITHMBEJNRHC-LSJOCFKGSA-N 0.000 description 5
- VXDSPJJQUQDCKH-UKJIMTQDSA-N Val-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N VXDSPJJQUQDCKH-UKJIMTQDSA-N 0.000 description 5
- YKNOJPJWNVHORX-UNQGMJICSA-N Val-Phe-Thr Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)O)C(O)=O)CC1=CC=CC=C1 YKNOJPJWNVHORX-UNQGMJICSA-N 0.000 description 5
- 108010044940 alanylglutamine Proteins 0.000 description 5
- 108010013835 arginine glutamate Proteins 0.000 description 5
- 108010008355 arginyl-glutamine Proteins 0.000 description 5
- 108010001271 arginyl-glutamyl-arginine Proteins 0.000 description 5
- 108010091092 arginyl-glycyl-proline Proteins 0.000 description 5
- 108010018691 arginyl-threonyl-arginine Proteins 0.000 description 5
- 108010077245 asparaginyl-proline Proteins 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000012217 deletion Methods 0.000 description 5
- 230000037430 deletion Effects 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 210000000981 epithelium Anatomy 0.000 description 5
- 238000001476 gene delivery Methods 0.000 description 5
- 230000002068 genetic effect Effects 0.000 description 5
- 108010040856 glutamyl-cysteinyl-alanine Proteins 0.000 description 5
- 108010049041 glutamylalanine Proteins 0.000 description 5
- 238000012744 immunostaining Methods 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 108010044374 isoleucyl-tyrosine Proteins 0.000 description 5
- 108010003700 lysyl aspartic acid Proteins 0.000 description 5
- 230000035800 maturation Effects 0.000 description 5
- 108010022588 methionyl-lysyl-proline Proteins 0.000 description 5
- 108010089198 phenylalanyl-prolyl-arginine Proteins 0.000 description 5
- 230000001242 postsynaptic effect Effects 0.000 description 5
- 108010029020 prolylglycine Proteins 0.000 description 5
- 108010090894 prolylleucine Proteins 0.000 description 5
- 230000000069 prophylactic effect Effects 0.000 description 5
- 210000000225 synapse Anatomy 0.000 description 5
- 230000003612 virological effect Effects 0.000 description 5
- 241001164825 Adeno-associated virus - 8 Species 0.000 description 4
- YLTKNGYYPIWKHZ-ACZMJKKPSA-N Ala-Ala-Glu Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCC(O)=O YLTKNGYYPIWKHZ-ACZMJKKPSA-N 0.000 description 4
- FJVAQLJNTSUQPY-CIUDSAMLSA-N Ala-Ala-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN FJVAQLJNTSUQPY-CIUDSAMLSA-N 0.000 description 4
- GWFSQQNGMPGBEF-GHCJXIJMSA-N Ala-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N GWFSQQNGMPGBEF-GHCJXIJMSA-N 0.000 description 4
- YSMPVONNIWLJML-FXQIFTODSA-N Ala-Asp-Pro Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(O)=O YSMPVONNIWLJML-FXQIFTODSA-N 0.000 description 4
- MPLOSMWGDNJSEV-WHFBIAKZSA-N Ala-Gly-Asp Chemical compound [H]N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MPLOSMWGDNJSEV-WHFBIAKZSA-N 0.000 description 4
- MDNAVFBZPROEHO-DCAQKATOSA-N Ala-Lys-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O MDNAVFBZPROEHO-DCAQKATOSA-N 0.000 description 4
- GXCSUJQOECMKPV-CIUDSAMLSA-N Arg-Ala-Gln Chemical compound C[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O GXCSUJQOECMKPV-CIUDSAMLSA-N 0.000 description 4
- LVMUGODRNHFGRA-AVGNSLFASA-N Arg-Leu-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O LVMUGODRNHFGRA-AVGNSLFASA-N 0.000 description 4
- FMYQECOAIFGQGU-CYDGBPFRSA-N Arg-Val-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FMYQECOAIFGQGU-CYDGBPFRSA-N 0.000 description 4
- FXGMURPOWCKNAZ-JYJNAYRXSA-N Arg-Val-Phe Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 FXGMURPOWCKNAZ-JYJNAYRXSA-N 0.000 description 4
- OLVIPTLKNSAYRJ-YUMQZZPRSA-N Asn-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N OLVIPTLKNSAYRJ-YUMQZZPRSA-N 0.000 description 4
- GLWFAWNYGWBMOC-SRVKXCTJSA-N Asn-Leu-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O GLWFAWNYGWBMOC-SRVKXCTJSA-N 0.000 description 4
- HOQGTAIGQSDCHR-SRVKXCTJSA-N Asp-Asn-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HOQGTAIGQSDCHR-SRVKXCTJSA-N 0.000 description 4
- VPSHHQXIWLGVDD-ZLUOBGJFSA-N Asp-Asp-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O VPSHHQXIWLGVDD-ZLUOBGJFSA-N 0.000 description 4
- XJQRWGXKUSDEFI-ACZMJKKPSA-N Asp-Glu-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O XJQRWGXKUSDEFI-ACZMJKKPSA-N 0.000 description 4
- PYXXJFRXIYAESU-PCBIJLKTSA-N Asp-Ile-Phe Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PYXXJFRXIYAESU-PCBIJLKTSA-N 0.000 description 4
- KLYPOCBLKMPBIQ-GHCJXIJMSA-N Asp-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(=O)O)N KLYPOCBLKMPBIQ-GHCJXIJMSA-N 0.000 description 4
- RQHLMGCXCZUOGT-ZPFDUUQYSA-N Asp-Leu-Ile Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O RQHLMGCXCZUOGT-ZPFDUUQYSA-N 0.000 description 4
- NZWDWXSWUQCNMG-GARJFASQSA-N Asp-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CC(=O)O)N)C(=O)O NZWDWXSWUQCNMG-GARJFASQSA-N 0.000 description 4
- VIOQRFNAZDMVLO-NRPADANISA-N Cys-Val-Glu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O VIOQRFNAZDMVLO-NRPADANISA-N 0.000 description 4
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 4
- WLODHVXYKYHLJD-ACZMJKKPSA-N Gln-Asp-Ser Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)O)N WLODHVXYKYHLJD-ACZMJKKPSA-N 0.000 description 4
- UTKUTMJSWKKHEM-WDSKDSINSA-N Glu-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(O)=O UTKUTMJSWKKHEM-WDSKDSINSA-N 0.000 description 4
- ZPASCJBSSCRWMC-GVXVVHGQSA-N Glu-His-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CCC(=O)O)N ZPASCJBSSCRWMC-GVXVVHGQSA-N 0.000 description 4
- VGUYMZGLJUJRBV-YVNDNENWSA-N Glu-Ile-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O VGUYMZGLJUJRBV-YVNDNENWSA-N 0.000 description 4
- JJSVALISDCNFCU-SZMVWBNQSA-N Glu-Leu-Trp Chemical compound CC(C)C[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(O)=O JJSVALISDCNFCU-SZMVWBNQSA-N 0.000 description 4
- UDEPRBFQTWGLCW-CIUDSAMLSA-N Glu-Pro-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O UDEPRBFQTWGLCW-CIUDSAMLSA-N 0.000 description 4
- DXVOKNVIKORTHQ-GUBZILKMSA-N Glu-Pro-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O DXVOKNVIKORTHQ-GUBZILKMSA-N 0.000 description 4
- GUOWMVFLAJNPDY-CIUDSAMLSA-N Glu-Ser-Met Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(O)=O GUOWMVFLAJNPDY-CIUDSAMLSA-N 0.000 description 4
- BDISFWMLMNBTGP-NUMRIWBASA-N Glu-Thr-Asp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O BDISFWMLMNBTGP-NUMRIWBASA-N 0.000 description 4
- RMWAOBGCZZSJHE-UMNHJUIQSA-N Glu-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N RMWAOBGCZZSJHE-UMNHJUIQSA-N 0.000 description 4
- OVSKVOOUFAKODB-UWVGGRQHSA-N Gly-Arg-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N OVSKVOOUFAKODB-UWVGGRQHSA-N 0.000 description 4
- DTRUBYPMMVPQPD-YUMQZZPRSA-N Gly-Gln-Arg Chemical compound [H]NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O DTRUBYPMMVPQPD-YUMQZZPRSA-N 0.000 description 4
- MOJKRXIRAZPZLW-WDSKDSINSA-N Gly-Glu-Ala Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O MOJKRXIRAZPZLW-WDSKDSINSA-N 0.000 description 4
- CCBIBMKQNXHNIN-ZETCQYMHSA-N Gly-Leu-Gly Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CCBIBMKQNXHNIN-ZETCQYMHSA-N 0.000 description 4
- HAOUOFNNJJLVNS-BQBZGAKWSA-N Gly-Pro-Ser Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O HAOUOFNNJJLVNS-BQBZGAKWSA-N 0.000 description 4
- CUVBTVWFVIIDOC-YEPSODPASA-N Gly-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)CN CUVBTVWFVIIDOC-YEPSODPASA-N 0.000 description 4
- BAYQNCWLXIDLHX-ONGXEEELSA-N Gly-Val-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)CN BAYQNCWLXIDLHX-ONGXEEELSA-N 0.000 description 4
- DMHGKBGOUAJRHU-UHFFFAOYSA-N Ile-Arg-Pro Natural products CCC(C)C(N)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(O)=O DMHGKBGOUAJRHU-UHFFFAOYSA-N 0.000 description 4
- RGSOCXHDOPQREB-ZPFDUUQYSA-N Ile-Asp-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)O)N RGSOCXHDOPQREB-ZPFDUUQYSA-N 0.000 description 4
- LGMUPVWZEYYUMU-YVNDNENWSA-N Ile-Glu-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N LGMUPVWZEYYUMU-YVNDNENWSA-N 0.000 description 4
- LPFBXFILACZHIB-LAEOZQHASA-N Ile-Gly-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)O)C(=O)O)N LPFBXFILACZHIB-LAEOZQHASA-N 0.000 description 4
- BZUOLKFQVVBTJY-SLBDDTMCSA-N Ile-Trp-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC(=O)N)C(=O)O)N BZUOLKFQVVBTJY-SLBDDTMCSA-N 0.000 description 4
- OMDWJWGZGMCQND-CFMVVWHZSA-N Ile-Tyr-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N OMDWJWGZGMCQND-CFMVVWHZSA-N 0.000 description 4
- YWCJXQKATPNPOE-UKJIMTQDSA-N Ile-Val-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N YWCJXQKATPNPOE-UKJIMTQDSA-N 0.000 description 4
- FADYJNXDPBKVCA-UHFFFAOYSA-N L-Phenylalanyl-L-lysin Natural products NCCCCC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FADYJNXDPBKVCA-UHFFFAOYSA-N 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- 241000880493 Leptailurus serval Species 0.000 description 4
- LJHGALIOHLRRQN-DCAQKATOSA-N Leu-Ala-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N LJHGALIOHLRRQN-DCAQKATOSA-N 0.000 description 4
- KKXDHFKZWKLYGB-GUBZILKMSA-N Leu-Asn-Glu Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N KKXDHFKZWKLYGB-GUBZILKMSA-N 0.000 description 4
- WIDZHJTYKYBLSR-DCAQKATOSA-N Leu-Glu-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WIDZHJTYKYBLSR-DCAQKATOSA-N 0.000 description 4
- QJXHMYMRGDOHRU-NHCYSSNCSA-N Leu-Ile-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O QJXHMYMRGDOHRU-NHCYSSNCSA-N 0.000 description 4
- DSFYPIUSAMSERP-IHRRRGAJSA-N Leu-Leu-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N DSFYPIUSAMSERP-IHRRRGAJSA-N 0.000 description 4
- XVZCXCTYGHPNEM-UHFFFAOYSA-N Leu-Leu-Pro Natural products CC(C)CC(N)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(O)=O XVZCXCTYGHPNEM-UHFFFAOYSA-N 0.000 description 4
- LVTJJOJKDCVZGP-QWRGUYRKSA-N Leu-Lys-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O LVTJJOJKDCVZGP-QWRGUYRKSA-N 0.000 description 4
- PTRKPHUGYULXPU-KKUMJFAQSA-N Leu-Phe-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(O)=O PTRKPHUGYULXPU-KKUMJFAQSA-N 0.000 description 4
- FBNPMTNBFFAMMH-UHFFFAOYSA-N Leu-Val-Arg Natural products CC(C)CC(N)C(=O)NC(C(C)C)C(=O)NC(C(O)=O)CCCN=C(N)N FBNPMTNBFFAMMH-UHFFFAOYSA-N 0.000 description 4
- AAKRWBIIGKPOKQ-ONGXEEELSA-N Leu-Val-Gly Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O AAKRWBIIGKPOKQ-ONGXEEELSA-N 0.000 description 4
- FDBTVENULFNTAL-XQQFMLRXSA-N Leu-Val-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@@H]1C(=O)O)N FDBTVENULFNTAL-XQQFMLRXSA-N 0.000 description 4
- NTSPQIONFJUMJV-AVGNSLFASA-N Lys-Arg-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(O)=O NTSPQIONFJUMJV-AVGNSLFASA-N 0.000 description 4
- IWWMPCPLFXFBAF-SRVKXCTJSA-N Lys-Asp-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O IWWMPCPLFXFBAF-SRVKXCTJSA-N 0.000 description 4
- FHIAJWBDZVHLAH-YUMQZZPRSA-N Lys-Gly-Ser Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O FHIAJWBDZVHLAH-YUMQZZPRSA-N 0.000 description 4
- LUTDBHBIHHREDC-IHRRRGAJSA-N Lys-Pro-Lys Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCCN)C(O)=O LUTDBHBIHHREDC-IHRRRGAJSA-N 0.000 description 4
- LOGFVTREOLYCPF-RHYQMDGZSA-N Lys-Pro-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-RHYQMDGZSA-N 0.000 description 4
- AXHNAGAYRGCDLG-UWVGGRQHSA-N Met-Lys-Gly Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O AXHNAGAYRGCDLG-UWVGGRQHSA-N 0.000 description 4
- WKTSCAXSYITIJJ-PCBIJLKTSA-N Phe-Ile-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(N)=O)C(O)=O WKTSCAXSYITIJJ-PCBIJLKTSA-N 0.000 description 4
- MGLBSROLWAWCKN-FCLVOEFKSA-N Phe-Phe-Thr Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MGLBSROLWAWCKN-FCLVOEFKSA-N 0.000 description 4
- ZJPGOXWRFNKIQL-JYJNAYRXSA-N Phe-Pro-Pro Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CC=CC=C1 ZJPGOXWRFNKIQL-JYJNAYRXSA-N 0.000 description 4
- QSKCKTUQPICLSO-AVGNSLFASA-N Pro-Arg-Lys Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O QSKCKTUQPICLSO-AVGNSLFASA-N 0.000 description 4
- VJLJGKQAOQJXJG-CIUDSAMLSA-N Pro-Asp-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O VJLJGKQAOQJXJG-CIUDSAMLSA-N 0.000 description 4
- CMOIIANLNNYUTP-SRVKXCTJSA-N Pro-Gln-His Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O CMOIIANLNNYUTP-SRVKXCTJSA-N 0.000 description 4
- MGDFPGCFVJFITQ-CIUDSAMLSA-N Pro-Glu-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O MGDFPGCFVJFITQ-CIUDSAMLSA-N 0.000 description 4
- SUENWIFTSTWUKD-AVGNSLFASA-N Pro-Leu-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O SUENWIFTSTWUKD-AVGNSLFASA-N 0.000 description 4
- SEZGGSHLMROBFX-CIUDSAMLSA-N Pro-Ser-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O SEZGGSHLMROBFX-CIUDSAMLSA-N 0.000 description 4
- 108010025216 RVF peptide Proteins 0.000 description 4
- DSGYZICNAMEJOC-AVGNSLFASA-N Ser-Glu-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O DSGYZICNAMEJOC-AVGNSLFASA-N 0.000 description 4
- BKZYBLLIBOBOOW-GHCJXIJMSA-N Ser-Ile-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O BKZYBLLIBOBOOW-GHCJXIJMSA-N 0.000 description 4
- MOINZPRHJGTCHZ-MMWGEVLESA-N Ser-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N MOINZPRHJGTCHZ-MMWGEVLESA-N 0.000 description 4
- BYCVMHKULKRVPV-GUBZILKMSA-N Ser-Lys-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O BYCVMHKULKRVPV-GUBZILKMSA-N 0.000 description 4
- KKKVOZNCLALMPV-XKBZYTNZSA-N Ser-Thr-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O KKKVOZNCLALMPV-XKBZYTNZSA-N 0.000 description 4
- BNGDYRRHRGOPHX-IFFSRLJSSA-N Thr-Glu-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)[C@@H](C)O)C(O)=O BNGDYRRHRGOPHX-IFFSRLJSSA-N 0.000 description 4
- DEGCBBCMYWNJNA-RHYQMDGZSA-N Thr-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)[C@@H](C)O DEGCBBCMYWNJNA-RHYQMDGZSA-N 0.000 description 4
- OGOYMQWIWHGTGH-KZVJFYERSA-N Thr-Val-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O OGOYMQWIWHGTGH-KZVJFYERSA-N 0.000 description 4
- TZNNEYFZZAHLBL-BPUTZDHNSA-N Trp-Arg-Asp Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O TZNNEYFZZAHLBL-BPUTZDHNSA-N 0.000 description 4
- GTNCSPKYWCJZAC-XIRDDKMYSA-N Trp-Asp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N GTNCSPKYWCJZAC-XIRDDKMYSA-N 0.000 description 4
- MTEQZJFSEMXXRK-CFMVVWHZSA-N Tyr-Asn-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)N MTEQZJFSEMXXRK-CFMVVWHZSA-N 0.000 description 4
- USYGMBIIUDLYHJ-GVARAGBVSA-N Tyr-Ile-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 USYGMBIIUDLYHJ-GVARAGBVSA-N 0.000 description 4
- MNWINJDPGBNOED-ULQDDVLXSA-N Tyr-Pro-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CC1=CC=C(O)C=C1 MNWINJDPGBNOED-ULQDDVLXSA-N 0.000 description 4
- COYSIHFOCOMGCF-UHFFFAOYSA-N Val-Arg-Gly Natural products CC(C)C(N)C(=O)NC(C(=O)NCC(O)=O)CCCN=C(N)N COYSIHFOCOMGCF-UHFFFAOYSA-N 0.000 description 4
- QHDXUYOYTPWCSK-RCOVLWMOSA-N Val-Asp-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)NCC(=O)O)N QHDXUYOYTPWCSK-RCOVLWMOSA-N 0.000 description 4
- VPGCVZRRBYOGCD-AVGNSLFASA-N Val-Lys-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O VPGCVZRRBYOGCD-AVGNSLFASA-N 0.000 description 4
- AJNUKMZFHXUBMK-GUBZILKMSA-N Val-Ser-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N AJNUKMZFHXUBMK-GUBZILKMSA-N 0.000 description 4
- VTIAEOKFUJJBTC-YDHLFZDLSA-N Val-Tyr-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N VTIAEOKFUJJBTC-YDHLFZDLSA-N 0.000 description 4
- RLVTVHSDKHBFQP-ULQDDVLXSA-N Val-Tyr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CC=C(O)C=C1 RLVTVHSDKHBFQP-ULQDDVLXSA-N 0.000 description 4
- JVGDAEKKZKKZFO-RCWTZXSCSA-N Val-Val-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)N)O JVGDAEKKZKKZFO-RCWTZXSCSA-N 0.000 description 4
- 230000002159 abnormal effect Effects 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 4
- 238000004220 aggregation Methods 0.000 description 4
- 108010069020 alanyl-prolyl-glycine Proteins 0.000 description 4
- 108010045350 alanyl-tyrosyl-alanine Proteins 0.000 description 4
- 108010005233 alanylglutamic acid Proteins 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 108010043240 arginyl-leucyl-glycine Proteins 0.000 description 4
- 108010029539 arginyl-prolyl-proline Proteins 0.000 description 4
- 108010059459 arginyl-threonyl-phenylalanine Proteins 0.000 description 4
- 108010036533 arginylvaline Proteins 0.000 description 4
- 108010021908 aspartyl-aspartyl-glutamyl-aspartic acid Proteins 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 4
- 230000008827 biological function Effects 0.000 description 4
- 239000006185 dispersion Substances 0.000 description 4
- 210000000959 ear middle Anatomy 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 108010025306 histidylleucine Proteins 0.000 description 4
- 238000009396 hybridization Methods 0.000 description 4
- 108010073472 leucyl-prolyl-proline Proteins 0.000 description 4
- 108010005942 methionylglycine Proteins 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 108010005652 splenotritin Proteins 0.000 description 4
- 230000000946 synaptic effect Effects 0.000 description 4
- 238000002560 therapeutic procedure Methods 0.000 description 4
- 108010084932 tryptophyl-proline Proteins 0.000 description 4
- 241000701161 unidentified adenovirus Species 0.000 description 4
- 210000004291 uterus Anatomy 0.000 description 4
- 239000013603 viral vector Substances 0.000 description 4
- 241001634120 Adeno-associated virus - 5 Species 0.000 description 3
- TTXMOJWKNRJWQJ-FXQIFTODSA-N Ala-Arg-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CCCN=C(N)N TTXMOJWKNRJWQJ-FXQIFTODSA-N 0.000 description 3
- WXERCAHAIKMTKX-ZLUOBGJFSA-N Ala-Asp-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O WXERCAHAIKMTKX-ZLUOBGJFSA-N 0.000 description 3
- ZIWWTZWAKYBUOB-CIUDSAMLSA-N Ala-Asp-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O ZIWWTZWAKYBUOB-CIUDSAMLSA-N 0.000 description 3
- LSLIRHLIUDVNBN-CIUDSAMLSA-N Ala-Asp-Lys Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCCN LSLIRHLIUDVNBN-CIUDSAMLSA-N 0.000 description 3
- MKZCBYZBCINNJN-DLOVCJGASA-N Ala-Asp-Phe Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MKZCBYZBCINNJN-DLOVCJGASA-N 0.000 description 3
- BUDNAJYVCUHLSV-ZLUOBGJFSA-N Ala-Asp-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O BUDNAJYVCUHLSV-ZLUOBGJFSA-N 0.000 description 3
- HXNNRBHASOSVPG-GUBZILKMSA-N Ala-Glu-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O HXNNRBHASOSVPG-GUBZILKMSA-N 0.000 description 3
- WMYJZJRILUVVRG-WDSKDSINSA-N Ala-Gly-Gln Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O WMYJZJRILUVVRG-WDSKDSINSA-N 0.000 description 3
- BLIMFWGRQKRCGT-YUMQZZPRSA-N Ala-Gly-Lys Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN BLIMFWGRQKRCGT-YUMQZZPRSA-N 0.000 description 3
- CKLDHDOIYBVUNP-KBIXCLLPSA-N Ala-Ile-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(O)=O)C(O)=O CKLDHDOIYBVUNP-KBIXCLLPSA-N 0.000 description 3
- DVJSJDDYCYSMFR-ZKWXMUAHSA-N Ala-Ile-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O DVJSJDDYCYSMFR-ZKWXMUAHSA-N 0.000 description 3
- CFPQUJZTLUQUTJ-HTFCKZLJSA-N Ala-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](C)N CFPQUJZTLUQUTJ-HTFCKZLJSA-N 0.000 description 3
- PIXQDIGKDNNOOV-GUBZILKMSA-N Ala-Lys-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O PIXQDIGKDNNOOV-GUBZILKMSA-N 0.000 description 3
- OINVDEKBKBCPLX-JXUBOQSCSA-N Ala-Lys-Thr Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OINVDEKBKBCPLX-JXUBOQSCSA-N 0.000 description 3
- KYDYGANDJHFBCW-DRZSPHRISA-N Ala-Phe-Gln Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N KYDYGANDJHFBCW-DRZSPHRISA-N 0.000 description 3
- YNOCMHZSWJMGBB-GCJQMDKQSA-N Ala-Thr-Asp Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O YNOCMHZSWJMGBB-GCJQMDKQSA-N 0.000 description 3
- QKHWNPQNOHEFST-VZFHVOOUSA-N Ala-Thr-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](C)N)O QKHWNPQNOHEFST-VZFHVOOUSA-N 0.000 description 3
- KWKQGHSSNHPGOW-BQBZGAKWSA-N Arg-Ala-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)NCC(O)=O KWKQGHSSNHPGOW-BQBZGAKWSA-N 0.000 description 3
- YFWTXMRJJDNTLM-LSJOCFKGSA-N Arg-Ala-His Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N YFWTXMRJJDNTLM-LSJOCFKGSA-N 0.000 description 3
- RVDVDRUZWZIBJQ-CIUDSAMLSA-N Arg-Asn-Glu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O RVDVDRUZWZIBJQ-CIUDSAMLSA-N 0.000 description 3
- YNSGXDWWPCGGQS-YUMQZZPRSA-N Arg-Gly-Gln Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O YNSGXDWWPCGGQS-YUMQZZPRSA-N 0.000 description 3
- PHHRSPBBQUFULD-UWVGGRQHSA-N Arg-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)N PHHRSPBBQUFULD-UWVGGRQHSA-N 0.000 description 3
- GRRXPUAICOGISM-RWMBFGLXSA-N Arg-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O GRRXPUAICOGISM-RWMBFGLXSA-N 0.000 description 3
- UGZUVYDKAYNCII-ULQDDVLXSA-N Arg-Phe-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(O)=O UGZUVYDKAYNCII-ULQDDVLXSA-N 0.000 description 3
- KZXPVYVSHUJCEO-ULQDDVLXSA-N Arg-Phe-Lys Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(O)=O)CC1=CC=CC=C1 KZXPVYVSHUJCEO-ULQDDVLXSA-N 0.000 description 3
- NGYHSXDNNOFHNE-AVGNSLFASA-N Arg-Pro-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O NGYHSXDNNOFHNE-AVGNSLFASA-N 0.000 description 3
- PYDIIVKGTBRIEL-SZMVWBNQSA-N Arg-Trp-Pro Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N1CCC[C@H]1C(O)=O PYDIIVKGTBRIEL-SZMVWBNQSA-N 0.000 description 3
- CTAPSNCVKPOOSM-KKUMJFAQSA-N Arg-Tyr-Gln Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O CTAPSNCVKPOOSM-KKUMJFAQSA-N 0.000 description 3
- CGWVCWFQGXOUSJ-ULQDDVLXSA-N Arg-Tyr-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O CGWVCWFQGXOUSJ-ULQDDVLXSA-N 0.000 description 3
- LUVODTFFSXVOAG-ACZMJKKPSA-N Asn-Cys-Glu Chemical compound C(CC(=O)O)[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC(=O)N)N LUVODTFFSXVOAG-ACZMJKKPSA-N 0.000 description 3
- YRTOMUMWSTUQAX-FXQIFTODSA-N Asn-Pro-Asp Chemical compound NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O YRTOMUMWSTUQAX-FXQIFTODSA-N 0.000 description 3
- QNNBHTFDFFFHGC-KKUMJFAQSA-N Asn-Tyr-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O QNNBHTFDFFFHGC-KKUMJFAQSA-N 0.000 description 3
- DPWDPEVGACCWTC-SRVKXCTJSA-N Asn-Tyr-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(O)=O DPWDPEVGACCWTC-SRVKXCTJSA-N 0.000 description 3
- CBHVAFXKOYAHOY-NHCYSSNCSA-N Asn-Val-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O CBHVAFXKOYAHOY-NHCYSSNCSA-N 0.000 description 3
- WSWYMRLTJVKRCE-ZLUOBGJFSA-N Asp-Ala-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O WSWYMRLTJVKRCE-ZLUOBGJFSA-N 0.000 description 3
- UGKZHCBLMLSANF-CIUDSAMLSA-N Asp-Asn-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O UGKZHCBLMLSANF-CIUDSAMLSA-N 0.000 description 3
- XACXDSRQIXRMNS-OLHMAJIHSA-N Asp-Asn-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)N)O XACXDSRQIXRMNS-OLHMAJIHSA-N 0.000 description 3
- FANQWNCPNFEPGZ-WHFBIAKZSA-N Asp-Asp-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O FANQWNCPNFEPGZ-WHFBIAKZSA-N 0.000 description 3
- LKIYSIYBKYLKPU-BIIVOSGPSA-N Asp-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)N)C(=O)O LKIYSIYBKYLKPU-BIIVOSGPSA-N 0.000 description 3
- VHQOCWWKXIOAQI-WDSKDSINSA-N Asp-Gln-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O VHQOCWWKXIOAQI-WDSKDSINSA-N 0.000 description 3
- RRUWMFBLFLUZSI-LPEHRKFASA-N Asp-Met-Pro Chemical compound CSCC[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N RRUWMFBLFLUZSI-LPEHRKFASA-N 0.000 description 3
- RCGVPVZHKAXDPA-NYVOZVTQSA-N Asp-Trp-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)O)NC(=O)[C@H](CC(=O)O)N RCGVPVZHKAXDPA-NYVOZVTQSA-N 0.000 description 3
- NWAHPBGBDIFUFD-KKUMJFAQSA-N Asp-Tyr-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(O)=O NWAHPBGBDIFUFD-KKUMJFAQSA-N 0.000 description 3
- XQFLFQWOBXPMHW-NHCYSSNCSA-N Asp-Val-His Chemical compound N[C@@H](CC(=O)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O XQFLFQWOBXPMHW-NHCYSSNCSA-N 0.000 description 3
- 241000283707 Capra Species 0.000 description 3
- LBOLGUYQEPZSKM-YUMQZZPRSA-N Cys-Gly-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CS)N LBOLGUYQEPZSKM-YUMQZZPRSA-N 0.000 description 3
- TXGDWPBLUFQODU-XGEHTFHBSA-N Cys-Pro-Thr Chemical compound [H]N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O TXGDWPBLUFQODU-XGEHTFHBSA-N 0.000 description 3
- GFAPBMCRSMSGDZ-XGEHTFHBSA-N Cys-Thr-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CS)N)O GFAPBMCRSMSGDZ-XGEHTFHBSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 101000834253 Gallus gallus Actin, cytoplasmic 1 Proteins 0.000 description 3
- UICOTGULOUGGLC-NUMRIWBASA-N Gln-Asp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)N)N)O UICOTGULOUGGLC-NUMRIWBASA-N 0.000 description 3
- COYGBRTZEVWZBW-XKBZYTNZSA-N Gln-Cys-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(N)=O COYGBRTZEVWZBW-XKBZYTNZSA-N 0.000 description 3
- XFKUFUJECJUQTQ-CIUDSAMLSA-N Gln-Gln-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XFKUFUJECJUQTQ-CIUDSAMLSA-N 0.000 description 3
- FGYPOQPQTUNESW-IUCAKERBSA-N Gln-Gly-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CCC(=O)N)N FGYPOQPQTUNESW-IUCAKERBSA-N 0.000 description 3
- TYRMVTKPOWPZBC-SXNHZJKMSA-N Gln-Ile-Trp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CCC(=O)N)N TYRMVTKPOWPZBC-SXNHZJKMSA-N 0.000 description 3
- XKPACHRGOWQHFH-IRIUXVKKSA-N Gln-Thr-Tyr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O XKPACHRGOWQHFH-IRIUXVKKSA-N 0.000 description 3
- KKCUFHUTMKQQCF-SRVKXCTJSA-N Glu-Arg-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O KKCUFHUTMKQQCF-SRVKXCTJSA-N 0.000 description 3
- YKLNMGJYMNPBCP-ACZMJKKPSA-N Glu-Asn-Asp Chemical compound C(CC(=O)O)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N YKLNMGJYMNPBCP-ACZMJKKPSA-N 0.000 description 3
- DSPQRJXOIXHOHK-WDSKDSINSA-N Glu-Asp-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O DSPQRJXOIXHOHK-WDSKDSINSA-N 0.000 description 3
- HJIFPJUEOGZWRI-GUBZILKMSA-N Glu-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCC(=O)O)N HJIFPJUEOGZWRI-GUBZILKMSA-N 0.000 description 3
- PBFGQTGPSKWHJA-QEJZJMRPSA-N Glu-Asp-Trp Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O PBFGQTGPSKWHJA-QEJZJMRPSA-N 0.000 description 3
- CGOHAEBMDSEKFB-FXQIFTODSA-N Glu-Glu-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O CGOHAEBMDSEKFB-FXQIFTODSA-N 0.000 description 3
- ILGFBUGLBSAQQB-GUBZILKMSA-N Glu-Glu-Arg Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O ILGFBUGLBSAQQB-GUBZILKMSA-N 0.000 description 3
- KUTPGXNAAOQSPD-LPEHRKFASA-N Glu-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)N)C(=O)O KUTPGXNAAOQSPD-LPEHRKFASA-N 0.000 description 3
- PHONAZGUEGIOEM-GLLZPBPUSA-N Glu-Glu-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PHONAZGUEGIOEM-GLLZPBPUSA-N 0.000 description 3
- YKBUCXNNBYZYAY-MNXVOIDGSA-N Glu-Lys-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YKBUCXNNBYZYAY-MNXVOIDGSA-N 0.000 description 3
- ZQYZDDXTNQXUJH-CIUDSAMLSA-N Glu-Met-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)N ZQYZDDXTNQXUJH-CIUDSAMLSA-N 0.000 description 3
- JDUKCSSHWNIQQZ-IHRRRGAJSA-N Glu-Phe-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O JDUKCSSHWNIQQZ-IHRRRGAJSA-N 0.000 description 3
- TWYSSILQABLLME-HJGDQZAQSA-N Glu-Thr-Arg Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O TWYSSILQABLLME-HJGDQZAQSA-N 0.000 description 3
- QCMVGXDELYMZET-GLLZPBPUSA-N Glu-Thr-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QCMVGXDELYMZET-GLLZPBPUSA-N 0.000 description 3
- 102100030651 Glutamate receptor 2 Human genes 0.000 description 3
- 101710087631 Glutamate receptor 2 Proteins 0.000 description 3
- KKBWDNZXYLGJEY-UHFFFAOYSA-N Gly-Arg-Pro Natural products NCC(=O)NC(CCNC(=N)N)C(=O)N1CCCC1C(=O)O KKBWDNZXYLGJEY-UHFFFAOYSA-N 0.000 description 3
- UXJHNZODTMHWRD-WHFBIAKZSA-N Gly-Asn-Ala Chemical compound [H]NCC(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O UXJHNZODTMHWRD-WHFBIAKZSA-N 0.000 description 3
- IWAXHBCACVWNHT-BQBZGAKWSA-N Gly-Asp-Arg Chemical compound NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IWAXHBCACVWNHT-BQBZGAKWSA-N 0.000 description 3
- BYYNJRSNDARRBX-YFKPBYRVSA-N Gly-Gln-Gly Chemical compound NCC(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O BYYNJRSNDARRBX-YFKPBYRVSA-N 0.000 description 3
- YWAQATDNEKZFFK-BYPYZUCNSA-N Gly-Gly-Ser Chemical compound NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O YWAQATDNEKZFFK-BYPYZUCNSA-N 0.000 description 3
- SWQALSGKVLYKDT-ZKWXMUAHSA-N Gly-Ile-Ala Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O SWQALSGKVLYKDT-ZKWXMUAHSA-N 0.000 description 3
- SWQALSGKVLYKDT-UHFFFAOYSA-N Gly-Ile-Ala Natural products NCC(=O)NC(C(C)CC)C(=O)NC(C)C(O)=O SWQALSGKVLYKDT-UHFFFAOYSA-N 0.000 description 3
- LIXWIUAORXJNBH-QWRGUYRKSA-N Gly-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)CN LIXWIUAORXJNBH-QWRGUYRKSA-N 0.000 description 3
- NNCSJUBVFBDDLC-YUMQZZPRSA-N Gly-Leu-Ser Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O NNCSJUBVFBDDLC-YUMQZZPRSA-N 0.000 description 3
- CLNSYANKYVMZNM-UWVGGRQHSA-N Gly-Lys-Arg Chemical compound NCCCC[C@H](NC(=O)CN)C(=O)N[C@H](C(O)=O)CCCN=C(N)N CLNSYANKYVMZNM-UWVGGRQHSA-N 0.000 description 3
- NTBOEZICHOSJEE-YUMQZZPRSA-N Gly-Lys-Ser Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O NTBOEZICHOSJEE-YUMQZZPRSA-N 0.000 description 3
- OQQKUTVULYLCDG-ONGXEEELSA-N Gly-Lys-Val Chemical compound CC(C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)CN)C(O)=O OQQKUTVULYLCDG-ONGXEEELSA-N 0.000 description 3
- WSLHFAFASQFMSK-SFTDATJTSA-N Gly-Trp-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CC=3C4=CC=CC=C4NC=3)NC(=O)CN)C(O)=O)=CNC2=C1 WSLHFAFASQFMSK-SFTDATJTSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- RVKIPWVMZANZLI-UHFFFAOYSA-N H-Lys-Trp-OH Natural products C1=CC=C2C(CC(NC(=O)C(N)CCCCN)C(O)=O)=CNC2=C1 RVKIPWVMZANZLI-UHFFFAOYSA-N 0.000 description 3
- YAALVYQFVJNXIV-KKUMJFAQSA-N His-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CN=CN1 YAALVYQFVJNXIV-KKUMJFAQSA-N 0.000 description 3
- HYWZHNUGAYVEEW-KKUMJFAQSA-N His-Phe-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC2=CN=CN2)N HYWZHNUGAYVEEW-KKUMJFAQSA-N 0.000 description 3
- RWIKBYVJQAJYDP-BJDJZHNGSA-N Ile-Ala-Lys Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN RWIKBYVJQAJYDP-BJDJZHNGSA-N 0.000 description 3
- SACHLUOUHCVIKI-GMOBBJLQSA-N Ile-Arg-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N SACHLUOUHCVIKI-GMOBBJLQSA-N 0.000 description 3
- WECYRWOMWSCWNX-XUXIUFHCSA-N Ile-Arg-Leu Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(O)=O WECYRWOMWSCWNX-XUXIUFHCSA-N 0.000 description 3
- UAVQIQOOBXFKRC-BYULHYEWSA-N Ile-Asn-Gly Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)NCC(O)=O UAVQIQOOBXFKRC-BYULHYEWSA-N 0.000 description 3
- PHRWFSFCNJPWRO-PPCPHDFISA-N Ile-Leu-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N PHRWFSFCNJPWRO-PPCPHDFISA-N 0.000 description 3
- HQLSBZFLOUHQJK-STECZYCISA-N Ile-Tyr-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N HQLSBZFLOUHQJK-STECZYCISA-N 0.000 description 3
- KXUKTDGKLAOCQK-LSJOCFKGSA-N Ile-Val-Gly Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O KXUKTDGKLAOCQK-LSJOCFKGSA-N 0.000 description 3
- 108010065920 Insulin Lispro Proteins 0.000 description 3
- UGTHTQWIQKEDEH-BQBZGAKWSA-N L-alanyl-L-prolylglycine zwitterion Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UGTHTQWIQKEDEH-BQBZGAKWSA-N 0.000 description 3
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 3
- BQSLGJHIAGOZCD-CIUDSAMLSA-N Leu-Ala-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O BQSLGJHIAGOZCD-CIUDSAMLSA-N 0.000 description 3
- YKNBJXOJTURHCU-DCAQKATOSA-N Leu-Asp-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YKNBJXOJTURHCU-DCAQKATOSA-N 0.000 description 3
- DLCOFDAHNMMQPP-SRVKXCTJSA-N Leu-Asp-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DLCOFDAHNMMQPP-SRVKXCTJSA-N 0.000 description 3
- YVKSMSDXKMSIRX-GUBZILKMSA-N Leu-Glu-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O YVKSMSDXKMSIRX-GUBZILKMSA-N 0.000 description 3
- LZHJZLHSRGWBBE-IHRRRGAJSA-N Leu-Lys-Val Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O LZHJZLHSRGWBBE-IHRRRGAJSA-N 0.000 description 3
- ZDBMWELMUCLUPL-QEJZJMRPSA-N Leu-Phe-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C)C(O)=O)CC1=CC=CC=C1 ZDBMWELMUCLUPL-QEJZJMRPSA-N 0.000 description 3
- UHNQRAFSEBGZFZ-YESZJQIVSA-N Leu-Phe-Pro Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@@H]2C(=O)O)N UHNQRAFSEBGZFZ-YESZJQIVSA-N 0.000 description 3
- QWWPYKKLXWOITQ-VOAKCMCISA-N Leu-Thr-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CC(C)C QWWPYKKLXWOITQ-VOAKCMCISA-N 0.000 description 3
- XOEDPXDZJHBQIX-ULQDDVLXSA-N Leu-Val-Phe Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 XOEDPXDZJHBQIX-ULQDDVLXSA-N 0.000 description 3
- MPGHETGWWWUHPY-CIUDSAMLSA-N Lys-Ala-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN MPGHETGWWWUHPY-CIUDSAMLSA-N 0.000 description 3
- QQUJSUFWEDZQQY-AVGNSLFASA-N Lys-Gln-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CCCCN QQUJSUFWEDZQQY-AVGNSLFASA-N 0.000 description 3
- GPJGFSFYBJGYRX-YUMQZZPRSA-N Lys-Gly-Asp Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(O)=O GPJGFSFYBJGYRX-YUMQZZPRSA-N 0.000 description 3
- KNKJPYAZQUFLQK-IHRRRGAJSA-N Lys-His-Arg Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CCCCN)N KNKJPYAZQUFLQK-IHRRRGAJSA-N 0.000 description 3
- YPLVCBKEPJPBDQ-MELADBBJSA-N Lys-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N YPLVCBKEPJPBDQ-MELADBBJSA-N 0.000 description 3
- PYFNONMJYNJENN-AVGNSLFASA-N Lys-Lys-Gln Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N PYFNONMJYNJENN-AVGNSLFASA-N 0.000 description 3
- UQRZFMQQXXJTTF-AVGNSLFASA-N Lys-Lys-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O UQRZFMQQXXJTTF-AVGNSLFASA-N 0.000 description 3
- PLDJDCJLRCYPJB-VOAKCMCISA-N Lys-Lys-Thr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O PLDJDCJLRCYPJB-VOAKCMCISA-N 0.000 description 3
- OBZHNHBAAVEWKI-DCAQKATOSA-N Lys-Pro-Asn Chemical compound NCCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O OBZHNHBAAVEWKI-DCAQKATOSA-N 0.000 description 3
- PDIDTSZKKFEDMB-UWVGGRQHSA-N Lys-Pro-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O PDIDTSZKKFEDMB-UWVGGRQHSA-N 0.000 description 3
- CTJUSALVKAWFFU-CIUDSAMLSA-N Lys-Ser-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N CTJUSALVKAWFFU-CIUDSAMLSA-N 0.000 description 3
- RMOKGALPSPOYKE-KATARQTJSA-N Lys-Thr-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O RMOKGALPSPOYKE-KATARQTJSA-N 0.000 description 3
- KDBDVESGGJYVEH-PMVMPFDFSA-N Lys-Trp-Phe Chemical compound C([C@H](NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](N)CCCCN)C(O)=O)C1=CC=CC=C1 KDBDVESGGJYVEH-PMVMPFDFSA-N 0.000 description 3
- TXTZMVNJIRZABH-ULQDDVLXSA-N Lys-Val-Phe Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 TXTZMVNJIRZABH-ULQDDVLXSA-N 0.000 description 3
- IKXQOBUBZSOWDY-AVGNSLFASA-N Lys-Val-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](CCCCN)N IKXQOBUBZSOWDY-AVGNSLFASA-N 0.000 description 3
- CTVJSFRHUOSCQQ-DCAQKATOSA-N Met-Arg-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O CTVJSFRHUOSCQQ-DCAQKATOSA-N 0.000 description 3
- FYRUJIJAUPHUNB-IUCAKERBSA-N Met-Gly-Arg Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCNC(N)=N FYRUJIJAUPHUNB-IUCAKERBSA-N 0.000 description 3
- JACAKCWAOHKQBV-UWVGGRQHSA-N Met-Gly-Lys Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN JACAKCWAOHKQBV-UWVGGRQHSA-N 0.000 description 3
- RRIHXWPHQSXHAQ-XUXIUFHCSA-N Met-Ile-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(O)=O RRIHXWPHQSXHAQ-XUXIUFHCSA-N 0.000 description 3
- NBEFNGUZUOUGFG-KKUMJFAQSA-N Met-Tyr-Gln Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N NBEFNGUZUOUGFG-KKUMJFAQSA-N 0.000 description 3
- 108010079364 N-glycylalanine Proteins 0.000 description 3
- 241000283973 Oryctolagus cuniculus Species 0.000 description 3
- JOXIIFVCSATTDH-IHPCNDPISA-N Phe-Asn-Trp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)O)N JOXIIFVCSATTDH-IHPCNDPISA-N 0.000 description 3
- IUVYJBMTHARMIP-PCBIJLKTSA-N Phe-Asp-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O IUVYJBMTHARMIP-PCBIJLKTSA-N 0.000 description 3
- SMFGCTXUBWEPKM-KBPBESRZSA-N Phe-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 SMFGCTXUBWEPKM-KBPBESRZSA-N 0.000 description 3
- CKJACGQPCPMWIT-UFYCRDLUSA-N Phe-Pro-Phe Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CKJACGQPCPMWIT-UFYCRDLUSA-N 0.000 description 3
- VXCHGLYSIOOZIS-GUBZILKMSA-N Pro-Ala-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 VXCHGLYSIOOZIS-GUBZILKMSA-N 0.000 description 3
- BNBBNGZZKQUWCD-IUCAKERBSA-N Pro-Arg-Gly Chemical compound NC(N)=NCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H]1CCCN1 BNBBNGZZKQUWCD-IUCAKERBSA-N 0.000 description 3
- JARJPEMLQAWNBR-GUBZILKMSA-N Pro-Asp-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JARJPEMLQAWNBR-GUBZILKMSA-N 0.000 description 3
- LSIWVWRUTKPXDS-DCAQKATOSA-N Pro-Gln-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O LSIWVWRUTKPXDS-DCAQKATOSA-N 0.000 description 3
- PULPZRAHVFBVTO-DCAQKATOSA-N Pro-Glu-Arg Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O PULPZRAHVFBVTO-DCAQKATOSA-N 0.000 description 3
- VOZIBWWZSBIXQN-SRVKXCTJSA-N Pro-Glu-Lys Chemical compound NCCCC[C@H](NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1)C(O)=O VOZIBWWZSBIXQN-SRVKXCTJSA-N 0.000 description 3
- BBFRBZYKHIKFBX-GMOBBJLQSA-N Pro-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@@H]1CCCN1 BBFRBZYKHIKFBX-GMOBBJLQSA-N 0.000 description 3
- LNOWDSPAYBWJOR-PEDHHIEDSA-N Pro-Ile-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O LNOWDSPAYBWJOR-PEDHHIEDSA-N 0.000 description 3
- HFNPOYOKIPGAEI-SRVKXCTJSA-N Pro-Leu-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H]1CCCN1 HFNPOYOKIPGAEI-SRVKXCTJSA-N 0.000 description 3
- DWGFLKQSGRUQTI-IHRRRGAJSA-N Pro-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H]1CCCN1 DWGFLKQSGRUQTI-IHRRRGAJSA-N 0.000 description 3
- XZBYTHCRAVAXQQ-DCAQKATOSA-N Pro-Met-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(O)=O XZBYTHCRAVAXQQ-DCAQKATOSA-N 0.000 description 3
- DWPXHLIBFQLKLK-CYDGBPFRSA-N Pro-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 DWPXHLIBFQLKLK-CYDGBPFRSA-N 0.000 description 3
- VDHGTOHMHHQSKG-JYJNAYRXSA-N Pro-Val-Phe Chemical compound CC(C)[C@H](NC(=O)[C@@H]1CCCN1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O VDHGTOHMHHQSKG-JYJNAYRXSA-N 0.000 description 3
- BTKUIVBNGBFTTP-WHFBIAKZSA-N Ser-Ala-Gly Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)NCC(O)=O BTKUIVBNGBFTTP-WHFBIAKZSA-N 0.000 description 3
- BRKHVZNDAOMAHX-BIIVOSGPSA-N Ser-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N BRKHVZNDAOMAHX-BIIVOSGPSA-N 0.000 description 3
- UBRXAVQWXOWRSJ-ZLUOBGJFSA-N Ser-Asn-Asp Chemical compound C([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CO)N)C(=O)N UBRXAVQWXOWRSJ-ZLUOBGJFSA-N 0.000 description 3
- SMIDBHKWSYUBRZ-ACZMJKKPSA-N Ser-Glu-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O SMIDBHKWSYUBRZ-ACZMJKKPSA-N 0.000 description 3
- LWMQRHDTXHQQOV-MXAVVETBSA-N Ser-Ile-Phe Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O LWMQRHDTXHQQOV-MXAVVETBSA-N 0.000 description 3
- IAORETPTUDBBGV-CIUDSAMLSA-N Ser-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CO)N IAORETPTUDBBGV-CIUDSAMLSA-N 0.000 description 3
- GJFYFGOEWLDQGW-GUBZILKMSA-N Ser-Leu-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CO)N GJFYFGOEWLDQGW-GUBZILKMSA-N 0.000 description 3
- HEYZPTCCEIWHRO-IHRRRGAJSA-N Ser-Met-Phe Chemical compound OC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 HEYZPTCCEIWHRO-IHRRRGAJSA-N 0.000 description 3
- ZKBKUWQVDWWSRI-BZSNNMDCSA-N Ser-Phe-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZKBKUWQVDWWSRI-BZSNNMDCSA-N 0.000 description 3
- NVNPWELENFJOHH-CIUDSAMLSA-N Ser-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)N NVNPWELENFJOHH-CIUDSAMLSA-N 0.000 description 3
- AXKJPUBALUNJEO-UBHSHLNASA-N Ser-Trp-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(N)=O)C(O)=O AXKJPUBALUNJEO-UBHSHLNASA-N 0.000 description 3
- UQGAAZXSCGWMFU-UBHSHLNASA-N Ser-Trp-Asp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CO)N UQGAAZXSCGWMFU-UBHSHLNASA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- VFEHSAJCWWHDBH-RHYQMDGZSA-N Thr-Arg-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O VFEHSAJCWWHDBH-RHYQMDGZSA-N 0.000 description 3
- XDARBNMYXKUFOJ-GSSVUCPTSA-N Thr-Asp-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XDARBNMYXKUFOJ-GSSVUCPTSA-N 0.000 description 3
- HJOSVGCWOTYJFG-WDCWCFNPSA-N Thr-Glu-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N)O HJOSVGCWOTYJFG-WDCWCFNPSA-N 0.000 description 3
- FDALPRWYVKJCLL-PMVVWTBXSA-N Thr-His-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)NCC(O)=O FDALPRWYVKJCLL-PMVVWTBXSA-N 0.000 description 3
- GUHLYMZJVXUIPO-RCWTZXSCSA-N Thr-Met-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](C(C)C)C(O)=O GUHLYMZJVXUIPO-RCWTZXSCSA-N 0.000 description 3
- STUAPCLEDMKXKL-LKXGYXEUSA-N Thr-Ser-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O STUAPCLEDMKXKL-LKXGYXEUSA-N 0.000 description 3
- 108700009124 Transcription Initiation Site Proteins 0.000 description 3
- VKMOGXREKGVZAF-QEJZJMRPSA-N Trp-Asp-Gln Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N VKMOGXREKGVZAF-QEJZJMRPSA-N 0.000 description 3
- RRVUOLRWIZXBRQ-IHPCNDPISA-N Trp-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N RRVUOLRWIZXBRQ-IHPCNDPISA-N 0.000 description 3
- NZFCWALTLNFHHC-JYJNAYRXSA-N Tyr-Glu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NZFCWALTLNFHHC-JYJNAYRXSA-N 0.000 description 3
- JHORGUYURUBVOM-KKUMJFAQSA-N Tyr-His-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O JHORGUYURUBVOM-KKUMJFAQSA-N 0.000 description 3
- GYKDRHDMGQUZPU-MGHWNKPDSA-N Tyr-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC1=CC=C(C=C1)O)N GYKDRHDMGQUZPU-MGHWNKPDSA-N 0.000 description 3
- DJSYPCWZPNHQQE-FHWLQOOXSA-N Tyr-Tyr-Gln Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(N)=O)C(O)=O)C1=CC=C(O)C=C1 DJSYPCWZPNHQQE-FHWLQOOXSA-N 0.000 description 3
- KLOZTPOXVVRVAQ-DZKIICNBSA-N Tyr-Val-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 KLOZTPOXVVRVAQ-DZKIICNBSA-N 0.000 description 3
- AZSHAZJLOZQYAY-FXQIFTODSA-N Val-Ala-Ser Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O AZSHAZJLOZQYAY-FXQIFTODSA-N 0.000 description 3
- LABUITCFCAABSV-UHFFFAOYSA-N Val-Ala-Tyr Natural products CC(C)C(N)C(=O)NC(C)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 LABUITCFCAABSV-UHFFFAOYSA-N 0.000 description 3
- COYSIHFOCOMGCF-WPRPVWTQSA-N Val-Arg-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CCCN=C(N)N COYSIHFOCOMGCF-WPRPVWTQSA-N 0.000 description 3
- TZVUSFMQWPWHON-NHCYSSNCSA-N Val-Asp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C(C)C)N TZVUSFMQWPWHON-NHCYSSNCSA-N 0.000 description 3
- DDNIHOWRDOXXPF-NGZCFLSTSA-N Val-Asp-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N DDNIHOWRDOXXPF-NGZCFLSTSA-N 0.000 description 3
- URIRWLJVWHYLET-ONGXEEELSA-N Val-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)C(C)C URIRWLJVWHYLET-ONGXEEELSA-N 0.000 description 3
- KZKMBGXCNLPYKD-YEPSODPASA-N Val-Gly-Thr Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O KZKMBGXCNLPYKD-YEPSODPASA-N 0.000 description 3
- OVBMCNDKCWAXMZ-NAKRPEOUSA-N Val-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](C(C)C)N OVBMCNDKCWAXMZ-NAKRPEOUSA-N 0.000 description 3
- HGJRMXOWUWVUOA-GVXVVHGQSA-N Val-Leu-Gln Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N HGJRMXOWUWVUOA-GVXVVHGQSA-N 0.000 description 3
- BCBFMJYTNKDALA-UFYCRDLUSA-N Val-Phe-Phe Chemical compound N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O BCBFMJYTNKDALA-UFYCRDLUSA-N 0.000 description 3
- GBIUHAYJGWVNLN-UHFFFAOYSA-N Val-Ser-Pro Natural products CC(C)C(N)C(=O)NC(CO)C(=O)N1CCCC1C(O)=O GBIUHAYJGWVNLN-UHFFFAOYSA-N 0.000 description 3
- PDDJTOSAVNRJRH-UNQGMJICSA-N Val-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](C(C)C)N)O PDDJTOSAVNRJRH-UNQGMJICSA-N 0.000 description 3
- BGTDGENDNWGMDQ-KJEVXHAQSA-N Val-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N)O BGTDGENDNWGMDQ-KJEVXHAQSA-N 0.000 description 3
- AEFJNECXZCODJM-UWVGGRQHSA-N Val-Val-Gly Chemical compound CC(C)[C@H]([NH3+])C(=O)N[C@@H](C(C)C)C(=O)NCC([O-])=O AEFJNECXZCODJM-UWVGGRQHSA-N 0.000 description 3
- 108700005077 Viral Genes Proteins 0.000 description 3
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 description 3
- 108010041407 alanylaspartic acid Proteins 0.000 description 3
- 108010070944 alanylhistidine Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 108010069205 aspartyl-phenylalanine Proteins 0.000 description 3
- 230000007850 degeneration Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 239000003623 enhancer Substances 0.000 description 3
- 108010008237 glutamyl-valyl-glycine Proteins 0.000 description 3
- 108010075431 glycyl-alanyl-phenylalanine Proteins 0.000 description 3
- 108010077435 glycyl-phenylalanyl-glycine Proteins 0.000 description 3
- 108010010147 glycylglutamine Proteins 0.000 description 3
- 108010077515 glycylproline Proteins 0.000 description 3
- 108010084389 glycyltryptophan Proteins 0.000 description 3
- 108010037850 glycylvaline Proteins 0.000 description 3
- 230000006801 homologous recombination Effects 0.000 description 3
- 238000002744 homologous recombination Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 108010000761 leucylarginine Proteins 0.000 description 3
- 108010064235 lysylglycine Proteins 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 108020004999 messenger RNA Proteins 0.000 description 3
- 238000009126 molecular therapy Methods 0.000 description 3
- 108010091617 pentalysine Proteins 0.000 description 3
- 210000004049 perilymph Anatomy 0.000 description 3
- 239000013612 plasmid Substances 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 108010004914 prolylarginine Proteins 0.000 description 3
- 108010053725 prolylvaline Proteins 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 238000010839 reverse transcription Methods 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 210000001079 scala tympani Anatomy 0.000 description 3
- 108010026333 seryl-proline Proteins 0.000 description 3
- 230000005062 synaptic transmission Effects 0.000 description 3
- 230000021966 synaptic vesicle transport Effects 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 230000005030 transcription termination Effects 0.000 description 3
- 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 3
- 108010051110 tyrosyl-lysine Proteins 0.000 description 3
- 108010078580 tyrosylleucine Proteins 0.000 description 3
- NTUPOKHATNSWCY-PMPSAXMXSA-N (2s)-2-[[(2s)-1-[(2r)-2-amino-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]-5-(diaminomethylideneamino)pentanoic acid Chemical compound C([C@@H](N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)C1=CC=CC=C1 NTUPOKHATNSWCY-PMPSAXMXSA-N 0.000 description 2
- PQFMROVJTOPVDF-JBDRJPRFSA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-amino-3-carboxypropanoyl]amino]-3-carboxypropanoyl]amino]-4-carboxybutanoyl]amino]butanedioic acid Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O PQFMROVJTOPVDF-JBDRJPRFSA-N 0.000 description 2
- RRBGTUQJDFBWNN-MUGJNUQGSA-N (2s)-6-amino-2-[[(2s)-6-amino-2-[[(2s)-6-amino-2-[[(2s)-2,6-diaminohexanoyl]amino]hexanoyl]amino]hexanoyl]amino]hexanoic acid Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(O)=O RRBGTUQJDFBWNN-MUGJNUQGSA-N 0.000 description 2
- PIDRBUDUWHBYSR-UHFFFAOYSA-N 1-[2-[[2-[(2-amino-4-methylpentanoyl)amino]-4-methylpentanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid Chemical compound CC(C)CC(N)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(O)=O PIDRBUDUWHBYSR-UHFFFAOYSA-N 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 2
- 241001655883 Adeno-associated virus - 1 Species 0.000 description 2
- 241000972680 Adeno-associated virus - 6 Species 0.000 description 2
- BUANFPRKJKJSRR-ACZMJKKPSA-N Ala-Ala-Gln Chemical compound C[C@H]([NH3+])C(=O)N[C@@H](C)C(=O)N[C@H](C([O-])=O)CCC(N)=O BUANFPRKJKJSRR-ACZMJKKPSA-N 0.000 description 2
- QDRGPQWIVZNJQD-CIUDSAMLSA-N Ala-Arg-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O QDRGPQWIVZNJQD-CIUDSAMLSA-N 0.000 description 2
- XEXJJJRVTFGWIC-FXQIFTODSA-N Ala-Asn-Arg Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N XEXJJJRVTFGWIC-FXQIFTODSA-N 0.000 description 2
- WKOBSJOZRJJVRZ-FXQIFTODSA-N Ala-Glu-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O WKOBSJOZRJJVRZ-FXQIFTODSA-N 0.000 description 2
- SIGTYDNEPYEXGK-ZANVPECISA-N Ala-Gly-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)CNC(=O)[C@@H](N)C)C(O)=O)=CNC2=C1 SIGTYDNEPYEXGK-ZANVPECISA-N 0.000 description 2
- MEFILNJXAVSUTO-JXUBOQSCSA-N Ala-Leu-Thr Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MEFILNJXAVSUTO-JXUBOQSCSA-N 0.000 description 2
- ZBLQIYPCUWZSRZ-QEJZJMRPSA-N Ala-Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CC1=CC=CC=C1 ZBLQIYPCUWZSRZ-QEJZJMRPSA-N 0.000 description 2
- DYXOFPBJBAHWFY-JBDRJPRFSA-N Ala-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)N DYXOFPBJBAHWFY-JBDRJPRFSA-N 0.000 description 2
- PEEYDECOOVQKRZ-DLOVCJGASA-N Ala-Ser-Phe Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PEEYDECOOVQKRZ-DLOVCJGASA-N 0.000 description 2
- WNHNMKOFKCHKKD-BFHQHQDPSA-N Ala-Thr-Gly Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O WNHNMKOFKCHKKD-BFHQHQDPSA-N 0.000 description 2
- QOIGKCBMXUCDQU-KDXUFGMBSA-N Ala-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C)N)O QOIGKCBMXUCDQU-KDXUFGMBSA-N 0.000 description 2
- KTXKIYXZQFWJKB-VZFHVOOUSA-N Ala-Thr-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O KTXKIYXZQFWJKB-VZFHVOOUSA-N 0.000 description 2
- XPBVBZPVNFIHOA-UVBJJODRSA-N Ala-Trp-Val Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](C(C)C)C(O)=O)NC(=O)[C@H](C)N)=CNC2=C1 XPBVBZPVNFIHOA-UVBJJODRSA-N 0.000 description 2
- AENHOIXXHKNIQL-AUTRQRHGSA-N Ala-Tyr-Ala Chemical compound [O-]C(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@@H]([NH3+])C)CC1=CC=C(O)C=C1 AENHOIXXHKNIQL-AUTRQRHGSA-N 0.000 description 2
- KLKARCOHVHLAJP-UWJYBYFXSA-N Ala-Tyr-Cys Chemical compound C[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CS)C(O)=O KLKARCOHVHLAJP-UWJYBYFXSA-N 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- OTOXOKCIIQLMFH-KZVJFYERSA-N Arg-Ala-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N OTOXOKCIIQLMFH-KZVJFYERSA-N 0.000 description 2
- KJGNDQCYBNBXDA-GUBZILKMSA-N Arg-Arg-Cys Chemical compound C(C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)O)N)CN=C(N)N KJGNDQCYBNBXDA-GUBZILKMSA-N 0.000 description 2
- NONSEUUPKITYQT-BQBZGAKWSA-N Arg-Asn-Gly Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)NCC(=O)O)N)CN=C(N)N NONSEUUPKITYQT-BQBZGAKWSA-N 0.000 description 2
- OTUQSEPIIVBYEM-IHRRRGAJSA-N Arg-Asn-Tyr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O OTUQSEPIIVBYEM-IHRRRGAJSA-N 0.000 description 2
- SQKPKIJVWHAWNF-DCAQKATOSA-N Arg-Asp-Lys Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(O)=O SQKPKIJVWHAWNF-DCAQKATOSA-N 0.000 description 2
- HKRXJBBCQBAGIM-FXQIFTODSA-N Arg-Asp-Ser Chemical compound C(C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)O)N)CN=C(N)N HKRXJBBCQBAGIM-FXQIFTODSA-N 0.000 description 2
- BQBPFMNVOWDLHO-XIRDDKMYSA-N Arg-Gln-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N BQBPFMNVOWDLHO-XIRDDKMYSA-N 0.000 description 2
- HAVKMRGWNXMCDR-STQMWFEESA-N Arg-Gly-Phe Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O HAVKMRGWNXMCDR-STQMWFEESA-N 0.000 description 2
- ZATRYQNPUHGXCU-DTWKUNHWSA-N Arg-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CCCN=C(N)N)N)C(=O)O ZATRYQNPUHGXCU-DTWKUNHWSA-N 0.000 description 2
- PCQXGEUALSFGIA-WDSOQIARSA-N Arg-His-Trp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O PCQXGEUALSFGIA-WDSOQIARSA-N 0.000 description 2
- NIUDXSFNLBIWOB-DCAQKATOSA-N Arg-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N NIUDXSFNLBIWOB-DCAQKATOSA-N 0.000 description 2
- UZGFHWIJWPUPOH-IHRRRGAJSA-N Arg-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N UZGFHWIJWPUPOH-IHRRRGAJSA-N 0.000 description 2
- JEOCWTUOMKEEMF-RHYQMDGZSA-N Arg-Leu-Thr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JEOCWTUOMKEEMF-RHYQMDGZSA-N 0.000 description 2
- CVXXSWQORBZAAA-SRVKXCTJSA-N Arg-Lys-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCN=C(N)N CVXXSWQORBZAAA-SRVKXCTJSA-N 0.000 description 2
- OISWSORSLQOGFV-AVGNSLFASA-N Arg-Met-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCSC)NC(=O)[C@@H](N)CCCN=C(N)N OISWSORSLQOGFV-AVGNSLFASA-N 0.000 description 2
- NIELFHOLFTUZME-HJWJTTGWSA-N Arg-Phe-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O NIELFHOLFTUZME-HJWJTTGWSA-N 0.000 description 2
- LXMKTIZAGIBQRX-HRCADAONSA-N Arg-Phe-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CCCN=C(N)N)N)C(=O)O LXMKTIZAGIBQRX-HRCADAONSA-N 0.000 description 2
- WKPXXXUSUHAXDE-SRVKXCTJSA-N Arg-Pro-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O WKPXXXUSUHAXDE-SRVKXCTJSA-N 0.000 description 2
- DNBMCNQKNOKOSD-DCAQKATOSA-N Arg-Pro-Gln Chemical compound NC(N)=NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O DNBMCNQKNOKOSD-DCAQKATOSA-N 0.000 description 2
- JJIBHAOBNIFUEL-SRVKXCTJSA-N Arg-Pro-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)N JJIBHAOBNIFUEL-SRVKXCTJSA-N 0.000 description 2
- YCYXHLZRUSJITQ-SRVKXCTJSA-N Arg-Pro-Pro Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 YCYXHLZRUSJITQ-SRVKXCTJSA-N 0.000 description 2
- ATABBWFGOHKROJ-GUBZILKMSA-N Arg-Pro-Ser Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O ATABBWFGOHKROJ-GUBZILKMSA-N 0.000 description 2
- JOTRDIXZHNQYGP-DCAQKATOSA-N Arg-Ser-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)N JOTRDIXZHNQYGP-DCAQKATOSA-N 0.000 description 2
- OQPAZKMGCWPERI-GUBZILKMSA-N Arg-Ser-Val Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O OQPAZKMGCWPERI-GUBZILKMSA-N 0.000 description 2
- AIFHRTPABBBHKU-RCWTZXSCSA-N Arg-Thr-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H]([C@H](O)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O AIFHRTPABBBHKU-RCWTZXSCSA-N 0.000 description 2
- SUMJNGAMIQSNGX-TUAOUCFPSA-N Arg-Val-Pro Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)CCCNC(N)=N)C(=O)N1CCC[C@@H]1C(O)=O SUMJNGAMIQSNGX-TUAOUCFPSA-N 0.000 description 2
- JJGRJMKUOYXZRA-LPEHRKFASA-N Asn-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)N)N)C(=O)O JJGRJMKUOYXZRA-LPEHRKFASA-N 0.000 description 2
- ZWASIOHRQWRWAS-UGYAYLCHSA-N Asn-Asp-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ZWASIOHRQWRWAS-UGYAYLCHSA-N 0.000 description 2
- IYVSIZAXNLOKFQ-BYULHYEWSA-N Asn-Asp-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O IYVSIZAXNLOKFQ-BYULHYEWSA-N 0.000 description 2
- XVAPVJNJGLWGCS-ACZMJKKPSA-N Asn-Glu-Asn Chemical compound C(CC(=O)O)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CC(=O)N)N XVAPVJNJGLWGCS-ACZMJKKPSA-N 0.000 description 2
- JREOBWLIZLXRIS-GUBZILKMSA-N Asn-Glu-Leu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O JREOBWLIZLXRIS-GUBZILKMSA-N 0.000 description 2
- BKDDABUWNKGZCK-XHNCKOQMSA-N Asn-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)N)N)C(=O)O BKDDABUWNKGZCK-XHNCKOQMSA-N 0.000 description 2
- GFFRWIJAFFMQGM-NUMRIWBASA-N Asn-Glu-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O GFFRWIJAFFMQGM-NUMRIWBASA-N 0.000 description 2
- JZDZLBJVYWIIQU-AVGNSLFASA-N Asn-Glu-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JZDZLBJVYWIIQU-AVGNSLFASA-N 0.000 description 2
- GJFYPBDMUGGLFR-NKWVEPMBSA-N Asn-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CC(=O)N)N)C(=O)O GJFYPBDMUGGLFR-NKWVEPMBSA-N 0.000 description 2
- ACKNRKFVYUVWAC-ZPFDUUQYSA-N Asn-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N ACKNRKFVYUVWAC-ZPFDUUQYSA-N 0.000 description 2
- HDHZCEDPLTVHFZ-GUBZILKMSA-N Asn-Leu-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O HDHZCEDPLTVHFZ-GUBZILKMSA-N 0.000 description 2
- ALHMNHZJBYBYHS-DCAQKATOSA-N Asn-Lys-Arg Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O ALHMNHZJBYBYHS-DCAQKATOSA-N 0.000 description 2
- MYVBTYXSWILFCG-BQBZGAKWSA-N Asn-Met-Gly Chemical compound CSCC[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC(=O)N)N MYVBTYXSWILFCG-BQBZGAKWSA-N 0.000 description 2
- KAZKWIKPEPABOO-IHRRRGAJSA-N Asn-Met-Tyr Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CC(=O)N)N KAZKWIKPEPABOO-IHRRRGAJSA-N 0.000 description 2
- AMGQTNHANMRPOE-LKXGYXEUSA-N Asn-Thr-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O AMGQTNHANMRPOE-LKXGYXEUSA-N 0.000 description 2
- BEHQTVDBCLSCBY-CFMVVWHZSA-N Asn-Tyr-Ile Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BEHQTVDBCLSCBY-CFMVVWHZSA-N 0.000 description 2
- XEGZSHSPQNDNRH-JRQIVUDYSA-N Asn-Tyr-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XEGZSHSPQNDNRH-JRQIVUDYSA-N 0.000 description 2
- LMIWYCWRJVMAIQ-NHCYSSNCSA-N Asn-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N LMIWYCWRJVMAIQ-NHCYSSNCSA-N 0.000 description 2
- WSOKZUVWBXVJHX-CIUDSAMLSA-N Asp-Arg-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(O)=O WSOKZUVWBXVJHX-CIUDSAMLSA-N 0.000 description 2
- FAEIQWHBRBWUBN-FXQIFTODSA-N Asp-Arg-Ser Chemical compound C(C[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC(=O)O)N)CN=C(N)N FAEIQWHBRBWUBN-FXQIFTODSA-N 0.000 description 2
- UQBGYPFHWFZMCD-ZLUOBGJFSA-N Asp-Asn-Asn Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O UQBGYPFHWFZMCD-ZLUOBGJFSA-N 0.000 description 2
- WCFCYFDBMNFSPA-ACZMJKKPSA-N Asp-Asp-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CCC(O)=O WCFCYFDBMNFSPA-ACZMJKKPSA-N 0.000 description 2
- SBHUBSDEZQFJHJ-CIUDSAMLSA-N Asp-Asp-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O SBHUBSDEZQFJHJ-CIUDSAMLSA-N 0.000 description 2
- OVPHVTCDVYYTHN-AVGNSLFASA-N Asp-Glu-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 OVPHVTCDVYYTHN-AVGNSLFASA-N 0.000 description 2
- XDGBFDYXZCMYEX-NUMRIWBASA-N Asp-Glu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)N)O XDGBFDYXZCMYEX-NUMRIWBASA-N 0.000 description 2
- WBDWQKRLTVCDSY-WHFBIAKZSA-N Asp-Gly-Asp Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O WBDWQKRLTVCDSY-WHFBIAKZSA-N 0.000 description 2
- PZXPWHFYZXTFBI-YUMQZZPRSA-N Asp-Gly-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(O)=O PZXPWHFYZXTFBI-YUMQZZPRSA-N 0.000 description 2
- POTCZYQVVNXUIG-BQBZGAKWSA-N Asp-Gly-Pro Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O POTCZYQVVNXUIG-BQBZGAKWSA-N 0.000 description 2
- RWHHSFSWKFBTCF-KKUMJFAQSA-N Asp-His-Phe Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)O)NC(=O)[C@H](CC2=CN=CN2)NC(=O)[C@H](CC(=O)O)N RWHHSFSWKFBTCF-KKUMJFAQSA-N 0.000 description 2
- GBSUGIXJAAKZOW-GMOBBJLQSA-N Asp-Ile-Arg Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O GBSUGIXJAAKZOW-GMOBBJLQSA-N 0.000 description 2
- YFSLJHLQOALGSY-ZPFDUUQYSA-N Asp-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)O)N YFSLJHLQOALGSY-ZPFDUUQYSA-N 0.000 description 2
- DWOGMPWRQQWPPF-GUBZILKMSA-N Asp-Leu-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O DWOGMPWRQQWPPF-GUBZILKMSA-N 0.000 description 2
- VSMYBNPOHYAXSD-GUBZILKMSA-N Asp-Lys-Glu Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O VSMYBNPOHYAXSD-GUBZILKMSA-N 0.000 description 2
- HJCGDIGVVWETRO-ZPFDUUQYSA-N Asp-Lys-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC(O)=O)C(O)=O HJCGDIGVVWETRO-ZPFDUUQYSA-N 0.000 description 2
- NVFSJIXJZCDICF-SRVKXCTJSA-N Asp-Lys-Lys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)O)N NVFSJIXJZCDICF-SRVKXCTJSA-N 0.000 description 2
- MYLZFUMPZCPJCJ-NHCYSSNCSA-N Asp-Lys-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O MYLZFUMPZCPJCJ-NHCYSSNCSA-N 0.000 description 2
- LIQNMKIBMPEOOP-IHRRRGAJSA-N Asp-Phe-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)O)N LIQNMKIBMPEOOP-IHRRRGAJSA-N 0.000 description 2
- KESWRFKUZRUTAH-FXQIFTODSA-N Asp-Pro-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O KESWRFKUZRUTAH-FXQIFTODSA-N 0.000 description 2
- MVRGBQGZSDJBSM-GMOBBJLQSA-N Asp-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)N MVRGBQGZSDJBSM-GMOBBJLQSA-N 0.000 description 2
- YFGUZQQCSDZRBN-DCAQKATOSA-N Asp-Pro-Leu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O YFGUZQQCSDZRBN-DCAQKATOSA-N 0.000 description 2
- XUVTWGPERWIERB-IHRRRGAJSA-N Asp-Pro-Phe Chemical compound N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(O)=O XUVTWGPERWIERB-IHRRRGAJSA-N 0.000 description 2
- ZVGRHIRJLWBWGJ-ACZMJKKPSA-N Asp-Ser-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O ZVGRHIRJLWBWGJ-ACZMJKKPSA-N 0.000 description 2
- YIDFBWRHIYOYAA-LKXGYXEUSA-N Asp-Ser-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O YIDFBWRHIYOYAA-LKXGYXEUSA-N 0.000 description 2
- UEFODXNXUAVPTC-VEVYYDQMSA-N Asp-Thr-Met Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)O)N)O UEFODXNXUAVPTC-VEVYYDQMSA-N 0.000 description 2
- GCACQYDBDHRVGE-LKXGYXEUSA-N Asp-Thr-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CC(O)=O GCACQYDBDHRVGE-LKXGYXEUSA-N 0.000 description 2
- OYSYWMMZGJSQRB-AVGNSLFASA-N Asp-Tyr-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O OYSYWMMZGJSQRB-AVGNSLFASA-N 0.000 description 2
- XWKBWZXGNXTDKY-ZKWXMUAHSA-N Asp-Val-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC(O)=O XWKBWZXGNXTDKY-ZKWXMUAHSA-N 0.000 description 2
- XWKPSMRPIKKDDU-RCOVLWMOSA-N Asp-Val-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(O)=O XWKPSMRPIKKDDU-RCOVLWMOSA-N 0.000 description 2
- 241000197194 Bulla Species 0.000 description 2
- 108090000565 Capsid Proteins Proteins 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 102100023321 Ceruloplasmin Human genes 0.000 description 2
- 108020004705 Codon Proteins 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 108091028732 Concatemer Proteins 0.000 description 2
- 206010010356 Congenital anomaly Diseases 0.000 description 2
- 108091035707 Consensus sequence Proteins 0.000 description 2
- AEJSNWMRPXAKCW-WHFBIAKZSA-N Cys-Ala-Gly Chemical compound SC[C@H](N)C(=O)N[C@@H](C)C(=O)NCC(O)=O AEJSNWMRPXAKCW-WHFBIAKZSA-N 0.000 description 2
- DCJNIJAWIRPPBB-CIUDSAMLSA-N Cys-Ala-Lys Chemical compound C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CS)N DCJNIJAWIRPPBB-CIUDSAMLSA-N 0.000 description 2
- JTNKVWLMDHIUOG-IHRRRGAJSA-N Cys-Arg-Phe Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O JTNKVWLMDHIUOG-IHRRRGAJSA-N 0.000 description 2
- WXKWQSDHEXKKNC-ZKWXMUAHSA-N Cys-Asp-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CS)N WXKWQSDHEXKKNC-ZKWXMUAHSA-N 0.000 description 2
- QADHATDBZXHRCA-ACZMJKKPSA-N Cys-Gln-Asn Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CS)N QADHATDBZXHRCA-ACZMJKKPSA-N 0.000 description 2
- URDUGPGPLNXXES-WHFBIAKZSA-N Cys-Gly-Cys Chemical compound SC[C@H](N)C(=O)NCC(=O)N[C@@H](CS)C(O)=O URDUGPGPLNXXES-WHFBIAKZSA-N 0.000 description 2
- PQHYZJPCYRDYNE-QWRGUYRKSA-N Cys-Gly-Phe Chemical compound [H]N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PQHYZJPCYRDYNE-QWRGUYRKSA-N 0.000 description 2
- YFAFBAPQHGULQT-HJPIBITLSA-N Cys-Ile-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CS)N YFAFBAPQHGULQT-HJPIBITLSA-N 0.000 description 2
- JLZCAZJGWNRXCI-XKBZYTNZSA-N Cys-Thr-Glu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(O)=O JLZCAZJGWNRXCI-XKBZYTNZSA-N 0.000 description 2
- 102000053602 DNA Human genes 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
- 208000003098 Ganglion Cysts Diseases 0.000 description 2
- JFOKLAPFYCTNHW-SRVKXCTJSA-N Gln-Arg-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)N)N JFOKLAPFYCTNHW-SRVKXCTJSA-N 0.000 description 2
- INFBPLSHYFALDE-ACZMJKKPSA-N Gln-Asn-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(O)=O INFBPLSHYFALDE-ACZMJKKPSA-N 0.000 description 2
- LPYPANUXJGFMGV-FXQIFTODSA-N Gln-Gln-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCC(=O)N)N LPYPANUXJGFMGV-FXQIFTODSA-N 0.000 description 2
- PXAFHUATEHLECW-GUBZILKMSA-N Gln-Glu-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)N)N PXAFHUATEHLECW-GUBZILKMSA-N 0.000 description 2
- SMLDOQHTOAAFJQ-WDSKDSINSA-N Gln-Gly-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CO)C(O)=O SMLDOQHTOAAFJQ-WDSKDSINSA-N 0.000 description 2
- HWEINOMSWQSJDC-SRVKXCTJSA-N Gln-Leu-Arg Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O HWEINOMSWQSJDC-SRVKXCTJSA-N 0.000 description 2
- VZRAXPGTUNDIDK-GUBZILKMSA-N Gln-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N VZRAXPGTUNDIDK-GUBZILKMSA-N 0.000 description 2
- QKCZZAZNMMVICF-DCAQKATOSA-N Gln-Leu-Glu Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O QKCZZAZNMMVICF-DCAQKATOSA-N 0.000 description 2
- FKXCBKCOSVIGCT-AVGNSLFASA-N Gln-Lys-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O FKXCBKCOSVIGCT-AVGNSLFASA-N 0.000 description 2
- FALJZCPMTGJOHX-SRVKXCTJSA-N Gln-Met-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O FALJZCPMTGJOHX-SRVKXCTJSA-N 0.000 description 2
- LGWNISYVKDNJRP-FXQIFTODSA-N Gln-Ser-Gln Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O LGWNISYVKDNJRP-FXQIFTODSA-N 0.000 description 2
- ZMXZGYLINVNTKH-DZKIICNBSA-N Gln-Val-Phe Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 ZMXZGYLINVNTKH-DZKIICNBSA-N 0.000 description 2
- SOEXCCGNHQBFPV-DLOVCJGASA-N Gln-Val-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O SOEXCCGNHQBFPV-DLOVCJGASA-N 0.000 description 2
- BPDVTFBJZNBHEU-HGNGGELXSA-N Glu-Ala-His Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CN=CN1 BPDVTFBJZNBHEU-HGNGGELXSA-N 0.000 description 2
- IRDASPPCLZIERZ-XHNCKOQMSA-N Glu-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)O)N IRDASPPCLZIERZ-XHNCKOQMSA-N 0.000 description 2
- NCWOMXABNYEPLY-NRPADANISA-N Glu-Ala-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(O)=O NCWOMXABNYEPLY-NRPADANISA-N 0.000 description 2
- VTTSANCGJWLPNC-ZPFDUUQYSA-N Glu-Arg-Ile Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VTTSANCGJWLPNC-ZPFDUUQYSA-N 0.000 description 2
- JPHYJQHPILOKHC-ACZMJKKPSA-N Glu-Asp-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O JPHYJQHPILOKHC-ACZMJKKPSA-N 0.000 description 2
- XXCDTYBVGMPIOA-FXQIFTODSA-N Glu-Asp-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O XXCDTYBVGMPIOA-FXQIFTODSA-N 0.000 description 2
- IESFZVCAVACGPH-PEFMBERDSA-N Glu-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCC(O)=O IESFZVCAVACGPH-PEFMBERDSA-N 0.000 description 2
- SJPMNHCEWPTRBR-BQBZGAKWSA-N Glu-Glu-Gly Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O SJPMNHCEWPTRBR-BQBZGAKWSA-N 0.000 description 2
- IQACOVZVOMVILH-FXQIFTODSA-N Glu-Glu-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O IQACOVZVOMVILH-FXQIFTODSA-N 0.000 description 2
- HILMIYALTUQTRC-XVKPBYJWSA-N Glu-Gly-Val Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O HILMIYALTUQTRC-XVKPBYJWSA-N 0.000 description 2
- XOIATPHFYVWFEU-DCAQKATOSA-N Glu-His-Gln Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)O)N XOIATPHFYVWFEU-DCAQKATOSA-N 0.000 description 2
- VSRCAOIHMGCIJK-SRVKXCTJSA-N Glu-Leu-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O VSRCAOIHMGCIJK-SRVKXCTJSA-N 0.000 description 2
- PJBVXVBTTFZPHJ-GUBZILKMSA-N Glu-Leu-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCC(=O)O)N PJBVXVBTTFZPHJ-GUBZILKMSA-N 0.000 description 2
- MWMJCGBSIORNCD-AVGNSLFASA-N Glu-Leu-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O MWMJCGBSIORNCD-AVGNSLFASA-N 0.000 description 2
- IVGJYOOGJLFKQE-AVGNSLFASA-N Glu-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N IVGJYOOGJLFKQE-AVGNSLFASA-N 0.000 description 2
- NJCALAAIGREHDR-WDCWCFNPSA-N Glu-Leu-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O NJCALAAIGREHDR-WDCWCFNPSA-N 0.000 description 2
- SWRVAQHFBRZVNX-GUBZILKMSA-N Glu-Lys-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O SWRVAQHFBRZVNX-GUBZILKMSA-N 0.000 description 2
- BCYGDJXHAGZNPQ-DCAQKATOSA-N Glu-Lys-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O BCYGDJXHAGZNPQ-DCAQKATOSA-N 0.000 description 2
- HRBYTAIBKPNZKQ-AVGNSLFASA-N Glu-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCC(O)=O HRBYTAIBKPNZKQ-AVGNSLFASA-N 0.000 description 2
- FMBWLLMUPXTXFC-SDDRHHMPSA-N Glu-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CCC(=O)O)N)C(=O)O FMBWLLMUPXTXFC-SDDRHHMPSA-N 0.000 description 2
- RBXSZQRSEGYDFG-GUBZILKMSA-N Glu-Lys-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O RBXSZQRSEGYDFG-GUBZILKMSA-N 0.000 description 2
- QNJNPKSWAHPYGI-JYJNAYRXSA-N Glu-Phe-Leu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C(O)=O)CC1=CC=CC=C1 QNJNPKSWAHPYGI-JYJNAYRXSA-N 0.000 description 2
- YTRBQAQSUDSIQE-FHWLQOOXSA-N Glu-Phe-Phe Chemical compound C([C@H](NC(=O)[C@H](CCC(O)=O)N)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 YTRBQAQSUDSIQE-FHWLQOOXSA-N 0.000 description 2
- QJVZSVUYZFYLFQ-CIUDSAMLSA-N Glu-Pro-Ala Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O QJVZSVUYZFYLFQ-CIUDSAMLSA-N 0.000 description 2
- BIYNPVYAZOUVFQ-CIUDSAMLSA-N Glu-Pro-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O BIYNPVYAZOUVFQ-CIUDSAMLSA-N 0.000 description 2
- YQAQQKPWFOBSMU-WDCWCFNPSA-N Glu-Thr-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O YQAQQKPWFOBSMU-WDCWCFNPSA-N 0.000 description 2
- MFYLRRCYBBJYPI-JYJNAYRXSA-N Glu-Tyr-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O MFYLRRCYBBJYPI-JYJNAYRXSA-N 0.000 description 2
- ZYRXTRTUCAVNBQ-GVXVVHGQSA-N Glu-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CCC(=O)O)N ZYRXTRTUCAVNBQ-GVXVVHGQSA-N 0.000 description 2
- WGYHAAXZWPEBDQ-IFFSRLJSSA-N Glu-Val-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O WGYHAAXZWPEBDQ-IFFSRLJSSA-N 0.000 description 2
- YMUFWNJHVPQNQD-ZKWXMUAHSA-N Gly-Ala-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)CN YMUFWNJHVPQNQD-ZKWXMUAHSA-N 0.000 description 2
- JBRBACJPBZNFMF-YUMQZZPRSA-N Gly-Ala-Lys Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN JBRBACJPBZNFMF-YUMQZZPRSA-N 0.000 description 2
- GWCRIHNSVMOBEQ-BQBZGAKWSA-N Gly-Arg-Ser Chemical compound [H]NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O GWCRIHNSVMOBEQ-BQBZGAKWSA-N 0.000 description 2
- DTPOVRRYXPJJAZ-FJXKBIBVSA-N Gly-Arg-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N DTPOVRRYXPJJAZ-FJXKBIBVSA-N 0.000 description 2
- NZAFOTBEULLEQB-WDSKDSINSA-N Gly-Asn-Glu Chemical compound C(CC(=O)O)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)CN NZAFOTBEULLEQB-WDSKDSINSA-N 0.000 description 2
- MHHUEAIBJZWDBH-YUMQZZPRSA-N Gly-Asp-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CN MHHUEAIBJZWDBH-YUMQZZPRSA-N 0.000 description 2
- YZACQYVWLCQWBT-BQBZGAKWSA-N Gly-Cys-Arg Chemical compound [H]NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O YZACQYVWLCQWBT-BQBZGAKWSA-N 0.000 description 2
- XTQFHTHIAKKCTM-YFKPBYRVSA-N Gly-Glu-Gly Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O XTQFHTHIAKKCTM-YFKPBYRVSA-N 0.000 description 2
- MBOAPAXLTUSMQI-JHEQGTHGSA-N Gly-Glu-Thr Chemical compound [H]NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MBOAPAXLTUSMQI-JHEQGTHGSA-N 0.000 description 2
- UTYGDAHJBBDPBA-BYULHYEWSA-N Gly-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)CN UTYGDAHJBBDPBA-BYULHYEWSA-N 0.000 description 2
- BHPQOIPBLYJNAW-NGZCFLSTSA-N Gly-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN BHPQOIPBLYJNAW-NGZCFLSTSA-N 0.000 description 2
- UHPAZODVFFYEEL-QWRGUYRKSA-N Gly-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN UHPAZODVFFYEEL-QWRGUYRKSA-N 0.000 description 2
- VBOBNHSVQKKTOT-YUMQZZPRSA-N Gly-Lys-Ala Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(O)=O VBOBNHSVQKKTOT-YUMQZZPRSA-N 0.000 description 2
- LOEANKRDMMVOGZ-YUMQZZPRSA-N Gly-Lys-Asp Chemical compound NCCCC[C@H](NC(=O)CN)C(=O)N[C@@H](CC(O)=O)C(O)=O LOEANKRDMMVOGZ-YUMQZZPRSA-N 0.000 description 2
- PDUHNKAFQXQNLH-ZETCQYMHSA-N Gly-Lys-Gly Chemical compound NCCCC[C@H](NC(=O)CN)C(=O)NCC(O)=O PDUHNKAFQXQNLH-ZETCQYMHSA-N 0.000 description 2
- PCPOYRCAHPJXII-UWVGGRQHSA-N Gly-Lys-Met Chemical compound [H]NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(O)=O PCPOYRCAHPJXII-UWVGGRQHSA-N 0.000 description 2
- YYXJFBMCOUSYSF-RYUDHWBXSA-N Gly-Phe-Gln Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(O)=O YYXJFBMCOUSYSF-RYUDHWBXSA-N 0.000 description 2
- ZZJVYSAQQMDIRD-UWVGGRQHSA-N Gly-Pro-His Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1cnc[nH]1)C(O)=O ZZJVYSAQQMDIRD-UWVGGRQHSA-N 0.000 description 2
- SSFWXSNOKDZNHY-QXEWZRGKSA-N Gly-Pro-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN SSFWXSNOKDZNHY-QXEWZRGKSA-N 0.000 description 2
- IRJWAYCXIYUHQE-WHFBIAKZSA-N Gly-Ser-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)CN IRJWAYCXIYUHQE-WHFBIAKZSA-N 0.000 description 2
- SOEGEPHNZOISMT-BYPYZUCNSA-N Gly-Ser-Gly Chemical compound NCC(=O)N[C@@H](CO)C(=O)NCC(O)=O SOEGEPHNZOISMT-BYPYZUCNSA-N 0.000 description 2
- WNGHUXFWEWTKAO-YUMQZZPRSA-N Gly-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN WNGHUXFWEWTKAO-YUMQZZPRSA-N 0.000 description 2
- LCRDMSSAKLTKBU-ZDLURKLDSA-N Gly-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)CN LCRDMSSAKLTKBU-ZDLURKLDSA-N 0.000 description 2
- IMRNSEPSPFQNHF-STQMWFEESA-N Gly-Ser-Trp Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=CC=CC=C12)C(=O)O IMRNSEPSPFQNHF-STQMWFEESA-N 0.000 description 2
- NVTPVQLIZCOJFK-FOHZUACHSA-N Gly-Thr-Asp Chemical compound [H]NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O NVTPVQLIZCOJFK-FOHZUACHSA-N 0.000 description 2
- UMBDRSMLCUYIRI-DVJZZOLTSA-N Gly-Trp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)CN)O UMBDRSMLCUYIRI-DVJZZOLTSA-N 0.000 description 2
- 102000018997 Growth Hormone Human genes 0.000 description 2
- 108010051696 Growth Hormone Proteins 0.000 description 2
- FLUVGKKRRMLNPU-CQDKDKBSSA-N His-Ala-Phe Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O FLUVGKKRRMLNPU-CQDKDKBSSA-N 0.000 description 2
- TVQGUFGDVODUIF-LSJOCFKGSA-N His-Arg-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC1=CN=CN1)N TVQGUFGDVODUIF-LSJOCFKGSA-N 0.000 description 2
- FYVHHKMHFPMBBG-GUBZILKMSA-N His-Gln-Asp Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N FYVHHKMHFPMBBG-GUBZILKMSA-N 0.000 description 2
- FIMNVXRZGUAGBI-AVGNSLFASA-N His-Glu-Leu Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O FIMNVXRZGUAGBI-AVGNSLFASA-N 0.000 description 2
- AKAPKBNIVNPIPO-KKUMJFAQSA-N His-His-Lys Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@@H](N)CC=1NC=NC=1)C1=CN=CN1 AKAPKBNIVNPIPO-KKUMJFAQSA-N 0.000 description 2
- PGRPSOUCWRBWKZ-DLOVCJGASA-N His-Lys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CC1=CN=CN1 PGRPSOUCWRBWKZ-DLOVCJGASA-N 0.000 description 2
- YXXKBPJEIYFGOD-MGHWNKPDSA-N His-Phe-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC2=CN=CN2)N YXXKBPJEIYFGOD-MGHWNKPDSA-N 0.000 description 2
- LNDVNHOSZQPJGI-AVGNSLFASA-N His-Pro-Pro Chemical compound C([C@H](N)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(O)=O)C1=CN=CN1 LNDVNHOSZQPJGI-AVGNSLFASA-N 0.000 description 2
- ALPXXNRQBMRCPZ-MEYUZBJRSA-N His-Thr-Phe Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O ALPXXNRQBMRCPZ-MEYUZBJRSA-N 0.000 description 2
- QTMKFZAYZKBFRC-BZSNNMDCSA-N His-Tyr-His Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CC3=CN=CN3)N)O QTMKFZAYZKBFRC-BZSNNMDCSA-N 0.000 description 2
- SYPULFZAGBBIOM-GVXVVHGQSA-N His-Val-Glu Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N SYPULFZAGBBIOM-GVXVVHGQSA-N 0.000 description 2
- 101001001817 Homo sapiens Pejvakin Proteins 0.000 description 2
- YKRYHWJRQUSTKG-KBIXCLLPSA-N Ile-Ala-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N YKRYHWJRQUSTKG-KBIXCLLPSA-N 0.000 description 2
- DMHGKBGOUAJRHU-RVMXOQNASA-N Ile-Arg-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N DMHGKBGOUAJRHU-RVMXOQNASA-N 0.000 description 2
- IDAHFEPYTJJZFD-PEFMBERDSA-N Ile-Asp-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N IDAHFEPYTJJZFD-PEFMBERDSA-N 0.000 description 2
- GYAFMRQGWHXMII-IUKAMOBKSA-N Ile-Asp-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N GYAFMRQGWHXMII-IUKAMOBKSA-N 0.000 description 2
- QRTVJGKXFSYJGW-KBIXCLLPSA-N Ile-Glu-Cys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N QRTVJGKXFSYJGW-KBIXCLLPSA-N 0.000 description 2
- SLQVFYWBGNNOTK-BYULHYEWSA-N Ile-Gly-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)N)C(=O)O)N SLQVFYWBGNNOTK-BYULHYEWSA-N 0.000 description 2
- CSQNHSGHAPRGPQ-YTFOTSKYSA-N Ile-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)O)N CSQNHSGHAPRGPQ-YTFOTSKYSA-N 0.000 description 2
- FFAUOCITXBMRBT-YTFOTSKYSA-N Ile-Lys-Ile Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FFAUOCITXBMRBT-YTFOTSKYSA-N 0.000 description 2
- GVNNAHIRSDRIII-AJNGGQMLSA-N Ile-Lys-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N GVNNAHIRSDRIII-AJNGGQMLSA-N 0.000 description 2
- AKOYRLRUFBZOSP-BJDJZHNGSA-N Ile-Lys-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)O)N AKOYRLRUFBZOSP-BJDJZHNGSA-N 0.000 description 2
- CKRFDMPBSWYOBT-PPCPHDFISA-N Ile-Lys-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)O)N CKRFDMPBSWYOBT-PPCPHDFISA-N 0.000 description 2
- FTUZWJVSNZMLPI-RVMXOQNASA-N Ile-Met-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N1CCC[C@@H]1C(=O)O)N FTUZWJVSNZMLPI-RVMXOQNASA-N 0.000 description 2
- WYUHAXJAMDTOAU-IAVJCBSLSA-N Ile-Phe-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N WYUHAXJAMDTOAU-IAVJCBSLSA-N 0.000 description 2
- IITVUURPOYGCTD-NAKRPEOUSA-N Ile-Pro-Ala Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O IITVUURPOYGCTD-NAKRPEOUSA-N 0.000 description 2
- CAHCWMVNBZJVAW-NAKRPEOUSA-N Ile-Pro-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)O)N CAHCWMVNBZJVAW-NAKRPEOUSA-N 0.000 description 2
- JODPUDMBQBIWCK-GHCJXIJMSA-N Ile-Ser-Asn Chemical compound [H]N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O JODPUDMBQBIWCK-GHCJXIJMSA-N 0.000 description 2
- ZNOBVZFCHNHKHA-KBIXCLLPSA-N Ile-Ser-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N ZNOBVZFCHNHKHA-KBIXCLLPSA-N 0.000 description 2
- PXKACEXYLPBMAD-JBDRJPRFSA-N Ile-Ser-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PXKACEXYLPBMAD-JBDRJPRFSA-N 0.000 description 2
- WXLYNEHOGRYNFU-URLPEUOOSA-N Ile-Thr-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N WXLYNEHOGRYNFU-URLPEUOOSA-N 0.000 description 2
- CRYJOCSSSACEAA-VKOGCVSHSA-N Ile-Trp-Met Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCSC)C(=O)O)N CRYJOCSSSACEAA-VKOGCVSHSA-N 0.000 description 2
- ZFWISYLMLXFBSX-KKPKCPPISA-N Ile-Trp-Phe Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)N ZFWISYLMLXFBSX-KKPKCPPISA-N 0.000 description 2
- BCISUQVFDGYZBO-QSFUFRPTSA-N Ile-Val-Asp Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(O)=O BCISUQVFDGYZBO-QSFUFRPTSA-N 0.000 description 2
- DLEBSGAVWRPTIX-PEDHHIEDSA-N Ile-Val-Ile Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)[C@@H](C)CC DLEBSGAVWRPTIX-PEDHHIEDSA-N 0.000 description 2
- 108020004684 Internal Ribosome Entry Sites Proteins 0.000 description 2
- KFKWRHQBZQICHA-STQMWFEESA-N L-leucyl-L-phenylalanine Natural products CC(C)C[C@H](N)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KFKWRHQBZQICHA-STQMWFEESA-N 0.000 description 2
- YOZCKMXHBYKOMQ-IHRRRGAJSA-N Leu-Arg-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCCN)C(=O)O)N YOZCKMXHBYKOMQ-IHRRRGAJSA-N 0.000 description 2
- VKOAHIRLIUESLU-ULQDDVLXSA-N Leu-Arg-Phe Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O VKOAHIRLIUESLU-ULQDDVLXSA-N 0.000 description 2
- IGUOAYLTQJLPPD-DCAQKATOSA-N Leu-Asn-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IGUOAYLTQJLPPD-DCAQKATOSA-N 0.000 description 2
- VCSBGUACOYUIGD-CIUDSAMLSA-N Leu-Asn-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O VCSBGUACOYUIGD-CIUDSAMLSA-N 0.000 description 2
- RIMMMMYKGIBOSN-DCAQKATOSA-N Leu-Asn-Met Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(O)=O RIMMMMYKGIBOSN-DCAQKATOSA-N 0.000 description 2
- ILJREDZFPHTUIE-GUBZILKMSA-N Leu-Asp-Glu Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ILJREDZFPHTUIE-GUBZILKMSA-N 0.000 description 2
- ZDSNOSQHMJBRQN-SRVKXCTJSA-N Leu-Asp-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N ZDSNOSQHMJBRQN-SRVKXCTJSA-N 0.000 description 2
- NHHKSOGJYNQENP-SRVKXCTJSA-N Leu-Cys-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)O)N NHHKSOGJYNQENP-SRVKXCTJSA-N 0.000 description 2
- RSFGIMMPWAXNML-MNXVOIDGSA-N Leu-Gln-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O RSFGIMMPWAXNML-MNXVOIDGSA-N 0.000 description 2
- ZFNLIDNJUWNIJL-WDCWCFNPSA-N Leu-Glu-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ZFNLIDNJUWNIJL-WDCWCFNPSA-N 0.000 description 2
- HYIFFZAQXPUEAU-QWRGUYRKSA-N Leu-Gly-Leu Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(C)C HYIFFZAQXPUEAU-QWRGUYRKSA-N 0.000 description 2
- YFBBUHJJUXXZOF-UWVGGRQHSA-N Leu-Gly-Pro Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N1CCC[C@H]1C(O)=O YFBBUHJJUXXZOF-UWVGGRQHSA-N 0.000 description 2
- CSFVADKICPDRRF-KKUMJFAQSA-N Leu-His-Leu Chemical compound CC(C)C[C@H]([NH3+])C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C([O-])=O)CC1=CN=CN1 CSFVADKICPDRRF-KKUMJFAQSA-N 0.000 description 2
- OHZIZVWQXJPBJS-IXOXFDKPSA-N Leu-His-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OHZIZVWQXJPBJS-IXOXFDKPSA-N 0.000 description 2
- KOSWSHVQIVTVQF-ZPFDUUQYSA-N Leu-Ile-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O KOSWSHVQIVTVQF-ZPFDUUQYSA-N 0.000 description 2
- VCHVSKNMTXWIIP-SRVKXCTJSA-N Leu-Lys-Ser Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(O)=O VCHVSKNMTXWIIP-SRVKXCTJSA-N 0.000 description 2
- OVZLLFONXILPDZ-VOAKCMCISA-N Leu-Lys-Thr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OVZLLFONXILPDZ-VOAKCMCISA-N 0.000 description 2
- CPONGMJGVIAWEH-DCAQKATOSA-N Leu-Met-Ala Chemical compound CSCC[C@H](NC(=O)[C@@H](N)CC(C)C)C(=O)N[C@@H](C)C(O)=O CPONGMJGVIAWEH-DCAQKATOSA-N 0.000 description 2
- INCJJHQRZGQLFC-KBPBESRZSA-N Leu-Phe-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(O)=O INCJJHQRZGQLFC-KBPBESRZSA-N 0.000 description 2
- DRWMRVFCKKXHCH-BZSNNMDCSA-N Leu-Phe-Leu Chemical compound CC(C)C[C@H]([NH3+])C(=O)N[C@H](C(=O)N[C@@H](CC(C)C)C([O-])=O)CC1=CC=CC=C1 DRWMRVFCKKXHCH-BZSNNMDCSA-N 0.000 description 2
- HGUUMQWGYCVPKG-DCAQKATOSA-N Leu-Pro-Cys Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)O)N HGUUMQWGYCVPKG-DCAQKATOSA-N 0.000 description 2
- UCBPDSYUVAAHCD-UWVGGRQHSA-N Leu-Pro-Gly Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UCBPDSYUVAAHCD-UWVGGRQHSA-N 0.000 description 2
- DPURXCQCHSQPAN-AVGNSLFASA-N Leu-Pro-Pro Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 DPURXCQCHSQPAN-AVGNSLFASA-N 0.000 description 2
- PWPBLZXWFXJFHE-RHYQMDGZSA-N Leu-Pro-Thr Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O PWPBLZXWFXJFHE-RHYQMDGZSA-N 0.000 description 2
- IDGZVZJLYFTXSL-DCAQKATOSA-N Leu-Ser-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N IDGZVZJLYFTXSL-DCAQKATOSA-N 0.000 description 2
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 2
- AMSSKPUHBUQBOQ-SRVKXCTJSA-N Leu-Ser-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N AMSSKPUHBUQBOQ-SRVKXCTJSA-N 0.000 description 2
- ZJZNLRVCZWUONM-JXUBOQSCSA-N Leu-Thr-Ala Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O ZJZNLRVCZWUONM-JXUBOQSCSA-N 0.000 description 2
- YWFZWQKWNDOWPA-XIRDDKMYSA-N Leu-Trp-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(N)=O)C(O)=O YWFZWQKWNDOWPA-XIRDDKMYSA-N 0.000 description 2
- WFCKERTZVCQXKH-KBPBESRZSA-N Leu-Tyr-Gly Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O WFCKERTZVCQXKH-KBPBESRZSA-N 0.000 description 2
- FBNPMTNBFFAMMH-AVGNSLFASA-N Leu-Val-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N FBNPMTNBFFAMMH-AVGNSLFASA-N 0.000 description 2
- YQFZRHYZLARWDY-IHRRRGAJSA-N Leu-Val-Lys Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN YQFZRHYZLARWDY-IHRRRGAJSA-N 0.000 description 2
- FZIJIFCXUCZHOL-CIUDSAMLSA-N Lys-Ala-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCCN FZIJIFCXUCZHOL-CIUDSAMLSA-N 0.000 description 2
- MPOHDJKRBLVGCT-CIUDSAMLSA-N Lys-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCCN)N MPOHDJKRBLVGCT-CIUDSAMLSA-N 0.000 description 2
- YIBOAHAOAWACDK-QEJZJMRPSA-N Lys-Ala-Phe Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 YIBOAHAOAWACDK-QEJZJMRPSA-N 0.000 description 2
- CKSXSQUVEYCDIW-AVGNSLFASA-N Lys-Arg-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCCCN)N CKSXSQUVEYCDIW-AVGNSLFASA-N 0.000 description 2
- DNEJSAIMVANNPA-DCAQKATOSA-N Lys-Asn-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O DNEJSAIMVANNPA-DCAQKATOSA-N 0.000 description 2
- SQXUUGUCGJSWCK-CIUDSAMLSA-N Lys-Asp-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CS)C(=O)O)N SQXUUGUCGJSWCK-CIUDSAMLSA-N 0.000 description 2
- HIIZIQUUHIXUJY-GUBZILKMSA-N Lys-Asp-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O HIIZIQUUHIXUJY-GUBZILKMSA-N 0.000 description 2
- AAORVPFVUIHEAB-YUMQZZPRSA-N Lys-Asp-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O AAORVPFVUIHEAB-YUMQZZPRSA-N 0.000 description 2
- DFXQCCBKGUNYGG-GUBZILKMSA-N Lys-Gln-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCCCN DFXQCCBKGUNYGG-GUBZILKMSA-N 0.000 description 2
- ZXEUFAVXODIPHC-GUBZILKMSA-N Lys-Glu-Asn Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O ZXEUFAVXODIPHC-GUBZILKMSA-N 0.000 description 2
- GRADYHMSAUIKPS-DCAQKATOSA-N Lys-Glu-Gln Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O GRADYHMSAUIKPS-DCAQKATOSA-N 0.000 description 2
- PAMDBWYMLWOELY-SDDRHHMPSA-N Lys-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCCCN)N)C(=O)O PAMDBWYMLWOELY-SDDRHHMPSA-N 0.000 description 2
- VEGLGAOVLFODGC-GUBZILKMSA-N Lys-Glu-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O VEGLGAOVLFODGC-GUBZILKMSA-N 0.000 description 2
- PBLLTSKBTAHDNA-KBPBESRZSA-N Lys-Gly-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PBLLTSKBTAHDNA-KBPBESRZSA-N 0.000 description 2
- ZASPELYMPSACER-HOCLYGCPSA-N Lys-Gly-Trp Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O ZASPELYMPSACER-HOCLYGCPSA-N 0.000 description 2
- HAUUXTXKJNVIFY-ONGXEEELSA-N Lys-Gly-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O HAUUXTXKJNVIFY-ONGXEEELSA-N 0.000 description 2
- MUXNCRWTWBMNHX-SRVKXCTJSA-N Lys-Leu-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O MUXNCRWTWBMNHX-SRVKXCTJSA-N 0.000 description 2
- VMTYLUGCXIEDMV-QWRGUYRKSA-N Lys-Leu-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCCCN VMTYLUGCXIEDMV-QWRGUYRKSA-N 0.000 description 2
- XOQMURBBIXRRCR-SRVKXCTJSA-N Lys-Lys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CCCCN XOQMURBBIXRRCR-SRVKXCTJSA-N 0.000 description 2
- RIJCHEVHFWMDKD-SRVKXCTJSA-N Lys-Lys-Asn Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O RIJCHEVHFWMDKD-SRVKXCTJSA-N 0.000 description 2
- YXPJCVNIDDKGOE-MELADBBJSA-N Lys-Lys-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)N)C(=O)O YXPJCVNIDDKGOE-MELADBBJSA-N 0.000 description 2
- HYSVGEAWTGPMOA-IHRRRGAJSA-N Lys-Pro-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O HYSVGEAWTGPMOA-IHRRRGAJSA-N 0.000 description 2
- SQXZLVXQXWILKW-KKUMJFAQSA-N Lys-Ser-Phe Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O SQXZLVXQXWILKW-KKUMJFAQSA-N 0.000 description 2
- DIBZLYZXTSVGLN-CIUDSAMLSA-N Lys-Ser-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O DIBZLYZXTSVGLN-CIUDSAMLSA-N 0.000 description 2
- YRNRVKTYDSLKMD-KKUMJFAQSA-N Lys-Ser-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O YRNRVKTYDSLKMD-KKUMJFAQSA-N 0.000 description 2
- GIKFNMZSGYAPEJ-HJGDQZAQSA-N Lys-Thr-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(O)=O GIKFNMZSGYAPEJ-HJGDQZAQSA-N 0.000 description 2
- JHNOXVASMSXSNB-WEDXCCLWSA-N Lys-Thr-Gly Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O JHNOXVASMSXSNB-WEDXCCLWSA-N 0.000 description 2
- RPWTZTBIFGENIA-VOAKCMCISA-N Lys-Thr-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(O)=O RPWTZTBIFGENIA-VOAKCMCISA-N 0.000 description 2
- XYLSGAWRCZECIQ-JYJNAYRXSA-N Lys-Tyr-Glu Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(O)=O)CC1=CC=C(O)C=C1 XYLSGAWRCZECIQ-JYJNAYRXSA-N 0.000 description 2
- LMMBAXJRYSXCOQ-ACRUOGEOSA-N Lys-Tyr-Phe Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](Cc1ccccc1)C(O)=O LMMBAXJRYSXCOQ-ACRUOGEOSA-N 0.000 description 2
- QLFAPXUXEBAWEK-NHCYSSNCSA-N Lys-Val-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O QLFAPXUXEBAWEK-NHCYSSNCSA-N 0.000 description 2
- QEVRUYFHWJJUHZ-DCAQKATOSA-N Met-Ala-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(C)C QEVRUYFHWJJUHZ-DCAQKATOSA-N 0.000 description 2
- MTBVQFFQMXHCPC-CIUDSAMLSA-N Met-Glu-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O MTBVQFFQMXHCPC-CIUDSAMLSA-N 0.000 description 2
- RAAVFTFEAUAVIY-DCAQKATOSA-N Met-Glu-Met Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCSC)C(=O)O)N RAAVFTFEAUAVIY-DCAQKATOSA-N 0.000 description 2
- JHDNAOVJJQSMMM-GMOBBJLQSA-N Met-Ile-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CCSC)N JHDNAOVJJQSMMM-GMOBBJLQSA-N 0.000 description 2
- HGAJNEWOUHDUMZ-SRVKXCTJSA-N Met-Leu-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCC(O)=O HGAJNEWOUHDUMZ-SRVKXCTJSA-N 0.000 description 2
- WPTHAGXMYDRPFD-SRVKXCTJSA-N Met-Lys-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O WPTHAGXMYDRPFD-SRVKXCTJSA-N 0.000 description 2
- KBTQZYASLSUFJR-KKUMJFAQSA-N Met-Phe-Gln Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N KBTQZYASLSUFJR-KKUMJFAQSA-N 0.000 description 2
- BJPQKNHZHUCQNQ-SRVKXCTJSA-N Met-Pro-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCSC)N BJPQKNHZHUCQNQ-SRVKXCTJSA-N 0.000 description 2
- PCTFVQATEGYHJU-FXQIFTODSA-N Met-Ser-Asn Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O PCTFVQATEGYHJU-FXQIFTODSA-N 0.000 description 2
- LPNWWHBFXPNHJG-AVGNSLFASA-N Met-Val-Lys Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN LPNWWHBFXPNHJG-AVGNSLFASA-N 0.000 description 2
- AUEJLPRZGVVDNU-UHFFFAOYSA-N N-L-tyrosyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 AUEJLPRZGVVDNU-UHFFFAOYSA-N 0.000 description 2
- XMBSYZWANAQXEV-UHFFFAOYSA-N N-alpha-L-glutamyl-L-phenylalanine Natural products OC(=O)CCC(N)C(=O)NC(C(O)=O)CC1=CC=CC=C1 XMBSYZWANAQXEV-UHFFFAOYSA-N 0.000 description 2
- 108010087066 N2-tryptophyllysine Proteins 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- 108050006335 Otoferlin Proteins 0.000 description 2
- 229930040373 Paraformaldehyde Natural products 0.000 description 2
- ULECEJGNDHWSKD-QEJZJMRPSA-N Phe-Ala-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 ULECEJGNDHWSKD-QEJZJMRPSA-N 0.000 description 2
- UHRNIXJAGGLKHP-DLOVCJGASA-N Phe-Ala-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O UHRNIXJAGGLKHP-DLOVCJGASA-N 0.000 description 2
- PLNHHOXNVSYKOB-JYJNAYRXSA-N Phe-Arg-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC1=CC=CC=C1)N PLNHHOXNVSYKOB-JYJNAYRXSA-N 0.000 description 2
- MECSIDWUTYRHRJ-KKUMJFAQSA-N Phe-Asn-Leu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O MECSIDWUTYRHRJ-KKUMJFAQSA-N 0.000 description 2
- DDYIRGBOZVKRFR-AVGNSLFASA-N Phe-Asp-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N DDYIRGBOZVKRFR-AVGNSLFASA-N 0.000 description 2
- LLGTYVHITPVGKR-RYUDHWBXSA-N Phe-Gln-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(O)=O LLGTYVHITPVGKR-RYUDHWBXSA-N 0.000 description 2
- NPLGQVKZFGJWAI-QWHCGFSZSA-N Phe-Gly-Pro Chemical compound C1C[C@@H](N(C1)C(=O)CNC(=O)[C@H](CC2=CC=CC=C2)N)C(=O)O NPLGQVKZFGJWAI-QWHCGFSZSA-N 0.000 description 2
- BIYWZVCPZIFGPY-QWRGUYRKSA-N Phe-Gly-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CO)C(O)=O BIYWZVCPZIFGPY-QWRGUYRKSA-N 0.000 description 2
- VADLTGVIOIOKGM-BZSNNMDCSA-N Phe-His-Leu Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CN=CN1 VADLTGVIOIOKGM-BZSNNMDCSA-N 0.000 description 2
- SPXWRYVHOZVYBU-ULQDDVLXSA-N Phe-His-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)NC(=O)[C@H](CC2=CC=CC=C2)N SPXWRYVHOZVYBU-ULQDDVLXSA-N 0.000 description 2
- NRKNYPRRWXVELC-NQCBNZPSSA-N Phe-Ile-Trp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC3=CC=CC=C3)N NRKNYPRRWXVELC-NQCBNZPSSA-N 0.000 description 2
- KBVJZCVLQWCJQN-KKUMJFAQSA-N Phe-Leu-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O KBVJZCVLQWCJQN-KKUMJFAQSA-N 0.000 description 2
- TXKWKTWYTIAZSV-KKUMJFAQSA-N Phe-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)N TXKWKTWYTIAZSV-KKUMJFAQSA-N 0.000 description 2
- RSPUIENXSJYZQO-JYJNAYRXSA-N Phe-Leu-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 RSPUIENXSJYZQO-JYJNAYRXSA-N 0.000 description 2
- LRBSWBVUCLLRLU-BZSNNMDCSA-N Phe-Leu-Lys Chemical compound CC(C)C[C@H](NC(=O)[C@@H](N)Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(O)=O LRBSWBVUCLLRLU-BZSNNMDCSA-N 0.000 description 2
- YCCUXNNKXDGMAM-KKUMJFAQSA-N Phe-Leu-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YCCUXNNKXDGMAM-KKUMJFAQSA-N 0.000 description 2
- MJAYDXWQQUOURZ-JYJNAYRXSA-N Phe-Lys-Gln Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O MJAYDXWQQUOURZ-JYJNAYRXSA-N 0.000 description 2
- AUJWXNGCAQWLEI-KBPBESRZSA-N Phe-Lys-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCCCN)C(=O)NCC(O)=O AUJWXNGCAQWLEI-KBPBESRZSA-N 0.000 description 2
- PHJUFDQVVKVOPU-ULQDDVLXSA-N Phe-Lys-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC1=CC=CC=C1)N PHJUFDQVVKVOPU-ULQDDVLXSA-N 0.000 description 2
- MRWOVVNKSXXLRP-IHPCNDPISA-N Phe-Ser-Trp Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O MRWOVVNKSXXLRP-IHPCNDPISA-N 0.000 description 2
- RAGOJJCBGXARPO-XVSYOHENSA-N Phe-Thr-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CC1=CC=CC=C1 RAGOJJCBGXARPO-XVSYOHENSA-N 0.000 description 2
- APMXLWHMIVWLLR-BZSNNMDCSA-N Phe-Tyr-Ser Chemical compound C([C@H](N)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(O)=O)C1=CC=CC=C1 APMXLWHMIVWLLR-BZSNNMDCSA-N 0.000 description 2
- VDTYRPWRWRCROL-UFYCRDLUSA-N Phe-Val-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 VDTYRPWRWRCROL-UFYCRDLUSA-N 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- KIZQGKLMXKGDIV-BQBZGAKWSA-N Pro-Ala-Gly Chemical compound OC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 KIZQGKLMXKGDIV-BQBZGAKWSA-N 0.000 description 2
- NHDVNAKDACFHPX-GUBZILKMSA-N Pro-Arg-Ala Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(O)=O NHDVNAKDACFHPX-GUBZILKMSA-N 0.000 description 2
- ICTZKEXYDDZZFP-SRVKXCTJSA-N Pro-Arg-Pro Chemical compound N([C@@H](CCCN=C(N)N)C(=O)N1[C@@H](CCC1)C(O)=O)C(=O)[C@@H]1CCCN1 ICTZKEXYDDZZFP-SRVKXCTJSA-N 0.000 description 2
- ILMLVTGTUJPQFP-FXQIFTODSA-N Pro-Asp-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O ILMLVTGTUJPQFP-FXQIFTODSA-N 0.000 description 2
- HJSCRFZVGXAGNG-SRVKXCTJSA-N Pro-Gln-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H]1CCCN1 HJSCRFZVGXAGNG-SRVKXCTJSA-N 0.000 description 2
- KIPIKSXPPLABPN-CIUDSAMLSA-N Pro-Glu-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H]1CCCN1 KIPIKSXPPLABPN-CIUDSAMLSA-N 0.000 description 2
- VPFGPKIWSDVTOY-SRVKXCTJSA-N Pro-Glu-His Chemical compound C1C[C@H](NC1)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O VPFGPKIWSDVTOY-SRVKXCTJSA-N 0.000 description 2
- NXEYSLRNNPWCRN-SRVKXCTJSA-N Pro-Glu-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O NXEYSLRNNPWCRN-SRVKXCTJSA-N 0.000 description 2
- DMKWYMWNEKIPFC-IUCAKERBSA-N Pro-Gly-Arg Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O DMKWYMWNEKIPFC-IUCAKERBSA-N 0.000 description 2
- DXTOOBDIIAJZBJ-BQBZGAKWSA-N Pro-Gly-Ser Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CO)C(O)=O DXTOOBDIIAJZBJ-BQBZGAKWSA-N 0.000 description 2
- QEWBZBLXDKIQPS-STQMWFEESA-N Pro-Gly-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O QEWBZBLXDKIQPS-STQMWFEESA-N 0.000 description 2
- XQHGISDMVBTGAL-ULQDDVLXSA-N Pro-His-Phe Chemical compound C([C@@H](C(=O)[O-])NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H]1[NH2+]CCC1)C1=CC=CC=C1 XQHGISDMVBTGAL-ULQDDVLXSA-N 0.000 description 2
- RUDOLGWDSKQQFF-DCAQKATOSA-N Pro-Leu-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O RUDOLGWDSKQQFF-DCAQKATOSA-N 0.000 description 2
- NFLNBHLMLYALOO-DCAQKATOSA-N Pro-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@@H]1CCCN1 NFLNBHLMLYALOO-DCAQKATOSA-N 0.000 description 2
- MRYUJHGPZQNOAD-IHRRRGAJSA-N Pro-Leu-Lys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]1CCCN1 MRYUJHGPZQNOAD-IHRRRGAJSA-N 0.000 description 2
- WIPAMEKBSHNFQE-IUCAKERBSA-N Pro-Met-Gly Chemical compound CSCC[C@@H](C(=O)NCC(=O)O)NC(=O)[C@@H]1CCCN1 WIPAMEKBSHNFQE-IUCAKERBSA-N 0.000 description 2
- ZUZINZIJHJFJRN-UBHSHLNASA-N Pro-Phe-Ala Chemical compound C([C@@H](C(=O)N[C@@H](C)C(O)=O)NC(=O)[C@H]1NCCC1)C1=CC=CC=C1 ZUZINZIJHJFJRN-UBHSHLNASA-N 0.000 description 2
- JLMZKEQFMVORMA-SRVKXCTJSA-N Pro-Pro-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 JLMZKEQFMVORMA-SRVKXCTJSA-N 0.000 description 2
- RFWXYTJSVDUBBZ-DCAQKATOSA-N Pro-Pro-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 RFWXYTJSVDUBBZ-DCAQKATOSA-N 0.000 description 2
- QAAYIXYLEMRULP-SRVKXCTJSA-N Pro-Pro-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 QAAYIXYLEMRULP-SRVKXCTJSA-N 0.000 description 2
- KBUAPZAZPWNYSW-SRVKXCTJSA-N Pro-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 KBUAPZAZPWNYSW-SRVKXCTJSA-N 0.000 description 2
- BGWKULMLUIUPKY-BQBZGAKWSA-N Pro-Ser-Gly Chemical compound OC(=O)CNC(=O)[C@H](CO)NC(=O)[C@@H]1CCCN1 BGWKULMLUIUPKY-BQBZGAKWSA-N 0.000 description 2
- CNUIHOAISPKQPY-HSHDSVGOSA-N Pro-Thr-Trp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O CNUIHOAISPKQPY-HSHDSVGOSA-N 0.000 description 2
- QDDJNKWPTJHROJ-UFYCRDLUSA-N Pro-Tyr-Tyr Chemical compound C([C@@H](C(=O)O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H]1NCCC1)C1=CC=C(O)C=C1 QDDJNKWPTJHROJ-UFYCRDLUSA-N 0.000 description 2
- OOZJHTXCLJUODH-QXEWZRGKSA-N Pro-Val-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 OOZJHTXCLJUODH-QXEWZRGKSA-N 0.000 description 2
- FUOGXAQMNJMBFG-WPRPVWTQSA-N Pro-Val-Gly Chemical compound OC(=O)CNC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 FUOGXAQMNJMBFG-WPRPVWTQSA-N 0.000 description 2
- FIODMZKLZFLYQP-GUBZILKMSA-N Pro-Val-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O FIODMZKLZFLYQP-GUBZILKMSA-N 0.000 description 2
- FHJQROWZEJFZPO-SRVKXCTJSA-N Pro-Val-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H]1CCCN1 FHJQROWZEJFZPO-SRVKXCTJSA-N 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 238000010240 RT-PCR analysis Methods 0.000 description 2
- 241000714474 Rous sarcoma virus Species 0.000 description 2
- LVVBAKCGXXUHFO-ZLUOBGJFSA-N Ser-Ala-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O LVVBAKCGXXUHFO-ZLUOBGJFSA-N 0.000 description 2
- IYCBDVBJWDXQRR-FXQIFTODSA-N Ser-Ala-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCSC)C(O)=O IYCBDVBJWDXQRR-FXQIFTODSA-N 0.000 description 2
- OOKCGAYXSNJBGQ-ZLUOBGJFSA-N Ser-Asn-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O OOKCGAYXSNJBGQ-ZLUOBGJFSA-N 0.000 description 2
- KCFKKAQKRZBWJB-ZLUOBGJFSA-N Ser-Cys-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](C)C(O)=O KCFKKAQKRZBWJB-ZLUOBGJFSA-N 0.000 description 2
- RNFKSBPHLTZHLU-WHFBIAKZSA-N Ser-Cys-Gly Chemical compound C([C@@H](C(=O)N[C@@H](CS)C(=O)NCC(=O)O)N)O RNFKSBPHLTZHLU-WHFBIAKZSA-N 0.000 description 2
- UCOYFSCEIWQYNL-FXQIFTODSA-N Ser-Cys-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCSC)C(O)=O UCOYFSCEIWQYNL-FXQIFTODSA-N 0.000 description 2
- MAWSJXHRLWVJEZ-ACZMJKKPSA-N Ser-Gln-Cys Chemical compound C(CC(=O)N)[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](CO)N MAWSJXHRLWVJEZ-ACZMJKKPSA-N 0.000 description 2
- BQWCDDAISCPDQV-XHNCKOQMSA-N Ser-Gln-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CO)N)C(=O)O BQWCDDAISCPDQV-XHNCKOQMSA-N 0.000 description 2
- SFTZWNJFZYOLBD-ZDLURKLDSA-N Ser-Gly-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO SFTZWNJFZYOLBD-ZDLURKLDSA-N 0.000 description 2
- CLKKNZQUQMZDGD-SRVKXCTJSA-N Ser-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CO)CC1=CN=CN1 CLKKNZQUQMZDGD-SRVKXCTJSA-N 0.000 description 2
- ZOPISOXXPQNOCO-SVSWQMSJSA-N Ser-Ile-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CO)N ZOPISOXXPQNOCO-SVSWQMSJSA-N 0.000 description 2
- MUJQWSAWLLRJCE-KATARQTJSA-N Ser-Leu-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O MUJQWSAWLLRJCE-KATARQTJSA-N 0.000 description 2
- IXZHZUGGKLRHJD-DCAQKATOSA-N Ser-Leu-Val Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O IXZHZUGGKLRHJD-DCAQKATOSA-N 0.000 description 2
- HDBOEVPDIDDEPC-CIUDSAMLSA-N Ser-Lys-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(O)=O HDBOEVPDIDDEPC-CIUDSAMLSA-N 0.000 description 2
- PPNPDKGQRFSCAC-CIUDSAMLSA-N Ser-Lys-Asp Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPNPDKGQRFSCAC-CIUDSAMLSA-N 0.000 description 2
- CRJZZXMAADSBBQ-SRVKXCTJSA-N Ser-Lys-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@@H](N)CO CRJZZXMAADSBBQ-SRVKXCTJSA-N 0.000 description 2
- QJKPECIAWNNKIT-KKUMJFAQSA-N Ser-Lys-Tyr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O QJKPECIAWNNKIT-KKUMJFAQSA-N 0.000 description 2
- NIOYDASGXWLHEZ-CIUDSAMLSA-N Ser-Met-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(O)=O NIOYDASGXWLHEZ-CIUDSAMLSA-N 0.000 description 2
- JAWGSPUJAXYXJA-IHRRRGAJSA-N Ser-Phe-Arg Chemical compound NC(N)=NCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CO)N)CC1=CC=CC=C1 JAWGSPUJAXYXJA-IHRRRGAJSA-N 0.000 description 2
- PJIQEIFXZPCWOJ-FXQIFTODSA-N Ser-Pro-Asp Chemical compound [H]N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O PJIQEIFXZPCWOJ-FXQIFTODSA-N 0.000 description 2
- KQNDIKOYWZTZIX-FXQIFTODSA-N Ser-Ser-Arg Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCNC(N)=N KQNDIKOYWZTZIX-FXQIFTODSA-N 0.000 description 2
- PPCZVWHJWJFTFN-ZLUOBGJFSA-N Ser-Ser-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O PPCZVWHJWJFTFN-ZLUOBGJFSA-N 0.000 description 2
- SRSPTFBENMJHMR-WHFBIAKZSA-N Ser-Ser-Gly Chemical compound OC[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O SRSPTFBENMJHMR-WHFBIAKZSA-N 0.000 description 2
- LLSLRQOEAFCZLW-NRPADANISA-N Ser-Val-Gln Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O LLSLRQOEAFCZLW-NRPADANISA-N 0.000 description 2
- JGUWRQWULDWNCM-FXQIFTODSA-N Ser-Val-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O JGUWRQWULDWNCM-FXQIFTODSA-N 0.000 description 2
- SIEBDTCABMZCLF-XGEHTFHBSA-N Ser-Val-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SIEBDTCABMZCLF-XGEHTFHBSA-N 0.000 description 2
- 208000005400 Synovial Cyst Diseases 0.000 description 2
- ZUXQFMVPAYGPFJ-JXUBOQSCSA-N Thr-Ala-Lys Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CCCCN ZUXQFMVPAYGPFJ-JXUBOQSCSA-N 0.000 description 2
- VASYSJHSMSBTDU-LKXGYXEUSA-N Thr-Asn-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CS)C(=O)O)N)O VASYSJHSMSBTDU-LKXGYXEUSA-N 0.000 description 2
- PZVGOVRNGKEFCB-KKHAAJSZSA-N Thr-Asn-Val Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)O)N)O PZVGOVRNGKEFCB-KKHAAJSZSA-N 0.000 description 2
- ZUUDNCOCILSYAM-KKHAAJSZSA-N Thr-Asp-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O ZUUDNCOCILSYAM-KKHAAJSZSA-N 0.000 description 2
- LYGKYFKSZTUXGZ-ZDLURKLDSA-N Thr-Cys-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)NCC(O)=O LYGKYFKSZTUXGZ-ZDLURKLDSA-N 0.000 description 2
- UDQBCBUXAQIZAK-GLLZPBPUSA-N Thr-Glu-Glu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O UDQBCBUXAQIZAK-GLLZPBPUSA-N 0.000 description 2
- NIEWSKWFURSECR-FOHZUACHSA-N Thr-Gly-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O NIEWSKWFURSECR-FOHZUACHSA-N 0.000 description 2
- ODXKUIGEPAGKKV-KATARQTJSA-N Thr-Leu-Cys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CS)C(=O)O)N)O ODXKUIGEPAGKKV-KATARQTJSA-N 0.000 description 2
- UUSQVWOVUYMLJA-PPCPHDFISA-N Thr-Lys-Ile Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O UUSQVWOVUYMLJA-PPCPHDFISA-N 0.000 description 2
- WVVOFCVMHAXGLE-LFSVMHDDSA-N Thr-Phe-Ala Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C)C(O)=O WVVOFCVMHAXGLE-LFSVMHDDSA-N 0.000 description 2
- JAJOFWABAUKAEJ-QTKMDUPCSA-N Thr-Pro-His Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N)O JAJOFWABAUKAEJ-QTKMDUPCSA-N 0.000 description 2
- WKGAAMOJPMBBMC-IXOXFDKPSA-N Thr-Ser-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O WKGAAMOJPMBBMC-IXOXFDKPSA-N 0.000 description 2
- WPSKTVVMQCXPRO-BWBBJGPYSA-N Thr-Ser-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WPSKTVVMQCXPRO-BWBBJGPYSA-N 0.000 description 2
- LECUEEHKUFYOOV-ZJDVBMNYSA-N Thr-Thr-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@@H](N)[C@@H](C)O LECUEEHKUFYOOV-ZJDVBMNYSA-N 0.000 description 2
- PELIQFPESHBTMA-WLTAIBSBSA-N Thr-Tyr-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@H](C(=O)NCC(O)=O)CC1=CC=C(O)C=C1 PELIQFPESHBTMA-WLTAIBSBSA-N 0.000 description 2
- CYCGARJWIQWPQM-YJRXYDGGSA-N Thr-Tyr-Ser Chemical compound C[C@@H](O)[C@H]([NH3+])C(=O)N[C@H](C(=O)N[C@@H](CO)C([O-])=O)CC1=CC=C(O)C=C1 CYCGARJWIQWPQM-YJRXYDGGSA-N 0.000 description 2
- QGVBFDIREUUSHX-IFFSRLJSSA-N Thr-Val-Gln Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O QGVBFDIREUUSHX-IFFSRLJSSA-N 0.000 description 2
- BPGDJSUFQKWUBK-KJEVXHAQSA-N Thr-Val-Tyr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 BPGDJSUFQKWUBK-KJEVXHAQSA-N 0.000 description 2
- 239000013504 Triton X-100 Substances 0.000 description 2
- 229920004890 Triton X-100 Polymers 0.000 description 2
- MJBBMTOGSOSAKJ-HJXMPXNTSA-N Trp-Ala-Ile Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O MJBBMTOGSOSAKJ-HJXMPXNTSA-N 0.000 description 2
- HQVKQINPFOCIIV-BVSLBCMMSA-N Trp-Arg-Tyr Chemical compound C([C@H](NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)N)C(O)=O)C1=CC=C(O)C=C1 HQVKQINPFOCIIV-BVSLBCMMSA-N 0.000 description 2
- BXKWZPXTTSCOMX-AQZXSJQPSA-N Trp-Asn-Thr Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O BXKWZPXTTSCOMX-AQZXSJQPSA-N 0.000 description 2
- PXQPYPMSLBQHJJ-WFBYXXMGSA-N Trp-Asp-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N PXQPYPMSLBQHJJ-WFBYXXMGSA-N 0.000 description 2
- UJRIVCPPPMYCNA-HOCLYGCPSA-N Trp-Leu-Gly Chemical compound CC(C)C[C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N UJRIVCPPPMYCNA-HOCLYGCPSA-N 0.000 description 2
- ABEVJDLMFPTGPS-SZMVWBNQSA-N Trp-Met-Met Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCSC)C(O)=O ABEVJDLMFPTGPS-SZMVWBNQSA-N 0.000 description 2
- YTVJTXJTNRWJCR-JBACZVJFSA-N Trp-Phe-Glu Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N YTVJTXJTNRWJCR-JBACZVJFSA-N 0.000 description 2
- XOLLWQIBBLBAHQ-WDSOQIARSA-N Trp-Pro-Leu Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(O)=O XOLLWQIBBLBAHQ-WDSOQIARSA-N 0.000 description 2
- CDEZPHVWBQFJQQ-NKKJXINNSA-N Trp-Trp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CNC3=CC=CC=C32)NC(=O)[C@H](CC4=CNC5=CC=CC=C54)N)C(=O)O CDEZPHVWBQFJQQ-NKKJXINNSA-N 0.000 description 2
- CRWOSTCODDFEKZ-HRCADAONSA-N Tyr-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)O CRWOSTCODDFEKZ-HRCADAONSA-N 0.000 description 2
- VFJIWSJKZJTQII-SRVKXCTJSA-N Tyr-Asp-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O VFJIWSJKZJTQII-SRVKXCTJSA-N 0.000 description 2
- LHTGRUZSZOIAKM-SOUVJXGZSA-N Tyr-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)C(=O)O LHTGRUZSZOIAKM-SOUVJXGZSA-N 0.000 description 2
- OLWFDNLLBWQWCP-STQMWFEESA-N Tyr-Gly-Met Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H](CCSC)C(O)=O OLWFDNLLBWQWCP-STQMWFEESA-N 0.000 description 2
- QARCDOCCDOLJSF-HJPIBITLSA-N Tyr-Ile-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N QARCDOCCDOLJSF-HJPIBITLSA-N 0.000 description 2
- KSCVLGXNQXKUAR-JYJNAYRXSA-N Tyr-Leu-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O KSCVLGXNQXKUAR-JYJNAYRXSA-N 0.000 description 2
- BJCILVZEZRDIDR-PMVMPFDFSA-N Tyr-Leu-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CC=C(O)C=C1 BJCILVZEZRDIDR-PMVMPFDFSA-N 0.000 description 2
- QKXAEWMHAAVVGS-KKUMJFAQSA-N Tyr-Pro-Glu Chemical compound N[C@@H](Cc1ccc(O)cc1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O QKXAEWMHAAVVGS-KKUMJFAQSA-N 0.000 description 2
- NHOVZGFNTGMYMI-KKUMJFAQSA-N Tyr-Ser-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 NHOVZGFNTGMYMI-KKUMJFAQSA-N 0.000 description 2
- CLEGSEJVGBYZBJ-MEYUZBJRSA-N Tyr-Thr-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H]([C@H](O)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 CLEGSEJVGBYZBJ-MEYUZBJRSA-N 0.000 description 2
- WQOHKVRQDLNDIL-YJRXYDGGSA-N Tyr-Thr-Ser Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O WQOHKVRQDLNDIL-YJRXYDGGSA-N 0.000 description 2
- GOPQNCQSXBJAII-ULQDDVLXSA-N Tyr-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N GOPQNCQSXBJAII-ULQDDVLXSA-N 0.000 description 2
- DJIJBQYBDKGDIS-JYJNAYRXSA-N Tyr-Val-Val Chemical compound CC(C)[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(C)C)C(O)=O DJIJBQYBDKGDIS-JYJNAYRXSA-N 0.000 description 2
- UEOOXDLMQZBPFR-ZKWXMUAHSA-N Val-Ala-Asn Chemical compound C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N UEOOXDLMQZBPFR-ZKWXMUAHSA-N 0.000 description 2
- FZSPNKUFROZBSG-ZKWXMUAHSA-N Val-Ala-Asp Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O FZSPNKUFROZBSG-ZKWXMUAHSA-N 0.000 description 2
- VDPRBUOZLIFUIM-GUBZILKMSA-N Val-Arg-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](C(C)C)N VDPRBUOZLIFUIM-GUBZILKMSA-N 0.000 description 2
- UBTBGUDNDFZLGP-SRVKXCTJSA-N Val-Arg-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](C(C)C)C(=O)O)N UBTBGUDNDFZLGP-SRVKXCTJSA-N 0.000 description 2
- XQVRMLRMTAGSFJ-QXEWZRGKSA-N Val-Asp-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N XQVRMLRMTAGSFJ-QXEWZRGKSA-N 0.000 description 2
- CFSSLXZJEMERJY-NRPADANISA-N Val-Gln-Ala Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(O)=O CFSSLXZJEMERJY-NRPADANISA-N 0.000 description 2
- CPTQYHDSVGVGDZ-UKJIMTQDSA-N Val-Gln-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)N CPTQYHDSVGVGDZ-UKJIMTQDSA-N 0.000 description 2
- PWRITNSESKQTPW-NRPADANISA-N Val-Gln-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CO)C(=O)O)N PWRITNSESKQTPW-NRPADANISA-N 0.000 description 2
- VLDMQVZZWDOKQF-AUTRQRHGSA-N Val-Glu-Gln Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N VLDMQVZZWDOKQF-AUTRQRHGSA-N 0.000 description 2
- JTWIMNMUYLQNPI-WPRPVWTQSA-N Val-Gly-Arg Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCNC(N)=N JTWIMNMUYLQNPI-WPRPVWTQSA-N 0.000 description 2
- DJEVQCWNMQOABE-RCOVLWMOSA-N Val-Gly-Asp Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)N DJEVQCWNMQOABE-RCOVLWMOSA-N 0.000 description 2
- KNYHAWKHFQRYOX-PYJNHQTQSA-N Val-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](C(C)C)N KNYHAWKHFQRYOX-PYJNHQTQSA-N 0.000 description 2
- FEXILLGKGGTLRI-NHCYSSNCSA-N Val-Leu-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](C(C)C)N FEXILLGKGGTLRI-NHCYSSNCSA-N 0.000 description 2
- BMOFUVHDBROBSE-DCAQKATOSA-N Val-Leu-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)O)NC(=O)[C@H](C(C)C)N BMOFUVHDBROBSE-DCAQKATOSA-N 0.000 description 2
- GVJUTBOZZBTBIG-AVGNSLFASA-N Val-Lys-Arg Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N GVJUTBOZZBTBIG-AVGNSLFASA-N 0.000 description 2
- IEBGHUMBJXIXHM-AVGNSLFASA-N Val-Lys-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)O)N IEBGHUMBJXIXHM-AVGNSLFASA-N 0.000 description 2
- XPKCFQZDQGVJCX-RHYQMDGZSA-N Val-Lys-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)N)O XPKCFQZDQGVJCX-RHYQMDGZSA-N 0.000 description 2
- RSGHLMMKXJGCMK-JYJNAYRXSA-N Val-Met-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N RSGHLMMKXJGCMK-JYJNAYRXSA-N 0.000 description 2
- WMRWZYSRQUORHJ-YDHLFZDLSA-N Val-Phe-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)O)C(=O)O)N WMRWZYSRQUORHJ-YDHLFZDLSA-N 0.000 description 2
- CKTMJBPRVQWPHU-JSGCOSHPSA-N Val-Phe-Gly Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)O)N CKTMJBPRVQWPHU-JSGCOSHPSA-N 0.000 description 2
- SSYBNWFXCFNRFN-GUBZILKMSA-N Val-Pro-Ser Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O SSYBNWFXCFNRFN-GUBZILKMSA-N 0.000 description 2
- VIKZGAUAKQZDOF-NRPADANISA-N Val-Ser-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCC(O)=O VIKZGAUAKQZDOF-NRPADANISA-N 0.000 description 2
- PGQUDQYHWICSAB-NAKRPEOUSA-N Val-Ser-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N PGQUDQYHWICSAB-NAKRPEOUSA-N 0.000 description 2
- PZTZYZUTCPZWJH-FXQIFTODSA-N Val-Ser-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)O)N PZTZYZUTCPZWJH-FXQIFTODSA-N 0.000 description 2
- DLRZGNXCXUGIDG-KKHAAJSZSA-N Val-Thr-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N)O DLRZGNXCXUGIDG-KKHAAJSZSA-N 0.000 description 2
- ZNGPROMGGGFOAA-JYJNAYRXSA-N Val-Tyr-Val Chemical compound CC(C)[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)CC1=CC=C(O)C=C1 ZNGPROMGGGFOAA-JYJNAYRXSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 210000003030 auditory receptor cell Anatomy 0.000 description 2
- 208000002352 blister Diseases 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 108010004073 cysteinylcysteine Proteins 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- FSXRLASFHBWESK-UHFFFAOYSA-N dipeptide phenylalanyl-tyrosine Natural products C=1C=C(O)C=CC=1CC(C(O)=O)NC(=O)C(N)CC1=CC=CC=C1 FSXRLASFHBWESK-UHFFFAOYSA-N 0.000 description 2
- 208000035475 disorder Diseases 0.000 description 2
- 239000002612 dispersion medium Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 210000003060 endolymph Anatomy 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 238000012239 gene modification Methods 0.000 description 2
- 230000005017 genetic modification Effects 0.000 description 2
- 235000013617 genetically modified food Nutrition 0.000 description 2
- 108010057083 glutamyl-aspartyl-leucine Proteins 0.000 description 2
- 108010082286 glycyl-seryl-alanine Proteins 0.000 description 2
- 108010087823 glycyltyrosine Proteins 0.000 description 2
- 239000000122 growth hormone Substances 0.000 description 2
- 238000012074 hearing test Methods 0.000 description 2
- 108010040030 histidinoalanine Proteins 0.000 description 2
- 108010036413 histidylglycine Proteins 0.000 description 2
- 108010092114 histidylphenylalanine Proteins 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000010166 immunofluorescence Methods 0.000 description 2
- 239000007943 implant Substances 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 238000001990 intravenous administration Methods 0.000 description 2
- 239000007951 isotonicity adjuster Substances 0.000 description 2
- 108010044056 leucyl-phenylalanine Proteins 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 238000012423 maintenance Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 108010085203 methionylmethionine Proteins 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 229940049982 murine ear Drugs 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 210000002985 organ of corti Anatomy 0.000 description 2
- 229920002866 paraformaldehyde Polymers 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N phenylalanine group Chemical group N[C@@H](CC1=CC=CC=C1)C(=O)O COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- 108010082795 phenylalanyl-arginyl-arginine Proteins 0.000 description 2
- 108010073101 phenylalanylleucine Proteins 0.000 description 2
- 238000002459 porosimetry Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 230000003518 presynaptic effect Effects 0.000 description 2
- 210000001525 retina Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 108010048818 seryl-histidine Proteins 0.000 description 2
- 108010069117 seryl-lysyl-aspartic acid Proteins 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 210000001323 spiral ganglion Anatomy 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- 210000001050 stape Anatomy 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 210000001578 tight junction Anatomy 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 230000010415 tropism Effects 0.000 description 2
- 108010020532 tyrosyl-proline Proteins 0.000 description 2
- 108010003137 tyrosyltyrosine Proteins 0.000 description 2
- IBIDRSSEHFLGSD-UHFFFAOYSA-N valinyl-arginine Natural products CC(C)C(N)C(=O)NC(C(O)=O)CCCN=C(N)N IBIDRSSEHFLGSD-UHFFFAOYSA-N 0.000 description 2
- 230000001720 vestibular Effects 0.000 description 2
- 210000002845 virion Anatomy 0.000 description 2
- 108010000998 wheylin-2 peptide Proteins 0.000 description 2
- XVZCXCTYGHPNEM-IHRRRGAJSA-N (2s)-1-[(2s)-2-[[(2s)-2-amino-4-methylpentanoyl]amino]-4-methylpentanoyl]pyrrolidine-2-carboxylic acid Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(O)=O XVZCXCTYGHPNEM-IHRRRGAJSA-N 0.000 description 1
- BRPMXFSTKXXNHF-IUCAKERBSA-N (2s)-1-[2-[[(2s)-pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H]1NCCC1 BRPMXFSTKXXNHF-IUCAKERBSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 1
- UPXRTVAIJMUAQR-UHFFFAOYSA-N 4-(9h-fluoren-9-ylmethoxycarbonylamino)-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid Chemical compound C1C(C(O)=O)N(C(=O)OC(C)(C)C)CC1NC(=O)OCC1C2=CC=CC=C2C2=CC=CC=C21 UPXRTVAIJMUAQR-UHFFFAOYSA-N 0.000 description 1
- TYJOQICPGZGYDT-UHFFFAOYSA-N 4-methylsulfonylbenzenesulfonyl chloride Chemical compound CS(=O)(=O)C1=CC=C(S(Cl)(=O)=O)C=C1 TYJOQICPGZGYDT-UHFFFAOYSA-N 0.000 description 1
- 108020003589 5' Untranslated Regions Proteins 0.000 description 1
- 108010036211 5-HT-moduline Proteins 0.000 description 1
- 241000202702 Adeno-associated virus - 3 Species 0.000 description 1
- 241000580270 Adeno-associated virus - 4 Species 0.000 description 1
- 241001164823 Adeno-associated virus - 7 Species 0.000 description 1
- FSBCNCKIQZZASN-GUBZILKMSA-N Ala-Arg-Met Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(O)=O FSBCNCKIQZZASN-GUBZILKMSA-N 0.000 description 1
- STACJSVFHSEZJV-GHCJXIJMSA-N Ala-Asn-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O STACJSVFHSEZJV-GHCJXIJMSA-N 0.000 description 1
- ZIBWKCRKNFYTPT-ZKWXMUAHSA-N Ala-Asn-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O ZIBWKCRKNFYTPT-ZKWXMUAHSA-N 0.000 description 1
- YIGLXQRFQVWFEY-NRPADANISA-N Ala-Gln-Val Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(O)=O YIGLXQRFQVWFEY-NRPADANISA-N 0.000 description 1
- PAIHPOGPJVUFJY-WDSKDSINSA-N Ala-Glu-Gly Chemical compound C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O PAIHPOGPJVUFJY-WDSKDSINSA-N 0.000 description 1
- PCIFXPRIFWKWLK-YUMQZZPRSA-N Ala-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@H](C)N PCIFXPRIFWKWLK-YUMQZZPRSA-N 0.000 description 1
- NIZKGBJVCMRDKO-KWQFWETISA-N Ala-Gly-Tyr Chemical compound C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 NIZKGBJVCMRDKO-KWQFWETISA-N 0.000 description 1
- RZZMZYZXNJRPOJ-BJDJZHNGSA-N Ala-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](C)N RZZMZYZXNJRPOJ-BJDJZHNGSA-N 0.000 description 1
- YHKANGMVQWRMAP-DCAQKATOSA-N Ala-Leu-Arg Chemical compound C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YHKANGMVQWRMAP-DCAQKATOSA-N 0.000 description 1
- WUHJHHGYVVJMQE-BJDJZHNGSA-N Ala-Leu-Ile Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O WUHJHHGYVVJMQE-BJDJZHNGSA-N 0.000 description 1
- PMQXMXAASGFUDX-SRVKXCTJSA-N Ala-Lys-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@H](C)N)CCCCN PMQXMXAASGFUDX-SRVKXCTJSA-N 0.000 description 1
- NINQYGGNRIBFSC-CIUDSAMLSA-N Ala-Lys-Ser Chemical compound NCCCC[C@H](NC(=O)[C@@H](N)C)C(=O)N[C@@H](CO)C(O)=O NINQYGGNRIBFSC-CIUDSAMLSA-N 0.000 description 1
- CNQAFFMNJIQYGX-DRZSPHRISA-N Ala-Phe-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C)CC1=CC=CC=C1 CNQAFFMNJIQYGX-DRZSPHRISA-N 0.000 description 1
- OSRZOHXQCUFIQG-FPMFFAJLSA-N Ala-Phe-Pro Chemical compound C([C@H](NC(=O)[C@@H]([NH3+])C)C(=O)N1[C@H](CCC1)C([O-])=O)C1=CC=CC=C1 OSRZOHXQCUFIQG-FPMFFAJLSA-N 0.000 description 1
- VQAVBBCZFQAAED-FXQIFTODSA-N Ala-Pro-Asn Chemical compound C[C@@H](C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(=O)N)C(=O)O)N VQAVBBCZFQAAED-FXQIFTODSA-N 0.000 description 1
- XWFWAXPOLRTDFZ-FXQIFTODSA-N Ala-Pro-Ser Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O XWFWAXPOLRTDFZ-FXQIFTODSA-N 0.000 description 1
- REWSWYIDQIELBE-FXQIFTODSA-N Ala-Val-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O REWSWYIDQIELBE-FXQIFTODSA-N 0.000 description 1
- 239000012103 Alexa Fluor 488 Substances 0.000 description 1
- 239000012109 Alexa Fluor 568 Substances 0.000 description 1
- VKKYFICVTYKFIO-CIUDSAMLSA-N Arg-Ala-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCN=C(N)N VKKYFICVTYKFIO-CIUDSAMLSA-N 0.000 description 1
- NTAZNGWBXRVEDJ-FXQIFTODSA-N Arg-Asp-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O NTAZNGWBXRVEDJ-FXQIFTODSA-N 0.000 description 1
- KBBKCNHWCDJPGN-GUBZILKMSA-N Arg-Gln-Gln Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O KBBKCNHWCDJPGN-GUBZILKMSA-N 0.000 description 1
- RYRQZJVFDVWURI-SRVKXCTJSA-N Arg-Gln-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCN=C(N)N)N RYRQZJVFDVWURI-SRVKXCTJSA-N 0.000 description 1
- HPKSHFSEXICTLI-CIUDSAMLSA-N Arg-Glu-Ala Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O HPKSHFSEXICTLI-CIUDSAMLSA-N 0.000 description 1
- PNIGSVZJNVUVJA-BQBZGAKWSA-N Arg-Gly-Asn Chemical compound NC(N)=NCCC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O PNIGSVZJNVUVJA-BQBZGAKWSA-N 0.000 description 1
- VRZDJJWOFXMFRO-ZFWWWQNUSA-N Arg-Gly-Trp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O VRZDJJWOFXMFRO-ZFWWWQNUSA-N 0.000 description 1
- YBZMTKUDWXZLIX-UWVGGRQHSA-N Arg-Leu-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O YBZMTKUDWXZLIX-UWVGGRQHSA-N 0.000 description 1
- BNYNOWJESJJIOI-XUXIUFHCSA-N Arg-Lys-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCN=C(N)N)N BNYNOWJESJJIOI-XUXIUFHCSA-N 0.000 description 1
- PYZPXCZNQSEHDT-GUBZILKMSA-N Arg-Met-Asn Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCCN=C(N)N)N PYZPXCZNQSEHDT-GUBZILKMSA-N 0.000 description 1
- UIUXXFIKWQVMEX-UFYCRDLUSA-N Arg-Phe-Tyr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O UIUXXFIKWQVMEX-UFYCRDLUSA-N 0.000 description 1
- VUGWHBXPMAHEGZ-SRVKXCTJSA-N Arg-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)CCCN=C(N)N VUGWHBXPMAHEGZ-SRVKXCTJSA-N 0.000 description 1
- DNLQVHBBMPZUGJ-BQBZGAKWSA-N Arg-Ser-Gly Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O DNLQVHBBMPZUGJ-BQBZGAKWSA-N 0.000 description 1
- LFAUVOXPCGJKTB-DCAQKATOSA-N Arg-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CCCN=C(N)N)N LFAUVOXPCGJKTB-DCAQKATOSA-N 0.000 description 1
- KMFPQTITXUKJOV-DCAQKATOSA-N Arg-Ser-Leu Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O KMFPQTITXUKJOV-DCAQKATOSA-N 0.000 description 1
- QTAIIXQCOPUNBQ-QXEWZRGKSA-N Arg-Val-Asp Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O QTAIIXQCOPUNBQ-QXEWZRGKSA-N 0.000 description 1
- ULBHWNVWSCJLCO-NHCYSSNCSA-N Arg-Val-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CCCN=C(N)N ULBHWNVWSCJLCO-NHCYSSNCSA-N 0.000 description 1
- APHUDFFMXFYRKP-CIUDSAMLSA-N Asn-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)N)N APHUDFFMXFYRKP-CIUDSAMLSA-N 0.000 description 1
- ZDOQDYFZNGASEY-BIIVOSGPSA-N Asn-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)N)N)C(=O)O ZDOQDYFZNGASEY-BIIVOSGPSA-N 0.000 description 1
- KUYKVGODHGHFDI-ACZMJKKPSA-N Asn-Gln-Ser Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O KUYKVGODHGHFDI-ACZMJKKPSA-N 0.000 description 1
- QYXNFROWLZPWPC-FXQIFTODSA-N Asn-Glu-Gln Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(N)=O)C(O)=O QYXNFROWLZPWPC-FXQIFTODSA-N 0.000 description 1
- GNKVBRYFXYWXAB-WDSKDSINSA-N Asn-Glu-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(O)=O GNKVBRYFXYWXAB-WDSKDSINSA-N 0.000 description 1
- WONGRTVAMHFGBE-WDSKDSINSA-N Asn-Gly-Gln Chemical compound C(CC(=O)N)[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CC(=O)N)N WONGRTVAMHFGBE-WDSKDSINSA-N 0.000 description 1
- JTXVXGXTRXMOFJ-FXQIFTODSA-N Asn-Pro-Asn Chemical compound NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(N)=O)C(O)=O JTXVXGXTRXMOFJ-FXQIFTODSA-N 0.000 description 1
- YUOXLJYVSZYPBJ-CIUDSAMLSA-N Asn-Pro-Glu Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(O)=O YUOXLJYVSZYPBJ-CIUDSAMLSA-N 0.000 description 1
- YSYTWUMRHSFODC-QWRGUYRKSA-N Asn-Tyr-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(O)=O YSYTWUMRHSFODC-QWRGUYRKSA-N 0.000 description 1
- QHAJMRDEWNAIBQ-FXQIFTODSA-N Asp-Arg-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(O)=O QHAJMRDEWNAIBQ-FXQIFTODSA-N 0.000 description 1
- AXXCUABIFZPKPM-BQBZGAKWSA-N Asp-Arg-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O AXXCUABIFZPKPM-BQBZGAKWSA-N 0.000 description 1
- SDHFVYLZFBDSQT-DCAQKATOSA-N Asp-Arg-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N SDHFVYLZFBDSQT-DCAQKATOSA-N 0.000 description 1
- DBWYWXNMZZYIRY-LPEHRKFASA-N Asp-Arg-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(=O)O)N)C(=O)O DBWYWXNMZZYIRY-LPEHRKFASA-N 0.000 description 1
- CELPEWWLSXMVPH-CIUDSAMLSA-N Asp-Asp-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC(O)=O CELPEWWLSXMVPH-CIUDSAMLSA-N 0.000 description 1
- SVFOIXMRMLROHO-SRVKXCTJSA-N Asp-Asp-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SVFOIXMRMLROHO-SRVKXCTJSA-N 0.000 description 1
- AMRANMVXQWXNAH-ZLUOBGJFSA-N Asp-Cys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CC(O)=O AMRANMVXQWXNAH-ZLUOBGJFSA-N 0.000 description 1
- XAJRHVUUVUPFQL-ACZMJKKPSA-N Asp-Glu-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O XAJRHVUUVUPFQL-ACZMJKKPSA-N 0.000 description 1
- ZEDBMCPXPIYJLW-XHNCKOQMSA-N Asp-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)N)C(=O)O ZEDBMCPXPIYJLW-XHNCKOQMSA-N 0.000 description 1
- VIRHEUMYXXLCBF-WDSKDSINSA-N Asp-Gly-Glu Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O VIRHEUMYXXLCBF-WDSKDSINSA-N 0.000 description 1
- QCVXMEHGFUMKCO-YUMQZZPRSA-N Asp-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC(O)=O QCVXMEHGFUMKCO-YUMQZZPRSA-N 0.000 description 1
- SPKCGKRUYKMDHP-GUDRVLHUSA-N Asp-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CC(=O)O)N SPKCGKRUYKMDHP-GUDRVLHUSA-N 0.000 description 1
- JNNVNVRBYUJYGS-CIUDSAMLSA-N Asp-Leu-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O JNNVNVRBYUJYGS-CIUDSAMLSA-N 0.000 description 1
- OEDJQRXNDRUGEU-SRVKXCTJSA-N Asp-Leu-His Chemical compound N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CNC=N1)C(=O)O OEDJQRXNDRUGEU-SRVKXCTJSA-N 0.000 description 1
- UJGRZQYSNYTCAX-SRVKXCTJSA-N Asp-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O UJGRZQYSNYTCAX-SRVKXCTJSA-N 0.000 description 1
- HKEZZWQWXWGASX-KKUMJFAQSA-N Asp-Leu-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 HKEZZWQWXWGASX-KKUMJFAQSA-N 0.000 description 1
- QNIACYURSSCLRP-GUBZILKMSA-N Asp-Lys-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(N)=O)C(O)=O QNIACYURSSCLRP-GUBZILKMSA-N 0.000 description 1
- WOPJVEMFXYHZEE-SRVKXCTJSA-N Asp-Phe-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O WOPJVEMFXYHZEE-SRVKXCTJSA-N 0.000 description 1
- LGGHQRZIJSYRHA-GUBZILKMSA-N Asp-Pro-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CC(=O)O)N LGGHQRZIJSYRHA-GUBZILKMSA-N 0.000 description 1
- BKOIIURTQAJHAT-GUBZILKMSA-N Asp-Pro-Pro Chemical compound OC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 BKOIIURTQAJHAT-GUBZILKMSA-N 0.000 description 1
- XXAMCEGRCZQGEM-ZLUOBGJFSA-N Asp-Ser-Asn Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O XXAMCEGRCZQGEM-ZLUOBGJFSA-N 0.000 description 1
- OFYVKOXTTDCUIL-FXQIFTODSA-N Asp-Ser-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)O)N OFYVKOXTTDCUIL-FXQIFTODSA-N 0.000 description 1
- MNQMTYSEKZHIDF-GCJQMDKQSA-N Asp-Thr-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O MNQMTYSEKZHIDF-GCJQMDKQSA-N 0.000 description 1
- QOCFFCUFZGDHTP-NUMRIWBASA-N Asp-Thr-Gln Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(O)=O QOCFFCUFZGDHTP-NUMRIWBASA-N 0.000 description 1
- YUELDQUPTAYEGM-XIRDDKMYSA-N Asp-Trp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC(=O)O)N YUELDQUPTAYEGM-XIRDDKMYSA-N 0.000 description 1
- WAEDSQFVZJUHLI-BYULHYEWSA-N Asp-Val-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O WAEDSQFVZJUHLI-BYULHYEWSA-N 0.000 description 1
- GXIUDSXIUSTSLO-QXEWZRGKSA-N Asp-Val-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCSC)C(=O)O)NC(=O)[C@H](CC(=O)O)N GXIUDSXIUSTSLO-QXEWZRGKSA-N 0.000 description 1
- SFJUYBCDQBAYAJ-YDHLFZDLSA-N Asp-Val-Phe Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SFJUYBCDQBAYAJ-YDHLFZDLSA-N 0.000 description 1
- QOJJMJKTMKNFEF-ZKWXMUAHSA-N Asp-Val-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)CC(O)=O QOJJMJKTMKNFEF-ZKWXMUAHSA-N 0.000 description 1
- 208000000477 Bilateral Hearing Loss Diseases 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 238000011740 C57BL/6 mouse Methods 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 108091062157 Cis-regulatory element Proteins 0.000 description 1
- 241000833010 Claudius Species 0.000 description 1
- 230000005788 Cochlea function Effects 0.000 description 1
- 208000026091 Congenital hearing disease Diseases 0.000 description 1
- MBPKYKSYUAPLMY-DCAQKATOSA-N Cys-Arg-Leu Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(O)=O MBPKYKSYUAPLMY-DCAQKATOSA-N 0.000 description 1
- XGIAHEUULGOZHH-GUBZILKMSA-N Cys-Arg-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CS)N XGIAHEUULGOZHH-GUBZILKMSA-N 0.000 description 1
- LDIKUWLAMDFHPU-FXQIFTODSA-N Cys-Cys-Arg Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O LDIKUWLAMDFHPU-FXQIFTODSA-N 0.000 description 1
- ANPADMNVVOOYKW-DCAQKATOSA-N Cys-His-Arg Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O ANPADMNVVOOYKW-DCAQKATOSA-N 0.000 description 1
- MKMKILWCRQLDFJ-DCAQKATOSA-N Cys-Lys-Arg Chemical compound [H]N[C@@H](CS)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O MKMKILWCRQLDFJ-DCAQKATOSA-N 0.000 description 1
- BNCKELUXXUYRNY-GUBZILKMSA-N Cys-Lys-Glu Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CS)N BNCKELUXXUYRNY-GUBZILKMSA-N 0.000 description 1
- KSMSFCBQBQPFAD-GUBZILKMSA-N Cys-Pro-Pro Chemical compound SC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 KSMSFCBQBQPFAD-GUBZILKMSA-N 0.000 description 1
- JUNZLDGUJZIUCO-IHRRRGAJSA-N Cys-Pro-Tyr Chemical compound C1C[C@H](N(C1)C(=O)[C@H](CS)N)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)O JUNZLDGUJZIUCO-IHRRRGAJSA-N 0.000 description 1
- YWEHYKGJWHPGPY-XGEHTFHBSA-N Cys-Thr-Arg Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CS)N)O YWEHYKGJWHPGPY-XGEHTFHBSA-N 0.000 description 1
- WVWRADGCZPIJJR-IHRRRGAJSA-N Cys-Val-Tyr Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CS)N WVWRADGCZPIJJR-IHRRRGAJSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102000056303 Ferlin Human genes 0.000 description 1
- 108700036130 Ferlin Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- INKFLNZBTSNFON-CIUDSAMLSA-N Gln-Ala-Arg Chemical compound NC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN=C(N)N)C(O)=O INKFLNZBTSNFON-CIUDSAMLSA-N 0.000 description 1
- XXLBHPPXDUWYAG-XQXXSGGOSA-N Gln-Ala-Thr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XXLBHPPXDUWYAG-XQXXSGGOSA-N 0.000 description 1
- XEYMBRRKIFYQMF-GUBZILKMSA-N Gln-Asp-Leu Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O XEYMBRRKIFYQMF-GUBZILKMSA-N 0.000 description 1
- CGVWDTRDPLOMHZ-FXQIFTODSA-N Gln-Glu-Asp Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O CGVWDTRDPLOMHZ-FXQIFTODSA-N 0.000 description 1
- XJKAKYXMFHUIHT-AUTRQRHGSA-N Gln-Glu-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)N)N XJKAKYXMFHUIHT-AUTRQRHGSA-N 0.000 description 1
- IKFZXRLDMYWNBU-YUMQZZPRSA-N Gln-Gly-Arg Chemical compound NC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N IKFZXRLDMYWNBU-YUMQZZPRSA-N 0.000 description 1
- GNMQDOGFWYWPNM-LAEOZQHASA-N Gln-Gly-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)CNC(=O)[C@@H](N)CCC(N)=O)C(O)=O GNMQDOGFWYWPNM-LAEOZQHASA-N 0.000 description 1
- FTIJVMLAGRAYMJ-MNXVOIDGSA-N Gln-Ile-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CCC(N)=O FTIJVMLAGRAYMJ-MNXVOIDGSA-N 0.000 description 1
- MWERYIXRDZDXOA-QEWYBTABSA-N Gln-Ile-Phe Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O MWERYIXRDZDXOA-QEWYBTABSA-N 0.000 description 1
- ZNTDJIMJKNNSLR-RWRJDSDZSA-N Gln-Ile-Thr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N ZNTDJIMJKNNSLR-RWRJDSDZSA-N 0.000 description 1
- JKGHMESJHRTHIC-SIUGBPQLSA-N Gln-Ile-Tyr Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)O)NC(=O)[C@H](CCC(=O)N)N JKGHMESJHRTHIC-SIUGBPQLSA-N 0.000 description 1
- CAXXTYYGFYTBPV-IUCAKERBSA-N Gln-Leu-Gly Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O CAXXTYYGFYTBPV-IUCAKERBSA-N 0.000 description 1
- IOFDDSNZJDIGPB-GVXVVHGQSA-N Gln-Leu-Val Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O IOFDDSNZJDIGPB-GVXVVHGQSA-N 0.000 description 1
- ZEEPYMXTJWIMSN-GUBZILKMSA-N Gln-Lys-Ser Chemical compound NCCCC[C@@H](C(=O)N[C@@H](CO)C(O)=O)NC(=O)[C@@H](N)CCC(N)=O ZEEPYMXTJWIMSN-GUBZILKMSA-N 0.000 description 1
- KFHASAPTUOASQN-JYJNAYRXSA-N Gln-Phe-His Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CCC(=O)N)N KFHASAPTUOASQN-JYJNAYRXSA-N 0.000 description 1
- RBSKVTZUFMIWFU-XEGUGMAKSA-N Gln-Trp-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C)C(O)=O RBSKVTZUFMIWFU-XEGUGMAKSA-N 0.000 description 1
- FITIQFSXXBKFFM-NRPADANISA-N Gln-Val-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(O)=O FITIQFSXXBKFFM-NRPADANISA-N 0.000 description 1
- FHPXTPQBODWBIY-CIUDSAMLSA-N Glu-Ala-Arg Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FHPXTPQBODWBIY-CIUDSAMLSA-N 0.000 description 1
- KBKGRMNVKPSQIF-XDTLVQLUSA-N Glu-Ala-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O KBKGRMNVKPSQIF-XDTLVQLUSA-N 0.000 description 1
- WOMUDRVDJMHTCV-DCAQKATOSA-N Glu-Arg-Arg Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O WOMUDRVDJMHTCV-DCAQKATOSA-N 0.000 description 1
- OJGLIOXAKGFFDW-SRVKXCTJSA-N Glu-Arg-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CCC(=O)O)N OJGLIOXAKGFFDW-SRVKXCTJSA-N 0.000 description 1
- FLLRAEJOLZPSMN-CIUDSAMLSA-N Glu-Asn-Arg Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N FLLRAEJOLZPSMN-CIUDSAMLSA-N 0.000 description 1
- RJONUNZIMUXUOI-GUBZILKMSA-N Glu-Asn-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)O)N RJONUNZIMUXUOI-GUBZILKMSA-N 0.000 description 1
- LJLPOZGRPLORTF-CIUDSAMLSA-N Glu-Asn-Met Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCSC)C(O)=O LJLPOZGRPLORTF-CIUDSAMLSA-N 0.000 description 1
- ZJICFHQSPWFBKP-AVGNSLFASA-N Glu-Asn-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ZJICFHQSPWFBKP-AVGNSLFASA-N 0.000 description 1
- SAEBUDRWKUXLOM-ACZMJKKPSA-N Glu-Cys-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(O)=O SAEBUDRWKUXLOM-ACZMJKKPSA-N 0.000 description 1
- PVBBEKPHARMPHX-DCAQKATOSA-N Glu-Gln-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCC(O)=O PVBBEKPHARMPHX-DCAQKATOSA-N 0.000 description 1
- QQLBPVKLJBAXBS-FXQIFTODSA-N Glu-Glu-Asn Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O QQLBPVKLJBAXBS-FXQIFTODSA-N 0.000 description 1
- MTAOBYXRYJZRGQ-WDSKDSINSA-N Glu-Gly-Asp Chemical compound OC(=O)CC[C@H](N)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(O)=O MTAOBYXRYJZRGQ-WDSKDSINSA-N 0.000 description 1
- QDMVXRNLOPTPIE-WDCWCFNPSA-N Glu-Lys-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O QDMVXRNLOPTPIE-WDCWCFNPSA-N 0.000 description 1
- GTFYQOVVVJASOA-ACZMJKKPSA-N Glu-Ser-Cys Chemical compound C(CC(=O)O)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N GTFYQOVVVJASOA-ACZMJKKPSA-N 0.000 description 1
- GMVCSRBOSIUTFC-FXQIFTODSA-N Glu-Ser-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMVCSRBOSIUTFC-FXQIFTODSA-N 0.000 description 1
- DTLLNDVORUEOTM-WDCWCFNPSA-N Glu-Thr-Lys Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(O)=O DTLLNDVORUEOTM-WDCWCFNPSA-N 0.000 description 1
- CQGBSALYGOXQPE-HTUGSXCWSA-N Glu-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)NC(=O)[C@H](CCC(=O)O)N)O CQGBSALYGOXQPE-HTUGSXCWSA-N 0.000 description 1
- MXJYXYDREQWUMS-XKBZYTNZSA-N Glu-Thr-Ser Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O MXJYXYDREQWUMS-XKBZYTNZSA-N 0.000 description 1
- LSYFGBRDBIQYAQ-FHWLQOOXSA-N Glu-Tyr-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LSYFGBRDBIQYAQ-FHWLQOOXSA-N 0.000 description 1
- HQTDNEZTGZUWSY-XVKPBYJWSA-N Glu-Val-Gly Chemical compound CC(C)[C@H](NC(=O)[C@@H](N)CCC(O)=O)C(=O)NCC(O)=O HQTDNEZTGZUWSY-XVKPBYJWSA-N 0.000 description 1
- VIPDPMHGICREIS-GVXVVHGQSA-N Glu-Val-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O VIPDPMHGICREIS-GVXVVHGQSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- MZZSCEANQDPJER-ONGXEEELSA-N Gly-Ala-Phe Chemical compound NCC(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 MZZSCEANQDPJER-ONGXEEELSA-N 0.000 description 1
- VXKCPBPQEKKERH-IUCAKERBSA-N Gly-Arg-Pro Chemical compound NC(N)=NCCC[C@H](NC(=O)CN)C(=O)N1CCC[C@H]1C(O)=O VXKCPBPQEKKERH-IUCAKERBSA-N 0.000 description 1
- FUTAPPOITCCWTH-WHFBIAKZSA-N Gly-Asp-Asp Chemical compound [H]NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O FUTAPPOITCCWTH-WHFBIAKZSA-N 0.000 description 1
- NMROINAYXCACKF-WHFBIAKZSA-N Gly-Cys-Cys Chemical compound NCC(=O)N[C@@H](CS)C(=O)N[C@@H](CS)C(O)=O NMROINAYXCACKF-WHFBIAKZSA-N 0.000 description 1
- HQRHFUYMGCHHJS-LURJTMIESA-N Gly-Gly-Arg Chemical compound NCC(=O)NCC(=O)N[C@H](C(O)=O)CCCN=C(N)N HQRHFUYMGCHHJS-LURJTMIESA-N 0.000 description 1
- LPCKHUXOGVNZRS-YUMQZZPRSA-N Gly-His-Ser Chemical compound [H]NCC(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(O)=O LPCKHUXOGVNZRS-YUMQZZPRSA-N 0.000 description 1
- SXJHOPPTOJACOA-QXEWZRGKSA-N Gly-Ile-Arg Chemical compound NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C(O)=O)CCCN=C(N)N SXJHOPPTOJACOA-QXEWZRGKSA-N 0.000 description 1
- HKSNHPVETYYJBK-LAEOZQHASA-N Gly-Ile-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)CN HKSNHPVETYYJBK-LAEOZQHASA-N 0.000 description 1
- IUZGUFAJDBHQQV-YUMQZZPRSA-N Gly-Leu-Asn Chemical compound NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O IUZGUFAJDBHQQV-YUMQZZPRSA-N 0.000 description 1
- UUYBFNKHOCJCHT-VHSXEESVSA-N Gly-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN UUYBFNKHOCJCHT-VHSXEESVSA-N 0.000 description 1
- JPAACTMBBBGAAR-HOTGVXAUSA-N Gly-Leu-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)CN)CC(C)C)C(O)=O)=CNC2=C1 JPAACTMBBBGAAR-HOTGVXAUSA-N 0.000 description 1
- QGDOOCIPHSSADO-STQMWFEESA-N Gly-Met-Phe Chemical compound [H]NCC(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O QGDOOCIPHSSADO-STQMWFEESA-N 0.000 description 1
- OMOZPGCHVWOXHN-BQBZGAKWSA-N Gly-Met-Ser Chemical compound CSCC[C@@H](C(=O)N[C@@H](CO)C(=O)O)NC(=O)CN OMOZPGCHVWOXHN-BQBZGAKWSA-N 0.000 description 1
- IGOYNRWLWHWAQO-JTQLQIEISA-N Gly-Phe-Gly Chemical compound OC(=O)CNC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 IGOYNRWLWHWAQO-JTQLQIEISA-N 0.000 description 1
- JPVGHHQGKPQYIL-KBPBESRZSA-N Gly-Phe-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CC=CC=C1 JPVGHHQGKPQYIL-KBPBESRZSA-N 0.000 description 1
- OOCFXNOVSLSHAB-IUCAKERBSA-N Gly-Pro-Pro Chemical compound NCC(=O)N1CCC[C@H]1C(=O)N1[C@H](C(O)=O)CCC1 OOCFXNOVSLSHAB-IUCAKERBSA-N 0.000 description 1
- ISSDODCYBOWWIP-GJZGRUSLSA-N Gly-Pro-Trp Chemical compound [H]NCC(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O ISSDODCYBOWWIP-GJZGRUSLSA-N 0.000 description 1
- BMWFDYIYBAFROD-WPRPVWTQSA-N Gly-Pro-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)CN BMWFDYIYBAFROD-WPRPVWTQSA-N 0.000 description 1
- YOBGUCWZPXJHTN-BQBZGAKWSA-N Gly-Ser-Arg Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YOBGUCWZPXJHTN-BQBZGAKWSA-N 0.000 description 1
- MKIAPEZXQDILRR-YUMQZZPRSA-N Gly-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)CN MKIAPEZXQDILRR-YUMQZZPRSA-N 0.000 description 1
- JSLVAHYTAJJEQH-QWRGUYRKSA-N Gly-Ser-Phe Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 JSLVAHYTAJJEQH-QWRGUYRKSA-N 0.000 description 1
- MYXNLWDWWOTERK-BHNWBGBOSA-N Gly-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN)O MYXNLWDWWOTERK-BHNWBGBOSA-N 0.000 description 1
- SFOXOSKVTLDEDM-HOTGVXAUSA-N Gly-Trp-Leu Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CN)=CNC2=C1 SFOXOSKVTLDEDM-HOTGVXAUSA-N 0.000 description 1
- YJDALMUYJIENAG-QWRGUYRKSA-N Gly-Tyr-Asn Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN)O YJDALMUYJIENAG-QWRGUYRKSA-N 0.000 description 1
- GNNJKUYDWFIBTK-QWRGUYRKSA-N Gly-Tyr-Asp Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O GNNJKUYDWFIBTK-QWRGUYRKSA-N 0.000 description 1
- DUAWRXXTOQOECJ-JSGCOSHPSA-N Gly-Tyr-Val Chemical compound [H]NCC(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O DUAWRXXTOQOECJ-JSGCOSHPSA-N 0.000 description 1
- GWCJMBNBFYBQCV-XPUUQOCRSA-N Gly-Val-Ala Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O GWCJMBNBFYBQCV-XPUUQOCRSA-N 0.000 description 1
- NGRPGJGKJMUGDM-XVKPBYJWSA-N Gly-Val-Gln Chemical compound NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O NGRPGJGKJMUGDM-XVKPBYJWSA-N 0.000 description 1
- YGHSQRJSHKYUJY-SCZZXKLOSA-N Gly-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)CN YGHSQRJSHKYUJY-SCZZXKLOSA-N 0.000 description 1
- JBCLFWXMTIKCCB-UHFFFAOYSA-N H-Gly-Phe-OH Natural products NCC(=O)NC(C(O)=O)CC1=CC=CC=C1 JBCLFWXMTIKCCB-UHFFFAOYSA-N 0.000 description 1
- VOKCBYNCZVSILJ-KKUMJFAQSA-N His-Asn-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC2=CN=CN2)N)O VOKCBYNCZVSILJ-KKUMJFAQSA-N 0.000 description 1
- CUEQQFOGARVNHU-VGDYDELISA-N His-Ser-Ile Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O CUEQQFOGARVNHU-VGDYDELISA-N 0.000 description 1
- UOYGZBIPZYKGSH-SRVKXCTJSA-N His-Ser-Lys Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N UOYGZBIPZYKGSH-SRVKXCTJSA-N 0.000 description 1
- VIJMRAIWYWRXSR-CIUDSAMLSA-N His-Ser-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CN=CN1 VIJMRAIWYWRXSR-CIUDSAMLSA-N 0.000 description 1
- VXZZUXWAOMWWJH-QTKMDUPCSA-N His-Thr-Val Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O VXZZUXWAOMWWJH-QTKMDUPCSA-N 0.000 description 1
- YSMZBYPVVYSGOT-SZMVWBNQSA-N His-Trp-Glu Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)[C@H](CC3=CN=CN3)N YSMZBYPVVYSGOT-SZMVWBNQSA-N 0.000 description 1
- KFQDSSNYWKZFOO-LSJOCFKGSA-N His-Val-Ala Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(O)=O KFQDSSNYWKZFOO-LSJOCFKGSA-N 0.000 description 1
- VSZALHITQINTGC-GHCJXIJMSA-N Ile-Ala-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)O)N VSZALHITQINTGC-GHCJXIJMSA-N 0.000 description 1
- HERITAGIPLEJMT-GVARAGBVSA-N Ile-Ala-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 HERITAGIPLEJMT-GVARAGBVSA-N 0.000 description 1
- YKRIXHPEIZUDDY-GMOBBJLQSA-N Ile-Asn-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N YKRIXHPEIZUDDY-GMOBBJLQSA-N 0.000 description 1
- KMBPQYKVZBMRMH-PEFMBERDSA-N Ile-Gln-Asn Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O KMBPQYKVZBMRMH-PEFMBERDSA-N 0.000 description 1
- HOLOYAZCIHDQNS-YVNDNENWSA-N Ile-Gln-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N HOLOYAZCIHDQNS-YVNDNENWSA-N 0.000 description 1
- UBHUJPVCJHPSEU-GRLWGSQLSA-N Ile-Glu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)O)N UBHUJPVCJHPSEU-GRLWGSQLSA-N 0.000 description 1
- GQKSJYINYYWPMR-NGZCFLSTSA-N Ile-Gly-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N1CCC[C@@H]1C(=O)O)N GQKSJYINYYWPMR-NGZCFLSTSA-N 0.000 description 1
- ZXIGYKICRDFISM-DJFWLOJKSA-N Ile-His-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N ZXIGYKICRDFISM-DJFWLOJKSA-N 0.000 description 1
- QZZIBQZLWBOOJH-PEDHHIEDSA-N Ile-Ile-Val Chemical compound N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)O QZZIBQZLWBOOJH-PEDHHIEDSA-N 0.000 description 1
- GVKKVHNRTUFCCE-BJDJZHNGSA-N Ile-Leu-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)O)N GVKKVHNRTUFCCE-BJDJZHNGSA-N 0.000 description 1
- FFJQAEYLAQMGDL-MGHWNKPDSA-N Ile-Lys-Tyr Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 FFJQAEYLAQMGDL-MGHWNKPDSA-N 0.000 description 1
- XQLGNKLSPYCRMZ-HJWJTTGWSA-N Ile-Phe-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(=O)O)N XQLGNKLSPYCRMZ-HJWJTTGWSA-N 0.000 description 1
- SVZFKLBRCYCIIY-CYDGBPFRSA-N Ile-Pro-Arg Chemical compound CC[C@H](C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(N)=N)C(O)=O SVZFKLBRCYCIIY-CYDGBPFRSA-N 0.000 description 1
- ZLFNNVATRMCAKN-ZKWXMUAHSA-N Ile-Ser-Gly Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)NCC(=O)O)N ZLFNNVATRMCAKN-ZKWXMUAHSA-N 0.000 description 1
- PELCGFMHLZXWBQ-BJDJZHNGSA-N Ile-Ser-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)O)N PELCGFMHLZXWBQ-BJDJZHNGSA-N 0.000 description 1
- VGSPNSSCMOHRRR-BJDJZHNGSA-N Ile-Ser-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N VGSPNSSCMOHRRR-BJDJZHNGSA-N 0.000 description 1
- JNLSTRPWUXOORL-MMWGEVLESA-N Ile-Ser-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N JNLSTRPWUXOORL-MMWGEVLESA-N 0.000 description 1
- HXIDVIFHRYRXLZ-NAKRPEOUSA-N Ile-Ser-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)O)N HXIDVIFHRYRXLZ-NAKRPEOUSA-N 0.000 description 1
- BLFXHAFTNYZEQE-VKOGCVSHSA-N Ile-Trp-Arg Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N BLFXHAFTNYZEQE-VKOGCVSHSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004310 Ion Channels Human genes 0.000 description 1
- 108090000862 Ion Channels Proteins 0.000 description 1
- IBMVEYRWAWIOTN-UHFFFAOYSA-N L-Leucyl-L-Arginyl-L-Proline Natural products CC(C)CC(N)C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(O)=O IBMVEYRWAWIOTN-UHFFFAOYSA-N 0.000 description 1
- RCFDOSNHHZGBOY-UHFFFAOYSA-N L-isoleucyl-L-alanine Natural products CCC(C)C(N)C(=O)NC(C)C(O)=O RCFDOSNHHZGBOY-UHFFFAOYSA-N 0.000 description 1
- REPPKAMYTOJTFC-DCAQKATOSA-N Leu-Arg-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(O)=O REPPKAMYTOJTFC-DCAQKATOSA-N 0.000 description 1
- GRZSCTXVCDUIPO-SRVKXCTJSA-N Leu-Arg-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(O)=O GRZSCTXVCDUIPO-SRVKXCTJSA-N 0.000 description 1
- FJUKMPUELVROGK-IHRRRGAJSA-N Leu-Arg-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)N FJUKMPUELVROGK-IHRRRGAJSA-N 0.000 description 1
- UCOCBWDBHCUPQP-DCAQKATOSA-N Leu-Arg-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(O)=O UCOCBWDBHCUPQP-DCAQKATOSA-N 0.000 description 1
- OXKYZSRZKBTVEY-ZPFDUUQYSA-N Leu-Asn-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O OXKYZSRZKBTVEY-ZPFDUUQYSA-N 0.000 description 1
- BPANDPNDMJHFEV-CIUDSAMLSA-N Leu-Asp-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O BPANDPNDMJHFEV-CIUDSAMLSA-N 0.000 description 1
- KTFHTMHHKXUYPW-ZPFDUUQYSA-N Leu-Asp-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KTFHTMHHKXUYPW-ZPFDUUQYSA-N 0.000 description 1
- GBDMISNMNXVTNV-XIRDDKMYSA-N Leu-Asp-Trp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O GBDMISNMNXVTNV-XIRDDKMYSA-N 0.000 description 1
- DKEZVKFLETVJFY-CIUDSAMLSA-N Leu-Cys-Asn Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)N)C(=O)O)N DKEZVKFLETVJFY-CIUDSAMLSA-N 0.000 description 1
- DZQMXBALGUHGJT-GUBZILKMSA-N Leu-Glu-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O DZQMXBALGUHGJT-GUBZILKMSA-N 0.000 description 1
- QVFGXCVIXXBFHO-AVGNSLFASA-N Leu-Glu-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O QVFGXCVIXXBFHO-AVGNSLFASA-N 0.000 description 1
- LLBQJYDYOLIQAI-JYJNAYRXSA-N Leu-Glu-Tyr Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LLBQJYDYOLIQAI-JYJNAYRXSA-N 0.000 description 1
- OXRLYTYUXAQTHP-YUMQZZPRSA-N Leu-Gly-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(O)=O OXRLYTYUXAQTHP-YUMQZZPRSA-N 0.000 description 1
- KGCLIYGPQXUNLO-IUCAKERBSA-N Leu-Gly-Glu Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(O)=O KGCLIYGPQXUNLO-IUCAKERBSA-N 0.000 description 1
- APFJUBGRZGMQFF-QWRGUYRKSA-N Leu-Gly-Lys Chemical compound CC(C)C[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN APFJUBGRZGMQFF-QWRGUYRKSA-N 0.000 description 1
- ORWTWZXGDBYVCP-BJDJZHNGSA-N Leu-Ile-Cys Chemical compound SC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H](N)CC(C)C ORWTWZXGDBYVCP-BJDJZHNGSA-N 0.000 description 1
- SEMUSFOBZGKBGW-YTFOTSKYSA-N Leu-Ile-Ile Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O SEMUSFOBZGKBGW-YTFOTSKYSA-N 0.000 description 1
- JNDYEOUZBLOVOF-AVGNSLFASA-N Leu-Leu-Gln Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O JNDYEOUZBLOVOF-AVGNSLFASA-N 0.000 description 1
- WXZOHBVPVKABQN-DCAQKATOSA-N Leu-Met-Asp Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(=O)O)C(=O)O)N WXZOHBVPVKABQN-DCAQKATOSA-N 0.000 description 1
- UCXQIIIFOOGYEM-ULQDDVLXSA-N Leu-Pro-Tyr Chemical compound CC(C)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 UCXQIIIFOOGYEM-ULQDDVLXSA-N 0.000 description 1
- KIZIOFNVSOSKJI-CIUDSAMLSA-N Leu-Ser-Cys Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)O)N KIZIOFNVSOSKJI-CIUDSAMLSA-N 0.000 description 1
- ZDJQVSIPFLMNOX-RHYQMDGZSA-N Leu-Thr-Arg Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N ZDJQVSIPFLMNOX-RHYQMDGZSA-N 0.000 description 1
- ILDSIMPXNFWKLH-KATARQTJSA-N Leu-Thr-Ser Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O ILDSIMPXNFWKLH-KATARQTJSA-N 0.000 description 1
- FPFOYSCDUWTZBF-IHPCNDPISA-N Leu-Trp-Leu Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H]([NH3+])CC(C)C)C(=O)N[C@@H](CC(C)C)C([O-])=O)=CNC2=C1 FPFOYSCDUWTZBF-IHPCNDPISA-N 0.000 description 1
- WUHBLPVELFTPQK-KKUMJFAQSA-N Leu-Tyr-Asn Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(O)=O WUHBLPVELFTPQK-KKUMJFAQSA-N 0.000 description 1
- NQCJGQHHYZNUDK-DCAQKATOSA-N Lys-Arg-Ser Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CO)C(O)=O)CCCN=C(N)N NQCJGQHHYZNUDK-DCAQKATOSA-N 0.000 description 1
- RDIILCRAWOSDOQ-CIUDSAMLSA-N Lys-Cys-Asp Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(=O)O)C(=O)O)N RDIILCRAWOSDOQ-CIUDSAMLSA-N 0.000 description 1
- WTZUSCUIVPVCRH-SRVKXCTJSA-N Lys-Gln-Arg Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N WTZUSCUIVPVCRH-SRVKXCTJSA-N 0.000 description 1
- GGNOBVSOZPHLCE-GUBZILKMSA-N Lys-Gln-Asp Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O GGNOBVSOZPHLCE-GUBZILKMSA-N 0.000 description 1
- RZHLIPMZXOEJTL-AVGNSLFASA-N Lys-Gln-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CCCCN)N RZHLIPMZXOEJTL-AVGNSLFASA-N 0.000 description 1
- DRCILAJNUJKAHC-SRVKXCTJSA-N Lys-Glu-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O DRCILAJNUJKAHC-SRVKXCTJSA-N 0.000 description 1
- DCRWPTBMWMGADO-AVGNSLFASA-N Lys-Glu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O DCRWPTBMWMGADO-AVGNSLFASA-N 0.000 description 1
- GQZMPWBZQALKJO-UWVGGRQHSA-N Lys-Gly-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O GQZMPWBZQALKJO-UWVGGRQHSA-N 0.000 description 1
- XNKDCYABMBBEKN-IUCAKERBSA-N Lys-Gly-Gln Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O XNKDCYABMBBEKN-IUCAKERBSA-N 0.000 description 1
- NKKFVJRLCCUJNA-QWRGUYRKSA-N Lys-Gly-Lys Chemical compound NCCCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCCCN NKKFVJRLCCUJNA-QWRGUYRKSA-N 0.000 description 1
- ZXFRGTAIIZHNHG-AJNGGQMLSA-N Lys-Ile-Leu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(C)C)C(=O)O)NC(=O)[C@H](CCCCN)N ZXFRGTAIIZHNHG-AJNGGQMLSA-N 0.000 description 1
- XREQQOATSMMAJP-MGHWNKPDSA-N Lys-Ile-Tyr Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O XREQQOATSMMAJP-MGHWNKPDSA-N 0.000 description 1
- WAIHHELKYSFIQN-XUXIUFHCSA-N Lys-Ile-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(O)=O WAIHHELKYSFIQN-XUXIUFHCSA-N 0.000 description 1
- OVAOHZIOUBEQCJ-IHRRRGAJSA-N Lys-Leu-Arg Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O OVAOHZIOUBEQCJ-IHRRRGAJSA-N 0.000 description 1
- AIRZWUMAHCDDHR-KKUMJFAQSA-N Lys-Leu-Leu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O AIRZWUMAHCDDHR-KKUMJFAQSA-N 0.000 description 1
- GAHJXEMYXKLZRQ-AJNGGQMLSA-N Lys-Lys-Ile Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O GAHJXEMYXKLZRQ-AJNGGQMLSA-N 0.000 description 1
- ZCWWVXAXWUAEPZ-SRVKXCTJSA-N Lys-Met-Glu Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZCWWVXAXWUAEPZ-SRVKXCTJSA-N 0.000 description 1
- WGILOYIKJVQUPT-DCAQKATOSA-N Lys-Pro-Asp Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O WGILOYIKJVQUPT-DCAQKATOSA-N 0.000 description 1
- YTJFXEDRUOQGSP-DCAQKATOSA-N Lys-Pro-Ser Chemical compound [H]N[C@@H](CCCCN)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(O)=O YTJFXEDRUOQGSP-DCAQKATOSA-N 0.000 description 1
- WQDKIVRHTQYJSN-DCAQKATOSA-N Lys-Ser-Arg Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)N WQDKIVRHTQYJSN-DCAQKATOSA-N 0.000 description 1
- BDFHWFUAQLIMJO-KXNHARMFSA-N Lys-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N)O BDFHWFUAQLIMJO-KXNHARMFSA-N 0.000 description 1
- VHTOGMKQXXJOHG-RHYQMDGZSA-N Lys-Thr-Val Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(O)=O VHTOGMKQXXJOHG-RHYQMDGZSA-N 0.000 description 1
- CNXOBMMOYZPPGS-NUTKFTJISA-N Lys-Trp-Ala Chemical compound [H]N[C@@H](CCCCN)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C)C(O)=O CNXOBMMOYZPPGS-NUTKFTJISA-N 0.000 description 1
- KXYLFJIQDIMURW-IHPCNDPISA-N Lys-Trp-Leu Chemical compound C1=CC=C2C(C[C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)[C@@H](N)CCCCN)=CNC2=C1 KXYLFJIQDIMURW-IHPCNDPISA-N 0.000 description 1
- PPNCMJARTHYNEC-MEYUZBJRSA-N Lys-Tyr-Thr Chemical compound NCCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H]([C@H](O)C)C(O)=O)CC1=CC=C(O)C=C1 PPNCMJARTHYNEC-MEYUZBJRSA-N 0.000 description 1
- NYTDJEZBAAFLLG-IHRRRGAJSA-N Lys-Val-Lys Chemical compound NCCCC[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(O)=O NYTDJEZBAAFLLG-IHRRRGAJSA-N 0.000 description 1
- OZVXDDFYCQOPFD-XQQFMLRXSA-N Lys-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCCCN)N OZVXDDFYCQOPFD-XQQFMLRXSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- VHGIWFGJIHTASW-FXQIFTODSA-N Met-Ala-Asp Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O VHGIWFGJIHTASW-FXQIFTODSA-N 0.000 description 1
- ZAJNRWKGHWGPDQ-SDDRHHMPSA-N Met-Arg-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@@H]1C(=O)O)N ZAJNRWKGHWGPDQ-SDDRHHMPSA-N 0.000 description 1
- DRINJBAHUGXNFC-DCAQKATOSA-N Met-Asp-His Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(O)=O DRINJBAHUGXNFC-DCAQKATOSA-N 0.000 description 1
- FBQMBZLJHOQAIH-GUBZILKMSA-N Met-Asp-Met Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCSC)C(O)=O FBQMBZLJHOQAIH-GUBZILKMSA-N 0.000 description 1
- DNDVVILEHVMWIS-LPEHRKFASA-N Met-Asp-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N1CCC[C@@H]1C(=O)O)N DNDVVILEHVMWIS-LPEHRKFASA-N 0.000 description 1
- PNDCUTDWYVKBHX-IHRRRGAJSA-N Met-Asp-Tyr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 PNDCUTDWYVKBHX-IHRRRGAJSA-N 0.000 description 1
- FVKRQMQQFGBXHV-QXEWZRGKSA-N Met-Asp-Val Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O FVKRQMQQFGBXHV-QXEWZRGKSA-N 0.000 description 1
- GPAHWYRSHCKICP-GUBZILKMSA-N Met-Glu-Glu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O GPAHWYRSHCKICP-GUBZILKMSA-N 0.000 description 1
- HLQWFLJOJRFXHO-CIUDSAMLSA-N Met-Glu-Ser Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O HLQWFLJOJRFXHO-CIUDSAMLSA-N 0.000 description 1
- GVIVXNFKJQFTCE-YUMQZZPRSA-N Met-Gly-Gln Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CCC(N)=O GVIVXNFKJQFTCE-YUMQZZPRSA-N 0.000 description 1
- HSJIGJRZYUADSS-IHRRRGAJSA-N Met-Lys-Leu Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(O)=O HSJIGJRZYUADSS-IHRRRGAJSA-N 0.000 description 1
- WTHGNAAQXISJHP-AVGNSLFASA-N Met-Lys-Val Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(O)=O WTHGNAAQXISJHP-AVGNSLFASA-N 0.000 description 1
- XOFDBXYPKZUAAM-GUBZILKMSA-N Met-Met-Ser Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CO)C(=O)O)N XOFDBXYPKZUAAM-GUBZILKMSA-N 0.000 description 1
- ILKCLLLOGPDNIP-RCWTZXSCSA-N Met-Met-Thr Chemical compound CSCC[C@H](N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ILKCLLLOGPDNIP-RCWTZXSCSA-N 0.000 description 1
- NTYQUVLERIHPMU-HRCADAONSA-N Met-Phe-Pro Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N2CCC[C@@H]2C(=O)O)N NTYQUVLERIHPMU-HRCADAONSA-N 0.000 description 1
- VQILILSLEFDECU-GUBZILKMSA-N Met-Pro-Ala Chemical compound [H]N[C@@H](CCSC)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O VQILILSLEFDECU-GUBZILKMSA-N 0.000 description 1
- PESQCPHRXOFIPX-UHFFFAOYSA-N N-L-methionyl-L-tyrosine Natural products CSCCC(N)C(=O)NC(C(O)=O)CC1=CC=C(O)C=C1 PESQCPHRXOFIPX-UHFFFAOYSA-N 0.000 description 1
- AJHCSUXXECOXOY-UHFFFAOYSA-N N-glycyl-L-tryptophan Natural products C1=CC=C2C(CC(NC(=O)CN)C(O)=O)=CNC2=C1 AJHCSUXXECOXOY-UHFFFAOYSA-N 0.000 description 1
- 241000701945 Parvoviridae Species 0.000 description 1
- JVTMTFMMMHAPCR-UBHSHLNASA-N Phe-Ala-Arg Chemical compound NC(=N)NCCC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC1=CC=CC=C1 JVTMTFMMMHAPCR-UBHSHLNASA-N 0.000 description 1
- JEGFCFLCRSJCMA-IHRRRGAJSA-N Phe-Arg-Ser Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CO)C(=O)O)N JEGFCFLCRSJCMA-IHRRRGAJSA-N 0.000 description 1
- HTKNPQZCMLBOTQ-XVSYOHENSA-N Phe-Asn-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC1=CC=CC=C1)N)O HTKNPQZCMLBOTQ-XVSYOHENSA-N 0.000 description 1
- WIVCOAKLPICYGY-KKUMJFAQSA-N Phe-Asp-Lys Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N WIVCOAKLPICYGY-KKUMJFAQSA-N 0.000 description 1
- DJPXNKUDJKGQEE-BZSNNMDCSA-N Phe-Asp-Phe Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O DJPXNKUDJKGQEE-BZSNNMDCSA-N 0.000 description 1
- OJUMUUXGSXUZJZ-SRVKXCTJSA-N Phe-Asp-Ser Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O OJUMUUXGSXUZJZ-SRVKXCTJSA-N 0.000 description 1
- CUMXHKAOHNWRFQ-BZSNNMDCSA-N Phe-Asp-Tyr Chemical compound C([C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)C1=CC=CC=C1 CUMXHKAOHNWRFQ-BZSNNMDCSA-N 0.000 description 1
- HQVPQHLNOVTLDD-IHRRRGAJSA-N Phe-Cys-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CS)NC(=O)[C@H](CC1=CC=CC=C1)N HQVPQHLNOVTLDD-IHRRRGAJSA-N 0.000 description 1
- UNLYPPYNDXHGDG-IHRRRGAJSA-N Phe-Gln-Glu Chemical compound OC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 UNLYPPYNDXHGDG-IHRRRGAJSA-N 0.000 description 1
- MPFGIYLYWUCSJG-AVGNSLFASA-N Phe-Glu-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](N)CC1=CC=CC=C1 MPFGIYLYWUCSJG-AVGNSLFASA-N 0.000 description 1
- LWPMGKSZPKFKJD-DZKIICNBSA-N Phe-Glu-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O LWPMGKSZPKFKJD-DZKIICNBSA-N 0.000 description 1
- ZLGQEBCCANLYRA-RYUDHWBXSA-N Phe-Gly-Glu Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(O)=O ZLGQEBCCANLYRA-RYUDHWBXSA-N 0.000 description 1
- MJQFZGOIVBDIMZ-WHOFXGATSA-N Phe-Ile-Gly Chemical compound N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)O MJQFZGOIVBDIMZ-WHOFXGATSA-N 0.000 description 1
- KXUZHWXENMYOHC-QEJZJMRPSA-N Phe-Leu-Ala Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O KXUZHWXENMYOHC-QEJZJMRPSA-N 0.000 description 1
- MSHZERMPZKCODG-ACRUOGEOSA-N Phe-Leu-Phe Chemical compound C([C@H](N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 MSHZERMPZKCODG-ACRUOGEOSA-N 0.000 description 1
- FENSZYFJQOFSQR-FIRPJDEBSA-N Phe-Phe-Ile Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(O)=O)NC(=O)[C@@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FENSZYFJQOFSQR-FIRPJDEBSA-N 0.000 description 1
- BSKMOCNNLNDIMU-CDMKHQONSA-N Phe-Thr-Gly Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O BSKMOCNNLNDIMU-CDMKHQONSA-N 0.000 description 1
- ZOGICTVLQDWPER-UFYCRDLUSA-N Phe-Tyr-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O ZOGICTVLQDWPER-UFYCRDLUSA-N 0.000 description 1
- XBCOOBCTVMMQSC-BVSLBCMMSA-N Phe-Val-Trp Chemical compound C([C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C1=CC=CC=C1 XBCOOBCTVMMQSC-BVSLBCMMSA-N 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- 206010036626 Presbyacusis Diseases 0.000 description 1
- CGBYDGAJHSOGFQ-LPEHRKFASA-N Pro-Ala-Pro Chemical compound C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 CGBYDGAJHSOGFQ-LPEHRKFASA-N 0.000 description 1
- ONPFOYPPPOHMNH-UVBJJODRSA-N Pro-Ala-Trp Chemical compound C[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@@H]3CCCN3 ONPFOYPPPOHMNH-UVBJJODRSA-N 0.000 description 1
- WPQKSRHDTMRSJM-CIUDSAMLSA-N Pro-Asp-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1 WPQKSRHDTMRSJM-CIUDSAMLSA-N 0.000 description 1
- GDXZRWYXJSGWIV-GMOBBJLQSA-N Pro-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@@H]1CCCN1 GDXZRWYXJSGWIV-GMOBBJLQSA-N 0.000 description 1
- ZCXQTRXYZOSGJR-FXQIFTODSA-N Pro-Asp-Ser Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CO)C(O)=O ZCXQTRXYZOSGJR-FXQIFTODSA-N 0.000 description 1
- SZZBUDVXWZZPDH-BQBZGAKWSA-N Pro-Cys-Gly Chemical compound OC(=O)CNC(=O)[C@H](CS)NC(=O)[C@@H]1CCCN1 SZZBUDVXWZZPDH-BQBZGAKWSA-N 0.000 description 1
- GQLOZEMWEBDEAY-NAKRPEOUSA-N Pro-Cys-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CS)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O GQLOZEMWEBDEAY-NAKRPEOUSA-N 0.000 description 1
- FRKBNXCFJBPJOL-GUBZILKMSA-N Pro-Glu-Glu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O FRKBNXCFJBPJOL-GUBZILKMSA-N 0.000 description 1
- ULIWFCCJIOEHMU-BQBZGAKWSA-N Pro-Gly-Asp Chemical compound OC(=O)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H]1CCCN1 ULIWFCCJIOEHMU-BQBZGAKWSA-N 0.000 description 1
- AFXCXDQNRXTSBD-FJXKBIBVSA-N Pro-Gly-Thr Chemical compound [H]N1CCC[C@H]1C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O AFXCXDQNRXTSBD-FJXKBIBVSA-N 0.000 description 1
- CFVRJNZJQHDQPP-CYDGBPFRSA-N Pro-Ile-Met Chemical compound CSCC[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]1CCCN1 CFVRJNZJQHDQPP-CYDGBPFRSA-N 0.000 description 1
- KLSOMAFWRISSNI-OSUNSFLBSA-N Pro-Ile-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@@H]1CCCN1 KLSOMAFWRISSNI-OSUNSFLBSA-N 0.000 description 1
- CLJLVCYFABNTHP-DCAQKATOSA-N Pro-Leu-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O CLJLVCYFABNTHP-DCAQKATOSA-N 0.000 description 1
- SRBFGSGDNNQABI-FHWLQOOXSA-N Pro-Leu-Trp Chemical compound N([C@@H](CC(C)C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)C(=O)[C@@H]1CCCN1 SRBFGSGDNNQABI-FHWLQOOXSA-N 0.000 description 1
- NTXFLJULRHQMDC-GUBZILKMSA-N Pro-Met-Asp Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@@H]1CCCN1 NTXFLJULRHQMDC-GUBZILKMSA-N 0.000 description 1
- FYKUEXMZYFIZKA-DCAQKATOSA-N Pro-Pro-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(N)=O)C(O)=O FYKUEXMZYFIZKA-DCAQKATOSA-N 0.000 description 1
- LEIKGVHQTKHOLM-IUCAKERBSA-N Pro-Pro-Gly Chemical compound OC(=O)CNC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 LEIKGVHQTKHOLM-IUCAKERBSA-N 0.000 description 1
- CGSOWZUPLOKYOR-AVGNSLFASA-N Pro-Pro-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NCCC1 CGSOWZUPLOKYOR-AVGNSLFASA-N 0.000 description 1
- POQFNPILEQEODH-FXQIFTODSA-N Pro-Ser-Ala Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O POQFNPILEQEODH-FXQIFTODSA-N 0.000 description 1
- OWQXAJQZLWHPBH-FXQIFTODSA-N Pro-Ser-Asn Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O OWQXAJQZLWHPBH-FXQIFTODSA-N 0.000 description 1
- ITUDDXVFGFEKPD-NAKRPEOUSA-N Pro-Ser-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ITUDDXVFGFEKPD-NAKRPEOUSA-N 0.000 description 1
- KWMZPPWYBVZIER-XGEHTFHBSA-N Pro-Ser-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(O)=O KWMZPPWYBVZIER-XGEHTFHBSA-N 0.000 description 1
- VVAWNPIOYXAMAL-KJEVXHAQSA-N Pro-Thr-Tyr Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O VVAWNPIOYXAMAL-KJEVXHAQSA-N 0.000 description 1
- BXHRXLMCYSZSIY-STECZYCISA-N Pro-Tyr-Ile Chemical compound CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1)C(O)=O BXHRXLMCYSZSIY-STECZYCISA-N 0.000 description 1
- KHRLUIPIMIQFGT-AVGNSLFASA-N Pro-Val-Leu Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O KHRLUIPIMIQFGT-AVGNSLFASA-N 0.000 description 1
- IIRBTQHFVNGPMQ-AVGNSLFASA-N Pro-Val-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@@H]1CCCN1 IIRBTQHFVNGPMQ-AVGNSLFASA-N 0.000 description 1
- ZMLRZBWCXPQADC-TUAOUCFPSA-N Pro-Val-Pro Chemical compound CC(C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@@H]2CCCN2 ZMLRZBWCXPQADC-TUAOUCFPSA-N 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 108010001267 Protein Subunits Proteins 0.000 description 1
- 102000002067 Protein Subunits Human genes 0.000 description 1
- 238000012181 QIAquick gel extraction kit Methods 0.000 description 1
- 108010003201 RGH 0205 Proteins 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- FIXILCYTSAUERA-FXQIFTODSA-N Ser-Ala-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O FIXILCYTSAUERA-FXQIFTODSA-N 0.000 description 1
- JPIDMRXXNMIVKY-VZFHVOOUSA-N Ser-Ala-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JPIDMRXXNMIVKY-VZFHVOOUSA-N 0.000 description 1
- OYEDZGNMSBZCIM-XGEHTFHBSA-N Ser-Arg-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(O)=O OYEDZGNMSBZCIM-XGEHTFHBSA-N 0.000 description 1
- QPFJSHSJFIYDJZ-GHCJXIJMSA-N Ser-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CO QPFJSHSJFIYDJZ-GHCJXIJMSA-N 0.000 description 1
- BYIROAKULFFTEK-CIUDSAMLSA-N Ser-Asp-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CO BYIROAKULFFTEK-CIUDSAMLSA-N 0.000 description 1
- GHPQVUYZQQGEDA-BIIVOSGPSA-N Ser-Asp-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)N)C(=O)O GHPQVUYZQQGEDA-BIIVOSGPSA-N 0.000 description 1
- ZOHGLPQGEHSLPD-FXQIFTODSA-N Ser-Gln-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O ZOHGLPQGEHSLPD-FXQIFTODSA-N 0.000 description 1
- YPUSXTWURJANKF-KBIXCLLPSA-N Ser-Gln-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O YPUSXTWURJANKF-KBIXCLLPSA-N 0.000 description 1
- BRGQQXQKPUCUJQ-KBIXCLLPSA-N Ser-Glu-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O BRGQQXQKPUCUJQ-KBIXCLLPSA-N 0.000 description 1
- LALNXSXEYFUUDD-GUBZILKMSA-N Ser-Glu-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O LALNXSXEYFUUDD-GUBZILKMSA-N 0.000 description 1
- VQBCMLMPEWPUTB-ACZMJKKPSA-N Ser-Glu-Ser Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O VQBCMLMPEWPUTB-ACZMJKKPSA-N 0.000 description 1
- GZFAWAQTEYDKII-YUMQZZPRSA-N Ser-Gly-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CO GZFAWAQTEYDKII-YUMQZZPRSA-N 0.000 description 1
- WSTIOCFMWXNOCX-YUMQZZPRSA-N Ser-Gly-Lys Chemical compound C(CCN)C[C@@H](C(=O)O)NC(=O)CNC(=O)[C@H](CO)N WSTIOCFMWXNOCX-YUMQZZPRSA-N 0.000 description 1
- UIGMAMGZOJVTDN-WHFBIAKZSA-N Ser-Gly-Ser Chemical compound OC[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O UIGMAMGZOJVTDN-WHFBIAKZSA-N 0.000 description 1
- BEAFYHFQTOTVFS-VGDYDELISA-N Ser-Ile-His Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CO)N BEAFYHFQTOTVFS-VGDYDELISA-N 0.000 description 1
- JIPVNVNKXJLFJF-BJDJZHNGSA-N Ser-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N JIPVNVNKXJLFJF-BJDJZHNGSA-N 0.000 description 1
- FUMGHWDRRFCKEP-CIUDSAMLSA-N Ser-Leu-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O FUMGHWDRRFCKEP-CIUDSAMLSA-N 0.000 description 1
- QYSFWUIXDFJUDW-DCAQKATOSA-N Ser-Leu-Arg Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O QYSFWUIXDFJUDW-DCAQKATOSA-N 0.000 description 1
- HEUVHBXOVZONPU-BJDJZHNGSA-N Ser-Leu-Ile Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O HEUVHBXOVZONPU-BJDJZHNGSA-N 0.000 description 1
- XXNYYSXNXCJYKX-DCAQKATOSA-N Ser-Leu-Met Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(O)=O XXNYYSXNXCJYKX-DCAQKATOSA-N 0.000 description 1
- GVMUJUPXFQFBBZ-GUBZILKMSA-N Ser-Lys-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O GVMUJUPXFQFBBZ-GUBZILKMSA-N 0.000 description 1
- JUTGONBTALQWMK-NAKRPEOUSA-N Ser-Met-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)N JUTGONBTALQWMK-NAKRPEOUSA-N 0.000 description 1
- IFLVBVIYADZIQO-DCAQKATOSA-N Ser-Met-Lys Chemical compound CSCC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CO)N IFLVBVIYADZIQO-DCAQKATOSA-N 0.000 description 1
- NUEHQDHDLDXCRU-GUBZILKMSA-N Ser-Pro-Arg Chemical compound OC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O NUEHQDHDLDXCRU-GUBZILKMSA-N 0.000 description 1
- BMKNXTJLHFIAAH-CIUDSAMLSA-N Ser-Ser-Leu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(O)=O BMKNXTJLHFIAAH-CIUDSAMLSA-N 0.000 description 1
- SQHKXWODKJDZRC-LKXGYXEUSA-N Ser-Thr-Asn Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O SQHKXWODKJDZRC-LKXGYXEUSA-N 0.000 description 1
- PURRNJBBXDDWLX-ZDLURKLDSA-N Ser-Thr-Gly Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)O)NC(=O)[C@H](CO)N)O PURRNJBBXDDWLX-ZDLURKLDSA-N 0.000 description 1
- QNBVFKZSSRYNFX-CUJWVEQBSA-N Ser-Thr-His Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CO)N)O QNBVFKZSSRYNFX-CUJWVEQBSA-N 0.000 description 1
- ZSDXEKUKQAKZFE-XAVMHZPKSA-N Ser-Thr-Pro Chemical compound C[C@H]([C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CO)N)O ZSDXEKUKQAKZFE-XAVMHZPKSA-N 0.000 description 1
- TYIHBQYLIPJSIV-NYVOZVTQSA-N Ser-Trp-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)O)NC(=O)[C@H](CO)N TYIHBQYLIPJSIV-NYVOZVTQSA-N 0.000 description 1
- QYBRQMLZDDJBSW-AVGNSLFASA-N Ser-Tyr-Glu Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CCC(O)=O)C(O)=O QYBRQMLZDDJBSW-AVGNSLFASA-N 0.000 description 1
- KIEIJCFVGZCUAS-MELADBBJSA-N Ser-Tyr-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)N)C(=O)O KIEIJCFVGZCUAS-MELADBBJSA-N 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- TYVAWPFQYFPSBR-BFHQHQDPSA-N Thr-Ala-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)NCC(O)=O TYVAWPFQYFPSBR-BFHQHQDPSA-N 0.000 description 1
- BSNZTJXVDOINSR-JXUBOQSCSA-N Thr-Ala-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(O)=O BSNZTJXVDOINSR-JXUBOQSCSA-N 0.000 description 1
- KEGBFULVYKYJRD-LFSVMHDDSA-N Thr-Ala-Phe Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 KEGBFULVYKYJRD-LFSVMHDDSA-N 0.000 description 1
- JMZKMSTYXHFYAK-VEVYYDQMSA-N Thr-Arg-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O JMZKMSTYXHFYAK-VEVYYDQMSA-N 0.000 description 1
- UNURFMVMXLENAZ-KJEVXHAQSA-N Thr-Arg-Tyr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O UNURFMVMXLENAZ-KJEVXHAQSA-N 0.000 description 1
- YOSLMIPKOUAHKI-OLHMAJIHSA-N Thr-Asp-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O YOSLMIPKOUAHKI-OLHMAJIHSA-N 0.000 description 1
- JEDIEMIJYSRUBB-FOHZUACHSA-N Thr-Asp-Gly Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O JEDIEMIJYSRUBB-FOHZUACHSA-N 0.000 description 1
- GKMYGVQDGVYCPC-IUKAMOBKSA-N Thr-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H]([C@@H](C)O)N GKMYGVQDGVYCPC-IUKAMOBKSA-N 0.000 description 1
- LIXBDERDAGNVAV-XKBZYTNZSA-N Thr-Gln-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(O)=O LIXBDERDAGNVAV-XKBZYTNZSA-N 0.000 description 1
- KCRQEJSKXAIULJ-FJXKBIBVSA-N Thr-Gly-Arg Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(O)=O KCRQEJSKXAIULJ-FJXKBIBVSA-N 0.000 description 1
- MPUMPERGHHJGRP-WEDXCCLWSA-N Thr-Gly-Lys Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)O)N)O MPUMPERGHHJGRP-WEDXCCLWSA-N 0.000 description 1
- MSIYNSBKKVMGFO-BHNWBGBOSA-N Thr-Gly-Pro Chemical compound C[C@H]([C@@H](C(=O)NCC(=O)N1CCC[C@@H]1C(=O)O)N)O MSIYNSBKKVMGFO-BHNWBGBOSA-N 0.000 description 1
- UDNVOQMPQBEITB-MEYUZBJRSA-N Thr-His-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O UDNVOQMPQBEITB-MEYUZBJRSA-N 0.000 description 1
- SXAGUVRFGJSFKC-ZEILLAHLSA-N Thr-His-Thr Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O SXAGUVRFGJSFKC-ZEILLAHLSA-N 0.000 description 1
- URPSJRMWHQTARR-MBLNEYKQSA-N Thr-Ile-Gly Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O URPSJRMWHQTARR-MBLNEYKQSA-N 0.000 description 1
- RFKVQLIXNVEOMB-WEDXCCLWSA-N Thr-Leu-Gly Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)O)N)O RFKVQLIXNVEOMB-WEDXCCLWSA-N 0.000 description 1
- MEJHFIOYJHTWMK-VOAKCMCISA-N Thr-Leu-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)[C@@H](C)O MEJHFIOYJHTWMK-VOAKCMCISA-N 0.000 description 1
- PRNGXSILMXSWQQ-OEAJRASXSA-N Thr-Leu-Phe Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O PRNGXSILMXSWQQ-OEAJRASXSA-N 0.000 description 1
- KDGBLMDAPJTQIW-RHYQMDGZSA-N Thr-Met-Lys Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)O)N)O KDGBLMDAPJTQIW-RHYQMDGZSA-N 0.000 description 1
- KZURUCDWKDEAFZ-XVSYOHENSA-N Thr-Phe-Asn Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(=O)N)C(=O)O)N)O KZURUCDWKDEAFZ-XVSYOHENSA-N 0.000 description 1
- XHWCDRUPDNSDAZ-XKBZYTNZSA-N Thr-Ser-Glu Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N)O XHWCDRUPDNSDAZ-XKBZYTNZSA-N 0.000 description 1
- IEZVHOULSUULHD-XGEHTFHBSA-N Thr-Ser-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O IEZVHOULSUULHD-XGEHTFHBSA-N 0.000 description 1
- XGFYGMKZKFRGAI-RCWTZXSCSA-N Thr-Val-Arg Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCN=C(N)N XGFYGMKZKFRGAI-RCWTZXSCSA-N 0.000 description 1
- ILUOMMDDGREELW-OSUNSFLBSA-N Thr-Val-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](N)[C@@H](C)O ILUOMMDDGREELW-OSUNSFLBSA-N 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- 102000000591 Tight Junction Proteins Human genes 0.000 description 1
- 108010002321 Tight Junction Proteins Proteins 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- DVIIYMVCSUQOJG-QEJZJMRPSA-N Trp-Glu-Asp Chemical compound [H]N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O DVIIYMVCSUQOJG-QEJZJMRPSA-N 0.000 description 1
- IQXWAJUIAQLZNX-IHPCNDPISA-N Trp-Leu-His Chemical compound CC(C)C[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)O)NC(=O)[C@H](CC2=CNC3=CC=CC=C32)N IQXWAJUIAQLZNX-IHPCNDPISA-N 0.000 description 1
- WSMVEHPVOYXPAQ-XIRDDKMYSA-N Trp-Ser-Lys Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)O)N WSMVEHPVOYXPAQ-XIRDDKMYSA-N 0.000 description 1
- STKZKWFOKOCSLW-UMPQAUOISA-N Trp-Thr-Val Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)[C@@H](C)O)=CNC2=C1 STKZKWFOKOCSLW-UMPQAUOISA-N 0.000 description 1
- YCEHCFIOIYNQTR-NYVOZVTQSA-N Trp-Trp-Ser Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)N[C@@H](CO)C(=O)O)N YCEHCFIOIYNQTR-NYVOZVTQSA-N 0.000 description 1
- RKISDJMICOREEL-QRTARXTBSA-N Trp-Val-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)N RKISDJMICOREEL-QRTARXTBSA-N 0.000 description 1
- AKXBNSZMYAOGLS-STQMWFEESA-N Tyr-Arg-Gly Chemical compound NC(N)=NCCC[C@@H](C(=O)NCC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AKXBNSZMYAOGLS-STQMWFEESA-N 0.000 description 1
- PEVVXUGSAKEPEN-AVGNSLFASA-N Tyr-Asn-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O PEVVXUGSAKEPEN-AVGNSLFASA-N 0.000 description 1
- IXTQGBGHWQEEDE-AVGNSLFASA-N Tyr-Asp-Gln Chemical compound NC(=O)CC[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 IXTQGBGHWQEEDE-AVGNSLFASA-N 0.000 description 1
- UXUFNBVCPAWACG-SIUGBPQLSA-N Tyr-Gln-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](CC1=CC=C(C=C1)O)N UXUFNBVCPAWACG-SIUGBPQLSA-N 0.000 description 1
- AZGZDDNKFFUDEH-QWRGUYRKSA-N Tyr-Gly-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 AZGZDDNKFFUDEH-QWRGUYRKSA-N 0.000 description 1
- WSFXJLFSJSXGMQ-MGHWNKPDSA-N Tyr-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N WSFXJLFSJSXGMQ-MGHWNKPDSA-N 0.000 description 1
- QHLIUFUEUDFAOT-MGHWNKPDSA-N Tyr-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=C(C=C1)O)N QHLIUFUEUDFAOT-MGHWNKPDSA-N 0.000 description 1
- CDKZJGMPZHPAJC-ULQDDVLXSA-N Tyr-Leu-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 CDKZJGMPZHPAJC-ULQDDVLXSA-N 0.000 description 1
- ZOBLBMGJKVJVEV-BZSNNMDCSA-N Tyr-Lys-Lys Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)O)N)O ZOBLBMGJKVJVEV-BZSNNMDCSA-N 0.000 description 1
- VUVVMFSDLYKHPA-PMVMPFDFSA-N Tyr-Lys-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC3=CC=C(C=C3)O)N VUVVMFSDLYKHPA-PMVMPFDFSA-N 0.000 description 1
- WTTRJMAZPDHPGS-KKXDTOCCSA-N Tyr-Phe-Ala Chemical compound C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](N)Cc1ccc(O)cc1)C(O)=O WTTRJMAZPDHPGS-KKXDTOCCSA-N 0.000 description 1
- ZMKDQRJLMRZHRI-ACRUOGEOSA-N Tyr-Phe-His Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)N ZMKDQRJLMRZHRI-ACRUOGEOSA-N 0.000 description 1
- FGVFBDZSGQTYQX-UFYCRDLUSA-N Tyr-Phe-Val Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O FGVFBDZSGQTYQX-UFYCRDLUSA-N 0.000 description 1
- IEWKKXZRJLTIOV-AVGNSLFASA-N Tyr-Ser-Gln Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(O)=O IEWKKXZRJLTIOV-AVGNSLFASA-N 0.000 description 1
- MQGGXGKQSVEQHR-KKUMJFAQSA-N Tyr-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 MQGGXGKQSVEQHR-KKUMJFAQSA-N 0.000 description 1
- TYFLVOUZHQUBGM-IHRRRGAJSA-N Tyr-Ser-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC1=CC=C(O)C=C1 TYFLVOUZHQUBGM-IHRRRGAJSA-N 0.000 description 1
- LABUITCFCAABSV-BPNCWPANSA-N Val-Ala-Tyr Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 LABUITCFCAABSV-BPNCWPANSA-N 0.000 description 1
- AUMNPAUHKUNHHN-BYULHYEWSA-N Val-Asn-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N AUMNPAUHKUNHHN-BYULHYEWSA-N 0.000 description 1
- LNYOXPDEIZJDEI-NHCYSSNCSA-N Val-Asn-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)N LNYOXPDEIZJDEI-NHCYSSNCSA-N 0.000 description 1
- NWDOPHYLSORNEX-QXEWZRGKSA-N Val-Asn-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCSC)C(=O)O)N NWDOPHYLSORNEX-QXEWZRGKSA-N 0.000 description 1
- CGGVNFJRZJUVAE-BYULHYEWSA-N Val-Asp-Asn Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)N)C(=O)O)N CGGVNFJRZJUVAE-BYULHYEWSA-N 0.000 description 1
- XLDYBRXERHITNH-QSFUFRPTSA-N Val-Asp-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)C(C)C XLDYBRXERHITNH-QSFUFRPTSA-N 0.000 description 1
- XJFXZQKJQGYFMM-GUBZILKMSA-N Val-Cys-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)O)N XJFXZQKJQGYFMM-GUBZILKMSA-N 0.000 description 1
- QHFQQRKNGCXTHL-AUTRQRHGSA-N Val-Gln-Glu Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O QHFQQRKNGCXTHL-AUTRQRHGSA-N 0.000 description 1
- UZDHNIJRRTUKKC-DLOVCJGASA-N Val-Gln-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](C(C)C)C(=O)O)N UZDHNIJRRTUKKC-DLOVCJGASA-N 0.000 description 1
- XWYUBUYQMOUFRQ-IFFSRLJSSA-N Val-Glu-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C(C)C)N)O XWYUBUYQMOUFRQ-IFFSRLJSSA-N 0.000 description 1
- OXGVAUFVTOPFFA-XPUUQOCRSA-N Val-Gly-Cys Chemical compound CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CS)C(=O)O)N OXGVAUFVTOPFFA-XPUUQOCRSA-N 0.000 description 1
- PMDOQZFYGWZSTK-LSJOCFKGSA-N Val-Gly-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)CNC(=O)[C@@H](N)C(C)C PMDOQZFYGWZSTK-LSJOCFKGSA-N 0.000 description 1
- KVRLNEILGGVBJX-IHRRRGAJSA-N Val-His-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)C(C)C)CC1=CN=CN1 KVRLNEILGGVBJX-IHRRRGAJSA-N 0.000 description 1
- RWOGENDAOGMHLX-DCAQKATOSA-N Val-Lys-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C(C)C)N RWOGENDAOGMHLX-DCAQKATOSA-N 0.000 description 1
- KISFXYYRKKNLOP-IHRRRGAJSA-N Val-Phe-Ser Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CO)C(=O)O)N KISFXYYRKKNLOP-IHRRRGAJSA-N 0.000 description 1
- SJRUJQFQVLMZFW-WPRPVWTQSA-N Val-Pro-Gly Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O SJRUJQFQVLMZFW-WPRPVWTQSA-N 0.000 description 1
- WANVRBAZGSICCP-SRVKXCTJSA-N Val-Pro-Met Chemical compound CSCC[C@H](NC(=O)[C@@H]1CCCN1C(=O)[C@@H](N)C(C)C)C(O)=O WANVRBAZGSICCP-SRVKXCTJSA-N 0.000 description 1
- KSFXWENSJABBFI-ZKWXMUAHSA-N Val-Ser-Asn Chemical compound [H]N[C@@H](C(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(O)=O KSFXWENSJABBFI-ZKWXMUAHSA-N 0.000 description 1
- VHIZXDZMTDVFGX-DCAQKATOSA-N Val-Ser-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](C(C)C)N VHIZXDZMTDVFGX-DCAQKATOSA-N 0.000 description 1
- GBIUHAYJGWVNLN-AEJSXWLSSA-N Val-Ser-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N1CCC[C@@H]1C(=O)O)N GBIUHAYJGWVNLN-AEJSXWLSSA-N 0.000 description 1
- LZRWTJSPTJSWDN-FKBYEOEOSA-N Val-Trp-Phe Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)N LZRWTJSPTJSWDN-FKBYEOEOSA-N 0.000 description 1
- PMKQKNBISAOSRI-XHSDSOJGSA-N Val-Tyr-Pro Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CC=C(C=C1)O)C(=O)N2CCC[C@@H]2C(=O)O)N PMKQKNBISAOSRI-XHSDSOJGSA-N 0.000 description 1
- AOILQMZPNLUXCM-AVGNSLFASA-N Val-Val-Lys Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CCCCN AOILQMZPNLUXCM-AVGNSLFASA-N 0.000 description 1
- 102100038033 Vesicular glutamate transporter 3 Human genes 0.000 description 1
- 101710107968 Vesicular glutamate transporter 3 Proteins 0.000 description 1
- 108010003533 Viral Envelope Proteins Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000007488 abnormal function Effects 0.000 description 1
- 239000003070 absorption delaying agent Substances 0.000 description 1
- NOSIYYJFMPDDSA-UHFFFAOYSA-N acepromazine Chemical compound C1=C(C(C)=O)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 NOSIYYJFMPDDSA-UHFFFAOYSA-N 0.000 description 1
- 229960005054 acepromazine Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 108010011559 alanylphenylalanine Proteins 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 108010052670 arginyl-glutamyl-glutamic acid Proteins 0.000 description 1
- 108010069926 arginyl-glycyl-serine Proteins 0.000 description 1
- 208000002982 auditory neuropathy Diseases 0.000 description 1
- 210000003984 auditory pathway Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000001815 biotherapy Methods 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- IVUMCTKHWDRRMH-UHFFFAOYSA-N carprofen Chemical compound C1=CC(Cl)=C[C]2C3=CC=C(C(C(O)=O)C)C=C3N=C21 IVUMCTKHWDRRMH-UHFFFAOYSA-N 0.000 description 1
- 229960003184 carprofen Drugs 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000030833 cell death Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000007248 cellular mechanism Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 210000004081 cilia Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- -1 coatings Substances 0.000 description 1
- 210000000262 cochlear duct Anatomy 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000004624 confocal microscopy Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 210000004292 cytoskeleton Anatomy 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000015155 detection of stimulus involved in sensory perception Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 210000001062 endolymphatic sac Anatomy 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000028023 exocytosis Effects 0.000 description 1
- 210000001808 exosome Anatomy 0.000 description 1
- 210000003195 fascia Anatomy 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000834 fixative Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000003976 gap junction Anatomy 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 210000004602 germ cell Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 108010042598 glutamyl-aspartyl-glycine Proteins 0.000 description 1
- 108010062266 glycyl-glycyl-argininal Proteins 0.000 description 1
- 108010074027 glycyl-seryl-phenylalanine Proteins 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 108010085325 histidylproline Proteins 0.000 description 1
- OCYSGIYOVXAGKQ-UHFFFAOYSA-N hydron;3-[1-hydroxy-2-(methylamino)ethyl]phenol;chloride Chemical compound Cl.CNCC(O)C1=CC=CC(O)=C1 OCYSGIYOVXAGKQ-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000008105 immune reaction Effects 0.000 description 1
- 238000010820 immunofluorescence microscopy Methods 0.000 description 1
- 230000005847 immunogenicity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000007972 injectable composition Substances 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000007913 intrathecal administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 229960004184 ketamine hydrochloride Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 210000003041 ligament Anatomy 0.000 description 1
- 239000008297 liquid dosage form Substances 0.000 description 1
- 239000006193 liquid solution Substances 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 239000008176 lyophilized powder Substances 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 238000007726 management method Methods 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 210000001595 mastoid Anatomy 0.000 description 1
- 230000028161 membrane depolarization Effects 0.000 description 1
- 210000004779 membrane envelope Anatomy 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 230000004879 molecular function Effects 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 230000008450 motivation Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000007474 nonparametric Mann- Whitney U test Methods 0.000 description 1
- 201000006790 nonsyndromic deafness Diseases 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000003463 organelle Anatomy 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000007918 pathogenicity Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 108010073025 phenylalanylphenylalanine Proteins 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000001323 posttranslational effect Effects 0.000 description 1
- 208000009800 presbycusis Diseases 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 108010014614 prolyl-glycyl-proline Proteins 0.000 description 1
- 108010087846 prolyl-prolyl-glycine Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 238000003259 recombinant expression Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 102220024085 rs397515607 Human genes 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 210000001605 scala vestibuli Anatomy 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 210000002480 semicircular canal Anatomy 0.000 description 1
- 239000008299 semisolid dosage form Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000019800 sensory organ development Effects 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 210000000130 stem cell Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000003568 synaptosome Anatomy 0.000 description 1
- 108060008004 synaptotagmin Proteins 0.000 description 1
- 102000003137 synaptotagmin Human genes 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 230000028016 temperature homeostasis Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000013518 transcription Methods 0.000 description 1
- 230000035897 transcription Effects 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 102000035160 transmembrane proteins Human genes 0.000 description 1
- 108091005703 transmembrane proteins Proteins 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 210000003454 tympanic membrane Anatomy 0.000 description 1
- 231100000402 unacceptable toxicity Toxicity 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 210000001213 vestibule labyrinth Anatomy 0.000 description 1
- 230000007482 viral spreading Effects 0.000 description 1
- 238000011179 visual inspection Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 229960004175 xylazine hydrochloride Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
- A01K67/0276—Knock-out vertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A01K2217/054—Animals comprising random inserted nucleic acids (transgenic) inducing loss of function
- A01K2217/056—Animals comprising random inserted nucleic acids (transgenic) inducing loss of function due to mutation of coding region of the transgene (dominant negative)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/20—Animal model comprising regulated expression system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/105—Murine
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
- A01K2267/0306—Animal model for genetic diseases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14141—Use of virus, viral particle or viral elements as a vector
- C12N2750/14144—Chimeric viral vector comprising heterologous viral elements for production of another viral vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14171—Demonstrated in vivo effect
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Environmental Sciences (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biodiversity & Conservation Biology (AREA)
- Animal Husbandry (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Toxicology (AREA)
- Marine Sciences & Fisheries (AREA)
- Cell Biology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
本发明人在此报告了在DFNB9小鼠模型(OTOF敲除小鼠)中的首个理论验证：当在小鼠听觉系统已经成熟(P30)之后，将片段化的cDNA通过双AAV载体方法耳蜗递送可以有效且持久地修正这些小鼠中的重度耳聋表型。本发明因此涉及一种允许在内毛细胞中表达全长耳畸蛋白多肽、或其功能片段的载体系统，其用于治疗患有DFNB9耳聋的患者、或在具有DFNB9突变的患者中预防DFNB9耳聋，其中所述患者是具有发育的和成熟的听觉系统的患者，例如新生儿、幼儿、儿童、青少年或成人。
Description
背景技术
超过一半的非综合征性重度先天性耳聋病例有遗传原因，大多数(～80％)是常染色体隐性(DFNB)形式(Duman D.&Tekin M，FrontBiosci(Landmark编)17：2213-2236(2012))。耳聋的基因诊断为耳蜗基因疗法提供必要信息，并且在过去几年中基因测试的准确性和可及性得到快速进展。可以在患者症状出现之前的很多年鉴定综合征耳聋基因中的突变，从而为计划疾病管理争取时间。
耳聋基因编码的蛋白具有对于耳蜗功能至关重要的大范围分子功能，例如感觉器官发育、毛细胞的静纤毛中的声音转导、维持耳蜗内电位(EP)和高浓度的细胞外钾、以及毛细胞和螺旋神经节神经元(SGN)之间的突触神经传递。耳聋基因产生的主要蛋白包括细胞骨架和分子马达中的离子通道和转运蛋白、间隙连接和紧密连接、蛋白亚基、以及在耳蜗发育中瞬时表达的转录因子。在确定“治疗时间窗”中的主要因素是突变是否会影响早期耳蜗发育以及导致显著的细胞变性，这是在该治疗领域中至关重要的问题。
虽然假体耳蜗植入物目前用于康复(Kral A&O’Donoghue GM N Engl J Med 363(15)：1438-1450(2010))，但因为由通道间电干扰对其施加的频率分辨率的固有限制，听力恢复远非完美，特别是对于在嘈杂环境中语音的感知或对音乐的感知。
开发生物治疗的主要动机是在没有植入任何假体设备的情况下恢复听力，并且实现远远优于耳蜗植入物目前可实现的声音分辨率质量和单位成本。具体地，已经建议使用局部腺相关病毒(AAV)介导的基因疗法的基因疗法用于治疗人的耳聋形式(Zhang等人，Frontiers in Molecular Neuroscience,第11卷，第221条，2018)。
使用研究Usher型1C疾病的Ush1c c.216G>A敲入小鼠模型，Pan等人，Naturebiotechnology；35(3):264-272(2017)测试了耳蜗基因疗法是否可用于靶向毛细胞以修正耳聋表型。一种新的合成的AAV(Anc80L65)能够转导>90％的毛细胞。该治疗显示耳蜗中的形态保持，并且当在P0-P1天(即，小鼠出生当天或之后一天，称为“出生后0日或1日”)注射重组病毒载体时，与未治疗的耳朵相比听觉阈值改善60-70dB。在P10-P12(即出生后的十或十二天，在听力出现之前(在该物种中约在P12发生))进行相同注射，没有产生任何治疗效果(Pan等人，Nature biotechnology；35(3):264-272(2017)。
Akil等人，Neuron 75：283-293(2012)使用AAV2/1将囊泡谷氨酸转运蛋白3(Vglut3)cDNA递送到新生(即，出生后1至12天)KO小鼠耳蜗中，以治疗内毛细胞的突触传递的病症。基于听觉脑干反应(ABR)和声惊吓反射的数据，他们证明经注射的耳朵中的听觉功能在2周内恢复。
这两项研究证明，当在出生后早期阶段(即在小鼠毛细胞成熟之前)注射重组病毒载体时，显著缓解耳蜗中的细胞变性。
迄今为止，所有评估小鼠内耳疗法的基因疗法研究都得出结论：这些疗法对成年动物无效。因此，人们一致认为，基因疗法在听力保存或恢复中的有效性存在关键时期，并且治疗的机会窗口只存在于处于胚胎中或出生后早期阶段的小鼠中，即在听力出现发生之前(Ahmed等人，JARO 18:649-670(2017))。
众所周知，小鼠内耳在出生时在结构和功能上仍不成熟，并且在该动物物种中听力出现发生在出生后第12天(P12)，至出生后约第20天(P20)结束(Shnerson和Willott，J.Comp.Physiol.Psychol.94,36-40(1980))。然而，在人中听力出现和成熟发生在完全不同的时间。事实上，人的内耳在早在子宫内4.5个月时就能够进行听觉功能，并且在出生时结束(参见图6和Hepper PG&Shahidullah BS，Arch Dis Child71(2):F81-87(1994))。
这意味着旨在于听力出现前或耳蜗成熟结束前恢复听觉功能的现有技术实验，当转移到人进行试验时应在子宫中进行(图6)。然而，因为在出生后阶段或儿童期(infancy)(即当听觉系统完全成熟和行使功能时)恢复听力被认为是不可能的，所以迄今为止还没有人接受过毛细胞基因疗法。
尽管如此，耳蜗基因疗法的最终目标是在可以检测出或诊断出潜在的遗传诱导的耳聋后(即，在其出生后的大多数时间中)，治疗人常见的遗传性耳聋。
确实不可能开发出涉及在子宫中将治疗递送到耳蜗中的基因疗法操作方案，因为这种外科手术可能会引起许多副作用，其中包括确定性的听力丧失(Zhang等人，Frontiersin Molecular Neuroscience，卷11，第221条，2018)。此外，众所周知，在人中DFNB耳聋通常在新生儿阶段(即，在出生后在0到4个月之间)被诊断出来。
因此，为可转用于(transposable)人，基因疗法方法应经过测试并在逆转已经建立的影响成熟听觉系统的耳聋表型中有效，例如，当施用于出生后天数>P20的小鼠时(对应于年轻人或成年人)。
这将是符合人伦理和福利的鉴定治疗时间窗口的唯一方法，因为这些治疗可以施用在听觉系统完善的出生后(post-natal)、儿童(infant)和成人中。
发明详述
本发明人已经开发可选择的研究，以鉴定有实际机会有效预防或逆转受试者(特别是人)中的听力丧失的治疗，在所述受试者中听觉系统(特别是耳蜗)是成熟的，并且不涉及胚胎基因递送。在这种情况下，他们能够证明在内毛细胞中耳畸蛋白(Otoferlin)的重组表达能够在出生后天数>P20时治疗的模型小鼠中(对应于年轻人或成人)恢复听觉。
耳畸蛋白在耳蜗的感觉内毛细胞(IHC)中大量表达。耳畸蛋白还在中枢神经系统的其他细胞中表达。它在耳蜗毛细胞突触与传入螺旋神经节神经元的突触囊泡融合的最后步骤中起着关键作用。更准确地说，耳畸蛋白对在听觉带状突触的细胞外泌很重要(Roux等人，Cell 127(2):277-89,2006)。
在人类中，影响耳畸蛋白基因(“OTOF基因”)的突变导致在出生后但在语言习得之前发生严重的非综合征双侧听觉丧失。其中一些还会导致当体温显著升高时触发的热敏非综合征性听觉神经病(例如，在发烧的情况下，参见Marlin S.等人，Biochemical andBiophysical Research Communications,394(2010)737-742和Varga R.等人，J.Med.Genet 2006；43：576-581)。目前已经鉴定至少60个突变(参见图7)，其中已知5个是热敏的(P.Q994VfsX6、P.I515T、p.G541S、PR1607W、p.E1804del，如Pangrsic T.等人，Trends in Neurosciences，2012，第35栏，第11期所述)。
在全世界都发现这两个耳聋表型(组成型和诱导型)并且称为“耳聋、常染色体隐性9”或“DFNB9”耳聋。
DFNB9耳聋在一些西方人群中占常染色体隐性非综合征听力丧失的多达8％，因此位于仍需要治疗干预的遗传性听力障碍的前五名。
本发明人在此报告了在DFNB9小鼠模型(OTOF敲除小鼠)中的首个理论验证：当在小鼠听觉系统已经成熟(P30)之后，将片段化的cDNA通过双AAV载体方法耳蜗递送可以有效且持久地修正这些小鼠中的重度耳聋表型。该结果表明，在具有由DFNB9导致的先天性耳聋的患者中，局部基因传递的治疗窗口实际上比最初怀疑的要长。
事实上，施用本发明的载体，每个载体提供一部分OTOF基因并能够在出生后晚期(P30)的OTOF敲除小鼠的转染的内毛细胞中表达全长OTOF蛋白，产生比治疗更年幼小鼠时更好的结果。
这是非常出人意料的，因为许多研究表明，患有遗传性耳聋的小鼠的局部基因传递的治疗窗口是胚胎期或出生后早期(Ahmed等人，JARO 18:649-670(2017)；Zhang等人，Frontiers in Molecular Neuroscience，第11卷，第221条，2018)。
众所周知，在小鼠中，可以在P14(即出生后的十四天)观察到全范围的反应频率。反应潜伏期和峰间间隔在生后第二周和第三周迅速成熟，并在P18达到成人特征(Song L.等人，J Acoust Soc Am 119(4):2242-2257(2006))。因此，小鼠的听觉系统在P30完全成熟。它对应于儿童或成人的听觉系统(见图6)。
因此，发明人获得的结果表明，本发明中使用的基因疗法不仅在出生前时间窗内对人有效，而且在被诊断患有先天性DFNB9耳聋的儿童患者中、或在稍晚诊断的成年患者(例如因为他们携带OTOF基因中的热敏突变)中有效。
在第一方面，本发明涉及允许全长耳畸蛋白多肽或其功能片段在内毛细胞中表达的载体系统，其用于在治疗患有DFNB9耳聋的患者，其中所述患者优选为幼儿(toddler)、儿童、青少年或成年人。
如本文所用，术语“耳畸蛋白”表示耳畸蛋白多肽。在此处缩写为“OTOF”。该多肽也称为“AUNB1”；“DFNB6”；“DFNB9”；“NSRD9”和“FER1L2”。
在SEQ ID NO:1(对应于Genbank号AF183185.1)中显示野生型人耳畸蛋白多肽的同种型1的全长。该多肽是跨膜蛋白的Ferlin家族的成员，它与突触结合蛋白、PKC和PLC一样具有C2结构域。该长形式包含六个C2结构域。如上所述，它涉及耳蜗毛细胞和传入螺旋神经节神经元之间的突触囊泡融合(Roux等人，Cell 127(2):277-89,2006；Michalski等人，Elife,2017年11月，7；6e31013)。
术语“耳畸蛋白多肽”指SEQ ID NO:1的耳畸蛋白多肽及其同源序列，其保留了本文感兴趣的耳畸蛋白多肽的至少一种生物学功能。例如，该生物学功能与激活初级听觉神经元的耳蜗内毛细胞带状突触中的囊泡融合的调节有关(Roux等人2006；Michalski等人；Elife,2017年11月7日；6e31013)。可以通过经典的离体电生理测量来评估该调节。
在优选的实施方案中，本发明的载体系统允许表达其氨基酸序列与SEQ ID NO:1具有至少70％的同一性和/或相似性的同源多肽。所述同源序列更优选地与SEQ ID NO:1具有至少75％、甚至更优选至少80％、或至少90％的同一性和/或相似性。当同源多肽比SEQID NO:1短得多时，可以考虑局部比对。
所述同源多肽可具有例如SEQ ID NO:5所示的氨基酸序列(对应于Genbank号NP_001274418)。所述序列表征野生型人耳畸蛋白多肽的同种型e(变体5)。该同种型e由具有序列SEQ ID NO:22的cDNA变体编码。该变体与SEQ ID NO:1相比在3'编码区中缺少可选择的框内(in-frame)外显子，并且使用下游终止密码子。与SEQ ID NO:1相比，其编码不同的C末端(但其N末端部分是相同的)。
所述同源多肽还可以具有SEQ ID NO:6所示的氨基酸序列(对应Genbank号NP_004793.2)或SEQ ID NO:24所示的氨基酸(对应于Genbank号NP_919303.1)，其分别对应短的同种型b和c(变体2和3)。更准确地说，SEQ ID NO:6表示同种型b(变体2，也称为“短型1”)，与SEQ ID NO:1相比其具有较短的N末端并且缺少一个区段。在另一方面，SEQ ID NO:24表示同种型c(变体3，也称为“短型2”)，与变体1(SEQ ID NO:1)相比其区别在于5'UTR和编码序列，因为其与SEQ ID NO:1相比，具有较短的和不同的C末端。
所述同源序列也可以是，例如另一种动物物种的耳畸蛋白多肽，例如，SEQ ID NO:7，其是小鼠耳畸蛋白多肽的全长同种型1(对应Genbank号NP_001093865.1)。该同种型由SEQ ID NO:16(NM_1100395)的cDNA编码。
在本发明的上下文中，当所述两个同源序列之间的同一性百分比可以通过序列在其整体上的全局比对所鉴定时(例如，当序列大致尺寸相同时)，可以通过本领域技术人员所公知的算法方式进行比对，例如在Needleman和Wunsch(1970)所公开。因此，两个氨基酸序列或两个核苷酸序列之间的序列比较可以通过以下进行，例如，通过使用本领域技术人员已知的任何软件，例如使用“needle”软件以及10的“空位打开”参数、0.5的“空位延伸”参数和“Blosum62”矩阵来进行。
当要考虑序列的局部比对时(例如，在同源物具有比本发明的序列更小尺寸的情况下)，那么所述比对可以通过常规算法的方式进行，例如，在Smith和Waterman(J.Mol.Evol.1981；18(1)38-46)中公开的算法。
本发明提供系统，其编码与SEQ ID NO:1或SEQ ID NO:5或SEQ ID NO:6或SEQ IDNO:24“相似”的同源氨基酸序列。两个靶氨基酸序列的“相似性”可以通过计算两个氨基酸序列的相似性评分来确定。如本文所用，“相似性评分”是指当两个序列最佳比对时，使用BLOSUM62氨基酸取代矩阵、11的空位存在罚分、和1的空位延伸罚分对两个序列产生的评分。当两个序列在比对时以便为成对的序列产生最大可能的评分时是“最佳比对”，这可能需要在一个或两个序列中引入空位以实现最大评分。如果两个氨基酸序列的相似性评分超过某个阈值，则它们实质上是相似的。阈值可以是针对具体参考序列(例如，SEQ ID NO:1)的至少1190到最高可能评分的任何整数。例如，相似性评分阈值可以是1190、1200、1210、1220、1230、1240、1250、1260、1270、1280、1290、1300、1310、1320、1330、1340、1350、1360、1370、1380、1390、1400、1410、1420、1430、1440、1450、1460、1470、1480、1490、1500或更高。如果在本发明的具体实施方案中，评分阈值被设定为例如1300并且参考序列是SEQ ID NO:1，然后与SEQ ID NO:1可以经最佳比对以产生大于1300的相似性评分的任何氨基酸序列对于SEQ ID NO:1而言是相似的。氨基酸取代矩阵及其在量化两个序列之间的相似性中的用途是本领域公知的并且描述见于，例如Dayhoff等人，(1978),“A model of evolutionarychange in proteins”,“Atlas of Protein Sequence and Structure,”第5卷，3增刊(M.O.Dayhoff编)，345–352页，Natl.Biomed.Res.Found.，华盛顿D.C和Henikoff等人(1992)Proc.Natl.Acad.Sci.USA 89:10915–10919。虽然可以手动完成最佳比对和评分，但通过使用计算机实现的比对算法可以促进该过程，例如，Altschul等人(1997)NucleicAcids Res.25:3389–3402中所述的空位BLAST 2.0，并且公众可在国家生物技术信息网站获得。为了使用NCBI BLAST生成准确的相似性分数，重要的是要关闭任何过滤(例如，低复杂度过滤)，并禁用基于组成的统计数据。人们还应该确认使用正确的取代矩阵和空位罚分。最佳比对(包括多重比对)可以使用例如PSI-BLAST来制备，PSI-BLAST可通过NCBI网站获得，并且描述见于Altschul等人，(1997)Nucleic Acids Res.25:3389–3402。
在另一个实施方案中，本发明的载体系统可以允许表达耳畸蛋白多肽的功能片段。术语“功能片段”本文是指人耳畸蛋白多肽的任何片段或具有如上定义的同源序列的多肽的任何片段，其中所述片段保留本文中感兴趣的耳畸蛋白多肽的至少一种生物学功能。例如，该生物学功能与激活初级听觉神经元的耳蜗内毛细胞带状突触中的囊泡融合的调节有关(Roux等人2006；Michalski等人；Elife,2017年11月7日；6e31013)。可以通过经典的离体电生理测量来评估该调节。
例如，所述功能片段可以具有SEQ ID NO:6所示的氨基酸序列(对应具有Genbank号NP_004793.2的同种型b)或SEQ ID NO:24所示的氨基酸序列(对应具有Genbank号NP_919303.1的同种型c)。所述序列表征野生型人耳畸蛋白多肽的短同种型，仅包含三个C2结构域。
在本发明的这个方面，本发明的载体系统施用于患有DFNB9耳聋的患者。通过“患有DFNB9耳聋的患者”，本文指患者、特别是人患者，其被认为具有(或已被诊断为具有)在组成型耳畸蛋白基因中的突变，所述突变触发耳畸蛋白蛋白的异常表达、异常功能或两者都有。在具体实施方案中，所述突变可以是热敏的。
迄今为止，在耳畸蛋白中报告多于60种致病性突变(参见图7)。其中包括在因发热引起的偶发性耳聋病状患者中鉴定出的至少五种热敏突变(P.Q994VfsX6、P.I515T、p.G541S、PR1607W、p.E1804del)。
这些患者可由熟练的医师鉴定，例如使用听觉脑干反应(ABR)的电生理学测试和/或基因测试的组合来鉴定OTOF基因中的突变。在一些实施方案中，患者在OTOF基因中具有以下无义或错义突变中的一种或多种：TYR730TER、GLN829TER、PR01825ALA、PRO50ARG、LEU1011PRO、ILE515THR、ARG1939GLN、或GLY541SER。在一些实施方案中，患者在内含子8/外显子9连接处具有A至G转换(IVS8-2A-G)、或在位置+1(外显子5的剪接供体位点中的第一个内含子核苷酸)处具有G至A转换、或在内含子39的供体剪接位点处具有G-C颠换。在一些实施方案中，患者在外显子16中具有一个碱基对缺失(1778G)，导致产生终止密码子，以及6141G-A改变，产生外显子48中的ARG到GLN的取代。
施用本发明的载体系统的患者是听觉系统(特别是耳蜗)已经发育和成熟的患者，特别是人患者。因为施用不旨在于子宫内进行，因此这些患者，特别是人患者不是人胚胎或胎儿。根据图7，本发明靶向的患者优选为新生人婴儿，通常小于6月龄，甚至小于3月龄(如果他们在幼时被诊断出来患DFNB9耳聋)。这些人婴儿更优选在3月龄和1岁之间。
注意，人耳蜗在孕龄17至19周时整体达到成人尺寸，在30-36周内完全形态学成熟(对应于小鼠出生后12天)。通过监测ABR记录的波I(在人孕龄约28周可以记录)可以评估内毛细胞带状突触的功能性成熟。ABR波I的记录和分析(反映了与初级听觉神经元相关的内毛细胞突触的功能)显示人婴儿在出生时完全功能性成熟(对应于小鼠出生后20天)。这在本领域中是众所周知的(参见例如Pujol et Lavigne-Rebillard，Acta oto-laryngologica.增刊·1991年2月)。
因此，还可以将本发明的载体系统施用于较大的人患者，例如幼儿(2-6岁)、儿童(6-12岁)、青少年(12-18岁)或成人(18岁及以上)。
因此，优选将本发明的载体系统施用至年龄在3月龄至25岁之间的人患者中。
本发明的患者特别是在语言习得后诊断患有DFNB9耳聋的人儿童。
在另一个具体实施方案中，本发明的患者是6岁及以上的人类，即当其中枢神经系统完全成熟时发生治疗的施用(参见图7)。
在具体实施方案中，本发明的载体系统被施用于患有热敏突变诱导的DFNB9耳聋的人患者，优选施用于携带至少一个上述耳畸蛋白热敏突变的青少年或成人。
如本文所用，术语“治疗”旨在表示将治疗有效量的本发明的载体系统之一施用至患有DFNB9耳聋的患者，以便部分地或完全恢复所述患者的听力。通过使用电生理设备测试听觉脑干反应(ABR)可以评估所述恢复。“治疗DFNB9耳聋”特别旨在指听力功能的完全恢复，而不考虑所涉及的细胞机制如何。
对于携带热敏突变的患者，也可以施用本发明的载体系统以预防体温调节诱导的听力丧失。在本发明的上下文中，术语“预防”指减少(impair)或延迟听觉频率范围内的听力丧失。
可以将本发明的载体系统施用在这些和其他DFNB9患者中，用于在听力丧失发生之前预防听力丧失，并且在听力丧失已经发生时恢复听力能力。
已经探索多个递送到内耳的途径。这些包括通过圆窗膜(round windowmembrane)(RWM)和通过卵圆窗注射到外淋巴空间，以及通过耳蜗造口术注射到鼓阶或前庭阶。已经证明所有这些递送途径分布在全部外淋巴空间。此外，已经证明流经耳蜗和前庭器官的平流可以促进治疗剂从注射部位分布到内耳更远区域。也已经探索通过耳蜗造口术进入蜗管(scala media)、通过小管造口术以及通过注射到内淋巴囊中来递送到内淋巴空间中。这些方法也产生了广泛的分布，但面临着破坏高钾内淋巴和外淋巴之间屏障的额外挑战。屏障的破坏会带来两个潜在问题。首先，高钾泄漏到外淋巴空间中，浸泡毛细胞和神经元的基底外侧表面，可使这些细胞慢性去极化并导致细胞死亡。其次，破坏内淋巴和外淋巴之间的紧密连接会导致耳蜗内电位下降，耳蜗内电位范围通常在+80和+120mV之间。耳蜗内电位的下降会降低毛细胞感觉转导的驱动力，从而导致耳蜗敏感性降低和听觉阈值升高。在成人耳蜗中避免这些并发症尤其具有挑战性。然而，通过靶向前庭系统中的内淋巴空间(其没有内淋巴电位但与耳蜗内淋巴空间连续)，可以使混杂的问题最小化，同时仍然在耳蜗内提供足够的分布(Ahmed等人，JARO 18:649-670(2017))。
耳蜗是高度分隔的并通过血-耳蜗屏障(BCB)与身体的其他部分隔开，从而最小化治疗注射体积以及使进入身体循环系统的泄漏最小化，从而保护耳蜗免疫赦免并减少全身不良免疫反应的机会。由于耳蜗中的毛细胞和支持细胞通常不会分裂，耳蜗中的细胞保持稳定，因此可以使用非整合病毒载体(例如AAV)进行持续的转基因表达。
因为在人中，后半规管似乎也是人可及的，因此半规方法已被认为是未来人试验中耳蜗基因疗法的有前途的注射途径(Suzuki等人，Sci.Rep.7:45524(2017)；Yoshimura等人，Sci.Rep.8:2980(2018)。
在本发明的一个优选实施方案中，本发明的载体系统通过临床耳科手术实践中常规使用的两种常见且成熟的技术之一在人耳中施用。更确切地说，将采用这些方法以靶向外淋巴空间。为此，通过使用激光镫骨足板造孔术(经镫骨)通过卵圆窗或经乳突/经圆窗进行使用微导管的注射(Dai C等人，JARO,18:601-617,2017)。
也可能通过静脉注射或输注全身施用。
本发明的载体系统包含至少一种多核苷酸载体，其可以触发在内毛细胞中全长耳畸蛋白多肽、或其功能片段的表达。优选地，所述多核苷酸载体包含编码所述多肽或其功能片段的编码序列，其可操作地连接至能够在所述细胞中特异性表达基因的启动子。
所述编码序列是例如SEQ ID NO:2的人耳畸蛋白基因，所述SEQ ID NO:2对应人野生型耳畸蛋白基因的同种型1的cDNA序列(NM_194248.2＝同种型a或变体1，其是最长的同种型)。
所述编码序列也可以是SEQ ID NO:22的较短的cDNA序列NM_001287489.1(同种型e或变体5)、cDNA序列NM_004802.3(同种型b或变体2)、cDNA序列NM_194322.2(同种型c或变体3)、或cDNA序列NM_194323.2(同种型d或变体4)。
已经开发了许多病毒和非病毒载体，用于在各种组织和器官中递送遗传物质。在大多数情况下，这些载体无复制能力，几乎没有病毒引起的疾病的威胁。相反，病毒基因组已经部分或完全缺失，从而扩大允许在病毒衣壳中包含治疗性DNA货物(cargo)的能力。一些载体包括单链DNA，而其他载体包括双链DNA。在本发明的上下文中特别优选的载体是慢病毒载体、腺病毒载体、腺相关病毒(AAV)，如Ahmed等人，JARO 18:649-670(2017)所公开。
具体来说，AAV是来自细小病毒科的小复制缺陷的腺病毒依赖性病毒。其具有直径为20-25nm的二十面体(icosaedrical)衣壳，和侧翼有两个反向末端重复(ITR)的4.8kb的基因组。在宿主细胞中脱壳后，AAV基因组可以通过形成高分子量的头对尾环状多联体而保持稳定的附加体状态，或者可以整合到宿主细胞基因组中。这两种情况都提供长期和高水平的转基因表达。
基于眼睛基因治疗的人试验所获得的结果，AAV似乎是用于耳蜗基因治疗的有前途的病毒。AAV在人眼睛基因治疗中取得成功的原因包括：(1)经证实的安全概况(大量人试验表明AAV缺乏致病性并且具有非常低的免疫原性)，(2)在非分裂细胞中持久的转基因表达，(3)AAV的小尺寸(≈20nm，比腺病毒小五倍)有助于穿过细胞屏障扩散，到达所靶向的细胞(Zhang等人，Frontiers in Molecular Neuroscience，第11卷，第221条，2018)。
在优选的实施方案中，本发明的载体系统包含至少一种AAV颗粒，其包含编码全长耳畸蛋白多肽或其功能片段的多核苷酸，如上所述。
在另一个优选的实施方案中，本发明的载体系统包含至少两种AAV颗粒，它们中的每一种包含患有部分编码序列的多核苷酸，对于一种AAV颗粒，所述部分编码序列编码：i)耳畸蛋白多肽或其功能片段的N末端部分，对于另一种AAV颗粒，所述部分编码序列编码ii)耳畸蛋白多肽或其功能片段的C末端部分。
迄今为止，已对12种天然存在的人AAV血清型进行表征。这些血清型在肌肉、肺、肝、脑、视网膜和血管系统中具有不同的固有趋向性和转导效率。在AAV假型(pseudotyping)和衣壳工程化的多种尝试导致在转导的趋向性和效率上有显著改善。至于内耳细胞，已证明AAV1-4、7和8在体内感染螺旋缘、螺旋韧带和螺旋神经节细胞。还证明AAV1-3、5、6和8感染IHC。AAV1是最有效的，偶尔会感染OHC和支持细胞。此外，证明AAV5对克劳狄斯(Claudius)细胞、螺旋神经节和内沟(sulcus)细胞有效。在假型载体中，发现在小鼠耳蜗中AAV2/1有效地转导产生IHC和OHC的祖细胞，而AAV2/2对于豚鼠耳蜗的IHC是最佳的(Ahmed等人，JARO 18:649-670(2017))。
因此，在优选的实施方案中，本发明的载体系统包含选自以下的AAV载体：AAV1、AAV2、AAV3、AAV4、AAV5、AAV6、AAV7、AAV8、AAV9和AAV10。
在更优选的实施方案中，所述载体的血清型是AAV2、AAV8、AAV5或AAV1。在甚至更优选的实施方案中，所述载体的血清型是AAV2或AAV8。在本发明的上下文中，AAV8是最优选的血清型，目前在体内进行测试。
为提高基因表达的效率，并防止病毒的意外扩散，可以进行AAV的遗传修饰。这些遗传修饰包括删除E1区、删除E1区并删除E2或E4区，或删除整个腺病毒基因组，顺式作用反向末端重复和包装信号除外。此类载体有利地包括在本发明中。
此外，可以使用具有突变的衣壳蛋白的遗传修饰的AAV以指导在特定的组织类型中基因表达，例如听觉细胞。为此，可以使用修饰的血清型2和8AAV载体，其中病毒包膜中的酪氨酸残基被丙氨酸残基取代。在酪氨酸突变血清型2的情况下，酪氨酸444可以被丙氨酸(AAV2-Y444A)取代。在血清型8的情况下，酪氨酸733可以被丙氨酸残基(AAV8-Y733A)取代。通过使用AAV2-Y444A或AAV8-Y733A，可能将基因传递增加多达10,000倍，从而减少感染耳蜗感觉毛细胞所需的AAV量。
在一个优选的实施方案中，表达耳畸蛋白多肽或其基因或其功能片段的本发明的多核苷酸包含在重组AAV2颗粒中，在所述AAV2颗粒中所有酪氨酸残基已被苯丙氨酸残基取代(AAV2(Y->F)或Quad Y-F，如Petrs-Silva H等人，Mol.Ther.19,293-301(2011)和在以下的实施例中所公开的。衣壳蛋白外表面上的突变酪氨酸残基包括，例如但不限于以下的突变：Tyr252至Phe252(Y252F)、Tyr272至Phe272(Y272F)、Tyr444至Phe444(Y444F)、Tyr500至Phe500(Y500F)、Tyr700至Phe700(Y700F)、Tyr704至Phe704(Y704F)、Tyr730至Phe730(Y730F)以及Tyr733至Phe733(Y733F)。这些修饰的载体促进载体穿过圆窗膜，这允许载体非侵入性地递送至耳蜗的毛细胞/螺旋神经节神经元。这些突变的载体避免被蛋白酶体所降解，并且它们的转导效率显著增加。
其它源自天然血清型1-10的重组AAV颗粒包括AAV2-AAV3杂合体、AAVrh.10、AAVhu.14、AAV3a/3b、AAVrh32.33、AAV-HSC15、AAV-HSC17、AAVhu.37、AAVrh.8、CHt-P6、AAV2.5、AAV6.2、AAV2i8、AAV-HSC15/17、AAVM41、AAV9.45、AAV6(Y445F/Y731F)、AAV2.5T、AAV-HAE1/2、AAV克隆32/83、AAVShH10、AAV8(Y733F)、AAV2.15、AAV2.4、AAVM41、和AAVr3.45(Asokan A等人，Mol.Therapy，第20卷，第4号，第699-708页,2012)。
也可以使用合成载体Anc80L65，其已被证明具有迄今为止报道的内耳毛细胞的最高转导效率(Suzuki等人,Sci.Rep.7:45524(2017))。也可能使用外来体相关的AAV，如
等人，Ther.25(2):379-391，2017所建议的。
也可以使用超载的AAV/PHP.B载体，其衣壳已被修饰以增强其包装能力。
制备包含异源多核苷酸或构建体的病毒和病毒粒子的方法是本领域已知的。在AAV的情况下，细胞可以用腺病毒或包含适合AAV辅助功能的腺病毒基因的多核苷酸构建体共感染或转染。材料和方法的示例在例如美国8,137,962和6,967,018中描述。
技术人员将容易地确定，在施用本发明的载体之前是否需要根据靶细胞来增强圆窗膜的渗透性，如WO 2011/075838中所建议。
即使使用AAV，本发明的系统也可以是单载体系统。在这种情况下，可以使用修饰的衣壳(参见AAV/PHP.B载体)。
如果所选择的AAV衣壳具有5千碱基的有限包装容量，则最好使用双载体系统，例如在WO 2013/075008中公开的，其通过引用并入本文。
本发明人已使用所述双AAV载体方法将耳畸蛋白基因分成两个部分提供至内毛细胞，在那里发生同源重组并表达全长蛋白。其结果表明，两种不同的AAV载体能够有效地转导所靶向的内毛细胞，在内毛细胞中产生耳畸蛋白，并以持久的方式恢复因DFNB9失效而患先天性耳聋的小鼠OTOF KO的严重耳聋表型。
因此，本发明的载体系统优选包含至少两种AAV颗粒，每种所述AAV颗粒包含：
a)第一多核苷酸，其包含在所述多核苷酸的每个末端的反向末端重复，以及在所述反向末端重复之间从5'至3’的合适的启动子、之后是含有耳畸蛋白基因的N末端部分的部分编码序列、以及剪接供体位点，或
b)第二多核苷酸，其包含在所述多核苷酸的每个末端的反向末端重复，以及在所述反向末端重复之间从5'至3'的剪接接受位点、含有耳畸蛋白基因的C末端部分的部分编码序列，之后任选的多腺苷酸化序列，
其中所述第一和第二多核苷酸还含有引起重组的序列，其位于所述第一多核苷酸的剪接供体位点之后，所述第二多核苷酸的剪接受体位点之前，以及
其中当第一和第二多核苷酸结合时其中的编码序列编码全长耳畸蛋白多肽。
该优选的实施方案使用“第一”和“第二”多核苷酸。然而，除非另有明确说明，否则“第一”和“第二”并不意味着表示特定的顺序或重要性。
如图1和WO 2013/075008所阐述，在该具体实施方案中使用的第一和第二多核苷酸应含有特定的遗传组分，以诱导靶细胞中耳畸蛋白的适当重组和表达。
这些特定组分如下：
·ITR
在本发明的一些实施方案中，OTOF基因的部分或全长cDNA插入到两个含ITR的质粒中。
如果使用AAV载体，则本文所述的多核苷酸的ITR序列可源自任何AAV血清型(例如，1、2、3、4、5、6、7、8、9或10)或可以源自一种以上血清型。在本文提供的多核苷酸的一些实施方案中，ITR序列源自AAV2。ITR序列和含有ITR序列的质粒在本领域中是已知的并且是商业上可获得的。
位于表达构建体的5'端侧翼的示例性AAV2 ITR序列包含序列SEQ ID NO:10。位于表达构建体的3'端侧翼的示例性AAV2 ITR序列包含序列SEQ ID NO:11。
如果本发明的多核苷酸是单载体系统，则可以有利地使用这种ITR。
·合适的启动子
预期用于本发明的载体系统的启动子包括、但不限于巨细胞病毒(CMV)启动子、SV40启动子、鲁斯氏肉瘤病毒(RSV)启动子、嵌合CMV/鸡-β肌动蛋白启动子(CBA)和CBA的截短形式(smCBA)(美国专利号8,298,818)。在一个特定实施方案中，启动子是包含CMV和β-肌动蛋白启动子的嵌合启动子。
在优选的实施方案中，在本发明的载体系统中使用的启动子是SEQ ID NO:8的截短的嵌合CMVβ肌动蛋白(smcBA)启动子或与SEQ ID NO:8具有至少75％、至少80％、至少85％、至少90％、至少95％、至少96％、至少97％、至少98％、至少99％、或100％序列同一性的启动子。
如果本发明的多核苷酸是单载体系统，则可以有利地使用这种启动子。
可以使用本领域已知的标准技术将启动子并入载体中。可以在本发明的载体系统中使用多拷贝的启动子或多个启动子。在一个实施方案中，启动子距转录起始位点的距离与其在天然遗传环境中距转录起始位点的距离可以大致相同。允许该距离的一些变化而无实质地降低启动子的活性。转录起始位点通常包括在载体中。
·一种引起重组的序列，其促进cDNA序列分开的两部分在体内的同源重组，从而在转染的内毛细胞中产生OTOF多肽的整个编码序列和其表达。
在一些实施方案中，本发明的两种多核苷酸(例如，第一和第二多核苷酸)包含所谓的“引起重组区域”，其可以促进当两种多核苷酸递送到细胞时两种多核苷酸之间的同源重组(参见例如Ghosh等人，Hum Gene Ther.2011年1月；22(l):77-83)。
该引起重组区域通常包含在第一多核苷酸的第一区域，其在第二多核苷酸中具有同源区域，反之亦然。如上所述，这两个区域优选彼此具有至少75％、至少80％、至少90％、至少95％、至少96％、至少97％、至少98％、至少99％或100％同一性的序列同一性的阈值水平。
该引起重组区域优选具有包含50至500、50至400、50至300、100至500、100至400、100至300、200至500、200至400、或200至300个核苷酸的尺寸。
在优选的实施方案中，两个区域是相同的并且具有200至300个核苷酸的尺寸。
这些引起重组的序列具有足够同源的序列，以便在标准严谨条件和标准方法下允许彼此杂交。
如本文所用，杂交的“严谨”条件指通常过夜进行杂交的条件：在20-25℃(低于DNA杂交的熔融温度(Tm))，在6×SSPE、5×Denhardt溶液、0.1％SDS、0.1mg/ml的变性DNA。熔融温度由下式描述：Tm＝81.5C+16.6Log[Na+]+0.41(％G+C)-0.61(％甲酰胺)-600/碱基对中的双链体的长度。
通常如下进行洗涤：(1)在室温下在1×SSPE、0.1％SDS中两次，每次15分钟(低严谨洗涤)。(2)在Tm-20℃下在0.2×SSPE、0.1％SDS中一次15分钟(中度严谨洗涤)。
在更优选的实施方案中，两个区域是相同的并且具有序列SEQ ID NO:9或与SEQID NO:9具有至少75％、至少80％、至少85％、至少90％、至少95％、至少96％、至少97％、至少98％、至少99％或100％序列同一性的同源序列。
·剪接供体位点和剪接受体位点
当在体内重组时，全长cDNA包含一个剪接供体/剪接受体对，其导致引起重组区域被剪接出。本发明的双载体系统中包括的多核苷酸包含剪接供体或剪接受体位点。在一个优选的实施方案中，剪接供体和/或剪接受体位点含有剪接共有序列。在更优选的实施方案中，包含在本发明载体系统中的多核苷酸所携带的剪接供体和/或剪接受体位点含有源自碱性磷酸酶的剪接共有序列。
在优选的实施方案中，包括在本发明的双载体系统中的多核苷酸分别包含作为剪接供体和受体位点的SEQ ID NO:12和/或SEQ ID NO:13，或包含与SEQ ID NO:12和/或SEQID NO:13具有至少75％、至少80％、至少85％、至少90％、至少95％、至少96％、至少97％、至少98％、至少99％、或100％序列同一性的剪接位点。
包含在单或在双载体系统中的本发明的多核苷酸序列，可含有在待表达载体的内毛细胞中具有功能的其他调节组分。本领域普通技术人员可以选择用于人内毛细胞中的调节元件。调节元件包括例如内部核糖体进入位点(IRES)、转录终止序列、翻译终止序列、增强子和聚腺苷酸化元件。
转录终止区通常可以从真核或病毒基因序列的3'非翻译区获得。转录终止序列可以定位在编码序列的下游以提供有效终止。信号肽序列是氨基末端序列，其编码的信息负责将可操作连接的多肽重新定位到广泛的翻译后细胞目的地，范围从特定的细胞器区室到蛋白质作用位点和细胞外环境。增强子是增加基因转录的顺式作用元件，也可以包含在载体中。增强子元件是本领域已知的，包括但不限于CaMV 35S增强子元件、巨细胞病毒(CMV)早期启动子增强子元件和SV40增强子元件。
在载体中还可以包括指导结构基因编码的mRNA聚腺苷酸化的DNA序列。
双载体方法有利地将OTOF基因的编码序列分成两部分，以便更容易地包装到具有有限包装能力的病毒粒子中。当使用AAV衣壳时，优选使用包含OTOF编码序列的多核苷酸，所述OTOF编码序列不超过5千碱基、不超过4千碱基、甚至更优选不超过3千碱基。
人OTOF基因的编码序列优选在天然剪接位点切割。
例如，SEQ ID NO:2的人OTOF基因同种型1可以被分成N末端部分和C末端部分，所述的N末端部分具有如SEQ ID NO:3(SEQ ID NO:2的核苷酸1-2676)所示的核苷酸序列，所述C末端部分具有如SEQ ID NO:4(SEQ ID NO:2的核苷酸2677-5994)所示的核苷酸序列。具有SEQ ID NO:22的人OTOF基因同种型5可以被分成SEQ ID NO:3的N末端部分和SEQ ID NO:23的C末端部分。
可以作为在本发明的载体系统中的第一和第二多核苷酸的示例性多核苷酸分别例如SEQ ID NO:19和SEQ ID NO:20。这两种多核苷酸分别编码人耳畸蛋白蛋白的同种型1的N末端和C末端部分。
SEQ ID NO:19包含：
-具有序列SEQ ID NO:10(nt20-162)的AAV2的5ITR序列、
-CMV增强子(nt186-440)、鸡β-肌动蛋白启动子(nt441-835)、β-肌动蛋白蛋白的外显子1和嵌合内含子(nt836-1130)，所有三个被称为“smCBA”，对应序列SEQ ID NO:8、
-人耳畸蛋白同种型1编码序列的5’部分，其具有序列SEQ ID NO:3(nt1153-3558)、
-具有序列SEQ ID NO:12(nt3559-3642)的碱性磷酸酶的剪接供体位点、
-具有序列SEQ ID NO:9(nt3649-3935)的引起重组的序列，以及
-具有序列SEQ ID NO:11的AAV2的3'ITR序列。
另一方面，SEQ ID NO:20包含：
-具有序列SEQ ID NO:10(nt20-162)的AAV2的5'ITR序列、
-具有序列SEQ ID NO:9(nt207-493)的引起重组的序列、
-具有序列SEQ ID NO:13(nt516-564)的碱性磷酸酶的剪接受体位点、
-人耳畸蛋白同种型1编码序列的3’部分，其具有序列SEQ ID NO:4(nt565-4152)、
和
-牛生长激素聚腺苷酸化信号(nt4190-4411)、以及
-具有序列SEQ ID NO:11的AAV2的3'ITR序列。
可以在本发明的载体系统中用作第一和第二多核苷酸的示例性多核苷酸分别为例如SEQ ID NO:19和SEQ ID NO:21。这两种多核苷酸分别编码SEQ ID NO:22的人耳畸蛋白基因的同种型5的N末端和C末端部分(因为同种型1&5的N末端部分相同，可以使用SEQ IDNO:19用于诱导两种同种型的表达)。
SEQ ID NO:21包含：
-具有序列SEQ ID NO:10(nt20-162)的AAV2的5'ITR序列、
-具有序列SEQ ID NO:9(nt207-493)的引起重组的序列、
-具有序列SEQ ID NO:13(nt516-564)的碱性磷酸酶的剪接受体位点、
-人耳畸蛋白同种型5的编码序列的3'部分，其具有SEQ ID NO:23(nt565-4152)、
和
-牛生长激素聚腺苷酸化信号(nt4190-4411)、以及
-AAV2的3'ITR序列，其具有序列SEQ ID NO:11。
本发明的药物组合物
在另一方面，本发明靶向包含本发明的载体系统的药物组合物，如上所述(即，多核苷酸或含有其的病毒粒子)，用于治疗患有DFNB9耳聋的具有成熟听觉系统患者(特别是人患者)，或用于预防具有DFNB9突变的患者中的DFNB9耳聋。
更普遍的，该药物组合物可以施用于由于DFNB59基因表达的改变或缺陷而患有先天性听力丧失的人受试者。所述缺陷，例如，可以当耳畸蛋白以正常水平表达但没有功能时观察到。
换句话说，如上所述，本发明涉及本发明的载体系统在制备用于预防和/或治疗具有成熟听觉系统的患者的药物组合物中的用途，所述患者(特别是人)患有与DFNB59基因表达的改变或缺陷相关的上述病症。
如本文所用，“药学上可接受的载体”包括任何和所有生理相容的溶剂、分散介质、涂层、抗菌剂和抗真菌剂、等渗剂和吸收延迟剂等。药学上可接受的载体的实例包括水、盐水、磷酸盐缓冲盐水、葡萄糖、甘油、乙醇等中的一种或多种，以及其组合。在许多情况下，可以优选在组合物中包括等渗剂，例如糖、多元醇如甘露醇、山梨糖醇或氯化钠。药学上可接受的载体可进一步包含少量辅助物质，例如润湿剂或乳化剂、防腐剂或缓冲剂，其提高抗氧化化合物或含有抗氧化化合物的药物组合物的保质期或有效性。
本发明的药物组合物可以是多种形式。这些包括，例如，液体、半固体和固体剂型，例如液体溶液(例如，可注射和不熔化溶液)、分散剂或混悬剂、片剂、丸剂、粉剂、脂质体和栓剂。使用的形式取决于预期的施用方式和治疗应用。典型的组合物是可注射或不熔化溶液的形式。
药物组合物通常在制造和储存条件下必须是无菌和稳定的。本发明的药物组合物优选配制成溶液、微乳液、分散剂、脂质体或其它适合高药物浓度的有序结构。根据需要，可以通过将所需量的本发明载体与一种以上列举的成分或以上列举的成分的组合，掺入适当的溶剂中，然后过滤除菌来制备无菌可注射溶液。通常，通过将本发明的载体掺入含有基本分散介质和来自上面列举的那些所需的其他成分的无菌载剂中来制备分散剂。在用于制备无菌可注射溶液的无菌冻干粉剂的情况下，优选的制备方法是真空干燥和喷雾干燥，其从其之前无菌过滤的溶液产生活性成分加上任何额外的所需成分的粉剂。可以通过以下维持溶液的适当流动性，例如通过使用诸如卵磷脂的涂层、在分散剂的情况下通过维持所需的粒度以及通过使用表面活性剂。可以通过在组合物中包含延迟吸收的试剂(例如，单硬脂酸盐和明胶)来实现延长吸收可注射组合物。
在本发明的上下文中，本发明组合物的典型施用模型是鼓室内(中耳)、耳蜗内、或肠胃外(例如，静脉内、皮下、腹膜内、肌肉内、鞘内(intrathecal))。在一个实例中，本发明的药物组合物通过静脉输注或注射施用。在另一个实例中，使用立体定位递送，特别是通过鼓膜或乳突递送进中耳，将本发明的药物组合物递送至特定位置。
更准确地，可以通过使用微导管施用本发明的组合物，其通过使用激光镫骨足板造孔术(经镫骨)通过卵圆窗或经乳突/经圆窗进行(Dai C等人，JARO,18:601-617，2017)。
在本发明的一个优选实施方案中，本发明的药物组合物通过耳蜗内施用在人耳中施用，更准确地说是通过靶向上述的前庭系统中的内淋巴空间或通过半规方法。
本发明的药物组合物通常包括“治疗有效量”或“预防有效量”的本发明载体。“治疗有效量”是指本发明的载体的量，其以必要的剂量和在必要的时间段内有效以实现期望的治疗结果，在这种情况下预防和治疗听力丧失而没有不可接受的毒性或不良副作用。
本发明的载体的治疗有效量可根据以下因素而变化：诸如受试者的疾病状态、年龄、性别和体重以及所述化合物在受试者中引发所需反应的能力。治疗有效量也可以是其中要求保护的化合物的任何毒性或有害效果被治疗有益效果超过的量。“预防有效量”是指以必要的剂量和在必要的时间段内有效以实现期望的预防结果的本发明的载体的量。通常，由于可在疾病发生之前或早期阶段对受试者使用预防剂量，因此预防有效量通常小于治疗有效量。
可以调整剂量方案以提供最佳的所需反应(例如，治疗或预防反应)。例如，根据治疗状况的迫切情况，可以施用单次大剂量、可以随时间施用数个分开的剂量，或可以成比例地减少或增加剂量。如本文所用的剂量单位形式是指适合作为待治疗哺乳动物受试者的单位剂量的物理离散单位；每个单位含有经计算的预定量的本发明载体化合物与所需的药物载体，以产生所期望的治疗或预防效果。剂量单位形式的规格(specification)可以由以下所决定并直接取决于以下：(a)载体的独特表征和待实现的具体治疗或预防效果，以及(b)在用于治疗或预防受试者听力丧失的此类载体的制剂领域的内在的限制。
在使用第一和第二AAV颗粒的一些实施方案中，第一和第二AAV多核苷酸/颗粒可以包含在相同组合物或不同组合物中并且可以一起或分开施用。
在某些实施方案中，本发明的组合物含有106至1014颗粒/mL或1010至1015颗粒/mL，或在任一范围之间的任何值，例如如，约106、107、108、109、1010、1011、1012、1013、或1014颗粒/mL。在一个实施方案中，本发明的组合物包含多于1013的AAV颗粒/mL。
在一些实施方案中，当施用包含第一多核苷酸的第一AAV颗粒和包含第二多核苷酸的第二AAV颗粒时，对两种颗粒而言施用量是相同的。
本发明还涉及治疗方法，该方法包括将载体系统和含有该载体系统的药物组合物施用至患有DFNB9耳聋的患者，特别是具有成熟听觉系统的人患者。以上公开的所有实施方案均适用于所述治疗方法。
附图说明
图1显示双AAV载体递送后HEK293细胞中耳畸蛋白的表达。
A)本研究中使用的重组AAV载体对，以及在共感染细胞中产生全长蛋白耳畸蛋白的重组、转录、剪接和翻译过程的示意图。重组的AAV-Otof NT和AAV-Otof CT载体分别含有耳畸蛋白cDNA的5'和3'部分。存在于两种重组载体中的引起重组的桥接序列由灰色球表示。蛋白图表下的红色棒表示两种肽，其用于产生针对耳畸蛋白的N末端和C末端部分的抗体。缩写：ITR，反向末端重复；smCBA，巨细胞病毒立即早期/鸡β-肌动蛋白嵌合启动子；SA，剪接受体位点；SD，剪接供体位点；polyA，聚腺苷酸化信号；C2，C2结构域；TM，跨膜结构域。b)用AAV-Otof NT单独(上图)、AAV-Otof CT单独(中图)、或AAV-Otof NT与AAV-Otof CT一起(下图)感染HEK293细胞。48小时之后，使用针对蛋白的C末端部分的多克隆抗体将耳畸蛋白染色(绿色)，并用DAPI标记细胞核(蓝色)。只有共感染的细胞产生耳畸蛋白。比例尺：15μm。
图2显示在P10 Otof-/-小鼠中进行双AAV介导的基因疗法恢复耳畸蛋白表达并预防耳聋。
(a)左图：在P70，注射耳蜗的中部和顶端转弯(turn)针对耳畸蛋白进行免疫染色的拼接共聚焦图像(绿色)。用DAPI染色细胞核(蓝色)。大部分IHC表达耳畸蛋白，但没有外毛细胞(OHC)表达耳畸蛋白。箭头表示非转导的IHC。插图：更高放大倍数的盒型区域。比例尺：50μm和10μm(插图)。右图：耳畸蛋白(绿色)、带状蛋白(ribbon protein)ribeye(蓝色)和突触后谷氨酸受体的GluA2亚基(红色)的IHC免疫共染色图像。突触活性区在表达耳畸蛋白的转导的IHC中具有正常分布，然而在非转导的IHC(由虚线表示)中倾向于形成簇(箭头)。比例尺：5μm。(b)左图：双AAV注射后四周，Otof-/-小鼠响应于短声或8kHz、16kHz和32kHz频率的猝发音(绿点，n＝8)显示的ABR阈值接近野生型小鼠的ABR阈值(黑点，n＝8)。与之相反的，接受AAV-Otof NT的Otof-/-小鼠(橙点，n＝3)或未注射的Otof-/-小鼠(蓝点，n＝6)在高达86dB SPL的声音强度水平时没有可识别的ABR波形。右图：在P10时治疗的Otof-/-小鼠中(箭头)，短声刺激的听力阈值在恢复后稳定至少六个月。(c)左图：在野生型小鼠、Otof-/-小鼠(Otof-/-)、以及拯救的Otof-/-小鼠(注射的Otof-/-)中在治疗性注射后三周记录的ABR轨迹，显示在野生型和拯救的小鼠中相似的波形。右图：柱状图显示在拯救的Otof-/-小鼠(灰色，n＝8)和野生型小鼠(黑色，n＝5)中ABR波I的潜伏期和归一化振幅。
图3显示对Otof-/-小鼠在P17进行双AAV介导的基因疗法持久恢复耳畸蛋白表达和听力。
(a)左图：在P80，注射的耳蜗的中部和顶端转弯针对耳畸蛋白进行免疫染色的拼接共聚焦图像(绿色)。用DAPI染色细胞核(蓝色)。大多数IHC表达耳畸蛋白，而外毛细胞(OHC)不表达。箭头表示未转导的IHC。插图：更高放大倍数的盒型区域。比例尺：50μm和10μm(插图)。右图：耳畸蛋白(绿色)、带状蛋白ribeye(蓝色)和突触后谷氨酸受体的GluA2亚基(红色)的IHC免疫共染色图像。在表达耳畸蛋白的转导的IHC中突触活性区具有正常分布，然而在非转导的IHC(由虚线表示)中倾向于形成簇(箭头)。比例尺：5μm。(b)左图：在治疗的小鼠中在耳蜗内注射重组载体对的四周后，未治疗的Otof-/-小鼠(蓝色，n＝5)、治疗的Otof-/-小鼠(绿色，n＝5)和野生型小鼠(黑色，n＝5)响应于短声或8、16和32kHz频率的猝发音刺激的ABR阈值。右图：在P17接受注射的Otof-/-小鼠(箭头)听力恢复的时间过程。接近野生型水平的听力恢复在注射后保持至少二十周。(c)左图：在野生型小鼠(黑色)、Otof-/-小鼠(Otof-/-)、以及拯救的Otof-/-小鼠(注射的Otof-/-)在治疗性注射后两周记录的ABR轨迹，显示在野生型和拯救的小鼠中相似的波形。右图：柱状图表明，在拯救的Otof-/-小鼠(n＝5)中ABR波形I的潜伏期(latency)与野生型小鼠(n＝5)相似，而拯救的Otof-/-小鼠的归一化振幅是在野生型小鼠中的约一半。
图4显示对Otof-/-小鼠在P30进行双AAV介导的基因疗法以持续的方式恢复耳畸蛋白表达和听力。
(a)左图：在P40，注射的耳蜗的中部和顶端转弯对耳畸蛋白进行免疫染色的拼接共聚焦图像(绿色)。用DAPI染色细胞核(蓝色)。大多数IHC表达耳畸蛋白，而外毛细胞(OHC)不表达。箭头表示未转导的IHC。插图：更高放大倍数的盒型区域。比例尺：50μm和10μm(插图)。右图：耳畸蛋白(绿色)、带状蛋白ribeye(蓝色)和突触后谷氨酸受体的GluA2亚基(红色)的IHC免疫共染色图像。突触活性区在表达耳畸蛋白的转导的IHC中具有正常分布，然而在非转导的IHC(由虚线表示)中倾向于形成簇(箭头)。比例尺：5μm。(b)在治疗的小鼠中在耳蜗内注射重组载体对后三周(左图)、十四周和二十周(右图)，未治疗的Otof-/-小鼠(蓝色，n＝3)、治疗的Otof-/-小鼠(绿色，n＝3)和野生型小鼠(黑色，n＝3)响应于短声或8、16和32kHz频率的猝发音刺激的ABR阈值。在这些小鼠中，接近野生型水平的听力恢复在注射后保持至少二十周。(c)左图：在野生型小鼠(黑色)、Otof-/-小鼠(Otof-/-)、以及拯救的Otof-/-小鼠(注射的Otof-/-)在治疗性注射后七周记录的ABR轨迹，显示在野生型和拯救的小鼠中相似的波形。右图：柱状图表明，在拯救的Otof-/-小鼠(n＝3)中的ABR波形I潜伏期与野生型小鼠(n＝3)相似，而拯救的Otof-/-小鼠的归一化振幅是在野生型小鼠中的约一半。
图5显示在Otofts/ts小鼠中的双AAV介导的基因疗法恢复耳畸蛋白正常表达和听力。A)对位于野生型(Otof+/+)小鼠(左图)、Otofts/ts小鼠(中图)、以及治疗的Otofts/ts(右图)小鼠中的中部转弯耳蜗的IHC(用虚线勾勒)对耳畸蛋白进行免疫染色(绿色)的共聚焦图像。虽然耳畸蛋白在未治疗的Otofts/ts小鼠的IHC底部(base)显示异常聚集，但耳畸蛋白在治疗小鼠的IHC中的表达是接近正常的。B)在野生型小鼠(黑色)、Otofts/ts小鼠(蓝色)、以及拯救的Otofts/ts小鼠(绿色)中在治疗性注射后四周记录的ABR波形，显示在野生型和拯救的小鼠中相似的波形，然而在未治疗的突变体中没有检测到ABR波。
图6中的图公开了人和小鼠中听力系统的成熟差异(Shnerson和Willott,J.Comp.Physiol.Psychol.1980年2月；94(1)：36-40)。
图7描述到目前为止已识别的DFNB9基因的一些突变。这些突变构成了语言习得前耳聋DFNB9的隐性形式。
图8显示(A)Otofts/ts小鼠的内毛细胞中耳畸蛋白的蛋白聚集和错误折叠，(B)Otof+/ts和Otofts/ts小鼠的听觉脑干反应(ABR)(也参见图5)。
图9公开单侧注射AAV-Otof NT加AAV-Otof CT重组载体对对Otofts/ts小鼠的影响。注射后5周，对治疗的三只Otofts/ts小鼠的耳蜗感觉上皮进行显微解剖并对耳畸蛋白进行免疫标记。已经测量治疗的耳蜗的IHC中的耳畸蛋白表达，并将其与在Otofts/ts未治疗的小鼠中的耳畸蛋白表达进行比较(也参见图5)。
图10公开在野生型、Otofts/ts和Otofts/ts治疗的IHC中ICa的电压激活曲线(A)和相应的ΔCm反应(B)。细胞膜电容(ΔCm)的变化用于监测在胞外分泌期间的突触囊泡融合。
实施例
I.材料和方法
动物
在C57BL/6种系中产生的耳畸蛋白敲除(Otof-/-)小鼠(RouxI.等人，Cell,127,277-289(2006)与FVB小鼠回交十代以上以获得同质FVB遗传背景，因为与C57BL/6背景不同，FVB遗传背景在生命的前十个月与稳定的听力阈值相关(Kommareddi,P.等人，J AssocRes Otolaryngol 16,695-712(2015))。将重组AAV2载体递送至FVB遗传背景中的Otof-/-小鼠中。所有方法和动物治疗均符合国家医学研究所(Institut National de la Santéetde la Recherche Médicale)、巴斯德研究所和NIH的福利指南，以及加州大学旧金山分校批准的操作方案要求。手术前，通过腹膜内注射盐酸氯胺酮(Ketaset，100mg/kg)、盐酸甲苯噻嗪(Xyla-ject，10mg/kg)和乙酰丙嗪(2mg/kg)的混合物麻醉小鼠。通过监测深层组织对脚趾挤压的反应来检查麻醉深度。在手术前以及手术后一周每24小时，小鼠接受卡洛芬(2mg/kg)皮下注射以减轻炎症和疼痛。在手术后监测动物的痛苦迹象和异常体重减轻。
产生在C2F结构域中携带热敏突变的小鼠模型(Otofts/ts)(p.E1804del)。Otofts/ts小鼠严重耳聋。图8中显示的结果突出显示，这些小鼠IHC中耳畸蛋白的分布异常/受到强烈干扰：蛋白在内毛细胞中聚集和错误折叠。此外，当在Otof+/ts和Otofts/ts小鼠记录听觉脑干反应(ABR)以监测对短声刺激的初级听觉神经元的电反应和中枢听觉通路的连续神经传递(relay)时，观察到在1个月龄时，Otof+/ts小鼠在各种测试强度(40-86dB)下获得ABR特征波形，但在Otofts/ts小鼠中，即使在100dB也没有引起反应。
重组的AAV2载体构建体和包装
将鼠耳畸蛋白cDNA的全长编码序列(Otof1同种型1；NM_001100395.1)分为5'片段(核苷酸1-2448)和3'片段(核苷酸2449-5979)，并合成这些片段(Genscript,piscataway,NJ)。5'构建体包含Otof1 cDNA的5'部分(编码氨基酸1-816，包括蛋白的C2A、C2B和C2C结构域)和剪接供体(SD)位点，3'构建体包含Otof1 cDNA的3'部分(编码氨基酸817-1992，包括蛋白的C2D、C2E、C2F和跨膜结构域)、剪接受体位点(SA)。此外，两种构建体都含有碱性磷酸酶引起重组的桥接序列[Lay Y等人，Hum Gene Ther 17,1036-1042(2006)；Ghosh A.等人，Hum Gene Ther 22,77-83(2011)；Dyka F.M.等人，Hum Gene Ther Methods 25,166-177(2014)]。将NotI/NheI和MfeI/KpnI限制性内切核酸酶的识别位点添加到这些构建体中，然后如前所述将其插入到AAV pTR22载体质粒中[Lay Y等人，Hum Gene Ther 17,1036-1042(2006)；Ghosh A.等人，Hum Gene Ther 22,77-83(2011)；Dyka F.M.等人，Hum Gene TherMethods 25,166-177(2014)]，产生了一对称为AAV-Otof NT和AAV-Otof CT的重组载体。另一个包含绿色荧光蛋白(GFP)cDNA的重组载体经工程化用作细胞转导的阳性对照。重组载体包装在AAV2 quadY-F衣壳中(Petrs-SilvaH等人，Molecular therapy:the journal ofthe American Society of Gene Therapy 19,293-301(2011),重组病毒在佛罗里达大学眼睛基因治疗中心(University of Florida Ocular Gene Therapy Core)得到纯化和滴定，如前所述[Zolotukhin S.等人，Methods 28,158-167(2002)；Jacobson SG等人，Molecular therapy:the journal of the American Society of Gene Therapy 13,1074-1084(2006)]。
转染的HEK293细胞中的转基因表达
HEK293细胞在6孔板中的聚赖氨酸包被的盖玻片上在Dulbecco改良的Eagle培养基中生长，该培养基中补充有1×非必需氨基酸和10％胎牛血清(Gibco)、以及青霉素-链霉素(Pen/Strep,Invitrogen)。第二天，如之前所述使细胞被感染(LopesV.S.等人，GeneTher 20,824-833(2013))。简而言之，将具有75％汇合的细胞的盖玻片在37℃下、于5％二氧化碳中孵育在200μl的无血清培养基中，该培养基含有AAV2-Otof重组病毒中的一种或两种(对每个载体而言为含10 000个基因组的颗粒/细胞)。两小时后，加入1ml的完全培养基。第二天更换培养基，将细胞再孵育另外48小时。用4％多聚甲醛在0.1M磷酸盐缓冲盐水(PBS)中(pH7.4)在4℃下将细胞固定2小时，用PBS冲洗3次，然后与0.25％Triton X-100和5％常规山羊血清在PBS中在室温下一起孵育一小时。然后，将细胞与之前表征的兔多克隆抗体14cc和C19在4℃孵育过夜，所述14cc和C19分别针对耳畸蛋白的N末端部分(氨基酸196-211)和C末端部分(氨基酸1848-1978)(Roux I.等人,Cell,127,277-289(2006)(1:200稀释))。将样品用PBS冲洗两次，并与Cy3缀合的山羊抗兔IgG二抗(Life Technologies，1:2000稀释)在PBS中在室温下孵育两小时。然后，将样品在PBS中冲洗两次，用4',6-二脒基-2-苯基吲哚(DAPI)染色以使得细胞核可视化，用一滴Fluorsave介质(BiochemLaboratories，法国)封在载玻片上，并用Olympus共聚焦免疫荧光显微镜观察。
向耳蜗的载体递送
如前所述，将病毒递送至左耳蜗(Akil O.等人，Neuron 75,283-293(2012))。在P10、P17或P30天，麻醉的Otof-/-小鼠接受AAV2-Otof载体对注射，所述注射通过圆窗膜进入耳蜗的鼓阶。通过背侧切口进入耳朵(Duan M等人，Gene Ther11增刊1,S51-56(2004))。用18G针在大疱(bulla)上打一个小孔，用钳子扩大。用硼硅酸盐毛细玻璃移液管轻轻刺破圆窗膜，然后将移液管取出。当外淋巴外流停止时，将含有AV2-Otof NT(6.3x1012 vg/ml)和AAV2-Otof CT(4.5x1012 vg/ml)载体对的固定体积(2μl)通过细玻璃微量移液器(外尖端直径为10μm)在一分钟的时间段内注入鼓阶。拔出移液管，用筋膜和脂肪组织迅速封闭凹口(niche)。伤口用6-0可吸收铬缝线(Ethicon)分层缝合。
听觉测试
如前所述，在隔音室中在不同时间点对麻醉的Otof+/+小鼠、Otof-/-小鼠和拯救的Otof-/-小鼠进行听觉测试(Akil O.等人，Neuron 75,283-293(2012)。通过腹膜内注射盐酸氯胺酮(Ketaset，100mg/ml)和盐酸甲苯噻嗪(Xyla-ject，10mg/ml)的混合物麻醉小鼠，如果需要，随后注射初始剂量的五分之一。体温用加热垫保持，并在整个记录过程中用直肠探头监测。使用TDT BioSig III系统(Tucker Davis Technologies)和位于小鼠头皮上的三个皮下针电极(一个在头顶、一个在左耳耳廓下方(参考电极)、一个在对侧耳朵下方(接地电极))记录听觉脑干反应(ABR)。声音刺激是短声(5ms持续时间、31Hz)和8、16和32kHz的调值(tone pip)(10ms持续时间、余弦平方成形、21Hz)。在自由场条件下递送声音，从左耳记录单声道反应(在记录过程中右耳被堵住)。对于每个声音刺激，以25kHz的采样率以及过滤(0.3-3kHz)记录脑电图(EEG)活动20ms。分别平均短声和猝发音的512个刺激和1000个刺激的EEG波形。声音刺激强度从最大测试强度(86dB SPL)以5dB声压级(SPL)间隔递减。听力阈值被定义为在目视检查时ABR的波I-V峰清晰且重复出现的最低刺激水平。通过对存储波形的离线分析确认这些阈值评估。ABR波I的潜伏期作为短声刺激和波I的峰值振幅之间的时间间隔测量。此外，为了比较拯救的Otof-/-小鼠和野生型小鼠，将在ABR轨迹上的波I的峰值振幅的值相对于对照野生型小鼠的平均值(取为100％)进行归一化。
内毛细胞和突触带计数
用4％多聚甲醛的0.1M PBS溶液(pH7.4)灌注小鼠耳蜗，并于4℃在相同固定剂中孵育两小时。将耳蜗用PBS冲洗3次，并通过在4℃下与5％乙二胺四乙酸(EDTA)的0.1M PBS溶液孵育过夜来脱钙。将耳蜗感觉上皮(Corti器官)显微切割成表面制备物，将其在0.25％Triton X-100和含5％正常山羊血清的PBS溶液(封闭缓冲液)中在室温下预孵育1小时，然后与一抗在4℃孵育过夜。使用以下抗体：兔抗耳畸蛋白C末端部分(C19，1:250稀释)1、小鼠(IgG1)抗-CtBP2/ribeye、小鼠(IgG2a)抗-谷氨酸受体亚基A2(Millipore，1:200稀释)和兔抗GFP(Invitrogen，A11122；1:250稀释)。样品在PBS中冲洗3次，并与合适的二抗一起孵育：Alexa Fluor 488缀合的抗小鼠IgG1、Alexa Fluor 568缀合的抗小鼠IgG2a(LifeTechnologies，1:1000稀释)或Atto Fluor 647缀合的抗兔IgG(Sigma，1:200稀释)。样品在PBS中洗涤3次，并在一滴Fluorsave中封在载玻片上，用DAPI染色细胞核。用配备高分辨率物镜(数值孔径为1.4，60x油浸物镜)的LSM700共聚焦显微镜(Zeiss，奥伯科亨，德国)获得Corti器官的荧光共聚焦z堆栈(z-stack)。在512×512或1024×1024光栅(在x和y中的像素尺寸＝0.036μm)以及0.2μm的z步长获取图像。通过多达20个共聚焦图像的z堆栈的3D渲染计数产生耳畸蛋白和突触带的内毛细胞(IHC)。为计算表达耳畸蛋白转基因的IHC的比例，我们将产生耳畸蛋白的IHC的总数除以DAPI染色的细胞核鉴定的IHC总数(至少150个连续分析)。
逆转录酶-聚合酶链式反应(RT-PCR)
从六只Otof+/+小鼠和六只在P10拯救的Otof-/-小鼠的左耳蜗中提取总mRNA(Trizol,Invitrogen)。使用寡dT引物和superscript II RNaseH-(Invitrogen)在42℃下进行逆转录(RT)50分钟。两微升RT反应产物用于聚合酶链反应(PCR；TaqDNA聚合酶，Invitrogen)包括35轮循环(94℃持续30s、60℃持续45s、72℃持续60s)，在72℃下进行最终延伸达10分钟。PCR引物对(正向引物TGTCTCAGAGCTCCGAGGCA(SEQ ID NO:14)和反向引物(ATCGTGGAGGAGGAACTGGGCA(SEQ ID NO:15)设计用于扩增耳畸蛋白cDNA的2676bp中间片段(核苷酸27至2702)(GenBank登录号NM_001100395.)，包括在AAV-Otof NT和AAV-Otof CT插入之间的连接。通过在含有0.5mg/ml溴化乙锭的2％琼脂糖凝胶(Qiaquick凝胶提取试剂盒，QIAGEN)上电泳纯化PCR产物、测序(Elim Biopharmaceuticals)、并检查与耳畸蛋白cDNA序列的序列同一性。
统计分析
数据表示为平均值±标准差(SD)。所有统计分析均采用非参数Mann-Whitney U检验进行。统计显著性在图中表示如下：n.s.，不显著；*，p<0.05；**，p<0.01；***，p<0.001。
II.结果
基于AAV2的载体被工程化为在嵌合CMV-鸡β-肌动蛋白启动子的控制下表达绿色荧光蛋白(GFP)基因。该表达盒被包装在AAV2 quadY-F衣壳中，其中AAV2衣壳的四个表面酪氨酸(Y)残基已被苯丙氨酸(F)残基取代，苯丙氨酸(F)残基显示出提高视网膜中基因传递的效率(Petrs-Silva H.等人，Molecular therapy:the journal of the AmericanSociety of Gene Therapy 19(2):293-301(2011))。在P2，将重组病毒通过圆窗膜注射到五只野生型小鼠的左耳蜗中。注射后三周的感觉上皮的GFP免疫染色显示包括IHC在内的各种类型细胞的转导。IHC的转导率为78±6％(平均值±SD)，表示这种AAV血清型适合将治疗基因递送给这些细胞(未显示)。将鼠耳畸蛋白cDNA的编码序列分为5'片段(Otof NT，核苷酸1-2448)和3'片段(Otof CT，核苷酸2449-5979)，每个片段插入携带引起重组的桥接序列的AAV载体中(Ghosh A.等人，Hum Gene Ther 22(1):77-83(2011)；Dyka FM等人，Hum GeneTher Methods 25(2):166-177(2014))。AAV-Otof NT重组载体携带cDNA的5'部分，之后是剪接供体位点，以及AAV-Otof CT重组载体携带剪接受体位点，之后是cDNA的3'部分(参见方法和图1)。这些重组载体中的每一个都被包装在AAV2 quadY-F衣壳中。使用AAV-OtofNT、AAV Otof CT或这两种重组病毒感染HEK293细胞，48小时后对耳畸蛋白进行免疫染色。针对蛋白的C末端部分或N末端部分使用两种不同的抗体(Roux I等人，Cell 127:277-289(2006))，并获得了相同的结果。仅在同时感染两种病毒的细胞中检测到耳畸蛋白，因此表明这两种载体能够通过它们的反向末端重复进行重组并产生多联体，正确剪接所得的转录本以产生蛋白(图1)。
在听力出现(在P10)之前或之后，单次单侧注射的AAV-Otof NT加AAV-Otof CT重组载体对通过圆窗膜进入左耳蜗施用至Otof-/-小鼠。因为IHC带状突触的成熟在P17仍在进行(Kros CJ等人，Nature 394(6690):281-284(1998)；Wong AB等人，EMBO J 33(3):247-264(2014))，而耳蜗在P30成熟(Song L.等人，J Acoust Soc Am 119(4):2242-2257(2006))，所以在两个不同时间点(P17和P30)之一进行听力出现后的注射。在P10注射重组载体对八周后，对三只Otof-/-小鼠治疗耳蜗的感觉上皮进行显微解剖并对耳畸蛋白进行免疫标记(使用针对蛋白的C末端部分的抗体)以估计IHC转导率。在60％以上的IHC(64±6％，平均值±SD，n＝3耳蜗)中检测到蛋白，但在其他细胞类型中没有检测到(图2a，左图)。该结果提供证据表明在体内局部递送重组AAV载体对时，可以在耳蜗感觉细胞中有效地重构大cDNA，其中通过大部分细胞持续、广泛地生产蛋白。通过对包括Otof NT和Otof CTcDNA之间的连接的耳畸蛋白转录本的大片段进行RT-PCR和序列分析，检查转导细胞中的前mRNA剪接过程的准确性(未显示)。
在P10注射后4周，在小鼠中记录的听觉脑干反应(ABR)证明在所有治疗的小鼠(n＝8)中实质上恢复了响应于短声和猝发音刺激(8、16和32kHz)的听力阈值，但在仅接受AAV-Otof NT或AAV-Otof CT单独(对于每种n＝3)或没有注射的Otof-/-小鼠(n＝6)中没有恢复听力阈值(图2b、2c)。在治疗的小鼠中，短声和猝发音刺激两者的ABR阈值与对照野生型小鼠的ABR阈值相似(n＝8；Mann-Whitney检验，对于所有比较p>0.15)。通过在1至30周之间的几个注射后时间点进行响应于短声的ABR记录，以评估基因治疗的长期效果。从第四周开始，治疗小鼠的ABR阈值与野生型小鼠的ABR阈值没有显著差异(Mann-Whitney U检验，对所有阶段的比较而言p>0.05)(图2b)。然而，反映初级听觉神经元对声音刺激的电反应的ABR波I的振幅是野生型小鼠平均值的39±7％(平均值±SD)(Mann-Whitney U检验，p＝0.002)，而波I潜伏期(1.15±0.09ms)与野生型小鼠的波I潜伏期相似(1.27±0.05ms；Mann-Whitney U检验，p＝0.06)(图2c)。
在P10接受注射的8只小鼠中有6只在注射后30周仍具有野生型小鼠的10dB以内的听力阈值。因此，在听力出现前进行基因治疗可预防Otof-/-小鼠耳聋。发明人之前已经证明，在Otof-/-小鼠中大约一半的IHC带变性(Rou xI等人，Cell 127：277-289(2006))。在P10注射后八周，通过免疫荧光和3D共聚焦显微镜成像在治疗的Otof-/-耳蜗的转导的IHC和未转导的IHC中分析突触前带(连同突触后谷氨酸受体)的数量(图2a，右图)。转导细胞中每个IHC的带数目(12.5±1.8，平均值±SD，n＝48个细胞，来自3只小鼠)几乎是未转导的细胞中的约两倍(6.9±1.3，n＝48个细胞，来自3只小鼠；Mann-Whitney U检验，p<10-4)，但仍低于野生型IHC(16±1.3，n＝48个细胞，来自3只小鼠；Mann-Whitney U检验，p<10-4)，这可能因为ABR记录中波I振幅没有完全恢复。
将重组载体对注射到P17或P30的Otof-/-小鼠的耳蜗后，在整个治疗的耳蜗的IHC中检测到耳畸蛋白，但在对侧耳蜗的IHC中没有检测到耳畸蛋白(未显示)。两组小鼠的IHC转导率相似(在P17和P30治疗的n＝5和n＝3个耳蜗，分别为82±9％和85±7％)，并且高于在P10接受注射的小鼠中的IHC转导率(Mann-Whitney U检验，对两种比较而言p<0.05)(图3a和图4a)。注射后4周的ABR记录显示所有在P17接受注射的小鼠的听力恢复(n＝5)，响应于短声和猝发音刺激的ABR阈值与野生型小鼠的ABR阈值(n＝5；Mann-Whitney U检验，对所有比较而言p>0.2)显著相似。注射后20周响应于短声的听力阈值保持不变，表明虽然这些小鼠的平均ABR波I振幅约为野生型小鼠的一半(47±10％)，但保持了听力恢复(图3b、图3c)。
同样，在P30接受注射的Otof-/-小鼠早在注射后三周就显示出类似的听力恢复，虽然平均ABR波I振幅约为野生型小鼠的一半(55±10％)，但响应于短声和猝发音刺激的ABR阈值在注射后20周保持在野生型水平(n＝3，Mann-Whitney U检验，在所有阶段进行比较时p>0.5)(图4b、图4c)。通过免疫荧光和3D共聚焦显微镜成像在P17和P30治疗的Otof-/-耳蜗的转导的IHC和未转导的IHC中分析突触前带(连同突触后谷氨酸受体)的数量(图3a和图4a)。在转导细胞中每个IHC的带数目(10.0±1.3，平均值±SD，n＝48个细胞，来自在P17治疗并在P80分析的3只小鼠，以及8.9±2.3，n＝48个细胞，来自在P30治疗并在P40分析的3只小鼠)高于来自相同耳蜗的未转导细胞(分别为6.2±1.3，n＝48个细胞和5.8±0.7，n＝48个细胞；Mann-Whitney U检验，对于两种比较而言p<10-4)，但低于10周龄野生型小鼠的IHC中的带数目(16±1.3，n＝48个细胞，来自3只小鼠；Mann-Whitney U检验，对于两种比较而言p<10-4)。因为在P15分析的未治疗的Otof-/-小鼠中每个IHC的带数目已经显著减少(8.2±1.0，n＝48个细胞，来自3只小鼠)，而治疗小鼠的非转导IHC在较晚阶段出人意料地保持稳定(见上文P40、P70和P80的值)，可以推断出基因疗法在Otof-/-小鼠的IHC中通过促进其生产而不是防止其变性(degeneration)来增加带的数目。
使用上述公开的双AAV基因疗法，在p30时施用至动物，也有可能在小鼠模型中恢复耳畸蛋白的正常分布以及将听力功能恢复到接近正常的ABR阈值，所述小鼠模型在小鼠DFNB9基因中携带人热敏突变(Otofts/ts小鼠，图5)。
更准确地说，已经表明，双病毒基因疗法改变了由在所述DFNB9小鼠模型中的人热敏突变导致的耳畸蛋白聚集(图9)。在该实验中，在听力出现之后，在P30，单次单侧注射的AAV-Otof NT加AAV-Otof CT重组载体对通过圆窗膜施用至Otofts/ts小鼠，进入左耳蜗。注射后5周，对三只Otofts/ts小鼠的治疗的耳蜗的感觉上皮进行显微解剖并对耳畸蛋白进行免疫标记(图9)。发现当与未治疗的Otofts/ts小鼠耳蜗中的耳畸蛋白聚集相比(箭头)时，治疗耳蜗的IHC(虚线)中的耳畸蛋白表达几乎正常。
最终发现，所述双病毒基因疗法在该动物模型中恢复IHC的钙流和细胞外泌，如图10所示。
序列表
<110> 巴斯德研究所
<120> AAV介导的基因疗法恢复耳畸蛋白基因
<130> B377344 D39106
<150> EP19305071.3
<151> 2019-01-18
<160> 24
<170> PatentIn version 3.5
<210> 1
<211> 1997
<212> PRT
<213> 智人
<400> 1
Met Ala Leu Leu Ile His Leu Lys Thr Val Ser Glu Leu Arg Gly Arg
1 5 10 15
Gly Asp Arg Ile Ala Lys Val Thr Phe Arg Gly Gln Ser Phe Tyr Ser
20 25 30
Arg Val Leu Glu Asn Cys Glu Asp Val Ala Asp Phe Asp Glu Thr Phe
35 40 45
Arg Trp Pro Val Ala Ser Ser Ile Asp Arg Asn Glu Met Leu Glu Ile
50 55 60
Gln Val Phe Asn Tyr Ser Lys Val Phe Ser Asn Lys Leu Ile Gly Thr
65 70 75 80
Phe Arg Met Val Leu Gln Lys Val Val Glu Glu Ser His Val Glu Val
85 90 95
Thr Asp Thr Leu Ile Asp Asp Asn Asn Ala Ile Ile Lys Thr Ser Leu
100 105 110
Cys Val Glu Val Arg Tyr Gln Ala Thr Asp Gly Thr Val Gly Ser Trp
115 120 125
Asp Asp Gly Asp Phe Leu Gly Asp Glu Ser Leu Gln Glu Glu Glu Lys
130 135 140
Asp Ser Gln Glu Thr Asp Gly Leu Leu Pro Gly Ser Arg Pro Ser Ser
145 150 155 160
Arg Pro Pro Gly Glu Lys Ser Phe Arg Arg Ala Gly Arg Ser Val Phe
165 170 175
Ser Ala Met Lys Leu Gly Lys Asn Arg Ser His Lys Glu Glu Pro Gln
180 185 190
Arg Pro Asp Glu Pro Ala Val Leu Glu Met Glu Asp Leu Asp His Leu
195 200 205
Ala Ile Arg Leu Gly Asp Gly Leu Asp Pro Asp Ser Val Ser Leu Ala
210 215 220
Ser Val Thr Ala Leu Thr Thr Asn Val Ser Asn Lys Arg Ser Lys Pro
225 230 235 240
Asp Ile Lys Met Glu Pro Ser Ala Gly Arg Pro Met Asp Tyr Gln Val
245 250 255
Ser Ile Thr Val Ile Glu Ala Arg Gln Leu Val Gly Leu Asn Met Asp
260 265 270
Pro Val Val Cys Val Glu Val Gly Asp Asp Lys Lys Tyr Thr Ser Met
275 280 285
Lys Glu Ser Thr Asn Cys Pro Tyr Tyr Asn Glu Tyr Phe Val Phe Asp
290 295 300
Phe His Val Ser Pro Asp Val Met Phe Asp Lys Ile Ile Lys Ile Ser
305 310 315 320
Val Ile His Ser Lys Asn Leu Leu Arg Ser Gly Thr Leu Val Gly Ser
325 330 335
Phe Lys Met Asp Val Gly Thr Val Tyr Ser Gln Pro Glu His Gln Phe
340 345 350
His His Lys Trp Ala Ile Leu Ser Asp Pro Asp Asp Ile Ser Ser Gly
355 360 365
Leu Lys Gly Tyr Val Lys Cys Asp Val Ala Val Val Gly Lys Gly Asp
370 375 380
Asn Ile Lys Thr Pro His Lys Ala Asn Glu Thr Asp Glu Asp Asp Ile
385 390 395 400
Glu Gly Asn Leu Leu Leu Pro Glu Gly Val Pro Pro Glu Arg Gln Trp
405 410 415
Ala Arg Phe Tyr Val Lys Ile Tyr Arg Ala Glu Gly Leu Pro Arg Met
420 425 430
Asn Thr Ser Leu Met Ala Asn Val Lys Lys Ala Phe Ile Gly Glu Asn
435 440 445
Lys Asp Leu Val Asp Pro Tyr Val Gln Val Phe Phe Ala Gly Gln Lys
450 455 460
Gly Lys Thr Ser Val Gln Lys Ser Ser Tyr Glu Pro Leu Trp Asn Glu
465 470 475 480
Gln Val Val Phe Thr Asp Leu Phe Pro Pro Leu Cys Lys Arg Met Lys
485 490 495
Val Gln Ile Arg Asp Ser Asp Lys Val Asn Asp Val Ala Ile Gly Thr
500 505 510
His Phe Ile Asp Leu Arg Lys Ile Ser Asn Asp Gly Asp Lys Gly Phe
515 520 525
Leu Pro Thr Leu Gly Pro Ala Trp Val Asn Met Tyr Gly Ser Thr Arg
530 535 540
Asn Tyr Thr Leu Leu Asp Glu His Gln Asp Leu Asn Glu Gly Leu Gly
545 550 555 560
Glu Gly Val Ser Phe Arg Ala Arg Leu Leu Leu Gly Leu Ala Val Glu
565 570 575
Ile Val Asp Thr Ser Asn Pro Glu Leu Thr Ser Ser Thr Glu Val Gln
580 585 590
Val Glu Gln Ala Thr Pro Ile Ser Glu Ser Cys Ala Gly Lys Met Glu
595 600 605
Glu Phe Phe Leu Phe Gly Ala Phe Leu Glu Ala Ser Met Ile Asp Arg
610 615 620
Arg Asn Gly Asp Lys Pro Ile Thr Phe Glu Val Thr Ile Gly Asn Tyr
625 630 635 640
Gly Asn Glu Val Asp Gly Leu Ser Arg Pro Gln Arg Pro Arg Pro Arg
645 650 655
Lys Glu Pro Gly Asp Glu Glu Glu Val Asp Leu Ile Gln Asn Ala Ser
660 665 670
Asp Asp Glu Ala Gly Asp Ala Gly Asp Leu Ala Ser Val Ser Ser Thr
675 680 685
Pro Pro Met Arg Pro Gln Val Thr Asp Arg Asn Tyr Phe His Leu Pro
690 695 700
Tyr Leu Glu Arg Lys Pro Cys Ile Tyr Ile Lys Ser Trp Trp Pro Asp
705 710 715 720
Gln Arg Arg Arg Leu Tyr Asn Ala Asn Ile Met Asp His Ile Ala Asp
725 730 735
Lys Leu Glu Glu Gly Leu Asn Asp Ile Gln Glu Met Ile Lys Thr Glu
740 745 750
Lys Ser Tyr Pro Glu Arg Arg Leu Arg Gly Val Leu Glu Glu Leu Ser
755 760 765
Cys Gly Cys Cys Arg Phe Leu Ser Leu Ala Asp Lys Asp Gln Gly His
770 775 780
Ser Ser Arg Thr Arg Leu Asp Arg Glu Arg Leu Lys Ser Cys Met Arg
785 790 795 800
Glu Leu Glu Asn Met Gly Gln Gln Ala Arg Met Leu Arg Ala Gln Val
805 810 815
Lys Arg His Thr Val Arg Asp Lys Leu Arg Leu Cys Gln Asn Phe Leu
820 825 830
Gln Lys Leu Arg Phe Leu Ala Asp Glu Pro Gln His Ser Ile Pro Asp
835 840 845
Ile Phe Ile Trp Met Met Ser Asn Asn Lys Arg Val Ala Tyr Ala Arg
850 855 860
Val Pro Ser Lys Asp Leu Leu Phe Ser Ile Val Glu Glu Glu Thr Gly
865 870 875 880
Lys Asp Cys Ala Lys Val Lys Thr Leu Phe Leu Lys Leu Pro Gly Lys
885 890 895
Arg Gly Phe Gly Ser Ala Gly Trp Thr Val Gln Ala Lys Val Glu Leu
900 905 910
Tyr Leu Trp Leu Gly Leu Ser Lys Gln Arg Lys Glu Phe Leu Cys Gly
915 920 925
Leu Pro Cys Gly Phe Gln Glu Val Lys Ala Ala Gln Gly Leu Gly Leu
930 935 940
His Ala Phe Pro Pro Val Ser Leu Val Tyr Thr Lys Lys Gln Ala Phe
945 950 955 960
Gln Leu Arg Ala His Met Tyr Gln Ala Arg Ser Leu Phe Ala Ala Asp
965 970 975
Ser Ser Gly Leu Ser Asp Pro Phe Ala Arg Val Phe Phe Ile Asn Gln
980 985 990
Ser Gln Cys Thr Glu Val Leu Asn Glu Thr Leu Cys Pro Thr Trp Asp
995 1000 1005
Gln Met Leu Val Phe Asp Asn Leu Glu Leu Tyr Gly Glu Ala His
1010 1015 1020
Glu Leu Arg Asp Asp Pro Pro Ile Ile Val Ile Glu Ile Tyr Asp
1025 1030 1035
Gln Asp Ser Met Gly Lys Ala Asp Phe Met Gly Arg Thr Phe Ala
1040 1045 1050
Lys Pro Leu Val Lys Met Ala Asp Glu Ala Tyr Cys Pro Pro Arg
1055 1060 1065
Phe Pro Pro Gln Leu Glu Tyr Tyr Gln Ile Tyr Arg Gly Asn Ala
1070 1075 1080
Thr Ala Gly Asp Leu Leu Ala Ala Phe Glu Leu Leu Gln Ile Gly
1085 1090 1095
Pro Ala Gly Lys Ala Asp Leu Pro Pro Ile Asn Gly Pro Val Asp
1100 1105 1110
Val Asp Arg Gly Pro Ile Met Pro Val Pro Met Gly Ile Arg Pro
1115 1120 1125
Val Leu Ser Lys Tyr Arg Val Glu Val Leu Phe Trp Gly Leu Arg
1130 1135 1140
Asp Leu Lys Arg Val Asn Leu Ala Gln Val Asp Arg Pro Arg Val
1145 1150 1155
Asp Ile Glu Cys Ala Gly Lys Gly Val Gln Ser Ser Leu Ile His
1160 1165 1170
Asn Tyr Lys Lys Asn Pro Asn Phe Asn Thr Leu Val Lys Trp Phe
1175 1180 1185
Glu Val Asp Leu Pro Glu Asn Glu Leu Leu His Pro Pro Leu Asn
1190 1195 1200
Ile Arg Val Val Asp Cys Arg Ala Phe Gly Arg Tyr Thr Leu Val
1205 1210 1215
Gly Ser His Ala Val Ser Ser Leu Arg Arg Phe Ile Tyr Arg Pro
1220 1225 1230
Pro Asp Arg Ser Ala Pro Ser Trp Asn Thr Thr Val Arg Leu Leu
1235 1240 1245
Arg Arg Cys Arg Val Leu Cys Asn Gly Gly Ser Ser Ser His Ser
1250 1255 1260
Thr Gly Glu Val Val Val Thr Met Glu Pro Glu Val Pro Ile Lys
1265 1270 1275
Lys Leu Glu Thr Met Val Lys Leu Asp Ala Thr Ser Glu Ala Val
1280 1285 1290
Val Lys Val Asp Val Ala Glu Glu Glu Lys Glu Lys Lys Lys Lys
1295 1300 1305
Lys Lys Gly Thr Ala Glu Glu Pro Glu Glu Glu Glu Pro Asp Glu
1310 1315 1320
Ser Met Leu Asp Trp Trp Ser Lys Tyr Phe Ala Ser Ile Asp Thr
1325 1330 1335
Met Lys Glu Gln Leu Arg Gln Gln Glu Pro Ser Gly Ile Asp Leu
1340 1345 1350
Glu Glu Lys Glu Glu Val Asp Asn Thr Glu Gly Leu Lys Gly Ser
1355 1360 1365
Met Lys Gly Lys Glu Lys Ala Arg Ala Ala Lys Glu Glu Lys Lys
1370 1375 1380
Lys Lys Thr Gln Ser Ser Gly Ser Gly Gln Gly Ser Glu Ala Pro
1385 1390 1395
Glu Lys Lys Lys Pro Lys Ile Asp Glu Leu Lys Val Tyr Pro Lys
1400 1405 1410
Glu Leu Glu Ser Glu Phe Asp Asn Phe Glu Asp Trp Leu His Thr
1415 1420 1425
Phe Asn Leu Leu Arg Gly Lys Thr Gly Asp Asp Glu Asp Gly Ser
1430 1435 1440
Thr Glu Glu Glu Arg Ile Val Gly Arg Phe Lys Gly Ser Leu Cys
1445 1450 1455
Val Tyr Lys Val Pro Leu Pro Glu Asp Val Ser Arg Glu Ala Gly
1460 1465 1470
Tyr Asp Ser Thr Tyr Gly Met Phe Gln Gly Ile Pro Ser Asn Asp
1475 1480 1485
Pro Ile Asn Val Leu Val Arg Val Tyr Val Val Arg Ala Thr Asp
1490 1495 1500
Leu His Pro Ala Asp Ile Asn Gly Lys Ala Asp Pro Tyr Ile Ala
1505 1510 1515
Ile Arg Leu Gly Lys Thr Asp Ile Arg Asp Lys Glu Asn Tyr Ile
1520 1525 1530
Ser Lys Gln Leu Asn Pro Val Phe Gly Lys Ser Phe Asp Ile Glu
1535 1540 1545
Ala Ser Phe Pro Met Glu Ser Met Leu Thr Val Ala Val Tyr Asp
1550 1555 1560
Trp Asp Leu Val Gly Thr Asp Asp Leu Ile Gly Glu Thr Lys Ile
1565 1570 1575
Asp Leu Glu Asn Arg Phe Tyr Ser Lys His Arg Ala Thr Cys Gly
1580 1585 1590
Ile Ala Gln Thr Tyr Ser Thr His Gly Tyr Asn Ile Trp Arg Asp
1595 1600 1605
Pro Met Lys Pro Ser Gln Ile Leu Thr Arg Leu Cys Lys Asp Gly
1610 1615 1620
Lys Val Asp Gly Pro His Phe Gly Pro Pro Gly Arg Val Lys Val
1625 1630 1635
Ala Asn Arg Val Phe Thr Gly Pro Ser Glu Ile Glu Asp Glu Asn
1640 1645 1650
Gly Gln Arg Lys Pro Thr Asp Glu His Val Ala Leu Leu Ala Leu
1655 1660 1665
Arg His Trp Glu Asp Ile Pro Arg Ala Gly Cys Arg Leu Val Pro
1670 1675 1680
Glu His Val Glu Thr Arg Pro Leu Leu Asn Pro Asp Lys Pro Gly
1685 1690 1695
Ile Glu Gln Gly Arg Leu Glu Leu Trp Val Asp Met Phe Pro Met
1700 1705 1710
Asp Met Pro Ala Pro Gly Thr Pro Leu Asp Ile Ser Pro Arg Lys
1715 1720 1725
Pro Lys Lys Tyr Glu Leu Arg Val Ile Ile Trp Asn Thr Asp Glu
1730 1735 1740
Val Val Leu Glu Asp Asp Asp Phe Phe Thr Gly Glu Lys Ser Ser
1745 1750 1755
Asp Ile Phe Val Arg Gly Trp Leu Lys Gly Gln Gln Glu Asp Lys
1760 1765 1770
Gln Asp Thr Asp Val His Tyr His Ser Leu Thr Gly Glu Gly Asn
1775 1780 1785
Phe Asn Trp Arg Tyr Leu Phe Pro Phe Asp Tyr Leu Ala Ala Glu
1790 1795 1800
Glu Lys Ile Val Ile Ser Lys Lys Glu Ser Met Phe Ser Trp Asp
1805 1810 1815
Glu Thr Glu Tyr Lys Ile Pro Ala Arg Leu Thr Leu Gln Ile Trp
1820 1825 1830
Asp Ala Asp His Phe Ser Ala Asp Asp Phe Leu Gly Ala Ile Glu
1835 1840 1845
Leu Asp Leu Asn Arg Phe Pro Arg Gly Ala Lys Thr Ala Lys Gln
1850 1855 1860
Cys Thr Met Glu Met Ala Thr Gly Glu Val Asp Val Pro Leu Val
1865 1870 1875
Ser Ile Phe Lys Gln Lys Arg Val Lys Gly Trp Trp Pro Leu Leu
1880 1885 1890
Ala Arg Asn Glu Asn Asp Glu Phe Glu Leu Thr Gly Lys Val Glu
1895 1900 1905
Ala Glu Leu His Leu Leu Thr Ala Glu Glu Ala Glu Lys Asn Pro
1910 1915 1920
Val Gly Leu Ala Arg Asn Glu Pro Asp Pro Leu Glu Lys Pro Asn
1925 1930 1935
Arg Pro Asp Thr Ser Phe Ile Trp Phe Leu Asn Pro Leu Lys Ser
1940 1945 1950
Ala Arg Tyr Phe Leu Trp His Thr Tyr Arg Trp Leu Leu Leu Lys
1955 1960 1965
Leu Leu Leu Leu Leu Leu Leu Leu Leu Leu Leu Ala Leu Phe Leu
1970 1975 1980
Tyr Ser Val Pro Gly Tyr Leu Val Lys Lys Ile Leu Gly Ala
1985 1990 1995
<210> 2
<211> 7171
<212> DNA
<213> 智人
<400> 2
atcggagggg ggtcgggagg aggaggagga ggcagcggca gagaagagag aggcgtgtga 60
gccgtgctcc accggctagc tccttcccgc tgctcctgcc tggcagtgcc aggcagccca 120
caccagcatg gccttgctca tccacctcaa gacagtctcg gagctgcggg gcaggggcga 180
ccggatcgcc aaagtgactt tccgagggca atccttctac tctcgggtcc tggagaactg 240
tgaggatgtg gctgactttg atgagacatt tcggtggccg gtggccagca gcatcgacag 300
aaatgagatg ctggagattc aggttttcaa ctacagcaaa gtcttcagca acaagctcat 360
cgggaccttc cgcatggtgc tgcagaaggt ggtagaggag agccatgtgg aggtgactga 420
cacgctgatt gatgacaaca atgctatcat caagaccagc ctgtgcgtgg aggtccggta 480
tcaggccact gacggcacag tgggctcctg ggacgatggg gacttcctgg gagatgagtc 540
tcttcaagag gaagagaagg acagccaaga gacggatgga ctgctcccag gctcccggcc 600
cagctcccgg cccccaggag agaagagctt ccggagagcc gggaggagcg tgttctccgc 660
catgaagctc ggcaaaaacc ggtctcacaa ggaggagccc caaagaccag atgaaccggc 720
ggtgctggag atggaagacc ttgaccatct ggccattcgg ctaggagatg gactggatcc 780
cgactcggtg tctctagcct cagtcacagc tctcaccact aatgtctcca acaagcgatc 840
taagccagac attaagatgg agccaagtgc tgggcggccc atggattacc aggtcagcat 900
cacggtgatc gaggcccggc agctggtggg cttgaacatg gaccctgtgg tgtgcgtgga 960
ggtgggtgac gacaagaagt acacatccat gaaggagtcc actaactgcc cctattacaa 1020
cgagtacttc gtcttcgact tccatgtctc tccggatgtc atgtttgaca agatcatcaa 1080
gatttcggtg attcactcca agaacctgct gcgcagtggc accctggtgg gctccttcaa 1140
aatggacgtg ggaaccgtgt actcgcagcc agagcaccag ttccatcaca agtgggccat 1200
cctgtctgac cccgatgaca tctcctcggg gctgaagggc tacgtgaagt gtgacgttgc 1260
cgtggtgggc aaaggggaca acatcaagac gccccacaag gccaatgaga ccgacgaaga 1320
tgacattgag gggaacttgc tgctccccga gggggtgccc cccgaacgcc agtgggcccg 1380
gttctatgtg aaaatttacc gagcagaggg gctgccccgt atgaacacaa gcctcatggc 1440
caatgtaaag aaggctttca tcggtgaaaa caaggacctc gtggacccct acgtgcaagt 1500
cttctttgct ggccagaagg gcaagacttc agtgcagaag agcagctatg agcccctgtg 1560
gaatgagcag gtcgtcttta cagacctctt ccccccactc tgcaaacgca tgaaggtgca 1620
gatccgagac tcggacaagg tcaacgacgt ggccatcggc acccacttca ttgacctgcg 1680
caagatttct aatgacggag acaaaggctt cctgcccaca ctgggcccag cctgggtgaa 1740
catgtacggc tccacacgta actacacgct gctggatgag catcaggacc tgaacgaggg 1800
cctgggggag ggtgtgtcct tccgggcccg gctcctgctg ggcctggctg tggagatcgt 1860
agacacctcc aaccctgagc tcaccagctc cacagaggtg caggtggagc aggccacgcc 1920
catctcggag agctgtgcag gtaaaatgga agaattcttt ctctttggag ccttcctgga 1980
ggcctcaatg atcgaccgga gaaacggaga caagcccatc acctttgagg tcaccatagg 2040
caactatggg aacgaagttg atggcctgtc ccggccccag cggcctcggc cccggaagga 2100
gccgggggat gaggaagaag tagacctgat tcagaacgca agtgatgacg aggccggtga 2160
tgccggggac ctggcctcag tctcctccac tccaccaatg cggccccagg tcaccgacag 2220
gaactacttc catctgccct acctggagcg aaagccctgc atctacatca agagctggtg 2280
gccggaccag cgccgccgcc tctacaatgc caacatcatg gaccacattg ccgacaagct 2340
ggaagaaggc ctgaacgaca tacaggagat gatcaaaacg gagaagtcct accctgagcg 2400
tcgcctgcgg ggcgtcctgg aggagctgag ctgtggctgc tgccgcttcc tctccctcgc 2460
tgacaaggac cagggccact catcccgcac caggcttgac cgggagcgcc tcaagtcctg 2520
catgagggag ctggaaaaca tggggcagca ggccaggatg ctgcgggccc aggtgaagcg 2580
gcacacggtg cgggacaagc tgaggctgtg ccagaacttc ctgcagaagc tgcgcttcct 2640
ggcggacgag ccccagcaca gcattcccga catcttcatc tggatgatga gcaacaacaa 2700
gcgtgtcgcc tatgcccgtg tgccctccaa ggacctgctc ttctccatcg tggaggagga 2760
gactggcaag gactgcgcca aggtcaagac gctcttcctt aagctgccag ggaagcgggg 2820
cttcggctcg gcaggctgga cagtgcaggc caaggtggag ctgtacctgt ggctgggcct 2880
cagcaaacag cgcaaggagt tcctgtgcgg cctgccctgt ggcttccagg aggtcaaggc 2940
agcccagggc ctgggcctgc atgccttccc acccgtcagc ctggtctaca ccaagaagca 3000
ggcgttccag ctccgagcgc acatgtacca ggcccgcagc ctctttgccg ccgacagcag 3060
cggactctca gacccctttg cccgcgtctt cttcatcaat cagagtcagt gcacagaggt 3120
gctgaatgag accctgtgtc ccacctggga ccagatgctg gtgttcgaca acctggagct 3180
ctatggtgaa gctcatgagc tgagggacga tccgcccatc attgtcattg aaatctatga 3240
ccaggattcc atgggcaaag ctgacttcat gggccggacc ttcgccaaac ccctggtgaa 3300
gatggcagac gaggcgtact gcccaccccg cttcccacct cagctcgagt actaccagat 3360
ctaccgtggc aacgccacag ctggagacct gctggcggcc ttcgagctgc tgcagattgg 3420
accagcaggg aaggctgacc tgccccccat caatggcccg gtggacgtgg accgaggtcc 3480
catcatgccc gtgcccatgg gcatccggcc cgtgctcagc aagtaccgag tggaggtgct 3540
gttctggggc ctacgggacc taaagcgggt gaacctggcc caggtggacc ggccacgggt 3600
ggacatcgag tgtgcaggga agggggtgca gtcgtccctg atccacaatt ataagaagaa 3660
ccccaacttc aacaccctcg tcaagtggtt tgaagtggac ctcccagaga acgagctgct 3720
gcacccgccc ttgaacatcc gtgtggtgga ctgccgggcc ttcggtcgct acacactggt 3780
gggctcccat gccgtcagct ccctgcgacg cttcatctac cggcccccag accgctcggc 3840
ccccagctgg aacaccacgg tcaggcttct ccggcgctgc cgtgtgctgt gcaatggggg 3900
ctcctcctct cactccacag gggaggttgt ggtgactatg gagccagagg tacccatcaa 3960
gaaactggag accatggtga agctggacgc gacttctgaa gctgttgtca aggtggatgt 4020
ggctgaggag gagaaggaga agaagaagaa gaagaagggc actgcggagg agccagagga 4080
ggaggagcca gacgagagca tgctggactg gtggtccaag tactttgcct ccattgacac 4140
catgaaggag caacttcgac aacaagagcc ctctggaatt gacttggagg agaaggagga 4200
agtggacaat accgagggcc tgaaggggtc aatgaagggc aaggagaagg caagggctgc 4260
caaagaggag aagaagaaga aaactcagag ctctggctct ggccaggggt ccgaggcccc 4320
cgagaagaag aaacccaaga ttgatgagct taaggtatac cccaaagagc tggagtccga 4380
gtttgataac tttgaggact ggctgcacac tttcaacttg cttcggggca agaccgggga 4440
tgatgaggat ggctccaccg aggaggagcg cattgtggga cgcttcaagg gctccctctg 4500
cgtgtacaaa gtgccactcc cagaggacgt gtcccgggaa gccggctacg actccaccta 4560
cggcatgttc cagggcatcc cgagcaatga ccccatcaat gtgctggtcc gagtctatgt 4620
ggtccgggcc acggacctgc accctgctga catcaacggc aaagctgacc cctacatcgc 4680
catccggcta ggcaagactg acatccgcga caaggagaac tacatctcca agcagctcaa 4740
ccctgtcttt gggaagtcct ttgacatcga ggcctccttc cccatggaat ccatgctgac 4800
ggtggctgtg tatgactggg acctggtggg cactgatgac ctcattgggg aaaccaagat 4860
cgacctggag aaccgcttct acagcaagca ccgcgccacc tgcggcatcg cccagaccta 4920
ctccacacat ggctacaata tctggcggga ccccatgaag cccagccaga tcctgacccg 4980
cctctgcaaa gacggcaaag tggacggccc ccactttggg ccccctggga gagtgaaggt 5040
ggccaaccgc gtcttcactg ggccctctga gattgaggac gagaacggtc agaggaagcc 5100
cacagacgag catgtggcgc tgttggccct gaggcactgg gaggacatcc cccgcgcagg 5160
ctgccgcctg gtgccagagc atgtggagac gaggccgctg ctcaaccccg acaagccggg 5220
catcgagcag ggccgcctgg agctgtgggt ggacatgttc cccatggaca tgccagcccc 5280
tgggacgcct ctggacatct cacctcggaa gcccaagaag tacgagctgc gggtcatcat 5340
ctggaacaca gatgaggtgg tcttggagga cgacgacttc ttcacagggg agaagtccag 5400
tgacatcttc gtgagggggt ggctgaaggg ccagcaggag gacaagcagg acacagacgt 5460
ccactaccac tccctcactg gcgagggcaa cttcaactgg cgctacctgt tccccttcga 5520
ctacctggcg gcggaggaga agatcgtcat ctccaagaag gagtccatgt tctcctggga 5580
cgagaccgag tacaagatcc ccgcgcggct caccctgcag atctgggatg cggaccactt 5640
ctccgctgac gacttcctgg gggccatcga gctggacctg aaccggttcc cgcggggcgc 5700
aaagacagcc aagcagtgca ccatggagat ggccaccggg gaggtggacg tgcccctcgt 5760
gtccatcttc aagcaaaagc gcgtcaaagg ctggtggccc ctcctggccc gcaatgagaa 5820
cgatgagttt gagctcacgg gcaaggtgga ggctgagctg catttactga cagcagagga 5880
ggcagagaag aacccagtgg gcctggcccg caatgaacct gaccccctag agaaacccaa 5940
ccggcccgac acgagcttca tctggttcct gaaccctctc aagtcggctc gctacttctt 6000
gtggcacacg tatcgctggc tgctcctcaa actgttgctg ctcctgctgc tgctcctcct 6060
cctcgccctg ttcctctact ctgtgcctgg ctacctggtc aagaaaatcc tcggggcctg 6120
agcccagtgg cctcctggcc ggcccgacac ggccttcgtc tggttcctca accctctcaa 6180
gtccatcaag tacctcatct gcacccggta caagtggctc atcatcaaga tcgtgctggc 6240
gctgttgggg ctgctcatgt tggggctctt cctctacagc ctccctggct acatggtcaa 6300
aaagctcctt ggggcatgaa ggccgccagc tcccgccagc cgctccccag ccctgccgca 6360
tttcctttca gtggcttgga ctctttccca tctcccctgg ggagcctgag gagcccagcg 6420
tccactcttc atgccttggg ccgagcctgc ctcctgcttg cgggggccgc ctgtcctcac 6480
tgccccaggc tgcggcttgc ccagtcccgc ccctctgacc cctgcctgtg ggctggggag 6540
ccttggatgg ggtggggacc tggaatgggt ctctcttgcc ccacctggct gaggcgccac 6600
ccttcttcag gcccaggctc cagaggaaga ctcctgaaac cctccccagg tcttccaagt 6660
acaggattga agctttagtg aaattaacca aggaccatgg gtcagtgccc agggctttaa 6720
aaagaatgaa cgagcaaaag gtatccccgc cgtgacccct gcagatagca ccggtctttg 6780
atccgcagca ggggccagac cctgcccaca agtcccagcg cggctgcttc tgccactgct 6840
gggctccact tggctcctct cacttcccag ggggtcgcct gtcctgcctg tgggtttcca 6900
tggcttccca gagctccctc tgccccagcc agcgcctcca ggcccagctg aggagctgtg 6960
agaagcagca gaggggactc cccatcccgg gcacaccctg tcctcccacc cctgccccct 7020
tgcccttcca gccctttcag ctgcagctgg gagctggccc gtcaagtgct gcccctgcct 7080
gtgtctgggt ttctgttggc tgtttttctt ttcttgagtg gtgatttttc tctaaataaa 7140
agaagtcaag cactgaaaaa aaaaaaaaaa a 7171
<210> 3
<211> 2676
<212> DNA
<213> 智人
<400> 3
atggccttgc tcatccacct caagacagtc tcggagctgc ggggcagggg cgaccggatc 60
gccaaagtga ctttccgagg gcaatccttc tactctcggg tcctggagaa ctgtgaggat 120
gtggctgact ttgatgagac atttcggtgg ccggtggcca gcagcatcga cagaaatgag 180
atgctggaga ttcaggtttt caactacagc aaagtcttca gcaacaagct catcgggacc 240
ttccgcatgg tgctgcagaa ggtggtagag gagagccatg tggaggtgac tgacacgctg 300
attgatgaca acaatgctat catcaagacc agcctgtgcg tggaggtccg gtatcaggcc 360
actgacggca cagtgggctc ctgggacgat ggggacttcc tgggagatga gtctcttcaa 420
gaggaagaga aggacagcca agagacggat ggactgctcc caggctcccg gcccagctcc 480
cggcccccag gagagaagag cttccggaga gccgggagga gcgtgttctc cgccatgaag 540
ctcggcaaaa accggtctca caaggaggag ccccaaagac cagatgaacc ggcggtgctg 600
gagatggaag accttgacca tctggccatt cggctaggag atggactgga tcccgactcg 660
gtgtctctag cctcagtcac agctctcacc actaatgtct ccaacaagcg atctaagcca 720
gacattaaga tggagccaag tgctgggcgg cccatggatt accaggtcag catcacggtg 780
atcgaggccc ggcagctggt gggcttgaac atggaccctg tggtgtgcgt ggaggtgggt 840
gacgacaaga agtacacatc catgaaggag tccactaact gcccctatta caacgagtac 900
ttcgtcttcg acttccatgt ctctccggat gtcatgtttg acaagatcat caagatttcg 960
gtgattcact ccaagaacct gctgcgcagt ggcaccctgg tgggctcctt caaaatggac 1020
gtgggaaccg tgtactcgca gccagagcac cagttccatc acaagtgggc catcctgtct 1080
gaccccgatg acatctcctc ggggctgaag ggctacgtga agtgtgacgt tgccgtggtg 1140
ggcaaagggg acaacatcaa gacgccccac aaggccaatg agaccgacga agatgacatt 1200
gaggggaact tgctgctccc cgagggggtg ccccccgaac gccagtgggc ccggttctat 1260
gtgaaaattt accgagcaga ggggctgccc cgtatgaaca caagcctcat ggccaatgta 1320
aagaaggctt tcatcggtga aaacaaggac ctcgtggacc cctacgtgca agtcttcttt 1380
gctggccaga agggcaagac ttcagtgcag aagagcagct atgagcccct gtggaatgag 1440
caggtcgtct ttacagacct cttcccccca ctctgcaaac gcatgaaggt gcagatccga 1500
gactcggaca aggtcaacga cgtggccatc ggcacccact tcattgacct gcgcaagatt 1560
tctaatgacg gagacaaagg cttcctgccc acactgggcc cagcctgggt gaacatgtac 1620
ggctccacac gtaactacac gctgctggat gagcatcagg acctgaacga gggcctgggg 1680
gagggtgtgt ccttccgggc ccggctcctg ctgggcctgg ctgtggagat cgtagacacc 1740
tccaaccctg agctcaccag ctccacagag gtgcaggtgg agcaggccac gcccatctcg 1800
gagagctgtg caggtaaaat ggaagaattc tttctctttg gagccttcct ggaggcctca 1860
atgatcgacc ggagaaacgg agacaagccc atcacctttg aggtcaccat aggcaactat 1920
gggaacgaag ttgatggcct gtcccggccc cagcggcctc ggccccggaa ggagccgggg 1980
gatgaggaag aagtagacct gattcagaac gcaagtgatg acgaggccgg tgatgccggg 2040
gacctggcct cagtctcctc cactccacca atgcggcccc aggtcaccga caggaactac 2100
ttccatctgc cctacctgga gcgaaagccc tgcatctaca tcaagagctg gtggccggac 2160
cagcgccgcc gcctctacaa tgccaacatc atggaccaca ttgccgacaa gctggaagaa 2220
ggcctgaacg acatacagga gatgatcaaa acggagaagt cctaccctga gcgtcgcctg 2280
cggggcgtcc tggaggagct gagctgtggc tgctgccgct tcctctccct cgctgacaag 2340
gaccagggcc actcatcccg caccaggctt gaccgggagc gcctcaagtc ctgcatgagg 2400
gagctggaaa acatggggca gcaggccagg atgctgcggg cccaggtgaa gcggcacacg 2460
gtgcgggaca agctgaggct gtgccagaac ttcctgcaga agctgcgctt cctggcggac 2520
gagccccagc acagcattcc cgacatcttc atctggatga tgagcaacaa caagcgtgtc 2580
gcctatgccc gtgtgccctc caaggacctg ctcttctcca tcgtggagga ggagactggc 2640
aaggactgcg ccaaggtcaa gacgctcttc cttaag 2676
<210> 4
<211> 3318
<212> DNA
<213> 智人
<400> 4
ctgccaggga agcggggctt cggctcggca ggctggacag tgcaggccaa ggtggagctg 60
tacctgtggc tgggcctcag caaacagcgc aaggagttcc tgtgcggcct gccctgtggc 120
ttccaggagg tcaaggcagc ccagggcctg ggcctgcatg ccttcccacc cgtcagcctg 180
gtctacacca agaagcaggc gttccagctc cgagcgcaca tgtaccaggc ccgcagcctc 240
tttgccgccg acagcagcgg actctcagac ccctttgccc gcgtcttctt catcaatcag 300
agtcagtgca cagaggtgct gaatgagacc ctgtgtccca cctgggacca gatgctggtg 360
ttcgacaacc tggagctcta tggtgaagct catgagctga gggacgatcc gcccatcatt 420
gtcattgaaa tctatgacca ggattccatg ggcaaagctg acttcatggg ccggaccttc 480
gccaaacccc tggtgaagat ggcagacgag gcgtactgcc caccccgctt cccacctcag 540
ctcgagtact accagatcta ccgtggcaac gccacagctg gagacctgct ggcggccttc 600
gagctgctgc agattggacc agcagggaag gctgacctgc cccccatcaa tggcccggtg 660
gacgtggacc gaggtcccat catgcccgtg cccatgggca tccggcccgt gctcagcaag 720
taccgagtgg aggtgctgtt ctggggccta cgggacctaa agcgggtgaa cctggcccag 780
gtggaccggc cacgggtgga catcgagtgt gcagggaagg gggtgcagtc gtccctgatc 840
cacaattata agaagaaccc caacttcaac accctcgtca agtggtttga agtggacctc 900
ccagagaacg agctgctgca cccgcccttg aacatccgtg tggtggactg ccgggccttc 960
ggtcgctaca cactggtggg ctcccatgcc gtcagctccc tgcgacgctt catctaccgg 1020
cccccagacc gctcggcccc cagctggaac accacggtca ggcttctccg gcgctgccgt 1080
gtgctgtgca atgggggctc ctcctctcac tccacagggg aggttgtggt gactatggag 1140
ccagaggtac ccatcaagaa actggagacc atggtgaagc tggacgcgac ttctgaagct 1200
gttgtcaagg tggatgtggc tgaggaggag aaggagaaga agaagaagaa gaagggcact 1260
gcggaggagc cagaggagga ggagccagac gagagcatgc tggactggtg gtccaagtac 1320
tttgcctcca ttgacaccat gaaggagcaa cttcgacaac aagagccctc tggaattgac 1380
ttggaggaga aggaggaagt ggacaatacc gagggcctga aggggtcaat gaagggcaag 1440
gagaaggcaa gggctgccaa agaggagaag aagaagaaaa ctcagagctc tggctctggc 1500
caggggtccg aggcccccga gaagaagaaa cccaagattg atgagcttaa ggtatacccc 1560
aaagagctgg agtccgagtt tgataacttt gaggactggc tgcacacttt caacttgctt 1620
cggggcaaga ccggggatga tgaggatggc tccaccgagg aggagcgcat tgtgggacgc 1680
ttcaagggct ccctctgcgt gtacaaagtg ccactcccag aggacgtgtc ccgggaagcc 1740
ggctacgact ccacctacgg catgttccag ggcatcccga gcaatgaccc catcaatgtg 1800
ctggtccgag tctatgtggt ccgggccacg gacctgcacc ctgctgacat caacggcaaa 1860
gctgacccct acatcgccat ccggctaggc aagactgaca tccgcgacaa ggagaactac 1920
atctccaagc agctcaaccc tgtctttggg aagtcctttg acatcgaggc ctccttcccc 1980
atggaatcca tgctgacggt ggctgtgtat gactgggacc tggtgggcac tgatgacctc 2040
attggggaaa ccaagatcga cctggagaac cgcttctaca gcaagcaccg cgccacctgc 2100
ggcatcgccc agacctactc cacacatggc tacaatatct ggcgggaccc catgaagccc 2160
agccagatcc tgacccgcct ctgcaaagac ggcaaagtgg acggccccca ctttgggccc 2220
cctgggagag tgaaggtggc caaccgcgtc ttcactgggc cctctgagat tgaggacgag 2280
aacggtcaga ggaagcccac agacgagcat gtggcgctgt tggccctgag gcactgggag 2340
gacatccccc gcgcaggctg ccgcctggtg ccagagcatg tggagacgag gccgctgctc 2400
aaccccgaca agccgggcat cgagcagggc cgcctggagc tgtgggtgga catgttcccc 2460
atggacatgc cagcccctgg gacgcctctg gacatctcac ctcggaagcc caagaagtac 2520
gagctgcggg tcatcatctg gaacacagat gaggtggtct tggaggacga cgacttcttc 2580
acaggggaga agtccagtga catcttcgtg agggggtggc tgaagggcca gcaggaggac 2640
aagcaggaca cagacgtcca ctaccactcc ctcactggcg agggcaactt caactggcgc 2700
tacctgttcc ccttcgacta cctggcggcg gaggagaaga tcgtcatctc caagaaggag 2760
tccatgttct cctgggacga gaccgagtac aagatccccg cgcggctcac cctgcagatc 2820
tgggatgcgg accacttctc cgctgacgac ttcctggggg ccatcgagct ggacctgaac 2880
cggttcccgc ggggcgcaaa gacagccaag cagtgcacca tggagatggc caccggggag 2940
gtggacgtgc ccctcgtgtc catcttcaag caaaagcgcg tcaaaggctg gtggcccctc 3000
ctggcccgca atgagaacga tgagtttgag ctcacgggca aggtggaggc tgagctgcat 3060
ttactgacag cagaggaggc agagaagaac ccagtgggcc tggcccgcaa tgaacctgac 3120
cccctagaga aacccaaccg gcccgacacg agcttcatct ggttcctgaa ccctctcaag 3180
tcggctcgct acttcttgtg gcacacgtat cgctggctgc tcctcaaact gttgctgctc 3240
ctgctgctgc tcctcctcct cgccctgttc ctctactctg tgcctggcta cctggtcaag 3300
aaaatcctcg gggcctga 3318
<210> 5
<211> 1997
<212> PRT
<213> 智人
<400> 5
Met Ala Leu Leu Ile His Leu Lys Thr Val Ser Glu Leu Arg Gly Arg
1 5 10 15
Gly Asp Arg Ile Ala Lys Val Thr Phe Arg Gly Gln Ser Phe Tyr Ser
20 25 30
Arg Val Leu Glu Asn Cys Glu Asp Val Ala Asp Phe Asp Glu Thr Phe
35 40 45
Arg Trp Pro Val Ala Ser Ser Ile Asp Arg Asn Glu Met Leu Glu Ile
50 55 60
Gln Val Phe Asn Tyr Ser Lys Val Phe Ser Asn Lys Leu Ile Gly Thr
65 70 75 80
Phe Arg Met Val Leu Gln Lys Val Val Glu Glu Ser His Val Glu Val
85 90 95
Thr Asp Thr Leu Ile Asp Asp Asn Asn Ala Ile Ile Lys Thr Ser Leu
100 105 110
Cys Val Glu Val Arg Tyr Gln Ala Thr Asp Gly Thr Val Gly Ser Trp
115 120 125
Asp Asp Gly Asp Phe Leu Gly Asp Glu Ser Leu Gln Glu Glu Glu Lys
130 135 140
Asp Ser Gln Glu Thr Asp Gly Leu Leu Pro Gly Ser Arg Pro Ser Ser
145 150 155 160
Arg Pro Pro Gly Glu Lys Ser Phe Arg Arg Ala Gly Arg Ser Val Phe
165 170 175
Ser Ala Met Lys Leu Gly Lys Asn Arg Ser His Lys Glu Glu Pro Gln
180 185 190
Arg Pro Asp Glu Pro Ala Val Leu Glu Met Glu Asp Leu Asp His Leu
195 200 205
Ala Ile Arg Leu Gly Asp Gly Leu Asp Pro Asp Ser Val Ser Leu Ala
210 215 220
Ser Val Thr Ala Leu Thr Thr Asn Val Ser Asn Lys Arg Ser Lys Pro
225 230 235 240
Asp Ile Lys Met Glu Pro Ser Ala Gly Arg Pro Met Asp Tyr Gln Val
245 250 255
Ser Ile Thr Val Ile Glu Ala Arg Gln Leu Val Gly Leu Asn Met Asp
260 265 270
Pro Val Val Cys Val Glu Val Gly Asp Asp Lys Lys Tyr Thr Ser Met
275 280 285
Lys Glu Ser Thr Asn Cys Pro Tyr Tyr Asn Glu Tyr Phe Val Phe Asp
290 295 300
Phe His Val Ser Pro Asp Val Met Phe Asp Lys Ile Ile Lys Ile Ser
305 310 315 320
Val Ile His Ser Lys Asn Leu Leu Arg Ser Gly Thr Leu Val Gly Ser
325 330 335
Phe Lys Met Asp Val Gly Thr Val Tyr Ser Gln Pro Glu His Gln Phe
340 345 350
His His Lys Trp Ala Ile Leu Ser Asp Pro Asp Asp Ile Ser Ser Gly
355 360 365
Leu Lys Gly Tyr Val Lys Cys Asp Val Ala Val Val Gly Lys Gly Asp
370 375 380
Asn Ile Lys Thr Pro His Lys Ala Asn Glu Thr Asp Glu Asp Asp Ile
385 390 395 400
Glu Gly Asn Leu Leu Leu Pro Glu Gly Val Pro Pro Glu Arg Gln Trp
405 410 415
Ala Arg Phe Tyr Val Lys Ile Tyr Arg Ala Glu Gly Leu Pro Arg Met
420 425 430
Asn Thr Ser Leu Met Ala Asn Val Lys Lys Ala Phe Ile Gly Glu Asn
435 440 445
Lys Asp Leu Val Asp Pro Tyr Val Gln Val Phe Phe Ala Gly Gln Lys
450 455 460
Gly Lys Thr Ser Val Gln Lys Ser Ser Tyr Glu Pro Leu Trp Asn Glu
465 470 475 480
Gln Val Val Phe Thr Asp Leu Phe Pro Pro Leu Cys Lys Arg Met Lys
485 490 495
Val Gln Ile Arg Asp Ser Asp Lys Val Asn Asp Val Ala Ile Gly Thr
500 505 510
His Phe Ile Asp Leu Arg Lys Ile Ser Asn Asp Gly Asp Lys Gly Phe
515 520 525
Leu Pro Thr Leu Gly Pro Ala Trp Val Asn Met Tyr Gly Ser Thr Arg
530 535 540
Asn Tyr Thr Leu Leu Asp Glu His Gln Asp Leu Asn Glu Gly Leu Gly
545 550 555 560
Glu Gly Val Ser Phe Arg Ala Arg Leu Leu Leu Gly Leu Ala Val Glu
565 570 575
Ile Val Asp Thr Ser Asn Pro Glu Leu Thr Ser Ser Thr Glu Val Gln
580 585 590
Val Glu Gln Ala Thr Pro Ile Ser Glu Ser Cys Ala Gly Lys Met Glu
595 600 605
Glu Phe Phe Leu Phe Gly Ala Phe Leu Glu Ala Ser Met Ile Asp Arg
610 615 620
Arg Asn Gly Asp Lys Pro Ile Thr Phe Glu Val Thr Ile Gly Asn Tyr
625 630 635 640
Gly Asn Glu Val Asp Gly Leu Ser Arg Pro Gln Arg Pro Arg Pro Arg
645 650 655
Lys Glu Pro Gly Asp Glu Glu Glu Val Asp Leu Ile Gln Asn Ala Ser
660 665 670
Asp Asp Glu Ala Gly Asp Ala Gly Asp Leu Ala Ser Val Ser Ser Thr
675 680 685
Pro Pro Met Arg Pro Gln Val Thr Asp Arg Asn Tyr Phe His Leu Pro
690 695 700
Tyr Leu Glu Arg Lys Pro Cys Ile Tyr Ile Lys Ser Trp Trp Pro Asp
705 710 715 720
Gln Arg Arg Arg Leu Tyr Asn Ala Asn Ile Met Asp His Ile Ala Asp
725 730 735
Lys Leu Glu Glu Gly Leu Asn Asp Ile Gln Glu Met Ile Lys Thr Glu
740 745 750
Lys Ser Tyr Pro Glu Arg Arg Leu Arg Gly Val Leu Glu Glu Leu Ser
755 760 765
Cys Gly Cys Cys Arg Phe Leu Ser Leu Ala Asp Lys Asp Gln Gly His
770 775 780
Ser Ser Arg Thr Arg Leu Asp Arg Glu Arg Leu Lys Ser Cys Met Arg
785 790 795 800
Glu Leu Glu Asn Met Gly Gln Gln Ala Arg Met Leu Arg Ala Gln Val
805 810 815
Lys Arg His Thr Val Arg Asp Lys Leu Arg Leu Cys Gln Asn Phe Leu
820 825 830
Gln Lys Leu Arg Phe Leu Ala Asp Glu Pro Gln His Ser Ile Pro Asp
835 840 845
Ile Phe Ile Trp Met Met Ser Asn Asn Lys Arg Val Ala Tyr Ala Arg
850 855 860
Val Pro Ser Lys Asp Leu Leu Phe Ser Ile Val Glu Glu Glu Thr Gly
865 870 875 880
Lys Asp Cys Ala Lys Val Lys Thr Leu Phe Leu Lys Leu Pro Gly Lys
885 890 895
Arg Gly Phe Gly Ser Ala Gly Trp Thr Val Gln Ala Lys Val Glu Leu
900 905 910
Tyr Leu Trp Leu Gly Leu Ser Lys Gln Arg Lys Glu Phe Leu Cys Gly
915 920 925
Leu Pro Cys Gly Phe Gln Glu Val Lys Ala Ala Gln Gly Leu Gly Leu
930 935 940
His Ala Phe Pro Pro Val Ser Leu Val Tyr Thr Lys Lys Gln Ala Phe
945 950 955 960
Gln Leu Arg Ala His Met Tyr Gln Ala Arg Ser Leu Phe Ala Ala Asp
965 970 975
Ser Ser Gly Leu Ser Asp Pro Phe Ala Arg Val Phe Phe Ile Asn Gln
980 985 990
Ser Gln Cys Thr Glu Val Leu Asn Glu Thr Leu Cys Pro Thr Trp Asp
995 1000 1005
Gln Met Leu Val Phe Asp Asn Leu Glu Leu Tyr Gly Glu Ala His
1010 1015 1020
Glu Leu Arg Asp Asp Pro Pro Ile Ile Val Ile Glu Ile Tyr Asp
1025 1030 1035
Gln Asp Ser Met Gly Lys Ala Asp Phe Met Gly Arg Thr Phe Ala
1040 1045 1050
Lys Pro Leu Val Lys Met Ala Asp Glu Ala Tyr Cys Pro Pro Arg
1055 1060 1065
Phe Pro Pro Gln Leu Glu Tyr Tyr Gln Ile Tyr Arg Gly Asn Ala
1070 1075 1080
Thr Ala Gly Asp Leu Leu Ala Ala Phe Glu Leu Leu Gln Ile Gly
1085 1090 1095
Pro Ala Gly Lys Ala Asp Leu Pro Pro Ile Asn Gly Pro Val Asp
1100 1105 1110
Val Asp Arg Gly Pro Ile Met Pro Val Pro Met Gly Ile Arg Pro
1115 1120 1125
Val Leu Ser Lys Tyr Arg Val Glu Val Leu Phe Trp Gly Leu Arg
1130 1135 1140
Asp Leu Lys Arg Val Asn Leu Ala Gln Val Asp Arg Pro Arg Val
1145 1150 1155
Asp Ile Glu Cys Ala Gly Lys Gly Val Gln Ser Ser Leu Ile His
1160 1165 1170
Asn Tyr Lys Lys Asn Pro Asn Phe Asn Thr Leu Val Lys Trp Phe
1175 1180 1185
Glu Val Asp Leu Pro Glu Asn Glu Leu Leu His Pro Pro Leu Asn
1190 1195 1200
Ile Arg Val Val Asp Cys Arg Ala Phe Gly Arg Tyr Thr Leu Val
1205 1210 1215
Gly Ser His Ala Val Ser Ser Leu Arg Arg Phe Ile Tyr Arg Pro
1220 1225 1230
Pro Asp Arg Ser Ala Pro Ser Trp Asn Thr Thr Val Arg Leu Leu
1235 1240 1245
Arg Arg Cys Arg Val Leu Cys Asn Gly Gly Ser Ser Ser His Ser
1250 1255 1260
Thr Gly Glu Val Val Val Thr Met Glu Pro Glu Val Pro Ile Lys
1265 1270 1275
Lys Leu Glu Thr Met Val Lys Leu Asp Ala Thr Ser Glu Ala Val
1280 1285 1290
Val Lys Val Asp Val Ala Glu Glu Glu Lys Glu Lys Lys Lys Lys
1295 1300 1305
Lys Lys Gly Thr Ala Glu Glu Pro Glu Glu Glu Glu Pro Asp Glu
1310 1315 1320
Ser Met Leu Asp Trp Trp Ser Lys Tyr Phe Ala Ser Ile Asp Thr
1325 1330 1335
Met Lys Glu Gln Leu Arg Gln Gln Glu Pro Ser Gly Ile Asp Leu
1340 1345 1350
Glu Glu Lys Glu Glu Val Asp Asn Thr Glu Gly Leu Lys Gly Ser
1355 1360 1365
Met Lys Gly Lys Glu Lys Ala Arg Ala Ala Lys Glu Glu Lys Lys
1370 1375 1380
Lys Lys Thr Gln Ser Ser Gly Ser Gly Gln Gly Ser Glu Ala Pro
1385 1390 1395
Glu Lys Lys Lys Pro Lys Ile Asp Glu Leu Lys Val Tyr Pro Lys
1400 1405 1410
Glu Leu Glu Ser Glu Phe Asp Asn Phe Glu Asp Trp Leu His Thr
1415 1420 1425
Phe Asn Leu Leu Arg Gly Lys Thr Gly Asp Asp Glu Asp Gly Ser
1430 1435 1440
Thr Glu Glu Glu Arg Ile Val Gly Arg Phe Lys Gly Ser Leu Cys
1445 1450 1455
Val Tyr Lys Val Pro Leu Pro Glu Asp Val Ser Arg Glu Ala Gly
1460 1465 1470
Tyr Asp Ser Thr Tyr Gly Met Phe Gln Gly Ile Pro Ser Asn Asp
1475 1480 1485
Pro Ile Asn Val Leu Val Arg Val Tyr Val Val Arg Ala Thr Asp
1490 1495 1500
Leu His Pro Ala Asp Ile Asn Gly Lys Ala Asp Pro Tyr Ile Ala
1505 1510 1515
Ile Arg Leu Gly Lys Thr Asp Ile Arg Asp Lys Glu Asn Tyr Ile
1520 1525 1530
Ser Lys Gln Leu Asn Pro Val Phe Gly Lys Ser Phe Asp Ile Glu
1535 1540 1545
Ala Ser Phe Pro Met Glu Ser Met Leu Thr Val Ala Val Tyr Asp
1550 1555 1560
Trp Asp Leu Val Gly Thr Asp Asp Leu Ile Gly Glu Thr Lys Ile
1565 1570 1575
Asp Leu Glu Asn Arg Phe Tyr Ser Lys His Arg Ala Thr Cys Gly
1580 1585 1590
Ile Ala Gln Thr Tyr Ser Thr His Gly Tyr Asn Ile Trp Arg Asp
1595 1600 1605
Pro Met Lys Pro Ser Gln Ile Leu Thr Arg Leu Cys Lys Asp Gly
1610 1615 1620
Lys Val Asp Gly Pro His Phe Gly Pro Pro Gly Arg Val Lys Val
1625 1630 1635
Ala Asn Arg Val Phe Thr Gly Pro Ser Glu Ile Glu Asp Glu Asn
1640 1645 1650
Gly Gln Arg Lys Pro Thr Asp Glu His Val Ala Leu Leu Ala Leu
1655 1660 1665
Arg His Trp Glu Asp Ile Pro Arg Ala Gly Cys Arg Leu Val Pro
1670 1675 1680
Glu His Val Glu Thr Arg Pro Leu Leu Asn Pro Asp Lys Pro Gly
1685 1690 1695
Ile Glu Gln Gly Arg Leu Glu Leu Trp Val Asp Met Phe Pro Met
1700 1705 1710
Asp Met Pro Ala Pro Gly Thr Pro Leu Asp Ile Ser Pro Arg Lys
1715 1720 1725
Pro Lys Lys Tyr Glu Leu Arg Val Ile Ile Trp Asn Thr Asp Glu
1730 1735 1740
Val Val Leu Glu Asp Asp Asp Phe Phe Thr Gly Glu Lys Ser Ser
1745 1750 1755
Asp Ile Phe Val Arg Gly Trp Leu Lys Gly Gln Gln Glu Asp Lys
1760 1765 1770
Gln Asp Thr Asp Val His Tyr His Ser Leu Thr Gly Glu Gly Asn
1775 1780 1785
Phe Asn Trp Arg Tyr Leu Phe Pro Phe Asp Tyr Leu Ala Ala Glu
1790 1795 1800
Glu Lys Ile Val Ile Ser Lys Lys Glu Ser Met Phe Ser Trp Asp
1805 1810 1815
Glu Thr Glu Tyr Lys Ile Pro Ala Arg Leu Thr Leu Gln Ile Trp
1820 1825 1830
Asp Ala Asp His Phe Ser Ala Asp Asp Phe Leu Gly Ala Ile Glu
1835 1840 1845
Leu Asp Leu Asn Arg Phe Pro Arg Gly Ala Lys Thr Ala Lys Gln
1850 1855 1860
Cys Thr Met Glu Met Ala Thr Gly Glu Val Asp Val Pro Leu Val
1865 1870 1875
Ser Ile Phe Lys Gln Lys Arg Val Lys Gly Trp Trp Pro Leu Leu
1880 1885 1890
Ala Arg Asn Glu Asn Asp Glu Phe Glu Leu Thr Gly Lys Val Glu
1895 1900 1905
Ala Glu Leu His Leu Leu Thr Ala Glu Glu Ala Glu Lys Asn Pro
1910 1915 1920
Val Gly Leu Ala Arg Asn Glu Pro Asp Pro Leu Glu Lys Pro Asn
1925 1930 1935
Arg Pro Asp Thr Ala Phe Val Trp Phe Leu Asn Pro Leu Lys Ser
1940 1945 1950
Ile Lys Tyr Leu Ile Cys Thr Arg Tyr Lys Trp Leu Ile Ile Lys
1955 1960 1965
Ile Val Leu Ala Leu Leu Gly Leu Leu Met Leu Gly Leu Phe Leu
1970 1975 1980
Tyr Ser Leu Pro Gly Tyr Met Val Lys Lys Leu Leu Gly Ala
1985 1990 1995
<210> 6
<211> 1230
<212> PRT
<213> 智人
<400> 6
Met Ile Lys Thr Glu Lys Ser Tyr Pro Glu Arg Arg Leu Arg Gly Val
1 5 10 15
Leu Glu Glu Leu Ser Cys Gly Cys Cys Arg Phe Leu Ser Leu Ala Asp
20 25 30
Lys Asp Gln Gly His Ser Ser Arg Thr Arg Leu Asp Arg Glu Arg Leu
35 40 45
Lys Ser Cys Met Arg Glu Leu Glu Asn Met Gly Gln Gln Ala Arg Met
50 55 60
Leu Arg Ala Gln Val Lys Arg His Thr Val Arg Asp Lys Leu Arg Leu
65 70 75 80
Cys Gln Asn Phe Leu Gln Lys Leu Arg Phe Leu Ala Asp Glu Pro Gln
85 90 95
His Ser Ile Pro Asp Ile Phe Ile Trp Met Met Ser Asn Asn Lys Arg
100 105 110
Val Ala Tyr Ala Arg Val Pro Ser Lys Asp Leu Leu Phe Ser Ile Val
115 120 125
Glu Glu Glu Thr Gly Lys Asp Cys Ala Lys Val Lys Thr Leu Phe Leu
130 135 140
Lys Leu Pro Gly Lys Arg Gly Phe Gly Ser Ala Gly Trp Thr Val Gln
145 150 155 160
Ala Lys Val Glu Leu Tyr Leu Trp Leu Gly Leu Ser Lys Gln Arg Lys
165 170 175
Glu Phe Leu Cys Gly Leu Pro Cys Gly Phe Gln Glu Val Lys Ala Ala
180 185 190
Gln Gly Leu Gly Leu His Ala Phe Pro Pro Val Ser Leu Val Tyr Thr
195 200 205
Lys Lys Gln Ala Phe Gln Leu Arg Ala His Met Tyr Gln Ala Arg Ser
210 215 220
Leu Phe Ala Ala Asp Ser Ser Gly Leu Ser Asp Pro Phe Ala Arg Val
225 230 235 240
Phe Phe Ile Asn Gln Ser Gln Cys Thr Glu Val Leu Asn Glu Thr Leu
245 250 255
Cys Pro Thr Trp Asp Gln Met Leu Val Phe Asp Asn Leu Glu Leu Tyr
260 265 270
Gly Glu Ala His Glu Leu Arg Asp Asp Pro Pro Ile Ile Val Ile Glu
275 280 285
Ile Tyr Asp Gln Asp Ser Met Gly Lys Ala Asp Phe Met Gly Arg Thr
290 295 300
Phe Ala Lys Pro Leu Val Lys Met Ala Asp Glu Ala Tyr Cys Pro Pro
305 310 315 320
Arg Phe Pro Pro Gln Leu Glu Tyr Tyr Gln Ile Tyr Arg Gly Asn Ala
325 330 335
Thr Ala Gly Asp Leu Leu Ala Ala Phe Glu Leu Leu Gln Ile Gly Pro
340 345 350
Ala Gly Lys Ala Asp Leu Pro Pro Ile Asn Gly Pro Val Asp Val Asp
355 360 365
Arg Gly Pro Ile Met Pro Val Pro Met Gly Ile Arg Pro Val Leu Ser
370 375 380
Lys Tyr Arg Val Glu Val Leu Phe Trp Gly Leu Arg Asp Leu Lys Arg
385 390 395 400
Val Asn Leu Ala Gln Val Asp Arg Pro Arg Val Asp Ile Glu Cys Ala
405 410 415
Gly Lys Gly Val Gln Ser Ser Leu Ile His Asn Tyr Lys Lys Asn Pro
420 425 430
Asn Phe Asn Thr Leu Val Lys Trp Phe Glu Val Asp Leu Pro Glu Asn
435 440 445
Glu Leu Leu His Pro Pro Leu Asn Ile Arg Val Val Asp Cys Arg Ala
450 455 460
Phe Gly Arg Tyr Thr Leu Val Gly Ser His Ala Val Ser Ser Leu Arg
465 470 475 480
Arg Phe Ile Tyr Arg Pro Pro Asp Arg Ser Ala Pro Ser Trp Asn Thr
485 490 495
Thr Gly Glu Val Val Val Thr Met Glu Pro Glu Val Pro Ile Lys Lys
500 505 510
Leu Glu Thr Met Val Lys Leu Asp Ala Thr Ser Glu Ala Val Val Lys
515 520 525
Val Asp Val Ala Glu Glu Glu Lys Glu Lys Lys Lys Lys Lys Lys Gly
530 535 540
Thr Ala Glu Glu Pro Glu Glu Glu Glu Pro Asp Glu Ser Met Leu Asp
545 550 555 560
Trp Trp Ser Lys Tyr Phe Ala Ser Ile Asp Thr Met Lys Glu Gln Leu
565 570 575
Arg Gln Gln Glu Pro Ser Gly Ile Asp Leu Glu Glu Lys Glu Glu Val
580 585 590
Asp Asn Thr Glu Gly Leu Lys Gly Ser Met Lys Gly Lys Glu Lys Ala
595 600 605
Arg Ala Ala Lys Glu Glu Lys Lys Lys Lys Thr Gln Ser Ser Gly Ser
610 615 620
Gly Gln Gly Ser Glu Ala Pro Glu Lys Lys Lys Pro Lys Ile Asp Glu
625 630 635 640
Leu Lys Val Tyr Pro Lys Glu Leu Glu Ser Glu Phe Asp Asn Phe Glu
645 650 655
Asp Trp Leu His Thr Phe Asn Leu Leu Arg Gly Lys Thr Gly Asp Asp
660 665 670
Glu Asp Gly Ser Thr Glu Glu Glu Arg Ile Val Gly Arg Phe Lys Gly
675 680 685
Ser Leu Cys Val Tyr Lys Val Pro Leu Pro Glu Asp Val Ser Arg Glu
690 695 700
Ala Gly Tyr Asp Ser Thr Tyr Gly Met Phe Gln Gly Ile Pro Ser Asn
705 710 715 720
Asp Pro Ile Asn Val Leu Val Arg Val Tyr Val Val Arg Ala Thr Asp
725 730 735
Leu His Pro Ala Asp Ile Asn Gly Lys Ala Asp Pro Tyr Ile Ala Ile
740 745 750
Arg Leu Gly Lys Thr Asp Ile Arg Asp Lys Glu Asn Tyr Ile Ser Lys
755 760 765
Gln Leu Asn Pro Val Phe Gly Lys Ser Phe Asp Ile Glu Ala Ser Phe
770 775 780
Pro Met Glu Ser Met Leu Thr Val Ala Val Tyr Asp Trp Asp Leu Val
785 790 795 800
Gly Thr Asp Asp Leu Ile Gly Glu Thr Lys Ile Asp Leu Glu Asn Arg
805 810 815
Phe Tyr Ser Lys His Arg Ala Thr Cys Gly Ile Ala Gln Thr Tyr Ser
820 825 830
Thr His Gly Tyr Asn Ile Trp Arg Asp Pro Met Lys Pro Ser Gln Ile
835 840 845
Leu Thr Arg Leu Cys Lys Asp Gly Lys Val Asp Gly Pro His Phe Gly
850 855 860
Pro Pro Gly Arg Val Lys Val Ala Asn Arg Val Phe Thr Gly Pro Ser
865 870 875 880
Glu Ile Glu Asp Glu Asn Gly Gln Arg Lys Pro Thr Asp Glu His Val
885 890 895
Ala Leu Leu Ala Leu Arg His Trp Glu Asp Ile Pro Arg Ala Gly Cys
900 905 910
Arg Leu Val Pro Glu His Val Glu Thr Arg Pro Leu Leu Asn Pro Asp
915 920 925
Lys Pro Gly Ile Glu Gln Gly Arg Leu Glu Leu Trp Val Asp Met Phe
930 935 940
Pro Met Asp Met Pro Ala Pro Gly Thr Pro Leu Asp Ile Ser Pro Arg
945 950 955 960
Lys Pro Lys Lys Tyr Glu Leu Arg Val Ile Ile Trp Asn Thr Asp Glu
965 970 975
Val Val Leu Glu Asp Asp Asp Phe Phe Thr Gly Glu Lys Ser Ser Asp
980 985 990
Ile Phe Val Arg Gly Trp Leu Lys Gly Gln Gln Glu Asp Lys Gln Asp
995 1000 1005
Thr Asp Val His Tyr His Ser Leu Thr Gly Glu Gly Asn Phe Asn
1010 1015 1020
Trp Arg Tyr Leu Phe Pro Phe Asp Tyr Leu Ala Ala Glu Glu Lys
1025 1030 1035
Ile Val Ile Ser Lys Lys Glu Ser Met Phe Ser Trp Asp Glu Thr
1040 1045 1050
Glu Tyr Lys Ile Pro Ala Arg Leu Thr Leu Gln Ile Trp Asp Ala
1055 1060 1065
Asp His Phe Ser Ala Asp Asp Phe Leu Gly Ala Ile Glu Leu Asp
1070 1075 1080
Leu Asn Arg Phe Pro Arg Gly Ala Lys Thr Ala Lys Gln Cys Thr
1085 1090 1095
Met Glu Met Ala Thr Gly Glu Val Asp Val Pro Leu Val Ser Ile
1100 1105 1110
Phe Lys Gln Lys Arg Val Lys Gly Trp Trp Pro Leu Leu Ala Arg
1115 1120 1125
Asn Glu Asn Asp Glu Phe Glu Leu Thr Gly Lys Val Glu Ala Glu
1130 1135 1140
Leu His Leu Leu Thr Ala Glu Glu Ala Glu Lys Asn Pro Val Gly
1145 1150 1155
Leu Ala Arg Asn Glu Pro Asp Pro Leu Glu Lys Pro Asn Arg Pro
1160 1165 1170
Asp Thr Ser Phe Ile Trp Phe Leu Asn Pro Leu Lys Ser Ala Arg
1175 1180 1185
Tyr Phe Leu Trp His Thr Tyr Arg Trp Leu Leu Leu Lys Leu Leu
1190 1195 1200
Leu Leu Leu Leu Leu Leu Leu Leu Leu Ala Leu Phe Leu Tyr Ser
1205 1210 1215
Val Pro Gly Tyr Leu Val Lys Lys Ile Leu Gly Ala
1220 1225 1230
<210> 7
<211> 1992
<212> PRT
<213> 小家鼠
<400> 7
Met Ala Leu Ile Val His Leu Lys Thr Val Ser Glu Leu Arg Gly Lys
1 5 10 15
Gly Asp Arg Ile Ala Lys Val Thr Phe Arg Gly Gln Ser Phe Tyr Ser
20 25 30
Arg Val Leu Glu Asn Cys Glu Gly Val Ala Asp Phe Asp Glu Thr Phe
35 40 45
Arg Trp Pro Val Ala Ser Ser Ile Asp Arg Asn Glu Val Leu Glu Ile
50 55 60
Gln Ile Phe Asn Tyr Ser Lys Val Phe Ser Asn Lys Leu Ile Gly Thr
65 70 75 80
Phe Cys Met Val Leu Gln Lys Val Val Glu Glu Asn Arg Val Glu Val
85 90 95
Thr Asp Thr Leu Met Asp Asp Ser Asn Ala Ile Ile Lys Thr Ser Leu
100 105 110
Ser Met Glu Val Arg Tyr Gln Ala Thr Asp Gly Thr Val Gly Pro Trp
115 120 125
Asp Asp Gly Asp Phe Leu Gly Asp Glu Ser Leu Gln Glu Glu Lys Asp
130 135 140
Ser Gln Glu Thr Asp Gly Leu Leu Pro Gly Ser Arg Pro Ser Thr Arg
145 150 155 160
Ile Ser Gly Glu Lys Ser Phe Arg Ser Lys Gly Arg Glu Lys Thr Lys
165 170 175
Gly Gly Arg Asp Gly Glu His Lys Ala Gly Arg Ser Val Phe Ser Ala
180 185 190
Met Lys Leu Gly Lys Thr Arg Ser His Lys Glu Glu Pro Gln Arg Gln
195 200 205
Asp Glu Pro Ala Val Leu Glu Met Glu Asp Leu Asp His Leu Ala Ile
210 215 220
Gln Leu Gly Asp Gly Leu Asp Pro Asp Ser Val Ser Leu Ala Ser Val
225 230 235 240
Thr Ala Leu Thr Ser Asn Val Ser Asn Lys Arg Ser Lys Pro Asp Ile
245 250 255
Lys Met Glu Pro Ser Ala Gly Arg Pro Met Asp Tyr Gln Val Ser Ile
260 265 270
Thr Val Ile Glu Ala Arg Gln Leu Val Gly Leu Asn Met Asp Pro Val
275 280 285
Val Cys Val Glu Val Gly Asp Asp Lys Lys Tyr Thr Ser Met Lys Glu
290 295 300
Ser Thr Asn Cys Pro Tyr Tyr Asn Glu Tyr Phe Val Phe Asp Phe His
305 310 315 320
Val Ser Pro Asp Val Met Phe Asp Lys Ile Ile Lys Ile Ser Val Ile
325 330 335
His Ser Lys Asn Leu Leu Arg Ser Gly Thr Leu Val Gly Ser Phe Lys
340 345 350
Met Asp Val Gly Thr Val Tyr Ser Gln Pro Glu His Gln Phe His His
355 360 365
Lys Trp Ala Ile Leu Ser Asp Pro Asp Asp Ile Ser Ala Gly Leu Lys
370 375 380
Gly Tyr Val Lys Cys Asp Val Ala Val Val Gly Lys Gly Asp Asn Ile
385 390 395 400
Lys Thr Pro His Lys Ala Asn Glu Thr Asp Glu Asp Asp Ile Glu Gly
405 410 415
Asn Leu Leu Leu Pro Glu Gly Val Pro Pro Glu Arg Gln Trp Ala Arg
420 425 430
Phe Tyr Val Lys Ile Tyr Arg Ala Glu Gly Leu Pro Arg Met Asn Thr
435 440 445
Ser Leu Met Ala Asn Val Lys Lys Ala Phe Ile Gly Glu Asn Lys Asp
450 455 460
Leu Val Asp Pro Tyr Val Gln Val Phe Phe Ala Gly Gln Lys Gly Lys
465 470 475 480
Thr Ser Val Gln Lys Ser Ser Tyr Glu Pro Leu Trp Asn Glu Gln Val
485 490 495
Val Phe Thr Asp Leu Phe Pro Pro Leu Cys Lys Arg Met Lys Val Gln
500 505 510
Ile Arg Asp Ser Asp Lys Val Asn Asp Val Ala Ile Gly Thr His Phe
515 520 525
Ile Asp Leu Arg Lys Ile Ser Asn Asp Gly Asp Lys Gly Phe Leu Pro
530 535 540
Thr Leu Gly Pro Ala Trp Val Asn Met Tyr Gly Ser Thr Arg Asn Tyr
545 550 555 560
Thr Leu Leu Asp Glu His Gln Asp Leu Asn Glu Gly Leu Gly Glu Gly
565 570 575
Val Ser Phe Arg Ala Arg Leu Met Leu Gly Leu Ala Val Glu Ile Leu
580 585 590
Asp Thr Ser Asn Pro Glu Leu Thr Ser Ser Thr Glu Val Gln Val Glu
595 600 605
Gln Ala Thr Pro Val Ser Glu Ser Cys Thr Gly Arg Met Glu Glu Phe
610 615 620
Phe Leu Phe Gly Ala Phe Leu Glu Ala Ser Met Ile Asp Arg Lys Asn
625 630 635 640
Gly Asp Lys Pro Ile Thr Phe Glu Val Thr Ile Gly Asn Tyr Gly Asn
645 650 655
Glu Val Asp Gly Met Ser Arg Pro Leu Arg Pro Arg Pro Arg Lys Glu
660 665 670
Pro Gly Asp Glu Glu Glu Val Asp Leu Ile Gln Asn Ser Ser Asp Asp
675 680 685
Glu Gly Asp Glu Ala Gly Asp Leu Ala Ser Val Ser Ser Thr Pro Pro
690 695 700
Met Arg Pro Gln Ile Thr Asp Arg Asn Tyr Phe His Leu Pro Tyr Leu
705 710 715 720
Glu Arg Lys Pro Cys Ile Tyr Ile Lys Ser Trp Trp Pro Asp Gln Arg
725 730 735
Arg Arg Leu Tyr Asn Ala Asn Ile Met Asp His Ile Ala Asp Lys Leu
740 745 750
Glu Glu Gly Leu Asn Asp Val Gln Glu Met Ile Lys Thr Glu Lys Ser
755 760 765
Tyr Pro Glu Arg Arg Leu Arg Gly Val Leu Glu Glu Leu Ser Cys Gly
770 775 780
Cys His Arg Phe Leu Ser Leu Ser Asp Lys Asp Gln Gly Arg Ser Ser
785 790 795 800
Arg Thr Arg Leu Asp Arg Glu Arg Leu Lys Ser Cys Met Arg Glu Leu
805 810 815
Glu Ser Met Gly Gln Gln Ala Lys Ser Leu Arg Ala Gln Val Lys Arg
820 825 830
His Thr Val Arg Asp Lys Leu Arg Ser Cys Gln Asn Phe Leu Gln Lys
835 840 845
Leu Arg Phe Leu Ala Asp Glu Pro Gln His Ser Ile Pro Asp Val Phe
850 855 860
Ile Trp Met Met Ser Asn Asn Lys Arg Ile Ala Tyr Ala Arg Val Pro
865 870 875 880
Ser Lys Asp Leu Leu Phe Ser Ile Val Glu Glu Glu Leu Gly Lys Asp
885 890 895
Cys Ala Lys Val Lys Thr Leu Phe Leu Lys Leu Pro Gly Lys Arg Gly
900 905 910
Phe Gly Ser Ala Gly Trp Thr Val Gln Ala Lys Leu Glu Leu Tyr Leu
915 920 925
Trp Leu Gly Leu Ser Lys Gln Arg Lys Asp Phe Leu Cys Gly Leu Pro
930 935 940
Cys Gly Phe Glu Glu Val Lys Ala Ala Gln Gly Leu Gly Leu His Ser
945 950 955 960
Phe Pro Pro Ile Ser Leu Val Tyr Thr Lys Lys Gln Ala Phe Gln Leu
965 970 975
Arg Ala His Met Tyr Gln Ala Arg Ser Leu Phe Ala Ala Asp Ser Ser
980 985 990
Gly Leu Ser Asp Pro Phe Ala Arg Val Phe Phe Ile Asn Gln Ser Gln
995 1000 1005
Cys Thr Glu Val Leu Asn Glu Thr Leu Cys Pro Thr Trp Asp Gln
1010 1015 1020
Met Leu Val Phe Asp Asn Leu Glu Leu Tyr Gly Glu Ala His Glu
1025 1030 1035
Leu Arg Asp Asp Pro Pro Ile Ile Val Ile Glu Ile Tyr Asp Gln
1040 1045 1050
Asp Ser Met Gly Lys Ala Asp Phe Met Gly Arg Thr Phe Ala Lys
1055 1060 1065
Pro Leu Val Lys Met Ala Asp Glu Ala Tyr Cys Pro Pro Arg Phe
1070 1075 1080
Pro Pro Gln Leu Glu Tyr Tyr Gln Ile Tyr Arg Gly Ser Ala Thr
1085 1090 1095
Ala Gly Asp Leu Leu Ala Ala Phe Glu Leu Leu Gln Ile Gly Pro
1100 1105 1110
Ser Gly Lys Ala Asp Leu Pro Pro Ile Asn Gly Pro Val Asp Met
1115 1120 1125
Asp Arg Gly Pro Ile Met Pro Val Pro Val Gly Ile Arg Pro Val
1130 1135 1140
Leu Ser Lys Tyr Arg Val Glu Val Leu Phe Trp Gly Leu Arg Asp
1145 1150 1155
Leu Lys Arg Val Asn Leu Ala Gln Val Asp Arg Pro Arg Val Asp
1160 1165 1170
Ile Glu Cys Ala Gly Lys Gly Val Gln Ser Ser Leu Ile His Asn
1175 1180 1185
Tyr Lys Lys Asn Pro Asn Phe Asn Thr Leu Val Lys Trp Phe Glu
1190 1195 1200
Val Asp Leu Pro Glu Asn Glu Leu Leu His Pro Pro Leu Asn Ile
1205 1210 1215
Arg Val Val Asp Cys Arg Ala Phe Gly Arg Tyr Thr Leu Val Gly
1220 1225 1230
Ser His Ala Val Ser Ser Leu Arg Arg Phe Ile Tyr Arg Pro Pro
1235 1240 1245
Asp Arg Ser Ala Pro Asn Trp Asn Thr Thr Gly Glu Val Val Val
1250 1255 1260
Ser Met Glu Pro Glu Glu Pro Val Lys Lys Leu Glu Thr Met Val
1265 1270 1275
Lys Leu Asp Ala Thr Ser Asp Ala Val Val Lys Val Asp Val Ala
1280 1285 1290
Glu Asp Glu Lys Glu Arg Lys Lys Lys Lys Lys Lys Gly Pro Ser
1295 1300 1305
Glu Glu Pro Glu Glu Glu Glu Pro Asp Glu Ser Met Leu Asp Trp
1310 1315 1320
Trp Ser Lys Tyr Phe Ala Ser Ile Asp Thr Met Lys Glu Gln Leu
1325 1330 1335
Arg Gln His Glu Thr Ser Gly Thr Asp Leu Glu Glu Lys Glu Glu
1340 1345 1350
Met Glu Ser Ala Glu Gly Leu Lys Gly Pro Met Lys Ser Lys Glu
1355 1360 1365
Lys Ser Arg Ala Ala Lys Glu Glu Lys Lys Lys Lys Asn Gln Ser
1370 1375 1380
Pro Gly Pro Gly Gln Gly Ser Glu Ala Pro Glu Lys Lys Lys Ala
1385 1390 1395
Lys Ile Asp Glu Leu Lys Val Tyr Pro Lys Glu Leu Glu Ser Glu
1400 1405 1410
Phe Asp Ser Phe Glu Asp Trp Leu His Thr Phe Asn Leu Leu Arg
1415 1420 1425
Gly Lys Thr Gly Asp Asp Glu Asp Gly Ser Thr Glu Glu Glu Arg
1430 1435 1440
Ile Val Gly Arg Phe Lys Gly Ser Leu Cys Val Tyr Lys Val Pro
1445 1450 1455
Leu Pro Glu Asp Val Ser Arg Glu Ala Gly Tyr Asp Pro Thr Tyr
1460 1465 1470
Gly Met Phe Gln Gly Ile Pro Ser Asn Asp Pro Ile Asn Val Leu
1475 1480 1485
Val Arg Ile Tyr Val Val Arg Ala Thr Asp Leu His Pro Ala Asp
1490 1495 1500
Ile Asn Gly Lys Ala Asp Pro Tyr Ile Ala Ile Lys Leu Gly Lys
1505 1510 1515
Thr Asp Ile Arg Asp Lys Glu Asn Tyr Ile Ser Lys Gln Leu Asn
1520 1525 1530
Pro Val Phe Gly Lys Ser Phe Asp Ile Glu Ala Ser Phe Pro Met
1535 1540 1545
Glu Ser Met Leu Thr Val Ala Val Tyr Asp Trp Asp Leu Val Gly
1550 1555 1560
Thr Asp Asp Leu Ile Gly Glu Thr Lys Ile Asp Leu Glu Asn Arg
1565 1570 1575
Phe Tyr Ser Lys His Arg Ala Thr Cys Gly Ile Ala Gln Thr Tyr
1580 1585 1590
Ser Ile His Gly Tyr Asn Ile Trp Arg Asp Pro Met Lys Pro Ser
1595 1600 1605
Gln Ile Leu Thr Arg Leu Cys Lys Glu Gly Lys Val Asp Gly Pro
1610 1615 1620
His Phe Gly Pro His Gly Arg Val Arg Val Ala Asn Arg Val Phe
1625 1630 1635
Thr Gly Pro Ser Glu Ile Glu Asp Glu Asn Gly Gln Arg Lys Pro
1640 1645 1650
Thr Asp Glu His Val Ala Leu Ser Ala Leu Arg His Trp Glu Asp
1655 1660 1665
Ile Pro Arg Val Gly Cys Arg Leu Val Pro Glu His Val Glu Thr
1670 1675 1680
Arg Pro Leu Leu Asn Pro Asp Lys Pro Gly Ile Glu Gln Gly Arg
1685 1690 1695
Leu Glu Leu Trp Val Asp Met Phe Pro Met Asp Met Pro Ala Pro
1700 1705 1710
Gly Thr Pro Leu Asp Ile Ser Pro Arg Lys Pro Lys Lys Tyr Glu
1715 1720 1725
Leu Arg Val Ile Val Trp Asn Thr Asp Glu Val Val Leu Glu Asp
1730 1735 1740
Asp Asp Phe Phe Thr Gly Glu Lys Ser Ser Asp Ile Phe Val Arg
1745 1750 1755
Gly Trp Leu Lys Gly Gln Gln Glu Asp Lys Gln Asp Thr Asp Val
1760 1765 1770
His Tyr His Ser Leu Thr Gly Glu Gly Asn Phe Asn Trp Arg Tyr
1775 1780 1785
Leu Phe Pro Phe Asp Tyr Leu Ala Ala Glu Glu Lys Ile Val Met
1790 1795 1800
Ser Lys Lys Glu Ser Met Phe Ser Trp Asp Glu Thr Glu Tyr Lys
1805 1810 1815
Ile Pro Ala Arg Leu Thr Leu Gln Ile Trp Asp Ala Asp His Phe
1820 1825 1830
Ser Ala Asp Asp Phe Leu Gly Ala Ile Glu Leu Asp Leu Asn Arg
1835 1840 1845
Phe Pro Arg Gly Ala Lys Thr Ala Lys Gln Cys Thr Met Glu Met
1850 1855 1860
Ala Thr Gly Glu Val Asp Val Pro Leu Val Ser Ile Phe Lys Gln
1865 1870 1875
Lys Arg Val Lys Gly Trp Trp Pro Leu Leu Ala Arg Asn Glu Asn
1880 1885 1890
Asp Glu Phe Glu Leu Thr Gly Lys Val Glu Ala Glu Leu His Leu
1895 1900 1905
Leu Thr Ala Glu Glu Ala Glu Lys Asn Pro Val Gly Leu Ala Arg
1910 1915 1920
Asn Glu Pro Asp Pro Leu Glu Lys Pro Asn Arg Pro Asp Thr Ala
1925 1930 1935
Phe Val Trp Phe Leu Asn Pro Leu Lys Ser Ile Lys Tyr Leu Ile
1940 1945 1950
Cys Thr Arg Tyr Lys Trp Leu Ile Ile Lys Ile Val Leu Ala Leu
1955 1960 1965
Leu Gly Leu Leu Met Leu Ala Leu Phe Leu Tyr Ser Leu Pro Gly
1970 1975 1980
Tyr Met Val Lys Lys Leu Leu Gly Ala
1985 1990
<210> 8
<211> 650
<212> DNA
<213> 人工序列
<220>
<223> 启动子CMV-β肌动蛋白= SmCBA
<400> 8
ggtaccctag ttattaatag taatcaatta cggggtcatt agttcatagc ccatatatgg 60
agttccgcgt tacataactt acggtaaatg gcccgcctgg ctgaccgccc aacgaccccc 120
gcccattgac gtcaataatg acgtatgttc ccatagtaac gccaataggg actttccatt 180
gacgtcaatg ggtggactat ttacggtaaa ctgcccactt ggcagtacat caagtgtatc 240
atatgccaag tacgccccct attgacgtca atgacggtaa atggcccgcc tggcattatg 300
cccagtacat gaccttatgg gactttccta cttggcagta catctacgta ttagtcatcg 360
ctattaccat ggtcgaggtg agccccacgt tctgcttcac tctccccatc tcccccccct 420
ccccaccccc aattttgtat ttatttattt tttaattatt ttgtgcagcg atgggggcgg 480
gggggggggg ggggcgcgcg ccaggcgggg cggggcgggg cgaggggcgg ggcggggcga 540
ggcggagagg tgcggcggca gccaatcaga gcggcgcgct ccgaaagttt ccttttatgg 600
cgaggcggcg gcggcggcgg ccctataaaa agcgaagcgc gcggcgggcg 650
<210> 9
<211> 287
<212> DNA
<213> 人工序列
<220>
<223> 引起重组的桥接序列
<400> 9
ccccgggtgc gcggcgtcgg tggtgccggc ggggggcgcc aggtcgcagg cggtgtaggg 60
ctccaggcag gcggcgaagg ccatgacgtg cgctatgaag gtctgctcct gcacgccgtg 120
aaccaggtgc gcctgcgggc cgcgcgcgaa caccgccacg tcctcgcctg cgtgggtctc 180
ttcgtccagg ggcactgctg actgctgccg atactcgggg ctcccgctct cgctctcggt 240
aacatccggc cgggcgccgt ccttgagcac atagcctgga ccgtttc 287
<210> 10
<211> 143
<212> DNA
<213> 人工序列
<220>
<223> 来自AAV2的ITR，5'端
<400> 10
ttggccactc cctctctgcg cgctcgctcg ctcactgagg ccgggcgacc aaaggtcgcc 60
cgacgcccgg gctttgcccg ggcggcctca gtgagcgagc gagcgcgcag agagggagtg 120
gccaactcca tcactagggg ttc 143
<210> 11
<211> 143
<212> DNA
<213> 人工序列
<220>
<223> 来自AAV2的ITR，3'端
<400> 11
acccctagtg atggagttgg ccactccctc tctgcgcgct cgctcgctca ctgaggccgc 60
ccgggcaaag cccgggcgtc gggcgacctt tggtcgcccg gcctcagtga gcgagcgagc 120
gcgcagagag ggagtggcca acc 143
<210> 12
<211> 84
<212> DNA
<213> 人工序列
<220>
<223> 碱性磷酸酶的剪接供体位点
<400> 12
gtaagtatca aggttacaag acaggtttaa ggagaccaat agaaactggg cttgtcgaga 60
cagagaagac tcttgcgttt ctga 84
<210> 13
<211> 49
<212> DNA
<213> 人工序列
<220>
<223> 碱性磷酸酶的剪接受体位点
<400> 13
taggcaccta ttggtcttac tgacatccac tttgcctttc tctccacag 49
<210> 14
<211> 20
<212> DNA
<213> 人工序列
<220>
<223> 用于扩增耳畸蛋白cDNA的2676bp中间片段（核苷酸27至2702）的正向引物
<400> 14
tgtctcagag ctccgaggca 20
<210> 15
<211> 22
<212> DNA
<213> 人工序列
<220>
<223> 用于扩增耳畸蛋白cDNA的2676bp中间片段（核苷酸27至2702）的反向引物
<400> 15
atcgtggagg aggaactggg ca 22
<210> 16
<211> 6907
<212> DNA
<213> 小家鼠
<400> 16
ttggttgcct tggtctctgt gggcagcagc aggaggaggc ggcagcagcc agagaagagg 60
gaggcgtgtg agccacactc caccagcgag cttcttcccg ctgctctgga actgcccagg 120
ctctccccac cagcatggcc ctgattgttc acctcaagac tgtctcagag ctccgaggca 180
aaggtgaccg gattgccaaa gtcactttcc gagggcagtc tttctactcc cgggtcctgg 240
agaactgcga gggtgtggct gactttgatg agacgttccg gtggccagtg gccagcagca 300
tcgaccggaa tgaagtgttg gagattcaga ttttcaacta cagcaaagtc ttcagcaaca 360
agctgatagg gaccttctgc atggtgctgc agaaagtggt ggaggagaat cgggtagagg 420
tgaccgacac gctgatggat gacagcaatg ctatcatcaa gaccagcctg agcatggagg 480
tccggtatca ggccacagat ggcactgtgg gcccctggga tgatggagac ttcctgggag 540
atgaatccct ccaggaggag aaggacagcc aggagacaga tgggctgcta cctggttccc 600
gacccagcac ccggatatct ggcgagaaga gctttcgcag caaaggcaga gagaagacca 660
agggaggcag agatggcgag cacaaagcgg gaaggagtgt gttctcggcc atgaaactcg 720
gcaaaactcg gtcccacaaa gaggagcccc aaagacaaga tgagccagca gtgctggaga 780
tggaggacct ggaccaccta gccattcagc tgggggatgg gctggatcct gactccgtgt 840
ctctagcctc ggtcaccgct ctcaccagca atgtctccaa caaacggtct aagccagata 900
ttaagatgga gcccagtgct ggaaggccca tggattacca ggtcagcatc acagtgattg 960
aggctcggca gctggtgggc ttgaacatgg accctgtggt gtgtgtggag gtgggtgatg 1020
acaagaaata cacgtcaatg aaggagtcca caaactgccc ttactacaac gagtactttg 1080
tcttcgactt ccatgtctct cctgatgtca tgtttgacaa gatcatcaag atctcggtta 1140
tccattctaa gaacctgctt cggagcggca ccctggtggg ttccttcaaa atggatgtgg 1200
ggactgtgta ttcccagcct gaacaccagt tccatcacaa atgggccatc ctgtcagacc 1260
ccgatgacat ctctgctggg ttgaagggtt atgtaaagtg tgatgtcgct gtggtgggca 1320
agggagacaa catcaagaca ccccacaagg ccaacgagac ggatgaggac gacattgaag 1380
ggaacttgct gctccccgag ggcgtgcccc ccgaacggca gtgggcacgg ttctatgtga 1440
aaatttaccg agcagaggga ctgccccgga tgaacacaag cctcatggcc aacgtgaaga 1500
aggcgttcat cggtgagaac aaggacctcg tcgaccccta tgtgcaagtc ttctttgctg 1560
gacaaaaggg caaaacatca gtgcagaaga gcagctatga gccgctatgg aatgagcagg 1620
tcgtcttcac agacttgttc cccccactct gcaaacgcat gaaggtgcag atccgggact 1680
ctgacaaggt caatgatgtg gccatcggca cccacttcat cgacctgcgc aagatttcca 1740
acgatggaga caaaggcttc ctgcctaccc tcggtccagc ctgggtgaac atgtacggct 1800
ccacgcgcaa ctacacactg ctggacgagc accaggactt gaatgaaggc ctgggggagg 1860
gtgtgtcctt ccgggcccgc ctcatgttgg gactagctgt ggagatcctg gacacctcca 1920
acccagagct caccagctcc acggaggtgc aggtggagca ggccacgcct gtctcggaga 1980
gctgcacagg gagaatggaa gaattttttc tatttggagc cttcttggaa gcctcaatga 2040
ttgaccggaa aaatggggac aagccaatta cctttgaggt gaccatagga aactacggca 2100
atgaagtcga tggtatgtcc cggcccctga ggcctcggcc ccggaaagag cctggggatg 2160
aagaagaggt agacctgatt cagaactcca gtgacgatga aggtgacgaa gccggggacc 2220
tggcctcggt gtcctccacc ccacctatgc ggccccagat cacggacagg aactatttcc 2280
acctgcccta cctggagcgc aagccctgca tctatatcaa gagctggtgg cctgaccaga 2340
ggcggcgcct ctacaatgcc aacatcatgg atcacattgc tgacaagctg gaagaaggcc 2400
tgaatgatgt acaggagatg atcaaaacgg agaagtccta cccggagcgc cgcctgcggg 2460
gtgtgctaga ggaactcagc tgtggctgcc accgcttcct ctccctctcg gacaaggacc 2520
agggccgctc gtcccgcacc aggctggatc gagagcgtct taagtcctgt atgagggagt 2580
tggagagcat gggacagcag gccaagagcc tgagggctca ggtgaagcgg cacactgttc 2640
gggacaagct gaggtcatgc cagaactttc tgcagaagct acgcttcctg gcggatgagc 2700
cccagcacag cattcctgat gtgttcattt ggatgatgag caacaacaaa cgtatcgcct 2760
atgcccgcgt gccttccaaa gacctgctct tctccatcgt ggaggaggaa ctgggcaagg 2820
actgcgccaa agtcaagacc ctcttcctga agctgccagg gaagaggggc ttcggctcgg 2880
caggctggac agtacaggcc aagctggagc tctacctgtg gctgggcctc agcaagcagc 2940
gaaaggactt cctgtgtggt ctgccctgtg gcttcgagga ggtcaaggca gcccaaggcc 3000
tgggcctgca ttcctttccg cccatcagcc tagtctacac caagaagcaa gccttccagc 3060
tccgagcaca catgtatcag gcccgaagcc tctttgctgc tgacagcagt gggctctctg 3120
atccctttgc ccgtgtcttc ttcatcaacc agagccaatg cactgaggtt ctaaacgaga 3180
cactgtgtcc cacctgggac cagatgctgg tatttgacaa cctggagctg tacggtgaag 3240
ctcacgagtt acgagatgat ccccccatca ttgtcattga aatctacgac caggacagca 3300
tgggcaaagc cgacttcatg ggccggacct tcgccaagcc cctggtgaag atggcagatg 3360
aagcatactg cccacctcgc ttcccgccgc agcttgagta ctaccagatc taccgaggca 3420
gtgccactgc cggagaccta ctggctgcct tcgagctgct gcagattggg ccatcaggga 3480
aggctgacct gccacccatc aatggcccag tggacatgga cagagggccc atcatgcctg 3540
tgcccgtggg aatccggcca gtgctcagca agtaccgagt ggaggtgctg ttctggggcc 3600
tgagggacct aaagagggtg aacctggccc aggtggaccg accacgggtg gacatcgagt 3660
gtgcaggaaa gggggtacaa tcctccctga ttcacaatta taagaagaac cccaacttca 3720
acacgctggt caagtggttt gaagtggacc tcccggagaa tgagctcctg cacccaccct 3780
tgaacatccg agtggtagat tgccgggcct ttggacgata caccctggtg ggttcccacg 3840
cagtcagctc actgaggcgc ttcatctacc gacctccaga ccgctcagcc cccaactgga 3900
acaccacagg ggaggttgta gtaagcatgg agcctgagga gccagttaag aagctggaga 3960
ccatggtgaa actggatgcg acttctgatg ctgtggtcaa ggtggatgtg gctgaagatg 4020
agaaggaaag gaagaagaag aaaaagaaag gcccgtcaga ggagccagag gaggaagagc 4080
ccgatgagag catgctggat tggtggtcca agtacttcgc ctccatcgac acaatgaagg 4140
agcaacttcg acaacatgag acctctggaa ctgacttgga agagaaggaa gagatggaaa 4200
gcgctgaggg cctgaaggga ccaatgaaga gcaaggagaa gtccagagct gcaaaggagg 4260
agaaaaagaa gaaaaaccag agccctggcc ctggccaggg atcggaggct cctgagaaga 4320
agaaagccaa gatcgatgag cttaaggtgt accccaagga gctggaatcg gagtttgaca 4380
gctttgagga ctggctgcac accttcaacc tgttgagggg caagacggga gatgatgagg 4440
atggctccac agaggaggag cgcatagtag gccgattcaa gggctccctc tgtgtgtaca 4500
aagtgccact cccagaagat gtatctcgag aagctggcta tgatcccacc tatggaatgt 4560
tccagggcat cccaagcaat gaccccatca atgtgctggt ccgaatctat gtggtccggg 4620
ccacagacct gcacccggcc gacatcaatg gcaaagctga cccctatatt gccatcaagt 4680
taggcaagac cgacatccga gacaaggaga actacatctc caagcagctc aaccctgtgt 4740
ttgggaagtc ctttgacatt gaggcctcct tccccatgga gtccatgttg acagtggccg 4800
tgtacgactg ggatctggtg ggcactgatg acctcatcgg agaaaccaag attgacctgg 4860
aaaaccgctt ctacagcaag catcgcgcca cctgcggcat cgcacagacc tattccatac 4920
atggctacaa tatctggagg gaccccatga agcccagcca gatcctgaca cgcctctgta 4980
aagagggcaa agtggacggc ccccactttg gtccccatgg gagagtgagg gttgccaacc 5040
gtgtcttcac ggggccttca gaaatagagg atgagaatgg tcagaggaag cccacagatg 5100
agcacgtggc actgtctgct ctgagacact gggaggacat cccccgggtg ggctgccgcc 5160
ttgtgccgga acacgtggag accaggccgc tgctcaaccc tgacaagcca ggcattgagc 5220
agggccgcct ggagctgtgg gtggacatgt tccccatgga catgccagcc cctgggacac 5280
ctctggatat atcccccagg aaacccaaga agtacgagct gcgggtcatc gtgtggaaca 5340
cagacgaggt ggtcctggaa gacgatgatt tcttcacggg agagaagtcc agtgacattt 5400
ttgtgagggg gtggctgaag ggccagcagg aggacaaaca ggacacagat gtccactatc 5460
actccctcac gggggagggc aacttcaact ggagatacct cttccccttc gactacctag 5520
cggccgaaga gaagatcgtt atgtccaaaa aggagtctat gttctcctgg gatgagacgg 5580
agtacaagat ccctgcgcgg ctcaccctgc agatctggga cgctgaccac ttctcggctg 5640
acgacttcct gggggctatc gagctggacc tgaaccggtt cccgaggggc gctaagacag 5700
ccaagcagtg caccatggag atggccaccg gggaggtgga cgtacccctg gtttccatct 5760
ttaaacagaa acgtgtcaaa ggctggtggc ccctcctggc ccgcaatgag aatgatgagt 5820
ttgagctcac aggcaaagtg gaggcggagc tacacctact cacggcagag gaggcagaga 5880
agaaccctgt gggcctggct cgcaatgaac ctgatcccct agaaaaaccc aaccggcctg 5940
acacggcatt cgtctggttc ctgaacccac tcaaatctat caagtacctc atctgcaccc 6000
ggtacaagtg gctgatcatc aagatcgtgc tggcgctgct ggggctgctc atgctggccc 6060
tcttccttta cagcctccca ggctacatgg tcaagaagct cctaggggcc tgaagtgtgc 6120
cccaccccag cccgctccag catccctcca ggggctgctg cgtattttgc cttccctcac 6180
ctggactctc tcccaactcc ctgaggagcc ctcccacgcc tgccagcctt gagcaagaca 6240
cctgcttgct ggacttcatc cccaccccac acccaaactg ttgcttgcct gatcttgtcc 6300
caggcctgcc tggggtttgg ggcacagttg gcctccaaaa ccagataccc tcttgtctaa 6360
agtaccaggt tcctctgccc aaccccaaga gtggtagtgg cccaaccctc cctgtgcttt 6420
ccaaatcttg tcttaaggca ccagtgaaat taaccaagaa acgcggagca atgcccaagg 6480
ctctgatgag taggaacacg tggaaagcac caggaatgcc agcagaggcg aggcggcaca 6540
cctctctgca gagcatccag gccgagcggc gggcagcggc cagctgcttc tgcgcatgct 6600
ctcctcttgg ctctgcttct ttctcacagt cacagtcact tcacagctta gccttgggct 6660
tcccatcact tccaggggtg cctctgcctt ggccagtgtg tgtcagctag tacacaagct 6720
ccaagtgtga atcaggtgta ctggccgtcc tgaagactga ctgccctgtc cttcctgccg 6780
acagccacac ccgagtgtac acttaaagcg gtgcccttct gcctctgtgg gcctgctggc 6840
tgctgttcct ttcttgagtg tgattttttt tttctctccc tcaataaaat aaatcaaact 6900
ctgagac 6907
<210> 17
<211> 7009
<212> DNA
<213> 人工序列
<220>
<223> pTR22-ITR-SmCBA-5'cDNA-otof-SD-RH-ITR
<400> 17
aggggggggg gggggggggt tggccactcc ctctctgcgc gctcgctcgc tcactgaggc 60
cgggcgacca aaggtcgccc gacgcccggg ctttgcccgg gcggcctcag tgagcgagcg 120
agcgcgcaga gagggagtgg ccaactccat cactaggggt tcctcagatc tggcgcgccc 180
aattcggtac cctagttatt aatagtaatc aattacgggg tcattagttc atagcccata 240
tatggagttc cgcgttacat aacttacggt aaatggcccg cctggctgac cgcccaacga 300
cccccgccca ttgacgtcaa taatgacgta tgttcccata gtaacgccaa tagggacttt 360
ccattgacgt caatgggtgg actatttacg gtaaactgcc cacttggcag tacatcaagt 420
gtatcatatg ccaagtacgc cccctattga cgtcaatgac ggtaaatggc ccgcctggca 480
ttatgcccag tacatgacct tatgggactt tcctacttgg cagtacatct acgtattagt 540
catcgctatt accatggtcg aggtgagccc cacgttctgc ttcactctcc ccatctcccc 600
cccctcccca cccccaattt tgtatttatt tattttttaa ttattttgtg cagcgatggg 660
ggcggggggg gggggggggc gcgcgccagg cggggcgggg cggggcgagg ggcggggcgg 720
ggcgaggcgg agaggtgcgg cggcagccaa tcagagcggc gcgctccgaa agtttccttt 780
tatggcgagg cggcggcggc ggcggcccta taaaaagcga agcgcgcggc gggcgggagt 840
cgctgcgacg ctgccttcgc cccgtgcccc gctccgccgc cgcctcgcgc cgcccgcccc 900
ggctctgact gaccgcgtta ctcccacagg tgagcgggcg ggacggccct tctcctccgg 960
gctgtaatta gcgcttggtt taatgacggc ttgtttcttt tctgtggctg cgtgaaagcc 1020
ttgaggggct ccgggagcta gagcctctgc taaccatgtt catgccttct tctttttcct 1080
acagctcctg ggcaacgtgc tggttattgt gctgtctcat cattttggca aagaattcta 1140
gcggccgcca ccatggccct gattgttcac ctcaagactg tctcagagct ccgaggcaaa 1200
ggtgaccgga ttgccaaagt cactttccga gggcagtctt tctactcccg ggtcctggag 1260
aactgcgagg gtgtggctga ctttgatgag acgttccggt ggccagtggc cagcagcatc 1320
gaccggaatg aagtgttgga gattcagatt ttcaactaca gcaaagtctt cagcaacaag 1380
ctgataggga ccttctgcat ggtgctgcag aaagtggtgg aggagaatcg ggtagaggtg 1440
accgacacgc tgatggatga cagcaatgct atcatcaaga ccagcctgag catggaggtc 1500
cggtatcagg ccacagatgg cactgtgggc ccctgggatg atggagactt cctgggagat 1560
gaatccctcc aggaggagaa ggacagccag gagacagatg ggctgctacc tggttcccga 1620
cccagcaccc ggatatctgg cgagaagagc tttcgcagca aaggcagaga gaagaccaag 1680
ggaggcagag atggcgagca caaagcggga aggagtgtgt tctcggccat gaaactcggc 1740
aaaactcggt cccacaaaga ggagccccaa agacaagatg agccagcagt gctggagatg 1800
gaggacctgg accacctagc cattcagctg ggggatgggc tggatcctga ctccgtgtct 1860
ctagcctcgg tcaccgctct caccagcaat gtctccaaca aacggtctaa gccagatatt 1920
aagatggagc ccagtgctgg aaggcccatg gattaccagg tcagcatcac agtgattgag 1980
gctcggcagc tggtgggctt gaacatggac cctgtggtgt gtgtggaggt gggtgatgac 2040
aagaaataca cgtcaatgaa ggagtccaca aactgccctt actacaacga gtactttgtc 2100
ttcgacttcc atgtctctcc tgatgtcatg tttgacaaga tcatcaagat ctcggttatc 2160
cattctaaga acctgcttcg gagcggcacc ctggtgggtt ccttcaaaat ggatgtgggg 2220
actgtgtatt cccagcctga acaccagttc catcacaaat gggccatcct gtcagacccc 2280
gatgacatct ctgctgggtt gaagggttat gtaaagtgtg atgtcgctgt ggtgggcaag 2340
ggagacaaca tcaagacacc ccacaaggcc aacgagacgg atgaggacga cattgaaggg 2400
aacttgctgc tccccgaggg cgtgcccccc gaacggcagt gggcacggtt ctatgtgaaa 2460
atttaccgag cagagggact gccccggatg aacacaagcc tcatggccaa cgtgaagaag 2520
gcgttcatcg gtgagaacaa ggacctcgtc gacccctatg tgcaagtctt ctttgctgga 2580
caaaagggca aaacatcagt gcagaagagc agctatgagc cgctatggaa tgagcaggtc 2640
gtcttcacag acttgttccc cccactctgc aaacgcatga aggtgcagat ccgggactct 2700
gacaaggtca atgatgtggc catcggcacc cacttcatcg acctgcgcaa gatttccaac 2760
gatggagaca aaggcttcct gcctaccctc ggtccagcct gggtgaacat gtacggctcc 2820
acgcgcaact acacactgct ggacgagcac caggacttga atgaaggcct gggggagggt 2880
gtgtccttcc gggcccgcct catgttggga ctagctgtgg agatcctgga cacctccaac 2940
ccagagctca ccagctccac ggaggtgcag gtggagcagg ccacgcctgt ctcggagagc 3000
tgcacaggga gaatggaaga attttttcta tttggagcct tcttggaagc ctcaatgatt 3060
gaccggaaaa atggggacaa gccaattacc tttgaggtga ccataggaaa ctacggcaat 3120
gaagtcgatg gtatgtcccg gcccctgagg cctcggcccc ggaaagagcc tggggatgaa 3180
gaagaggtag acctgattca gaactccagt gacgatgaag gtgacgaagc cggggacctg 3240
gcctcggtgt cctccacccc acctatgcgg ccccagatca cggacaggaa ctatttccac 3300
ctgccctacc tggagcgcaa gccctgcatc tatatcaaga gctggtggcc tgaccagagg 3360
cggcgcctct acaatgccaa catcatggat cacattgctg acaagctgga agaaggcctg 3420
aatgatgtac aggagatgat caaaacggag aagtcctacc cggagcgccg cctgcggggt 3480
gtgctagagg aactcagctg tggctgccac cgcttcctct ccctctcgga caaggaccag 3540
ggccgctcgt cccgcaccag gctggatcga gagcgtctta agtcctgtat gagggagttg 3600
gtaagtatca aggttacaag acaggtttaa ggagaccaat agaaactggg cttgtcgaga 3660
cagagaagac tcttgcgttt ctgagctagc ccccgggtgc gcggcgtcgg tggtgccggc 3720
ggggggcgcc aggtcgcagg cggtgtaggg ctccaggcag gcggcgaagg ccatgacgtg 3780
cgctatgaag gtctgctcct gcacgccgtg aaccaggtgc gcctgcgggc cgcgcgcgaa 3840
caccgccacg tcctcgcctg cgtgggtctc ttcgtccagg ggcactgctg actgctgccg 3900
atactcgggg ctcccgctct cgctctcggt aacatccggc cgggcgccgt ccttgagcac 3960
atagcctgga ccgtttcgtc gactgttaat taagcatgct ggggagagat ctaggaaccc 4020
ctagtgatgg agttggccac tccctctctg cgcgctcgct cgctcactga ggccgcccgg 4080
gcaaagcccg ggcgtcgggc gacctttggt cgcccggcct cagtgagcga gcgagcgcgc 4140
agagagggag tggccaaccc cccccccccc ccccctgcag ccctgcatta atgaatcggc 4200
caacgcgcgg ggagaggcgg tttgcgtatt gggcgctctt ccgcttcctc gctcactgac 4260
tcgctgcgct cggtcgttcg gctgcggcga gcggtatcag ctcactcaaa ggcggtaata 4320
cggttatcca cagaatcagg ggataacgca ggaaagaaca tgtgagcaaa aggccagcaa 4380
aaggccagga accgtaaaaa ggccgcgttg ctggcgtttt tccataggct ccgcccccct 4440
gacgagcatc acaaaaatcg acgctcaagt cagaggtggc gaaacccgac aggactataa 4500
agataccagg cgtttccccc tggaagctcc ctcgtgcgct ctcctgttcc gaccctgccg 4560
cttaccggat acctgtccgc ctttctccct tcgggaagcg tggcgctttc tcaatgctca 4620
cgctgtaggt atctcagttc ggtgtaggtc gttcgctcca agctgggctg tgtgcacgaa 4680
ccccccgttc agcccgaccg ctgcgcctta tccggtaact atcgtcttga gtccaacccg 4740
gtaagacacg acttatcgcc actggcagca gccactggta acaggattag cagagcgagg 4800
tatgtaggcg gtgctacaga gttcttgaag tggtggccta actacggcta cactagaagg 4860
acagtatttg gtatctgcgc tctgctgaag ccagttacct tcggaaaaag agttggtagc 4920
tcttgatccg gcaaacaaac caccgctggt agcggtggtt tttttgtttg caagcagcag 4980
attacgcgca gaaaaaaagg atctcaagaa gatcctttga tcttttctac ggggtctgac 5040
gctcagtgga acgaaaactc acgttaaggg attttggtca tgagattatc aaaaaggatc 5100
ttcacctaga tccttttaaa ttaaaaatga agttttaaat caatctaaag tatatatgag 5160
taaacttggt ctgacagtta ccaatgctta atcagtgagg cacctatctc agcgatctgt 5220
ctatttcgtt catccatagt tgcctgactc cccgtcgtgt agataactac gatacgggag 5280
ggcttaccat ctggccccag tgctgcaatg ataccgcgag acccacgctc accggctcca 5340
gatttatcag caataaacca gccagccgga agggccgagc gcagaagtgg tcctgcaact 5400
ttatccgcct ccatccagtc tattaattgt tgccgggaag ctagagtaag tagttcgcca 5460
gttaatagtt tgcgcaacgt tgttgccatt gctacaggca tcgtggtgtc acgctcgtcg 5520
tttggtatgg cttcattcag ctccggttcc caacgatcaa ggcgagttac atgatccccc 5580
atgttgtgca aaaaagcggt tagctccttc ggtcctccga tcgttgtcag aagtaagttg 5640
gccgcagtgt tatcactcat ggttatggca gcactgcata attctcttac tgtcatgcca 5700
tccgtaagat gcttttctgt gactggtgag tactcaacca agtcattctg agaatagtgt 5760
atgcggcgac cgagttgctc ttgcccggcg tcaatacggg ataataccgc gccacatagc 5820
agaactttaa aagtgctcat cattggaaaa cgttcttcgg ggcgaaaact ctcaaggatc 5880
ttaccgctgt tgagatccag ttcgatgtaa cccactcgtg cacccaactg atcttcagca 5940
tcttttactt tcaccagcgt ttctgggtga gcaaaaacag gaaggcaaaa tgccgcaaaa 6000
aagggaataa gggcgacacg gaaatgttga atactcatac tcttcctttt tcaatattat 6060
tgaagcattt atcagggtta ttgtctcatg agcggataca tatttgaatg tatttagaaa 6120
aataaacaaa taggggttcc gcgcacattt ccccgaaaag tgccacctga cgtctaagaa 6180
accattatta tcatgacatt aacctataaa aataggcgta tcacgaggcc ctttcgtctc 6240
gcgcgtttcg gtgatgacgg tgaaaacctc tgacacatgc agctcccgga gacggtcaca 6300
gcttgtctgt aagcggatgc cgggagcaga caagcccgtc agggcgcgtc agcgggtgtt 6360
ggcgggtgtc ggggctggct taactatgcg gcatcagagc agattgtact gagagtgcac 6420
catatgcggt gtgaaatacc gcacagatgc gtaaggagaa aataccgcat caggaaattg 6480
taaacgttaa tattttgtta aaattcgcgt taaatttttg ttaaatcagc tcatttttta 6540
accaataggc cgaaatcggc aaaatccctt ataaatcaaa agaatagacc gagatagggt 6600
tgagtgttgt tccagtttgg aacaagagtc cactattaaa gaacgtggac tccaacgtca 6660
aagggcgaaa aaccgtctat cagggcgatg gcccactacg tgaaccatca ccctaatcaa 6720
gttttttggg gtcgaggtgc cgtaaagcac taaatcggaa ccctaaaggg agcccccgat 6780
ttagagcttg acggggaaag ccggcgaacg tggcgagaaa ggaagggaag aaagcgaaag 6840
gagcgggcgc tagggcgctg gcaagtgtag cggtcacgct gcgcgtaacc accacacccg 6900
ccgcgcttaa tgcgccgcta cagggcgcgt cgcgccattc gccattcagg ctacgcaact 6960
gttgggaagg gcgatcggtg cgggcctctt cgctattacg ccaggctgc 7009
<210> 18
<211> 7413
<212> DNA
<213> 人工序列
<220>
<223> pTR22-ITR-RH-SA- 3'cDNAerlin-polyA-ITR
<400> 18
aggggggggg gggggggggt tggccactcc ctctctgcgc gctcgctcgc tcactgaggc 60
cgggcgacca aaggtcgccc gacgcccggg ctttgcccgg gcggcctcag tgagcgagcg 120
agcgcgcaga gagggagtgg ccaactccat cactaggggt tcctcagatc tggcgcgccc 180
aattggcttc gaattctagc ggccgccccc gggtgcgcgg cgtcggtggt gccggcgggg 240
ggcgccaggt cgcaggcggt gtagggctcc aggcaggcgg cgaaggccat gacgtgcgct 300
atgaaggtct gctcctgcac gccgtgaacc aggtgcgcct gcgggccgcg cgcgaacacc 360
gccacgtcct cgcctgcgtg ggtctcttcg tccaggggca ctgctgactg ctgccgatac 420
tcggggctcc cgctctcgct ctcggtaaca tccggccggg cgccgtcctt gagcacatag 480
cctggaccgt ttccttaagc gacgcatgct cgcgataggc acctattggt cttactgaca 540
tccactttgc ctttctctcc acaggagagc atgggacagc aggccaagag cctgagggct 600
caggtgaagc ggcacactgt tcgggacaag ctgaggtcat gccagaactt tctgcagaag 660
ctacgcttcc tggcggatga gccccagcac agcattcctg atgtgttcat ttggatgatg 720
agcaacaaca aacgtatcgc ctatgcccgc gtgccttcca aagacctgct cttctccatc 780
gtggaggagg aactgggcaa ggactgcgcc aaagtcaaga ccctcttcct gaagctgcca 840
gggaagaggg gcttcggctc ggcaggctgg acagtacagg ccaagctgga gctctacctg 900
tggctgggcc tcagcaagca gcgaaaggac ttcctgtgtg gtctgccctg tggcttcgag 960
gaggtcaagg cagcccaagg cctgggcctg cattcctttc cgcccatcag cctagtctac 1020
accaagaagc aagccttcca gctccgagca cacatgtatc aggcccgaag cctctttgct 1080
gctgacagca gtgggctctc tgatcccttt gcccgtgtct tcttcatcaa ccagagccaa 1140
tgcactgagg ttctaaacga gacactgtgt cccacctggg accagatgct ggtatttgac 1200
aacctggagc tgtacggtga agctcacgag ttacgagatg atccccccat cattgtcatt 1260
gaaatctacg accaggacag catgggcaaa gccgacttca tgggccggac cttcgccaag 1320
cccctggtga agatggcaga tgaagcatac tgcccacctc gcttcccgcc gcagcttgag 1380
tactaccaga tctaccgagg cagtgccact gccggagacc tactggctgc cttcgagctg 1440
ctgcagattg ggccatcagg gaaggctgac ctgccaccca tcaatggccc agtggacatg 1500
gacagagggc ccatcatgcc tgtgcccgtg ggaatccggc cagtgctcag caagtaccga 1560
gtggaggtgc tgttctgggg cctgagggac ctaaagaggg tgaacctggc ccaggtggac 1620
cgaccacggg tggacatcga gtgtgcagga aagggggtac aatcctccct gattcacaat 1680
tataagaaga accccaactt caacacgctg gtcaagtggt ttgaagtgga cctcccggag 1740
aatgagctcc tgcacccacc cttgaacatc cgagtggtag attgccgggc ctttggacga 1800
tacaccctgg tgggttccca cgcagtcagc tcactgaggc gcttcatcta ccgacctcca 1860
gaccgctcag cccccaactg gaacaccaca ggggaggttg tagtaagcat ggagcctgag 1920
gagccagtta agaagctgga gaccatggtg aaactggatg cgacttctga tgctgtggtc 1980
aaggtggatg tggctgaaga tgagaaggaa aggaagaaga agaaaaagaa aggcccgtca 2040
gaggagccag aggaggaaga gcccgatgag agcatgctgg attggtggtc caagtacttc 2100
gcctccatcg acacaatgaa ggagcaactt cgacaacatg agacctctgg aactgacttg 2160
gaagagaagg aagagatgga aagcgctgag ggcctgaagg gaccaatgaa gagcaaggag 2220
aagtccagag ctgcaaagga ggagaaaaag aagaaaaacc agagccctgg ccctggccag 2280
ggatcggagg ctcctgagaa gaagaaagcc aagatcgatg agcttaaggt gtaccccaag 2340
gagctggaat cggagtttga cagctttgag gactggctgc acaccttcaa cctgttgagg 2400
ggcaagacgg gagatgatga ggatggctcc acagaggagg agcgcatagt aggccgattc 2460
aagggctccc tctgtgtgta caaagtgcca ctcccagaag atgtatctcg agaagctggc 2520
tatgatccca cctatggaat gttccagggc atcccaagca atgaccccat caatgtgctg 2580
gtccgaatct atgtggtccg ggccacagac ctgcacccgg ccgacatcaa tggcaaagct 2640
gacccctata ttgccatcaa gttaggcaag accgacatcc gagacaagga gaactacatc 2700
tccaagcagc tcaaccctgt gtttgggaag tcctttgaca ttgaggcctc cttccccatg 2760
gagtccatgt tgacagtggc cgtgtacgac tgggatctgg tgggcactga tgacctcatc 2820
ggagaaacca agattgacct ggaaaaccgc ttctacagca agcatcgcgc cacctgcggc 2880
atcgcacaga cctattccat acatggctac aatatctgga gggaccccat gaagcccagc 2940
cagatcctga cacgcctctg taaagagggc aaagtggacg gcccccactt tggtccccat 3000
gggagagtga gggttgccaa ccgtgtcttc acggggcctt cagaaataga ggatgagaat 3060
ggtcagagga agcccacaga tgagcacgtg gcactgtctg ctctgagaca ctgggaggac 3120
atcccccggg tgggctgccg ccttgtgccg gaacacgtgg agaccaggcc gctgctcaac 3180
cctgacaagc caggcattga gcagggccgc ctggagctgt gggtggacat gttccccatg 3240
gacatgccag cccctgggac acctctggat atatccccca ggaaacccaa gaagtacgag 3300
ctgcgggtca tcgtgtggaa cacagacgag gtggtcctgg aagacgatga tttcttcacg 3360
ggagagaagt ccagtgacat ttttgtgagg gggtggctga agggccagca ggaggacaaa 3420
caggacacag atgtccacta tcactccctc acgggggagg gcaacttcaa ctggagatac 3480
ctcttcccct tcgactacct agcggccgaa gagaagatcg ttatgtccaa aaaggagtct 3540
atgttctcct gggatgagac ggagtacaag atccctgcgc ggctcaccct gcagatctgg 3600
gacgctgacc acttctcggc tgacgacttc ctgggggcta tcgagctgga cctgaaccgg 3660
ttcccgaggg gcgctaagac agccaagcag tgcaccatgg agatggccac cggggaggtg 3720
gacgtacccc tggtttccat ctttaaacag aaacgtgtca aaggctggtg gcccctcctg 3780
gcccgcaatg agaatgatga gtttgagctc acaggcaaag tggaggcgga gctacaccta 3840
ctcacggcag aggaggcaga gaagaaccct gtgggcctgg ctcgcaatga acctgatccc 3900
ctagaaaaac ccaaccggcc tgacacggca ttcgtctggt tcctgaaccc actcaaatct 3960
atcaagtacc tcatctgcac ccggtacaag tggctgatca tcaagatcgt gctggcgctg 4020
ctggggctgc tcatgctggc cctcttcctt tacagcctcc caggctacat ggtcaagaag 4080
ctcctagggg cctgagcggc cgcggtacca agggcgaatt ctgcagtcga ctagagctcg 4140
ctgatcagcc tcgactgtgc cttctagttg ccagccatct gttgtttgcc cctcccccgt 4200
gccttccttg accctggaag gtgccactcc cactgtcctt tcctaataaa atgaggaaat 4260
tgcatcgcat tgtctgagta ggtgtcattc tattctgggg ggtggggtgg ggcaggacag 4320
caagggggag gattgggaag acaatagcag gcatgctggg gagagatctg aggactagtc 4380
cgtcgactgt taattaagca tgctggggag agatctagga acccctagtg atggagttgg 4440
ccactccctc tctgcgcgct cgctcgctca ctgaggccgc ccgggcaaag cccgggcgtc 4500
gggcgacctt tggtcgcccg gcctcagtga gcgagcgagc gcgcagagag ggagtggcca 4560
accccccccc ccccccccct gcagccctgc attaatgaat cggccaacgc gcggggagag 4620
gcggtttgcg tattgggcgc tcttccgctt cctcgctcac tgactcgctg cgctcggtcg 4680
ttcggctgcg gcgagcggta tcagctcact caaaggcggt aatacggtta tccacagaat 4740
caggggataa cgcaggaaag aacatgtgag caaaaggcca gcaaaaggcc aggaaccgta 4800
aaaaggccgc gttgctggcg tttttccata ggctccgccc ccctgacgag catcacaaaa 4860
atcgacgctc aagtcagagg tggcgaaacc cgacaggact ataaagatac caggcgtttc 4920
cccctggaag ctccctcgtg cgctctcctg ttccgaccct gccgcttacc ggatacctgt 4980
ccgcctttct cccttcggga agcgtggcgc tttctcaatg ctcacgctgt aggtatctca 5040
gttcggtgta ggtcgttcgc tccaagctgg gctgtgtgca cgaacccccc gttcagcccg 5100
accgctgcgc cttatccggt aactatcgtc ttgagtccaa cccggtaaga cacgacttat 5160
cgccactggc agcagccact ggtaacagga ttagcagagc gaggtatgta ggcggtgcta 5220
cagagttctt gaagtggtgg cctaactacg gctacactag aaggacagta tttggtatct 5280
gcgctctgct gaagccagtt accttcggaa aaagagttgg tagctcttga tccggcaaac 5340
aaaccaccgc tggtagcggt ggtttttttg tttgcaagca gcagattacg cgcagaaaaa 5400
aaggatctca agaagatcct ttgatctttt ctacggggtc tgacgctcag tggaacgaaa 5460
actcacgtta agggattttg gtcatgagat tatcaaaaag gatcttcacc tagatccttt 5520
taaattaaaa atgaagtttt aaatcaatct aaagtatata tgagtaaact tggtctgaca 5580
gttaccaatg cttaatcagt gaggcaccta tctcagcgat ctgtctattt cgttcatcca 5640
tagttgcctg actccccgtc gtgtagataa ctacgatacg ggagggctta ccatctggcc 5700
ccagtgctgc aatgataccg cgagacccac gctcaccggc tccagattta tcagcaataa 5760
accagccagc cggaagggcc gagcgcagaa gtggtcctgc aactttatcc gcctccatcc 5820
agtctattaa ttgttgccgg gaagctagag taagtagttc gccagttaat agtttgcgca 5880
acgttgttgc cattgctaca ggcatcgtgg tgtcacgctc gtcgtttggt atggcttcat 5940
tcagctccgg ttcccaacga tcaaggcgag ttacatgatc ccccatgttg tgcaaaaaag 6000
cggttagctc cttcggtcct ccgatcgttg tcagaagtaa gttggccgca gtgttatcac 6060
tcatggttat ggcagcactg cataattctc ttactgtcat gccatccgta agatgctttt 6120
ctgtgactgg tgagtactca accaagtcat tctgagaata gtgtatgcgg cgaccgagtt 6180
gctcttgccc ggcgtcaata cgggataata ccgcgccaca tagcagaact ttaaaagtgc 6240
tcatcattgg aaaacgttct tcggggcgaa aactctcaag gatcttaccg ctgttgagat 6300
ccagttcgat gtaacccact cgtgcaccca actgatcttc agcatctttt actttcacca 6360
gcgtttctgg gtgagcaaaa acaggaaggc aaaatgccgc aaaaaaggga ataagggcga 6420
cacggaaatg ttgaatactc atactcttcc tttttcaata ttattgaagc atttatcagg 6480
gttattgtct catgagcgga tacatatttg aatgtattta gaaaaataaa caaatagggg 6540
ttccgcgcac atttccccga aaagtgccac ctgacgtcta agaaaccatt attatcatga 6600
cattaaccta taaaaatagg cgtatcacga ggccctttcg tctcgcgcgt ttcggtgatg 6660
acggtgaaaa cctctgacac atgcagctcc cggagacggt cacagcttgt ctgtaagcgg 6720
atgccgggag cagacaagcc cgtcagggcg cgtcagcggg tgttggcggg tgtcggggct 6780
ggcttaacta tgcggcatca gagcagattg tactgagagt gcaccatatg cggtgtgaaa 6840
taccgcacag atgcgtaagg agaaaatacc gcatcaggaa attgtaaacg ttaatatttt 6900
gttaaaattc gcgttaaatt tttgttaaat cagctcattt tttaaccaat aggccgaaat 6960
cggcaaaatc ccttataaat caaaagaata gaccgagata gggttgagtg ttgttccagt 7020
ttggaacaag agtccactat taaagaacgt ggactccaac gtcaaagggc gaaaaaccgt 7080
ctatcagggc gatggcccac tacgtgaacc atcaccctaa tcaagttttt tggggtcgag 7140
gtgccgtaaa gcactaaatc ggaaccctaa agggagcccc cgatttagag cttgacgggg 7200
aaagccggcg aacgtggcga gaaaggaagg gaagaaagcg aaaggagcgg gcgctagggc 7260
gctggcaagt gtagcggtca cgctgcgcgt aaccaccaca cccgccgcgc ttaatgcgcc 7320
gctacagggc gcgtcgcgcc attcgccatt caggctacgc aactgttggg aagggcgatc 7380
ggtgcgggcc tcttcgctat tacgccaggc tgc 7413
<210> 19
<211> 6967
<212> DNA
<213> 人工序列
<220>
<223> pTR22-SmCBA-耳畸蛋白NT-SD-RH-ITR
<400> 19
aggggggggg gggggggggt tggccactcc ctctctgcgc gctcgctcgc tcactgaggc 60
cgggcgacca aaggtcgccc gacgcccggg ctttgcccgg gcggcctcag tgagcgagcg 120
agcgcgcaga gagggagtgg ccaactccat cactaggggt tcctcagatc tggcgcgccc 180
aattcggtac cctagttatt aatagtaatc aattacgggg tcattagttc atagcccata 240
tatggagttc cgcgttacat aacttacggt aaatggcccg cctggctgac cgcccaacga 300
cccccgccca ttgacgtcaa taatgacgta tgttcccata gtaacgccaa tagggacttt 360
ccattgacgt caatgggtgg actatttacg gtaaactgcc cacttggcag tacatcaagt 420
gtatcatatg ccaagtacgc cccctattga cgtcaatgac ggtaaatggc ccgcctggca 480
ttatgcccag tacatgacct tatgggactt tcctacttgg cagtacatct acgtattagt 540
catcgctatt accatggtcg aggtgagccc cacgttctgc ttcactctcc ccatctcccc 600
cccctcccca cccccaattt tgtatttatt tattttttaa ttattttgtg cagcgatggg 660
ggcggggggg gggggggggc gcgcgccagg cggggcgggg cggggcgagg ggcggggcgg 720
ggcgaggcgg agaggtgcgg cggcagccaa tcagagcggc gcgctccgaa agtttccttt 780
tatggcgagg cggcggcggc ggcggcccta taaaaagcga agcgcgcggc gggcgggagt 840
cgctgcgacg ctgccttcgc cccgtgcccc gctccgccgc cgcctcgcgc cgcccgcccc 900
ggctctgact gaccgcgtta ctcccacagg tgagcgggcg ggacggccct tctcctccgg 960
gctgtaatta gcgcttggtt taatgacggc ttgtttcttt tctgtggctg cgtgaaagcc 1020
ttgaggggct ccgggagcta gagcctctgc taaccatgtt catgccttct tctttttcct 1080
acagctcctg ggcaacgtgc tggttattgt gctgtctcat cattttggca aagaattcta 1140
gcggccgcca ccatggcctt gctcatccac ctcaagacag tctcggagct gcggggcagg 1200
ggcgaccgga tcgccaaagt gactttccga gggcaatcct tctactctcg ggtcctggag 1260
aactgtgagg atgtggctga ctttgatgag acatttcggt ggccggtggc cagcagcatc 1320
gacagaaatg agatgctgga gattcaggtt ttcaactaca gcaaagtctt cagcaacaag 1380
ctcatcggga ccttccgcat ggtgctgcag aaggtggtag aggagagcca tgtggaggtg 1440
actgacacgc tgattgatga caacaatgct atcatcaaga ccagcctgtg cgtggaggtc 1500
cggtatcagg ccactgacgg cacagtgggc tcctgggacg atggggactt cctgggagat 1560
gagtctcttc aagaggaaga gaaggacagc caagagacgg atggactgct cccaggctcc 1620
cggcccagct cccggccccc aggagagaag agcttccgga gagccgggag gagcgtgttc 1680
tccgccatga agctcggcaa aaaccggtct cacaaggagg agccccaaag accagatgaa 1740
ccggcggtgc tggagatgga agaccttgac catctggcca ttcggctagg agatggactg 1800
gatcccgact cggtgtctct agcctcagtc acagctctca ccactaatgt ctccaacaag 1860
cgatctaagc cagacattaa gatggagcca agtgctgggc ggcccatgga ttaccaggtc 1920
agcatcacgg tgatcgaggc ccggcagctg gtgggcttga acatggaccc tgtggtgtgc 1980
gtggaggtgg gtgacgacaa gaagtacaca tccatgaagg agtccactaa ctgcccctat 2040
tacaacgagt acttcgtctt cgacttccat gtctctccgg atgtcatgtt tgacaagatc 2100
atcaagattt cggtgattca ctccaagaac ctgctgcgca gtggcaccct ggtgggctcc 2160
ttcaaaatgg acgtgggaac cgtgtactcg cagccagagc accagttcca tcacaagtgg 2220
gccatcctgt ctgaccccga tgacatctcc tcggggctga agggctacgt gaagtgtgac 2280
gttgccgtgg tgggcaaagg ggacaacatc aagacgcccc acaaggccaa tgagaccgac 2340
gaagatgaca ttgaggggaa cttgctgctc cccgaggggg tgccccccga acgccagtgg 2400
gcccggttct atgtgaaaat ttaccgagca gaggggctgc cccgtatgaa cacaagcctc 2460
atggccaatg taaagaaggc tttcatcggt gaaaacaagg acctcgtgga cccctacgtg 2520
caagtcttct ttgctggcca gaagggcaag acttcagtgc agaagagcag ctatgagccc 2580
ctgtggaatg agcaggtcgt ctttacagac ctcttccccc cactctgcaa acgcatgaag 2640
gtgcagatcc gagactcgga caaggtcaac gacgtggcca tcggcaccca cttcattgac 2700
ctgcgcaaga tttctaatga cggagacaaa ggcttcctgc ccacactggg cccagcctgg 2760
gtgaacatgt acggctccac acgtaactac acgctgctgg atgagcatca ggacctgaac 2820
gagggcctgg gggagggtgt gtccttccgg gcccggctcc tgctgggcct ggctgtggag 2880
atcgtagaca cctccaaccc tgagctcacc agctccacag aggtgcaggt ggagcaggcc 2940
acgcccatct cggagagctg tgcaggtaaa atggaagaat tctttctctt tggagccttc 3000
ctggaggcct caatgatcga ccggagaaac ggagacaagc ccatcacctt tgaggtcacc 3060
ataggcaact atgggaacga agttgatggc ctgtcccggc cccagcggcc tcggccccgg 3120
aaggagccgg gggatgagga agaagtagac ctgattcaga acgcaagtga tgacgaggcc 3180
ggtgatgccg gggacctggc ctcagtctcc tccactccac caatgcggcc ccaggtcacc 3240
gacaggaact acttccatct gccctacctg gagcgaaagc cctgcatcta catcaagagc 3300
tggtggccgg accagcgccg ccgcctctac aatgccaaca tcatggacca cattgccgac 3360
aagctggaag aaggcctgaa cgacatacag gagatgatca aaacggagaa gtcctaccct 3420
gagcgtcgcc tgcggggcgt cctggaggag ctgagctgtg gctgctgccg cttcctctcc 3480
ctcgctgaca aggaccaggg ccactcatcc cgcaccaggc ttgaccggga gcgcctcaag 3540
tcctgcatga gggagctggt aagtatcaag gttacaagac aggtttaagg agaccaatag 3600
aaactgggct tgtcgagaca gagaagactc ttgcgtttct gagctagccc ccgggtgcgc 3660
ggcgtcggtg gtgccggcgg ggggcgccag gtcgcaggcg gtgtagggct ccaggcaggc 3720
ggcgaaggcc atgacgtgcg ctatgaaggt ctgctcctgc acgccgtgaa ccaggtgcgc 3780
ctgcgggccg cgcgcgaaca ccgccacgtc ctcgcctgcg tgggtctctt cgtccagggg 3840
cactgctgac tgctgccgat actcggggct cccgctctcg ctctcggtaa catccggccg 3900
ggcgccgtcc ttgagcacat agcctggacc gtttcgtcga ctgttaatta agcatgctgg 3960
ggagagatct aggaacccct agtgatggag ttggccactc cctctctgcg cgctcgctcg 4020
ctcactgagg ccgcccgggc aaagcccggg cgtcgggcga cctttggtcg cccggcctca 4080
gtgagcgagc gagcgcgcag agagggagtg gccaaccccc cccccccccc ccctgcagcc 4140
ctgcattaat gaatcggcca acgcgcgggg agaggcggtt tgcgtattgg gcgctcttcc 4200
gcttcctcgc tcactgactc gctgcgctcg gtcgttcggc tgcggcgagc ggtatcagct 4260
cactcaaagg cggtaatacg gttatccaca gaatcagggg ataacgcagg aaagaacatg 4320
tgagcaaaag gccagcaaaa ggccaggaac cgtaaaaagg ccgcgttgct ggcgtttttc 4380
cataggctcc gcccccctga cgagcatcac aaaaatcgac gctcaagtca gaggtggcga 4440
aacccgacag gactataaag ataccaggcg tttccccctg gaagctccct cgtgcgctct 4500
cctgttccga ccctgccgct taccggatac ctgtccgcct ttctcccttc gggaagcgtg 4560
gcgctttctc aatgctcacg ctgtaggtat ctcagttcgg tgtaggtcgt tcgctccaag 4620
ctgggctgtg tgcacgaacc ccccgttcag cccgaccgct gcgccttatc cggtaactat 4680
cgtcttgagt ccaacccggt aagacacgac ttatcgccac tggcagcagc cactggtaac 4740
aggattagca gagcgaggta tgtaggcggt gctacagagt tcttgaagtg gtggcctaac 4800
tacggctaca ctagaaggac agtatttggt atctgcgctc tgctgaagcc agttaccttc 4860
ggaaaaagag ttggtagctc ttgatccggc aaacaaacca ccgctggtag cggtggtttt 4920
tttgtttgca agcagcagat tacgcgcaga aaaaaaggat ctcaagaaga tcctttgatc 4980
ttttctacgg ggtctgacgc tcagtggaac gaaaactcac gttaagggat tttggtcatg 5040
agattatcaa aaaggatctt cacctagatc cttttaaatt aaaaatgaag ttttaaatca 5100
atctaaagta tatatgagta aacttggtct gacagttacc aatgcttaat cagtgaggca 5160
cctatctcag cgatctgtct atttcgttca tccatagttg cctgactccc cgtcgtgtag 5220
ataactacga tacgggaggg cttaccatct ggccccagtg ctgcaatgat accgcgagac 5280
ccacgctcac cggctccaga tttatcagca ataaaccagc cagccggaag ggccgagcgc 5340
agaagtggtc ctgcaacttt atccgcctcc atccagtcta ttaattgttg ccgggaagct 5400
agagtaagta gttcgccagt taatagtttg cgcaacgttg ttgccattgc tacaggcatc 5460
gtggtgtcac gctcgtcgtt tggtatggct tcattcagct ccggttccca acgatcaagg 5520
cgagttacat gatcccccat gttgtgcaaa aaagcggtta gctccttcgg tcctccgatc 5580
gttgtcagaa gtaagttggc cgcagtgtta tcactcatgg ttatggcagc actgcataat 5640
tctcttactg tcatgccatc cgtaagatgc ttttctgtga ctggtgagta ctcaaccaag 5700
tcattctgag aatagtgtat gcggcgaccg agttgctctt gcccggcgtc aatacgggat 5760
aataccgcgc cacatagcag aactttaaaa gtgctcatca ttggaaaacg ttcttcgggg 5820
cgaaaactct caaggatctt accgctgttg agatccagtt cgatgtaacc cactcgtgca 5880
cccaactgat cttcagcatc ttttactttc accagcgttt ctgggtgagc aaaaacagga 5940
aggcaaaatg ccgcaaaaaa gggaataagg gcgacacgga aatgttgaat actcatactc 6000
ttcctttttc aatattattg aagcatttat cagggttatt gtctcatgag cggatacata 6060
tttgaatgta tttagaaaaa taaacaaata ggggttccgc gcacatttcc ccgaaaagtg 6120
ccacctgacg tctaagaaac cattattatc atgacattaa cctataaaaa taggcgtatc 6180
acgaggccct ttcgtctcgc gcgtttcggt gatgacggtg aaaacctctg acacatgcag 6240
ctcccggaga cggtcacagc ttgtctgtaa gcggatgccg ggagcagaca agcccgtcag 6300
ggcgcgtcag cgggtgttgg cgggtgtcgg ggctggctta actatgcggc atcagagcag 6360
attgtactga gagtgcacca tatgcggtgt gaaataccgc acagatgcgt aaggagaaaa 6420
taccgcatca ggaaattgta aacgttaata ttttgttaaa attcgcgtta aatttttgtt 6480
aaatcagctc attttttaac caataggccg aaatcggcaa aatcccttat aaatcaaaag 6540
aatagaccga gatagggttg agtgttgttc cagtttggaa caagagtcca ctattaaaga 6600
acgtggactc caacgtcaaa gggcgaaaaa ccgtctatca gggcgatggc ccactacgtg 6660
aaccatcacc ctaatcaagt tttttggggt cgaggtgccg taaagcacta aatcggaacc 6720
ctaaagggag cccccgattt agagcttgac ggggaaagcc ggcgaacgtg gcgagaaagg 6780
aagggaagaa agcgaaagga gcgggcgcta gggcgctggc aagtgtagcg gtcacgctgc 6840
gcgtaaccac cacacccgcc gcgcttaatg cgccgctaca gggcgcgtcg cgccattcgc 6900
cattcaggct acgcaactgt tgggaagggc gatcggtgcg ggcctcttcg ctattacgcc 6960
aggctgc 6967
<210> 20
<211> 7470
<212> DNA
<213> 人工序列
<220>
<223> pTR22-ITR-RH-SA-耳畸蛋白CT-polyA-ITR
<400> 20
aggggggggg gggggggggt tggccactcc ctctctgcgc gctcgctcgc tcactgaggc 60
cgggcgacca aaggtcgccc gacgcccggg ctttgcccgg gcggcctcag tgagcgagcg 120
agcgcgcaga gagggagtgg ccaactccat cactaggggt tcctcagatc tggcgcgccc 180
aattggcttc gaattctagc ggccgccccc gggtgcgcgg cgtcggtggt gccggcgggg 240
ggcgccaggt cgcaggcggt gtagggctcc aggcaggcgg cgaaggccat gacgtgcgct 300
atgaaggtct gctcctgcac gccgtgaacc aggtgcgcct gcgggccgcg cgcgaacacc 360
gccacgtcct cgcctgcgtg ggtctcttcg tccaggggca ctgctgactg ctgccgatac 420
tcggggctcc cgctctcgct ctcggtaaca tccggccggg cgccgtcctt gagcacatag 480
cctggaccgt ttccttaagc gacgcatgct cgcgataggc acctattggt cttactgaca 540
tccactttgc ctttctctcc acaggaaaac atggggcagc aggccaggat gctgcgggcc 600
caggtgaagc ggcacacggt gcgggacaag ctgaggctgt gccagaactt cctgcagaag 660
ctgcgcttcc tggcggacga gccccagcac agcattcccg acatcttcat ctggatgatg 720
agcaacaaca agcgtgtcgc ctatgcccgt gtgccctcca aggacctgct cttctccatc 780
gtggaggagg agactggcaa ggactgcgcc aaggtcaaga cgctcttcct taagctgcca 840
gggaagcggg gcttcggctc ggcaggctgg acagtgcagg ccaaggtgga gctgtacctg 900
tggctgggcc tcagcaaaca gcgcaaggag ttcctgtgcg gcctgccctg tggcttccag 960
gaggtcaagg cagcccaggg cctgggcctg catgccttcc cacccgtcag cctggtctac 1020
accaagaagc aggcgttcca gctccgagcg cacatgtacc aggcccgcag cctctttgcc 1080
gccgacagca gcggactctc agaccccttt gcccgcgtct tcttcatcaa tcagagtcag 1140
tgcacagagg tgctgaatga gaccctgtgt cccacctggg accagatgct ggtgttcgac 1200
aacctggagc tctatggtga agctcatgag ctgagggacg atccgcccat cattgtcatt 1260
gaaatctatg accaggattc catgggcaaa gctgacttca tgggccggac cttcgccaaa 1320
cccctggtga agatggcaga cgaggcgtac tgcccacccc gcttcccacc tcagctcgag 1380
tactaccaga tctaccgtgg caacgccaca gctggagacc tgctggcggc cttcgagctg 1440
ctgcagattg gaccagcagg gaaggctgac ctgcccccca tcaatggccc ggtggacgtg 1500
gaccgaggtc ccatcatgcc cgtgcccatg ggcatccggc ccgtgctcag caagtaccga 1560
gtggaggtgc tgttctgggg cctacgggac ctaaagcggg tgaacctggc ccaggtggac 1620
cggccacggg tggacatcga gtgtgcaggg aagggggtgc agtcgtccct gatccacaat 1680
tataagaaga accccaactt caacaccctc gtcaagtggt ttgaagtgga cctcccagag 1740
aacgagctgc tgcacccgcc cttgaacatc cgtgtggtgg actgccgggc cttcggtcgc 1800
tacacactgg tgggctccca tgccgtcagc tccctgcgac gcttcatcta ccggccccca 1860
gaccgctcgg cccccagctg gaacaccacg gtcaggcttc tccggcgctg ccgtgtgctg 1920
tgcaatgggg gctcctcctc tcactccaca ggggaggttg tggtgactat ggagccagag 1980
gtacccatca agaaactgga gaccatggtg aagctggacg cgacttctga agctgttgtc 2040
aaggtggatg tggctgagga ggagaaggag aagaagaaga agaagaaggg cactgcggag 2100
gagccagagg aggaggagcc agacgagagc atgctggact ggtggtccaa gtactttgcc 2160
tccattgaca ccatgaagga gcaacttcga caacaagagc cctctggaat tgacttggag 2220
gagaaggagg aagtggacaa taccgagggc ctgaaggggt caatgaaggg caaggagaag 2280
gcaagggctg ccaaagagga gaagaagaag aaaactcaga gctctggctc tggccagggg 2340
tccgaggccc ccgagaagaa gaaacccaag attgatgagc ttaaggtata ccccaaagag 2400
ctggagtccg agtttgataa ctttgaggac tggctgcaca ctttcaactt gcttcggggc 2460
aagaccgggg atgatgagga tggctccacc gaggaggagc gcattgtggg acgcttcaag 2520
ggctccctct gcgtgtacaa agtgccactc ccagaggacg tgtcccggga agccggctac 2580
gactccacct acggcatgtt ccagggcatc ccgagcaatg accccatcaa tgtgctggtc 2640
cgagtctatg tggtccgggc cacggacctg caccctgctg acatcaacgg caaagctgac 2700
ccctacatcg ccatccggct aggcaagact gacatccgcg acaaggagaa ctacatctcc 2760
aagcagctca accctgtctt tgggaagtcc tttgacatcg aggcctcctt ccccatggaa 2820
tccatgctga cggtggctgt gtatgactgg gacctggtgg gcactgatga cctcattggg 2880
gaaaccaaga tcgacctgga gaaccgcttc tacagcaagc accgcgccac ctgcggcatc 2940
gcccagacct actccacaca tggctacaat atctggcggg accccatgaa gcccagccag 3000
atcctgaccc gcctctgcaa agacggcaaa gtggacggcc cccactttgg gccccctggg 3060
agagtgaagg tggccaaccg cgtcttcact gggccctctg agattgagga cgagaacggt 3120
cagaggaagc ccacagacga gcatgtggcg ctgttggccc tgaggcactg ggaggacatc 3180
ccccgcgcag gctgccgcct ggtgccagag catgtggaga cgaggccgct gctcaacccc 3240
gacaagccgg gcatcgagca gggccgcctg gagctgtggg tggacatgtt ccccatggac 3300
atgccagccc ctgggacgcc tctggacatc tcacctcgga agcccaagaa gtacgagctg 3360
cgggtcatca tctggaacac agatgaggtg gtcttggagg acgacgactt cttcacaggg 3420
gagaagtcca gtgacatctt cgtgaggggg tggctgaagg gccagcagga ggacaagcag 3480
gacacagacg tccactacca ctccctcact ggcgagggca acttcaactg gcgctacctg 3540
ttccccttcg actacctggc ggcggaggag aagatcgtca tctccaagaa ggagtccatg 3600
ttctcctggg acgagaccga gtacaagatc cccgcgcggc tcaccctgca gatctgggat 3660
gcggaccact tctccgctga cgacttcctg ggggccatcg agctggacct gaaccggttc 3720
ccgcggggcg caaagacagc caagcagtgc accatggaga tggccaccgg ggaggtggac 3780
gtgcccctcg tgtccatctt caagcaaaag cgcgtcaaag gctggtggcc cctcctggcc 3840
cgcaatgaga acgatgagtt tgagctcacg ggcaaggtgg aggctgagct gcatttactg 3900
acagcagagg aggcagagaa gaacccagtg ggcctggccc gcaatgaacc tgacccccta 3960
gagaaaccca accggcccga cacgagcttc atctggttcc tgaaccctct caagtcggct 4020
cgctacttct tgtggcacac gtatcgctgg ctgctcctca aactgttgct gctcctgctg 4080
ctgctcctcc tcctcgccct gttcctctac tctgtgcctg gctacctggt caagaaaatc 4140
ctcggggcct gagcggccgc ggtaccaagg gcgaattctg cagtcgacta gagctcgctg 4200
atcagcctcg actgtgcctt ctagttgcca gccatctgtt gtttgcccct cccccgtgcc 4260
ttccttgacc ctggaaggtg ccactcccac tgtcctttcc taataaaatg aggaaattgc 4320
atcgcattgt ctgagtaggt gtcattctat tctggggggt ggggtggggc aggacagcaa 4380
gggggaggat tgggaagaca atagcaggca tgctggggag agatctgagg actagtccgt 4440
cgactgttaa ttaagcatgc tggggagaga tctaggaacc cctagtgatg gagttggcca 4500
ctccctctct gcgcgctcgc tcgctcactg aggccgcccg ggcaaagccc gggcgtcggg 4560
cgacctttgg tcgcccggcc tcagtgagcg agcgagcgcg cagagaggga gtggccaacc 4620
cccccccccc cccccctgca gccctgcatt aatgaatcgg ccaacgcgcg gggagaggcg 4680
gtttgcgtat tgggcgctct tccgcttcct cgctcactga ctcgctgcgc tcggtcgttc 4740
ggctgcggcg agcggtatca gctcactcaa aggcggtaat acggttatcc acagaatcag 4800
gggataacgc aggaaagaac atgtgagcaa aaggccagca aaaggccagg aaccgtaaaa 4860
aggccgcgtt gctggcgttt ttccataggc tccgcccccc tgacgagcat cacaaaaatc 4920
gacgctcaag tcagaggtgg cgaaacccga caggactata aagataccag gcgtttcccc 4980
ctggaagctc cctcgtgcgc tctcctgttc cgaccctgcc gcttaccgga tacctgtccg 5040
cctttctccc ttcgggaagc gtggcgcttt ctcaatgctc acgctgtagg tatctcagtt 5100
cggtgtaggt cgttcgctcc aagctgggct gtgtgcacga accccccgtt cagcccgacc 5160
gctgcgcctt atccggtaac tatcgtcttg agtccaaccc ggtaagacac gacttatcgc 5220
cactggcagc agccactggt aacaggatta gcagagcgag gtatgtaggc ggtgctacag 5280
agttcttgaa gtggtggcct aactacggct acactagaag gacagtattt ggtatctgcg 5340
ctctgctgaa gccagttacc ttcggaaaaa gagttggtag ctcttgatcc ggcaaacaaa 5400
ccaccgctgg tagcggtggt ttttttgttt gcaagcagca gattacgcgc agaaaaaaag 5460
gatctcaaga agatcctttg atcttttcta cggggtctga cgctcagtgg aacgaaaact 5520
cacgttaagg gattttggtc atgagattat caaaaaggat cttcacctag atccttttaa 5580
attaaaaatg aagttttaaa tcaatctaaa gtatatatga gtaaacttgg tctgacagtt 5640
accaatgctt aatcagtgag gcacctatct cagcgatctg tctatttcgt tcatccatag 5700
ttgcctgact ccccgtcgtg tagataacta cgatacggga gggcttacca tctggcccca 5760
gtgctgcaat gataccgcga gacccacgct caccggctcc agatttatca gcaataaacc 5820
agccagccgg aagggccgag cgcagaagtg gtcctgcaac tttatccgcc tccatccagt 5880
ctattaattg ttgccgggaa gctagagtaa gtagttcgcc agttaatagt ttgcgcaacg 5940
ttgttgccat tgctacaggc atcgtggtgt cacgctcgtc gtttggtatg gcttcattca 6000
gctccggttc ccaacgatca aggcgagtta catgatcccc catgttgtgc aaaaaagcgg 6060
ttagctcctt cggtcctccg atcgttgtca gaagtaagtt ggccgcagtg ttatcactca 6120
tggttatggc agcactgcat aattctctta ctgtcatgcc atccgtaaga tgcttttctg 6180
tgactggtga gtactcaacc aagtcattct gagaatagtg tatgcggcga ccgagttgct 6240
cttgcccggc gtcaatacgg gataataccg cgccacatag cagaacttta aaagtgctca 6300
tcattggaaa acgttcttcg gggcgaaaac tctcaaggat cttaccgctg ttgagatcca 6360
gttcgatgta acccactcgt gcacccaact gatcttcagc atcttttact ttcaccagcg 6420
tttctgggtg agcaaaaaca ggaaggcaaa atgccgcaaa aaagggaata agggcgacac 6480
ggaaatgttg aatactcata ctcttccttt ttcaatatta ttgaagcatt tatcagggtt 6540
attgtctcat gagcggatac atatttgaat gtatttagaa aaataaacaa ataggggttc 6600
cgcgcacatt tccccgaaaa gtgccacctg acgtctaaga aaccattatt atcatgacat 6660
taacctataa aaataggcgt atcacgaggc cctttcgtct cgcgcgtttc ggtgatgacg 6720
gtgaaaacct ctgacacatg cagctcccgg agacggtcac agcttgtctg taagcggatg 6780
ccgggagcag acaagcccgt cagggcgcgt cagcgggtgt tggcgggtgt cggggctggc 6840
ttaactatgc ggcatcagag cagattgtac tgagagtgca ccatatgcgg tgtgaaatac 6900
cgcacagatg cgtaaggaga aaataccgca tcaggaaatt gtaaacgtta atattttgtt 6960
aaaattcgcg ttaaattttt gttaaatcag ctcatttttt aaccaatagg ccgaaatcgg 7020
caaaatccct tataaatcaa aagaatagac cgagataggg ttgagtgttg ttccagtttg 7080
gaacaagagt ccactattaa agaacgtgga ctccaacgtc aaagggcgaa aaaccgtcta 7140
tcagggcgat ggcccactac gtgaaccatc accctaatca agttttttgg ggtcgaggtg 7200
ccgtaaagca ctaaatcgga accctaaagg gagcccccga tttagagctt gacggggaaa 7260
gccggcgaac gtggcgagaa aggaagggaa gaaagcgaaa ggagcgggcg ctagggcgct 7320
ggcaagtgta gcggtcacgc tgcgcgtaac caccacaccc gccgcgctta atgcgccgct 7380
acagggcgcg tcgcgccatt cgccattcag gctacgcaac tgttgggaag ggcgatcggt 7440
gcgggcctct tcgctattac gccaggctgc 7470
<210> 21
<211> 7470
<212> DNA
<213> 人工序列
<220>
<223> pTR22-ITR-RH-SA-耳畸蛋白CT-polyA-ITR
<400> 21
aggggggggg gggggggggt tggccactcc ctctctgcgc gctcgctcgc tcactgaggc 60
cgggcgacca aaggtcgccc gacgcccggg ctttgcccgg gcggcctcag tgagcgagcg 120
agcgcgcaga gagggagtgg ccaactccat cactaggggt tcctcagatc tggcgcgccc 180
aattggcttc gaattctagc ggccgccccc gggtgcgcgg cgtcggtggt gccggcgggg 240
ggcgccaggt cgcaggcggt gtagggctcc aggcaggcgg cgaaggccat gacgtgcgct 300
atgaaggtct gctcctgcac gccgtgaacc aggtgcgcct gcgggccgcg cgcgaacacc 360
gccacgtcct cgcctgcgtg ggtctcttcg tccaggggca ctgctgactg ctgccgatac 420
tcggggctcc cgctctcgct ctcggtaaca tccggccggg cgccgtcctt gagcacatag 480
cctggaccgt ttccttaagc gacgcatgct cgcgataggc acctattggt cttactgaca 540
tccactttgc ctttctctcc acaggaaaac atggggcagc aggccaggat gctgcgggcc 600
caggtgaagc ggcacacggt gcgggacaag ctgaggctgt gccagaactt cctgcagaag 660
ctgcgcttcc tggcggacga gccccagcac agcattcccg acatcttcat ctggatgatg 720
agcaacaaca agcgtgtcgc ctatgcccgt gtgccctcca aggacctgct cttctccatc 780
gtggaggagg agactggcaa ggactgcgcc aaggtcaaga cgctcttcct taagctgcca 840
gggaagcggg gcttcggctc ggcaggctgg acagtgcagg ccaaggtgga gctgtacctg 900
tggctgggcc tcagcaaaca gcgcaaggag ttcctgtgcg gcctgccctg tggcttccag 960
gaggtcaagg cagcccaggg cctgggcctg catgccttcc cacccgtcag cctggtctac 1020
accaagaagc aggcgttcca gctccgagcg cacatgtacc aggcccgcag cctctttgcc 1080
gccgacagca gcggactctc agaccccttt gcccgcgtct tcttcatcaa tcagagtcag 1140
tgcacagagg tgctgaatga gaccctgtgt cccacctggg accagatgct ggtgttcgac 1200
aacctggagc tctatggtga agctcatgag ctgagggacg atccgcccat cattgtcatt 1260
gaaatctatg accaggattc catgggcaaa gctgacttca tgggccggac cttcgccaaa 1320
cccctggtga agatggcaga cgaggcgtac tgcccacccc gcttcccacc tcagctcgag 1380
tactaccaga tctaccgtgg caacgccaca gctggagacc tgctggcggc cttcgagctg 1440
ctgcagattg gaccagcagg gaaggctgac ctgcccccca tcaatggccc ggtggacgtg 1500
gaccgaggtc ccatcatgcc cgtgcccatg ggcatccggc ccgtgctcag caagtaccga 1560
gtggaggtgc tgttctgggg cctacgggac ctaaagcggg tgaacctggc ccaggtggac 1620
cggccacggg tggacatcga gtgtgcaggg aagggggtgc agtcgtccct gatccacaat 1680
tataagaaga accccaactt caacaccctc gtcaagtggt ttgaagtgga cctcccagag 1740
aacgagctgc tgcacccgcc cttgaacatc cgtgtggtgg actgccgggc cttcggtcgc 1800
tacacactgg tgggctccca tgccgtcagc tccctgcgac gcttcatcta ccggccccca 1860
gaccgctcgg cccccagctg gaacaccacg gtcaggcttc tccggcgctg ccgtgtgctg 1920
tgcaatgggg gctcctcctc tcactccaca ggggaggttg tggtgactat ggagccagag 1980
gtacccatca agaaactgga gaccatggtg aagctggacg cgacttctga agctgttgtc 2040
aaggtggatg tggctgagga ggagaaggag aagaagaaga agaagaaggg cactgcggag 2100
gagccagagg aggaggagcc agacgagagc atgctggact ggtggtccaa gtactttgcc 2160
tccattgaca ccatgaagga gcaacttcga caacaagagc cctctggaat tgacttggag 2220
gagaaggagg aagtggacaa taccgagggc ctgaaggggt caatgaaggg caaggagaag 2280
gcaagggctg ccaaagagga gaagaagaag aaaactcaga gctctggctc tggccagggg 2340
tccgaggccc ccgagaagaa gaaacccaag attgatgagc ttaaggtata ccccaaagag 2400
ctggagtccg agtttgataa ctttgaggac tggctgcaca ctttcaactt gcttcggggc 2460
aagaccgggg atgatgagga tggctccacc gaggaggagc gcattgtggg acgcttcaag 2520
ggctccctct gcgtgtacaa agtgccactc ccagaggacg tgtcccggga agccggctac 2580
gactccacct acggcatgtt ccagggcatc ccgagcaatg accccatcaa tgtgctggtc 2640
cgagtctatg tggtccgggc cacggacctg caccctgctg acatcaacgg caaagctgac 2700
ccctacatcg ccatccggct aggcaagact gacatccgcg acaaggagaa ctacatctcc 2760
aagcagctca accctgtctt tgggaagtcc tttgacatcg aggcctcctt ccccatggaa 2820
tccatgctga cggtggctgt gtatgactgg gacctggtgg gcactgatga cctcattggg 2880
gaaaccaaga tcgacctgga gaaccgcttc tacagcaagc accgcgccac ctgcggcatc 2940
gcccagacct actccacaca tggctacaat atctggcggg accccatgaa gcccagccag 3000
atcctgaccc gcctctgcaa agacggcaaa gtggacggcc cccactttgg gccccctggg 3060
agagtgaagg tggccaaccg cgtcttcact gggccctctg agattgagga cgagaacggt 3120
cagaggaagc ccacagacga gcatgtggcg ctgttggccc tgaggcactg ggaggacatc 3180
ccccgcgcag gctgccgcct ggtgccagag catgtggaga cgaggccgct gctcaacccc 3240
gacaagccgg gcatcgagca gggccgcctg gagctgtggg tggacatgtt ccccatggac 3300
atgccagccc ctgggacgcc tctggacatc tcacctcgga agcccaagaa gtacgagctg 3360
cgggtcatca tctggaacac agatgaggtg gtcttggagg acgacgactt cttcacaggg 3420
gagaagtcca gtgacatctt cgtgaggggg tggctgaagg gccagcagga ggacaagcag 3480
gacacagacg tccactacca ctccctcact ggcgagggca acttcaactg gcgctacctg 3540
ttccccttcg actacctggc ggcggaggag aagatcgtca tctccaagaa ggagtccatg 3600
ttctcctggg acgagaccga gtacaagatc cccgcgcggc tcaccctgca gatctgggat 3660
gcggaccact tctccgctga cgacttcctg ggggccatcg agctggacct gaaccggttc 3720
ccgcggggcg caaagacagc caagcagtgc accatggaga tggccaccgg ggaggtggac 3780
gtgcccctcg tgtccatctt caagcaaaag cgcgtcaaag gctggtggcc cctcctggcc 3840
cgcaatgaga acgatgagtt tgagctcacg ggcaaggtgg aggctgagct gcatttactg 3900
acagcagagg aggcagagaa gaacccagtg ggcctggccc gcaatgaacc tgacccccta 3960
gagaaaccca accggcccga cacggccttc gtctggttcc tcaaccctct caagtccatc 4020
aagtacctca tctgcacccg gtacaagtgg ctcatcatca agatcgtgct ggcgctgttg 4080
gggctgctca tgttggggct cttcctctac agcctccctg gctacatggt caaaaagctc 4140
cttggggcat gagcggccgc ggtaccaagg gcgaattctg cagtcgacta gagctcgctg 4200
atcagcctcg actgtgcctt ctagttgcca gccatctgtt gtttgcccct cccccgtgcc 4260
ttccttgacc ctggaaggtg ccactcccac tgtcctttcc taataaaatg aggaaattgc 4320
atcgcattgt ctgagtaggt gtcattctat tctggggggt ggggtggggc aggacagcaa 4380
gggggaggat tgggaagaca atagcaggca tgctggggag agatctgagg actagtccgt 4440
cgactgttaa ttaagcatgc tggggagaga tctaggaacc cctagtgatg gagttggcca 4500
ctccctctct gcgcgctcgc tcgctcactg aggccgcccg ggcaaagccc gggcgtcggg 4560
cgacctttgg tcgcccggcc tcagtgagcg agcgagcgcg cagagaggga gtggccaacc 4620
cccccccccc cccccctgca gccctgcatt aatgaatcgg ccaacgcgcg gggagaggcg 4680
gtttgcgtat tgggcgctct tccgcttcct cgctcactga ctcgctgcgc tcggtcgttc 4740
ggctgcggcg agcggtatca gctcactcaa aggcggtaat acggttatcc acagaatcag 4800
gggataacgc aggaaagaac atgtgagcaa aaggccagca aaaggccagg aaccgtaaaa 4860
aggccgcgtt gctggcgttt ttccataggc tccgcccccc tgacgagcat cacaaaaatc 4920
gacgctcaag tcagaggtgg cgaaacccga caggactata aagataccag gcgtttcccc 4980
ctggaagctc cctcgtgcgc tctcctgttc cgaccctgcc gcttaccgga tacctgtccg 5040
cctttctccc ttcgggaagc gtggcgcttt ctcaatgctc acgctgtagg tatctcagtt 5100
cggtgtaggt cgttcgctcc aagctgggct gtgtgcacga accccccgtt cagcccgacc 5160
gctgcgcctt atccggtaac tatcgtcttg agtccaaccc ggtaagacac gacttatcgc 5220
cactggcagc agccactggt aacaggatta gcagagcgag gtatgtaggc ggtgctacag 5280
agttcttgaa gtggtggcct aactacggct acactagaag gacagtattt ggtatctgcg 5340
ctctgctgaa gccagttacc ttcggaaaaa gagttggtag ctcttgatcc ggcaaacaaa 5400
ccaccgctgg tagcggtggt ttttttgttt gcaagcagca gattacgcgc agaaaaaaag 5460
gatctcaaga agatcctttg atcttttcta cggggtctga cgctcagtgg aacgaaaact 5520
cacgttaagg gattttggtc atgagattat caaaaaggat cttcacctag atccttttaa 5580
attaaaaatg aagttttaaa tcaatctaaa gtatatatga gtaaacttgg tctgacagtt 5640
accaatgctt aatcagtgag gcacctatct cagcgatctg tctatttcgt tcatccatag 5700
ttgcctgact ccccgtcgtg tagataacta cgatacggga gggcttacca tctggcccca 5760
gtgctgcaat gataccgcga gacccacgct caccggctcc agatttatca gcaataaacc 5820
agccagccgg aagggccgag cgcagaagtg gtcctgcaac tttatccgcc tccatccagt 5880
ctattaattg ttgccgggaa gctagagtaa gtagttcgcc agttaatagt ttgcgcaacg 5940
ttgttgccat tgctacaggc atcgtggtgt cacgctcgtc gtttggtatg gcttcattca 6000
gctccggttc ccaacgatca aggcgagtta catgatcccc catgttgtgc aaaaaagcgg 6060
ttagctcctt cggtcctccg atcgttgtca gaagtaagtt ggccgcagtg ttatcactca 6120
tggttatggc agcactgcat aattctctta ctgtcatgcc atccgtaaga tgcttttctg 6180
tgactggtga gtactcaacc aagtcattct gagaatagtg tatgcggcga ccgagttgct 6240
cttgcccggc gtcaatacgg gataataccg cgccacatag cagaacttta aaagtgctca 6300
tcattggaaa acgttcttcg gggcgaaaac tctcaaggat cttaccgctg ttgagatcca 6360
gttcgatgta acccactcgt gcacccaact gatcttcagc atcttttact ttcaccagcg 6420
tttctgggtg agcaaaaaca ggaaggcaaa atgccgcaaa aaagggaata agggcgacac 6480
ggaaatgttg aatactcata ctcttccttt ttcaatatta ttgaagcatt tatcagggtt 6540
attgtctcat gagcggatac atatttgaat gtatttagaa aaataaacaa ataggggttc 6600
cgcgcacatt tccccgaaaa gtgccacctg acgtctaaga aaccattatt atcatgacat 6660
taacctataa aaataggcgt atcacgaggc cctttcgtct cgcgcgtttc ggtgatgacg 6720
gtgaaaacct ctgacacatg cagctcccgg agacggtcac agcttgtctg taagcggatg 6780
ccgggagcag acaagcccgt cagggcgcgt cagcgggtgt tggcgggtgt cggggctggc 6840
ttaactatgc ggcatcagag cagattgtac tgagagtgca ccatatgcgg tgtgaaatac 6900
cgcacagatg cgtaaggaga aaataccgca tcaggaaatt gtaaacgtta atattttgtt 6960
aaaattcgcg ttaaattttt gttaaatcag ctcatttttt aaccaatagg ccgaaatcgg 7020
caaaatccct tataaatcaa aagaatagac cgagataggg ttgagtgttg ttccagtttg 7080
gaacaagagt ccactattaa agaacgtgga ctccaacgtc aaagggcgaa aaaccgtcta 7140
tcagggcgat ggcccactac gtgaaccatc accctaatca agttttttgg ggtcgaggtg 7200
ccgtaaagca ctaaatcgga accctaaagg gagcccccga tttagagctt gacggggaaa 7260
gccggcgaac gtggcgagaa aggaagggaa gaaagcgaaa ggagcgggcg ctagggcgct 7320
ggcaagtgta gcggtcacgc tgcgcgtaac caccacaccc gccgcgctta atgcgccgct 7380
acagggcgcg tcgcgccatt cgccattcag gctacgcaac tgttgggaag ggcgatcggt 7440
gcgggcctct tcgctattac gccaggctgc 7470
<210> 22
<211> 6973
<212> DNA
<213> 智人
<400> 22
atcggagggg ggtcgggagg aggaggagga ggcagcggca gagaagagag aggcgtgtga 60
gccgtgctcc accggctagc tccttcccgc tgctcctgcc tggcagtgcc aggcagccca 120
caccagcatg gccttgctca tccacctcaa gacagtctcg gagctgcggg gcaggggcga 180
ccggatcgcc aaagtgactt tccgagggca atccttctac tctcgggtcc tggagaactg 240
tgaggatgtg gctgactttg atgagacatt tcggtggccg gtggccagca gcatcgacag 300
aaatgagatg ctggagattc aggttttcaa ctacagcaaa gtcttcagca acaagctcat 360
cgggaccttc cgcatggtgc tgcagaaggt ggtagaggag agccatgtgg aggtgactga 420
cacgctgatt gatgacaaca atgctatcat caagaccagc ctgtgcgtgg aggtccggta 480
tcaggccact gacggcacag tgggctcctg ggacgatggg gacttcctgg gagatgagtc 540
tcttcaagag gaagagaagg acagccaaga gacggatgga ctgctcccag gctcccggcc 600
cagctcccgg cccccaggag agaagagctt ccggagagcc gggaggagcg tgttctccgc 660
catgaagctc ggcaaaaacc ggtctcacaa ggaggagccc caaagaccag atgaaccggc 720
ggtgctggag atggaagacc ttgaccatct ggccattcgg ctaggagatg gactggatcc 780
cgactcggtg tctctagcct cagtcacagc tctcaccact aatgtctcca acaagcgatc 840
taagccagac attaagatgg agccaagtgc tgggcggccc atggattacc aggtcagcat 900
cacggtgatc gaggcccggc agctggtggg cttgaacatg gaccctgtgg tgtgcgtgga 960
ggtgggtgac gacaagaagt acacatccat gaaggagtcc actaactgcc cctattacaa 1020
cgagtacttc gtcttcgact tccatgtctc tccggatgtc atgtttgaca agatcatcaa 1080
gatttcggtg attcactcca agaacctgct gcgcagtggc accctggtgg gctccttcaa 1140
aatggacgtg ggaaccgtgt actcgcagcc agagcaccag ttccatcaca agtgggccat 1200
cctgtctgac cccgatgaca tctcctcggg gctgaagggc tacgtgaagt gtgacgttgc 1260
cgtggtgggc aaaggggaca acatcaagac gccccacaag gccaatgaga ccgacgaaga 1320
tgacattgag gggaacttgc tgctccccga gggggtgccc cccgaacgcc agtgggcccg 1380
gttctatgtg aaaatttacc gagcagaggg gctgccccgt atgaacacaa gcctcatggc 1440
caatgtaaag aaggctttca tcggtgaaaa caaggacctc gtggacccct acgtgcaagt 1500
cttctttgct ggccagaagg gcaagacttc agtgcagaag agcagctatg agcccctgtg 1560
gaatgagcag gtcgtcttta cagacctctt ccccccactc tgcaaacgca tgaaggtgca 1620
gatccgagac tcggacaagg tcaacgacgt ggccatcggc acccacttca ttgacctgcg 1680
caagatttct aatgacggag acaaaggctt cctgcccaca ctgggcccag cctgggtgaa 1740
catgtacggc tccacacgta actacacgct gctggatgag catcaggacc tgaacgaggg 1800
cctgggggag ggtgtgtcct tccgggcccg gctcctgctg ggcctggctg tggagatcgt 1860
agacacctcc aaccctgagc tcaccagctc cacagaggtg caggtggagc aggccacgcc 1920
catctcggag agctgtgcag gtaaaatgga agaattcttt ctctttggag ccttcctgga 1980
ggcctcaatg atcgaccgga gaaacggaga caagcccatc acctttgagg tcaccatagg 2040
caactatggg aacgaagttg atggcctgtc ccggccccag cggcctcggc cccggaagga 2100
gccgggggat gaggaagaag tagacctgat tcagaacgca agtgatgacg aggccggtga 2160
tgccggggac ctggcctcag tctcctccac tccaccaatg cggccccagg tcaccgacag 2220
gaactacttc catctgccct acctggagcg aaagccctgc atctacatca agagctggtg 2280
gccggaccag cgccgccgcc tctacaatgc caacatcatg gaccacattg ccgacaagct 2340
ggaagaaggc ctgaacgaca tacaggagat gatcaaaacg gagaagtcct accctgagcg 2400
tcgcctgcgg ggcgtcctgg aggagctgag ctgtggctgc tgccgcttcc tctccctcgc 2460
tgacaaggac cagggccact catcccgcac caggcttgac cgggagcgcc tcaagtcctg 2520
catgagggag ctggaaaaca tggggcagca ggccaggatg ctgcgggccc aggtgaagcg 2580
gcacacggtg cgggacaagc tgaggctgtg ccagaacttc ctgcagaagc tgcgcttcct 2640
ggcggacgag ccccagcaca gcattcccga catcttcatc tggatgatga gcaacaacaa 2700
gcgtgtcgcc tatgcccgtg tgccctccaa ggacctgctc ttctccatcg tggaggagga 2760
gactggcaag gactgcgcca aggtcaagac gctcttcctt aagctgccag ggaagcgggg 2820
cttcggctcg gcaggctgga cagtgcaggc caaggtggag ctgtacctgt ggctgggcct 2880
cagcaaacag cgcaaggagt tcctgtgcgg cctgccctgt ggcttccagg aggtcaaggc 2940
agcccagggc ctgggcctgc atgccttccc acccgtcagc ctggtctaca ccaagaagca 3000
ggcgttccag ctccgagcgc acatgtacca ggcccgcagc ctctttgccg ccgacagcag 3060
cggactctca gacccctttg cccgcgtctt cttcatcaat cagagtcagt gcacagaggt 3120
gctgaatgag accctgtgtc ccacctggga ccagatgctg gtgttcgaca acctggagct 3180
ctatggtgaa gctcatgagc tgagggacga tccgcccatc attgtcattg aaatctatga 3240
ccaggattcc atgggcaaag ctgacttcat gggccggacc ttcgccaaac ccctggtgaa 3300
gatggcagac gaggcgtact gcccaccccg cttcccacct cagctcgagt actaccagat 3360
ctaccgtggc aacgccacag ctggagacct gctggcggcc ttcgagctgc tgcagattgg 3420
accagcaggg aaggctgacc tgccccccat caatggcccg gtggacgtgg accgaggtcc 3480
catcatgccc gtgcccatgg gcatccggcc cgtgctcagc aagtaccgag tggaggtgct 3540
gttctggggc ctacgggacc taaagcgggt gaacctggcc caggtggacc ggccacgggt 3600
ggacatcgag tgtgcaggga agggggtgca gtcgtccctg atccacaatt ataagaagaa 3660
ccccaacttc aacaccctcg tcaagtggtt tgaagtggac ctcccagaga acgagctgct 3720
gcacccgccc ttgaacatcc gtgtggtgga ctgccgggcc ttcggtcgct acacactggt 3780
gggctcccat gccgtcagct ccctgcgacg cttcatctac cggcccccag accgctcggc 3840
ccccagctgg aacaccacgg tcaggcttct ccggcgctgc cgtgtgctgt gcaatggggg 3900
ctcctcctct cactccacag gggaggttgt ggtgactatg gagccagagg tacccatcaa 3960
gaaactggag accatggtga agctggacgc gacttctgaa gctgttgtca aggtggatgt 4020
ggctgaggag gagaaggaga agaagaagaa gaagaagggc actgcggagg agccagagga 4080
ggaggagcca gacgagagca tgctggactg gtggtccaag tactttgcct ccattgacac 4140
catgaaggag caacttcgac aacaagagcc ctctggaatt gacttggagg agaaggagga 4200
agtggacaat accgagggcc tgaaggggtc aatgaagggc aaggagaagg caagggctgc 4260
caaagaggag aagaagaaga aaactcagag ctctggctct ggccaggggt ccgaggcccc 4320
cgagaagaag aaacccaaga ttgatgagct taaggtatac cccaaagagc tggagtccga 4380
gtttgataac tttgaggact ggctgcacac tttcaacttg cttcggggca agaccgggga 4440
tgatgaggat ggctccaccg aggaggagcg cattgtggga cgcttcaagg gctccctctg 4500
cgtgtacaaa gtgccactcc cagaggacgt gtcccgggaa gccggctacg actccaccta 4560
cggcatgttc cagggcatcc cgagcaatga ccccatcaat gtgctggtcc gagtctatgt 4620
ggtccgggcc acggacctgc accctgctga catcaacggc aaagctgacc cctacatcgc 4680
catccggcta ggcaagactg acatccgcga caaggagaac tacatctcca agcagctcaa 4740
ccctgtcttt gggaagtcct ttgacatcga ggcctccttc cccatggaat ccatgctgac 4800
ggtggctgtg tatgactggg acctggtggg cactgatgac ctcattgggg aaaccaagat 4860
cgacctggag aaccgcttct acagcaagca ccgcgccacc tgcggcatcg cccagaccta 4920
ctccacacat ggctacaata tctggcggga ccccatgaag cccagccaga tcctgacccg 4980
cctctgcaaa gacggcaaag tggacggccc ccactttggg ccccctggga gagtgaaggt 5040
ggccaaccgc gtcttcactg ggccctctga gattgaggac gagaacggtc agaggaagcc 5100
cacagacgag catgtggcgc tgttggccct gaggcactgg gaggacatcc cccgcgcagg 5160
ctgccgcctg gtgccagagc atgtggagac gaggccgctg ctcaaccccg acaagccggg 5220
catcgagcag ggccgcctgg agctgtgggt ggacatgttc cccatggaca tgccagcccc 5280
tgggacgcct ctggacatct cacctcggaa gcccaagaag tacgagctgc gggtcatcat 5340
ctggaacaca gatgaggtgg tcttggagga cgacgacttc ttcacagggg agaagtccag 5400
tgacatcttc gtgagggggt ggctgaaggg ccagcaggag gacaagcagg acacagacgt 5460
ccactaccac tccctcactg gcgagggcaa cttcaactgg cgctacctgt tccccttcga 5520
ctacctggcg gcggaggaga agatcgtcat ctccaagaag gagtccatgt tctcctggga 5580
cgagaccgag tacaagatcc ccgcgcggct caccctgcag atctgggatg cggaccactt 5640
ctccgctgac gacttcctgg gggccatcga gctggacctg aaccggttcc cgcggggcgc 5700
aaagacagcc aagcagtgca ccatggagat ggccaccggg gaggtggacg tgcccctcgt 5760
gtccatcttc aagcaaaagc gcgtcaaagg ctggtggccc ctcctggccc gcaatgagaa 5820
cgatgagttt gagctcacgg gcaaggtgga ggctgagctg catttactga cagcagagga 5880
ggcagagaag aacccagtgg gcctggcccg caatgaacct gaccccctag agaaacccaa 5940
ccggcccgac acggccttcg tctggttcct caaccctctc aagtccatca agtacctcat 6000
ctgcacccgg tacaagtggc tcatcatcaa gatcgtgctg gcgctgttgg ggctgctcat 6060
gttggggctc ttcctctaca gcctccctgg ctacatggtc aaaaagctcc ttggggcatg 6120
aaggccgcca gctcccgcca gccgctcccc agccctgccg catttccttt cagtggcttg 6180
gactctttcc catctcccct ggggagcctg aggagcccag cgtccactct tcatgccttg 6240
ggccgagcct gcctcctgct tgcgggggcc gcctgtcctc actgccccag gctgcggctt 6300
gcccagtccc gcccctctga cccctgcctg tgggctgggg agccttggat ggggtgggga 6360
cctggaatgg gtctctcttg ccccacctgg ctgaggcgcc acccttcttc aggcccaggc 6420
tccagaggaa gactcctgaa accctcccca ggtcttccaa gtacaggatt gaagctttag 6480
tgaaattaac caaggaccat gggtcagtgc ccagggcttt aaaaagaatg aacgagcaaa 6540
aggtatcccc gccgtgaccc ctgcagatag caccggtctt tgatccgcag caggggccag 6600
accctgccca caagtcccag cgcggctgct tctgccactg ctgggctcca cttggctcct 6660
ctcacttccc agggggtcgc ctgtcctgcc tgtgggtttc catggcttcc cagagctccc 6720
tctgccccag ccagcgcctc caggcccagc tgaggagctg tgagaagcag cagaggggac 6780
tccccatccc gggcacaccc tgtcctccca cccctgcccc cttgcccttc cagccctttc 6840
agctgcagct gggagctggc ccgtcaagtg ctgcccctgc ctgtgtctgg gtttctgttg 6900
gctgtttttc ttttcttgag tggtgatttt tctctaaata aaagaagtca agcactgaaa 6960
aaaaaaaaaa aaa 6973
<210> 23
<211> 3318
<212> DNA
<213> 智人
<400> 23
ctgccaggga agcggggctt cggctcggca ggctggacag tgcaggccaa ggtggagctg 60
tacctgtggc tgggcctcag caaacagcgc aaggagttcc tgtgcggcct gccctgtggc 120
ttccaggagg tcaaggcagc ccagggcctg ggcctgcatg ccttcccacc cgtcagcctg 180
gtctacacca agaagcaggc gttccagctc cgagcgcaca tgtaccaggc ccgcagcctc 240
tttgccgccg acagcagcgg actctcagac ccctttgccc gcgtcttctt catcaatcag 300
agtcagtgca cagaggtgct gaatgagacc ctgtgtccca cctgggacca gatgctggtg 360
ttcgacaacc tggagctcta tggtgaagct catgagctga gggacgatcc gcccatcatt 420
gtcattgaaa tctatgacca ggattccatg ggcaaagctg acttcatggg ccggaccttc 480
gccaaacccc tggtgaagat ggcagacgag gcgtactgcc caccccgctt cccacctcag 540
ctcgagtact accagatcta ccgtggcaac gccacagctg gagacctgct ggcggccttc 600
gagctgctgc agattggacc agcagggaag gctgacctgc cccccatcaa tggcccggtg 660
gacgtggacc gaggtcccat catgcccgtg cccatgggca tccggcccgt gctcagcaag 720
taccgagtgg aggtgctgtt ctggggccta cgggacctaa agcgggtgaa cctggcccag 780
gtggaccggc cacgggtgga catcgagtgt gcagggaagg gggtgcagtc gtccctgatc 840
cacaattata agaagaaccc caacttcaac accctcgtca agtggtttga agtggacctc 900
ccagagaacg agctgctgca cccgcccttg aacatccgtg tggtggactg ccgggccttc 960
ggtcgctaca cactggtggg ctcccatgcc gtcagctccc tgcgacgctt catctaccgg 1020
cccccagacc gctcggcccc cagctggaac accacggtca ggcttctccg gcgctgccgt 1080
gtgctgtgca atgggggctc ctcctctcac tccacagggg aggttgtggt gactatggag 1140
ccagaggtac ccatcaagaa actggagacc atggtgaagc tggacgcgac ttctgaagct 1200
gttgtcaagg tggatgtggc tgaggaggag aaggagaaga agaagaagaa gaagggcact 1260
gcggaggagc cagaggagga ggagccagac gagagcatgc tggactggtg gtccaagtac 1320
tttgcctcca ttgacaccat gaaggagcaa cttcgacaac aagagccctc tggaattgac 1380
ttggaggaga aggaggaagt ggacaatacc gagggcctga aggggtcaat gaagggcaag 1440
gagaaggcaa gggctgccaa agaggagaag aagaagaaaa ctcagagctc tggctctggc 1500
caggggtccg aggcccccga gaagaagaaa cccaagattg atgagcttaa ggtatacccc 1560
aaagagctgg agtccgagtt tgataacttt gaggactggc tgcacacttt caacttgctt 1620
cggggcaaga ccggggatga tgaggatggc tccaccgagg aggagcgcat tgtgggacgc 1680
ttcaagggct ccctctgcgt gtacaaagtg ccactcccag aggacgtgtc ccgggaagcc 1740
ggctacgact ccacctacgg catgttccag ggcatcccga gcaatgaccc catcaatgtg 1800
ctggtccgag tctatgtggt ccgggccacg gacctgcacc ctgctgacat caacggcaaa 1860
gctgacccct acatcgccat ccggctaggc aagactgaca tccgcgacaa ggagaactac 1920
atctccaagc agctcaaccc tgtctttggg aagtcctttg acatcgaggc ctccttcccc 1980
atggaatcca tgctgacggt ggctgtgtat gactgggacc tggtgggcac tgatgacctc 2040
attggggaaa ccaagatcga cctggagaac cgcttctaca gcaagcaccg cgccacctgc 2100
ggcatcgccc agacctactc cacacatggc tacaatatct ggcgggaccc catgaagccc 2160
agccagatcc tgacccgcct ctgcaaagac ggcaaagtgg acggccccca ctttgggccc 2220
cctgggagag tgaaggtggc caaccgcgtc ttcactgggc cctctgagat tgaggacgag 2280
aacggtcaga ggaagcccac agacgagcat gtggcgctgt tggccctgag gcactgggag 2340
gacatccccc gcgcaggctg ccgcctggtg ccagagcatg tggagacgag gccgctgctc 2400
aaccccgaca agccgggcat cgagcagggc cgcctggagc tgtgggtgga catgttcccc 2460
atggacatgc cagcccctgg gacgcctctg gacatctcac ctcggaagcc caagaagtac 2520
gagctgcggg tcatcatctg gaacacagat gaggtggtct tggaggacga cgacttcttc 2580
acaggggaga agtccagtga catcttcgtg agggggtggc tgaagggcca gcaggaggac 2640
aagcaggaca cagacgtcca ctaccactcc ctcactggcg agggcaactt caactggcgc 2700
tacctgttcc ccttcgacta cctggcggcg gaggagaaga tcgtcatctc caagaaggag 2760
tccatgttct cctgggacga gaccgagtac aagatccccg cgcggctcac cctgcagatc 2820
tgggatgcgg accacttctc cgctgacgac ttcctggggg ccatcgagct ggacctgaac 2880
cggttcccgc ggggcgcaaa gacagccaag cagtgcacca tggagatggc caccggggag 2940
gtggacgtgc ccctcgtgtc catcttcaag caaaagcgcg tcaaaggctg gtggcccctc 3000
ctggcccgca atgagaacga tgagtttgag ctcacgggca aggtggaggc tgagctgcat 3060
ttactgacag cagaggaggc agagaagaac ccagtgggcc tggcccgcaa tgaacctgac 3120
cccctagaga aacccaaccg gcccgacacg gccttcgtct ggttcctcaa ccctctcaag 3180
tccatcaagt acctcatctg cacccggtac aagtggctca tcatcaagat cgtgctggcg 3240
ctgttggggc tgctcatgtt ggggctcttc ctctacagcc tccctggcta catggtcaaa 3300
aagctccttg gggcatga 3318
<210> 24
<211> 1260
<212> PRT
<213> 智人
<400> 24
Met Met Thr Asp Thr Gln Asp Gly Pro Ser Glu Ser Ser Gln Ile Met
1 5 10 15
Arg Ser Leu Thr Pro Leu Ile Asn Arg Glu Glu Ala Phe Gly Glu Ala
20 25 30
Gly Glu Ala Gly Leu Trp Pro Ser Ile Thr His Thr Pro Asp Ser Gln
35 40 45
Glu Glu Gly Leu Asn Asp Ile Gln Glu Met Ile Lys Thr Glu Lys Ser
50 55 60
Tyr Pro Glu Arg Arg Leu Arg Gly Val Leu Glu Glu Leu Ser Cys Gly
65 70 75 80
Cys Cys Arg Phe Leu Ser Leu Ala Asp Lys Asp Gln Gly His Ser Ser
85 90 95
Arg Thr Arg Leu Asp Arg Glu Arg Leu Lys Ser Cys Met Arg Glu Leu
100 105 110
Glu Asn Met Gly Gln Gln Ala Arg Met Leu Arg Ala Gln Val Lys Arg
115 120 125
His Thr Val Arg Asp Lys Leu Arg Leu Cys Gln Asn Phe Leu Gln Lys
130 135 140
Leu Arg Phe Leu Ala Asp Glu Pro Gln His Ser Ile Pro Asp Ile Phe
145 150 155 160
Ile Trp Met Met Ser Asn Asn Lys Arg Val Ala Tyr Ala Arg Val Pro
165 170 175
Ser Lys Asp Leu Leu Phe Ser Ile Val Glu Glu Glu Thr Gly Lys Asp
180 185 190
Cys Ala Lys Val Lys Thr Leu Phe Leu Lys Leu Pro Gly Lys Arg Gly
195 200 205
Phe Gly Ser Ala Gly Trp Thr Val Gln Ala Lys Val Glu Leu Tyr Leu
210 215 220
Trp Leu Gly Leu Ser Lys Gln Arg Lys Glu Phe Leu Cys Gly Leu Pro
225 230 235 240
Cys Gly Phe Gln Glu Val Lys Ala Ala Gln Gly Leu Gly Leu His Ala
245 250 255
Phe Pro Pro Val Ser Leu Val Tyr Thr Lys Lys Gln Ala Phe Gln Leu
260 265 270
Arg Ala His Met Tyr Gln Ala Arg Ser Leu Phe Ala Ala Asp Ser Ser
275 280 285
Gly Leu Ser Asp Pro Phe Ala Arg Val Phe Phe Ile Asn Gln Ser Gln
290 295 300
Cys Thr Glu Val Leu Asn Glu Thr Leu Cys Pro Thr Trp Asp Gln Met
305 310 315 320
Leu Val Phe Asp Asn Leu Glu Leu Tyr Gly Glu Ala His Glu Leu Arg
325 330 335
Asp Asp Pro Pro Ile Ile Val Ile Glu Ile Tyr Asp Gln Asp Ser Met
340 345 350
Gly Lys Ala Asp Phe Met Gly Arg Thr Phe Ala Lys Pro Leu Val Lys
355 360 365
Met Ala Asp Glu Ala Tyr Cys Pro Pro Arg Phe Pro Pro Gln Leu Glu
370 375 380
Tyr Tyr Gln Ile Tyr Arg Gly Asn Ala Thr Ala Gly Asp Leu Leu Ala
385 390 395 400
Ala Phe Glu Leu Leu Gln Ile Gly Pro Ala Gly Lys Ala Asp Leu Pro
405 410 415
Pro Ile Asn Gly Pro Val Asp Val Asp Arg Gly Pro Ile Met Pro Val
420 425 430
Pro Met Gly Ile Arg Pro Val Leu Ser Lys Tyr Arg Val Glu Val Leu
435 440 445
Phe Trp Gly Leu Arg Asp Leu Lys Arg Val Asn Leu Ala Gln Val Asp
450 455 460
Arg Pro Arg Val Asp Ile Glu Cys Ala Gly Lys Gly Val Gln Ser Ser
465 470 475 480
Leu Ile His Asn Tyr Lys Lys Asn Pro Asn Phe Asn Thr Leu Val Lys
485 490 495
Trp Phe Glu Val Asp Leu Pro Glu Asn Glu Leu Leu His Pro Pro Leu
500 505 510
Asn Ile Arg Val Val Asp Cys Arg Ala Phe Gly Arg Tyr Thr Leu Val
515 520 525
Gly Ser His Ala Val Ser Ser Leu Arg Arg Phe Ile Tyr Arg Pro Pro
530 535 540
Asp Arg Ser Ala Pro Ser Trp Asn Thr Thr Val Arg Leu Leu Arg Arg
545 550 555 560
Cys Arg Val Leu Cys Asn Gly Gly Ser Ser Ser His Ser Thr Gly Glu
565 570 575
Val Val Val Thr Met Glu Pro Glu Val Pro Ile Lys Lys Leu Glu Thr
580 585 590
Met Val Lys Leu Asp Ala Thr Ser Glu Ala Val Val Lys Val Asp Val
595 600 605
Ala Glu Glu Glu Lys Glu Lys Lys Lys Lys Lys Lys Gly Thr Ala Glu
610 615 620
Glu Pro Glu Glu Glu Glu Pro Asp Glu Ser Met Leu Asp Trp Trp Ser
625 630 635 640
Lys Tyr Phe Ala Ser Ile Asp Thr Met Lys Glu Gln Leu Arg Gln Gln
645 650 655
Glu Pro Ser Gly Ile Asp Leu Glu Glu Lys Glu Glu Val Asp Asn Thr
660 665 670
Glu Gly Leu Lys Gly Ser Met Lys Gly Lys Glu Lys Ala Arg Ala Ala
675 680 685
Lys Glu Glu Lys Lys Lys Lys Thr Gln Ser Ser Gly Ser Gly Gln Gly
690 695 700
Ser Glu Ala Pro Glu Lys Lys Lys Pro Lys Ile Asp Glu Leu Lys Val
705 710 715 720
Tyr Pro Lys Glu Leu Glu Ser Glu Phe Asp Asn Phe Glu Asp Trp Leu
725 730 735
His Thr Phe Asn Leu Leu Arg Gly Lys Thr Gly Asp Asp Glu Asp Gly
740 745 750
Ser Thr Glu Glu Glu Arg Ile Val Gly Arg Phe Lys Gly Ser Leu Cys
755 760 765
Val Tyr Lys Val Pro Leu Pro Glu Asp Val Ser Arg Glu Ala Gly Tyr
770 775 780
Asp Ser Thr Tyr Gly Met Phe Gln Gly Ile Pro Ser Asn Asp Pro Ile
785 790 795 800
Asn Val Leu Val Arg Val Tyr Val Val Arg Ala Thr Asp Leu His Pro
805 810 815
Ala Asp Ile Asn Gly Lys Ala Asp Pro Tyr Ile Ala Ile Arg Leu Gly
820 825 830
Lys Thr Asp Ile Arg Asp Lys Glu Asn Tyr Ile Ser Lys Gln Leu Asn
835 840 845
Pro Val Phe Gly Lys Ser Phe Asp Ile Glu Ala Ser Phe Pro Met Glu
850 855 860
Ser Met Leu Thr Val Ala Val Tyr Asp Trp Asp Leu Val Gly Thr Asp
865 870 875 880
Asp Leu Ile Gly Glu Thr Lys Ile Asp Leu Glu Asn Arg Phe Tyr Ser
885 890 895
Lys His Arg Ala Thr Cys Gly Ile Ala Gln Thr Tyr Ser Thr His Gly
900 905 910
Tyr Asn Ile Trp Arg Asp Pro Met Lys Pro Ser Gln Ile Leu Thr Arg
915 920 925
Leu Cys Lys Asp Gly Lys Val Asp Gly Pro His Phe Gly Pro Pro Gly
930 935 940
Arg Val Lys Val Ala Asn Arg Val Phe Thr Gly Pro Ser Glu Ile Glu
945 950 955 960
Asp Glu Asn Gly Gln Arg Lys Pro Thr Asp Glu His Val Ala Leu Leu
965 970 975
Ala Leu Arg His Trp Glu Asp Ile Pro Arg Ala Gly Cys Arg Leu Val
980 985 990
Pro Glu His Val Glu Thr Arg Pro Leu Leu Asn Pro Asp Lys Pro Gly
995 1000 1005
Ile Glu Gln Gly Arg Leu Glu Leu Trp Val Asp Met Phe Pro Met
1010 1015 1020
Asp Met Pro Ala Pro Gly Thr Pro Leu Asp Ile Ser Pro Arg Lys
1025 1030 1035
Pro Lys Lys Tyr Glu Leu Arg Val Ile Ile Trp Asn Thr Asp Glu
1040 1045 1050
Val Val Leu Glu Asp Asp Asp Phe Phe Thr Gly Glu Lys Ser Ser
1055 1060 1065
Asp Ile Phe Val Arg Gly Trp Leu Lys Gly Gln Gln Glu Asp Lys
1070 1075 1080
Gln Asp Thr Asp Val His Tyr His Ser Leu Thr Gly Glu Gly Asn
1085 1090 1095
Phe Asn Trp Arg Tyr Leu Phe Pro Phe Asp Tyr Leu Ala Ala Glu
1100 1105 1110
Glu Lys Ile Val Ile Ser Lys Lys Glu Ser Met Phe Ser Trp Asp
1115 1120 1125
Glu Thr Glu Tyr Lys Ile Pro Ala Arg Leu Thr Leu Gln Ile Trp
1130 1135 1140
Asp Ala Asp His Phe Ser Ala Asp Asp Phe Leu Gly Ala Ile Glu
1145 1150 1155
Leu Asp Leu Asn Arg Phe Pro Arg Gly Ala Lys Thr Ala Lys Gln
1160 1165 1170
Cys Thr Met Glu Met Ala Thr Gly Glu Val Asp Val Pro Leu Val
1175 1180 1185
Ser Ile Phe Lys Gln Lys Arg Val Lys Gly Trp Trp Pro Leu Leu
1190 1195 1200
Ala Arg Asn Glu Asn Asp Glu Phe Glu Leu Thr Gly Lys Val Glu
1205 1210 1215
Ala Glu Leu His Leu Leu Thr Ala Glu Glu Ala Glu Lys Asn Pro
1220 1225 1230
Val Gly Leu Ala Arg Asn Glu Pro Asp Pro Leu Glu Lys Pro Asn
1235 1240 1245
Arg Pro Asp Thr Ser Phe Ile Trp Phe Leu Asn Pro
1250 1255 1260
Claims (12)
1.一种允许在内毛细胞中表达全长耳畸蛋白多肽或其功能片段的载体系统，其用于治疗患有DFNB9耳聋的患者、或在具有DFNB9突变的患者中预防DFNB9耳聋，其中所述患者是具有发育的和成熟的听觉系统的人，例如新生儿、幼儿、儿童、青少年或成人。
2.根据权利要求1所述用途的载体系统，其中所述耳畸蛋白多肽具有序列SEQ ID NO:1。
3.根据权利要求1所述用途的载体系统，其包含至少一种AAV颗粒，所述AAV颗粒包含编码全长耳畸蛋白多肽或其功能片段的多核苷酸。
4.根据权利要求1所述用途的载体系统，其包含至少两种AAV颗粒，它们中的每一种包含含有部分编码序列的多核苷酸，对于一种AAV颗粒，所述部分编码序列编码i)耳畸蛋白多肽或其功能片段的N末端部分，对于另一种AAV颗粒，所述部分编码序列编码ii)耳畸蛋白多肽或其功能片段的C末端部分。
5.根据权利要求1所述用途的载体系统，其包含至少两种AAV颗粒，每种所述AAV颗粒包含：
a)第一多核苷酸，其包含在所述多核苷酸的每个末端的反向末端重复，以及在所述反向末端重复之间从5'至3’的合适的启动子、之后是含有耳畸蛋白基因的N末端部分的部分编码序列、以及剪接供体位点，或
b)第二多核苷酸，其包含在所述多核苷酸的每个末端的反向末端重复，以及在所述反向末端重复之间的从5'至3’的剪接受体位点、含有耳畸蛋白基因的C末端部分的部分编码序列，之后任选的聚腺苷酸化序列，
其中所述第一和第二多核苷酸还含有引起重组的序列，其位于所述第一多核苷酸的剪接供体位点之后，所述第二多核苷酸的剪接受体位点之前，以及
其中当第一和第二多核苷酸结合时其中的编码序列编码全长耳畸蛋白多肽、或其功能片段。
6.根据权利要求5所述用途的载体系统，其中所述耳畸蛋白基因具有序列SEQ ID NO:2。
7.根据权利要求5所述用途的载体系统，其中所述耳畸蛋白基因的N末端部分是SEQ IDNO:3，以及所述耳畸蛋白基因的C末端部分是SEQ ID NO:4。
8.根据权利要求3所述用途的载体系统，其中所述AAV颗粒是AAV2血清型。
9.根据权利要求1所述用途的载体系统，其包含AAV2颗粒，其中通过将酪氨酸氨基酸残基取代成苯丙氨酸氨基酸残基对衣壳进行修饰。
10.根据权利要求1所述用途的载体系统，其中所述人患者在语言习得之后被诊断患有DFNB9耳聋。
11.根据权利要求1所述用途的载体系统，其中所述患者是患有由热敏突变诱导的DFNB9耳聋的青少年或成人，所述热敏突变优选选自：P.Q994VfsX6、P.I515T、p.G541S、PR1607W、p.E1804del。
12.一种药物组合物，其包含根据权利要求1至9中任一项所述的载体系统以及药学上可接受的载剂，所述药物组合物用于治疗患有DFNB9耳聋的患者、或在具有DFNB9突变的患者中预防DFNB9耳聋，其中所述患者是具有发育的和成熟的听觉系统的人，例如新生儿、幼儿、儿童、青少年或成人。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19305071.3 | 2019-01-18 | ||
| EP19305071 | 2019-01-18 | ||
| PCT/EP2020/051283 WO2020148458A1 (en) | 2019-01-18 | 2020-01-20 | Aav-mediated gene therapy restoring the otoferlin gene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113924109A true CN113924109A (zh) | 2022-01-11 |
Family
ID=65351986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202080022300.3A Pending CN113924109A (zh) | 2019-01-18 | 2020-01-20 | Aav介导的基因疗法恢复耳畸蛋白基因 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20220125875A1 (zh) |
| EP (2) | EP3911354B8 (zh) |
| JP (1) | JP2022522996A (zh) |
| KR (1) | KR20210118112A (zh) |
| CN (1) | CN113924109A (zh) |
| AU (1) | AU2020208933A1 (zh) |
| BR (1) | BR112021013996A2 (zh) |
| CA (1) | CA3126884A1 (zh) |
| DK (1) | DK3911354T5 (zh) |
| ES (1) | ES2960880T3 (zh) |
| FI (1) | FI3911354T3 (zh) |
| HR (1) | HRP20231296T1 (zh) |
| HU (1) | HUE063458T2 (zh) |
| IL (1) | IL284742B2 (zh) |
| LT (1) | LT3911354T (zh) |
| MX (1) | MX2021008622A (zh) |
| PL (1) | PL3911354T3 (zh) |
| PT (1) | PT3911354T (zh) |
| RS (1) | RS64794B1 (zh) |
| SI (1) | SI3911354T1 (zh) |
| WO (1) | WO2020148458A1 (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116925239A (zh) * | 2023-07-17 | 2023-10-24 | 苏州星奥拓维生物技术有限公司 | 双载体系统表达Otof基因的组合物和方法 |
| WO2023221530A1 (zh) * | 2022-05-17 | 2023-11-23 | 复旦大学附属眼耳鼻喉科医院 | 一种治疗听力损伤的双载体系统及其应用 |
| CN117305367A (zh) * | 2023-08-21 | 2023-12-29 | 复旦大学附属眼耳鼻喉科医院 | 一种表达全长耳畸蛋白的双aav载体系统及其应用 |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11660353B2 (en) | 2018-04-27 | 2023-05-30 | Decibel Therapeutics, Inc. | Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems |
| AU2021225035A1 (en) | 2020-02-21 | 2022-10-13 | Akouos, Inc. | Compositions and methods for treating non-age-associated hearing impairment in a human subject |
| WO2022178298A1 (en) * | 2021-02-19 | 2022-08-25 | Decibel Therapeutics, Inc. | Methods for treating sensorineural hearing loss using otoferlin dual vector systems |
| KR20240053630A (ko) * | 2021-09-10 | 2024-04-24 | 앵스띠뛰 파스퇴르 | 오토페를린의 이소형 5를 인코딩하는 이중 재조합 aav8 벡터 시스템 및 이의 용도 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016520311A (ja) * | 2013-05-21 | 2016-07-14 | ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド | キャプシド修飾ｒＡＡＶ３ベクター組成物およびヒト肝がんの遺伝子治療における使用方法 |
| WO2018204734A1 (en) * | 2017-05-05 | 2018-11-08 | University Of Florida Research Foundation, Incorporated | Compositions and methods for expressing otoferlin |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2975413T3 (es) | 2001-12-17 | 2024-07-05 | Univ Pennsylvania | Secuencias de serotipo 8 de virus adenoasociado (AAV), vectores que las contienen y usos de las mismas |
| US6967018B2 (en) | 2002-01-11 | 2005-11-22 | Applied Genetic Technologies Corporation | Adiponectin gene therapy |
| WO2006036465A2 (en) | 2004-09-03 | 2006-04-06 | University Of Florida | Compositions and methods for treating cystic fibrosis |
| US8298818B2 (en) | 2006-04-28 | 2012-10-30 | University Of Florida Research Foundation, Inc. | Self-complementary adeno-associated virus having a truncated CMV-chicken β-actin promoter |
| WO2011075838A1 (en) | 2009-12-21 | 2011-06-30 | Audigen Inc. | Method of treating or preventing hearing loss |
| WO2013075008A1 (en) | 2011-11-16 | 2013-05-23 | University Of Florida Research Foundation Inc. | Aav dual vector systems for gene therapy |
| ES2903000T3 (es) * | 2015-12-11 | 2022-03-30 | Massachusetts Eye & Ear Infirmary | Materiales y métodos para administrar ácidos nucleicos a las células cocleares y vestibulares |
| CN110225975A (zh) | 2016-08-23 | 2019-09-10 | 阿库斯股份有限公司 | 用于治疗人受试者中非年龄相关的听力损害的组合物和方法 |
| EA202091995A1 (ru) | 2018-02-22 | 2021-03-30 | Акуос, Инк. | Композиции и способы лечения не связанного с возрастом нарушения слуха у субъекта-человека |
| US11660353B2 (en) * | 2018-04-27 | 2023-05-30 | Decibel Therapeutics, Inc. | Compositions and methods for treating sensorineural hearing loss using otoferlin dual vector systems |
| IL292620A (en) | 2019-10-30 | 2022-07-01 | Decibel Therapeutics Inc | Compounds and methods for use in dual vector autoperlin arrays for the treatment of structural hearing loss |
-
2020
- 2020-01-20 WO PCT/EP2020/051283 patent/WO2020148458A1/en active Application Filing
- 2020-01-20 DK DK20701951.4T patent/DK3911354T5/da active
- 2020-01-20 SI SI202030290T patent/SI3911354T1/sl unknown
- 2020-01-20 KR KR1020217026056A patent/KR20210118112A/ko active Search and Examination
- 2020-01-20 HU HUE20701951A patent/HUE063458T2/hu unknown
- 2020-01-20 CA CA3126884A patent/CA3126884A1/en active Pending
- 2020-01-20 CN CN202080022300.3A patent/CN113924109A/zh active Pending
- 2020-01-20 MX MX2021008622A patent/MX2021008622A/es unknown
- 2020-01-20 IL IL284742A patent/IL284742B2/en unknown
- 2020-01-20 ES ES20701951T patent/ES2960880T3/es active Active
- 2020-01-20 EP EP20701951.4A patent/EP3911354B8/en active Active
- 2020-01-20 EP EP23184106.5A patent/EP4295913A3/en active Pending
- 2020-01-20 BR BR112021013996-6A patent/BR112021013996A2/pt unknown
- 2020-01-20 RS RS20230958A patent/RS64794B1/sr unknown
- 2020-01-20 AU AU2020208933A patent/AU2020208933A1/en active Pending
- 2020-01-20 JP JP2021541524A patent/JP2022522996A/ja active Pending
- 2020-01-20 PT PT207019514T patent/PT3911354T/pt unknown
- 2020-01-20 LT LTEPPCT/EP2020/051283T patent/LT3911354T/lt unknown
- 2020-01-20 HR HRP20231296TT patent/HRP20231296T1/hr unknown
- 2020-01-20 FI FIEP20701951.4T patent/FI3911354T3/fi active
- 2020-01-20 PL PL20701951.4T patent/PL3911354T3/pl unknown
-
2021
- 2021-01-20 US US17/422,737 patent/US20220125875A1/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016520311A (ja) * | 2013-05-21 | 2016-07-14 | ユニバーシティ オブ フロリダ リサーチ ファンデーション インコーポレーティッド | キャプシド修飾ｒＡＡＶ３ベクター組成物およびヒト肝がんの遺伝子治療における使用方法 |
| WO2018204734A1 (en) * | 2017-05-05 | 2018-11-08 | University Of Florida Research Foundation, Incorporated | Compositions and methods for expressing otoferlin |
Non-Patent Citations (1)
| Title |
|---|
| QIUJING ZHANG等: ""Temperature sensitive auditory neuropathy"", HEARING RESEARCH, no. 335, pages 1 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023221530A1 (zh) * | 2022-05-17 | 2023-11-23 | 复旦大学附属眼耳鼻喉科医院 | 一种治疗听力损伤的双载体系统及其应用 |
| CN116925239A (zh) * | 2023-07-17 | 2023-10-24 | 苏州星奥拓维生物技术有限公司 | 双载体系统表达Otof基因的组合物和方法 |
| CN117305367A (zh) * | 2023-08-21 | 2023-12-29 | 复旦大学附属眼耳鼻喉科医院 | 一种表达全长耳畸蛋白的双aav载体系统及其应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2020208933A1 (en) | 2021-07-29 |
| PT3911354T (pt) | 2023-10-24 |
| CA3126884A1 (en) | 2020-07-23 |
| SI3911354T1 (sl) | 2023-12-29 |
| HUE063458T2 (hu) | 2024-01-28 |
| LT3911354T (lt) | 2023-11-27 |
| FI3911354T3 (fi) | 2023-10-17 |
| MX2021008622A (es) | 2021-12-15 |
| IL284742B2 (en) | 2024-06-01 |
| WO2020148458A1 (en) | 2020-07-23 |
| EP4295913A2 (en) | 2023-12-27 |
| KR20210118112A (ko) | 2021-09-29 |
| EP4295913A3 (en) | 2024-03-06 |
| IL284742B1 (en) | 2024-02-01 |
| BR112021013996A2 (pt) | 2021-10-26 |
| RS64794B1 (sr) | 2023-11-30 |
| ES2960880T3 (es) | 2024-03-07 |
| IL284742A (en) | 2021-08-31 |
| DK3911354T5 (da) | 2024-08-05 |
| JP2022522996A (ja) | 2022-04-21 |
| EP3911354A1 (en) | 2021-11-24 |
| HRP20231296T1 (hr) | 2024-02-16 |
| EP3911354B1 (en) | 2023-07-19 |
| AU2020208933A8 (en) | 2021-08-26 |
| PL3911354T3 (pl) | 2024-03-11 |
| EP3911354B8 (en) | 2024-04-03 |
| US20220125875A1 (en) | 2022-04-28 |
| DK3911354T3 (da) | 2023-10-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102606810B1 (ko) | 오토펄린을 발현시키기 위한 조성물 및 방법 | |
| CN113924109A (zh) | Aav介导的基因疗法恢复耳畸蛋白基因 | |
| KR102446169B1 (ko) | 리소좀 저장 장애의 치료를 위한 아데노연관 바이러스 벡터 | |
| ES2819976T3 (es) | Composiciones y usos médicos para la reprogramación de TCR con proteínas de fusión | |
| CN109863243B (zh) | 用于治疗粘多糖症的腺相关病毒载体 | |
| JP4843663B2 (ja) | 神経系の細胞へのｄｎａのａａｖ仲介送達 | |
| CA2462455C (en) | Development of a preventive vaccine for filovirus infection in primates | |
| KR20180048743A (ko) | 2a 펩타이드를 포함하는 재조합 벡터 | |
| PT2048955E (pt) | Administração de gene alvo para vacinação de células dendríticas | |
| AU2016378480A1 (en) | Endothelium-specific nucleic acid regulatory elements and methods and use thereof | |
| KR20210150486A (ko) | 리소좀 장애에 대한 유전자 요법 | |
| KR20230066360A (ko) | 신경퇴행성 장애를 위한 유전자 요법 | |
| KR20110126586A (ko) | 단일 재조합 계 및 그의 사용 방법 | |
| KR20230019063A (ko) | C9orf72 연관 질환의 치료를 위한 삼중 기능 아데노-연관 바이러스 (aav) 벡터 | |
| KR20230054840A (ko) | rAAV 비리온의 유도 생산을 위한 안정화된 세포주 | |
| KR20220016485A (ko) | 미엘린 단백질 제로 프로모터를 갖는 aav 벡터, 및 샤르코-마리-투스 질환과 같은 슈반 세포-관련 질환을 치료하기 위한 이의 용도 | |
| KR20200104343A (ko) | 라싸 백신 | |
| KR20240021906A (ko) | 발현 벡터, 박테리아 서열-무함유 벡터, 및 이를 제조하고 사용하는 방법 | |
| CN117881788A (zh) | 表达载体、无细菌序列载体及其制备和使用方法 | |
| KR102346159B1 (ko) | 고효율 발현 벡터 및 이의 용도 | |
| CN114364792B (zh) | 溶瘤牛痘病毒 | |
| KR20240023100A (ko) | 유전자 발현을 조절하기 위한 조성물 및 방법 | |
| JP2003250579A (ja) | 細胞特異的発現複製ベクター | |
| CN114025806A (zh) | 用于溶酶体障碍的基因疗法 | |
| CN113677800A (zh) | 包含用于结合结构域和可分泌肽的基因的重组载体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |